{"sentText": "At 4 hours losartan blocked 43 of the Ang II induced systolic blood pressure increase valsartan 51 and irbesartan 88 P001 between drugs", "relationMentions": [{"em1Text": "Ang II", "em2Text": "valsartan", "label": "CPR:4"}, {"em1Text": "Ang II", "em2Text": "irbesartan", "label": "CPR:4"}]}
{"sentText": "This study thus demonstrates that the first administration of the recommended starting dose of irbesartan induces a greater and longer lasting Ang II receptor blockade than that of valsartan and losartan in normotensive subjects", "relationMentions": [{"em1Text": "irbesartan", "em2Text": "Ang II receptor", "label": "CPR:4"}, {"em1Text": "Ang II receptor", "em2Text": "valsartan", "label": "CPR:4"}, {"em1Text": "Ang II receptor", "em2Text": "losartan", "label": "CPR:4"}]}
{"sentText": "In humans prolonged administration of the beta 2adrenoceptor agonist terbutaline leads to a desensitization of beta 2adrenoceptormediated cardiovascular responses which can be blunted by concomitant administration of the antianaphylactic drug ketotifen", "relationMentions": [{"em1Text": "beta 2adrenoceptor", "em2Text": "terbutaline", "label": "CPR:5"}]}
{"sentText": "beta 2Adrenoceptor cardiovascular function was assessed by the increase in heart rate and reduction of diastolic blood pressure induced by an incremental intravenous infusion of the unselective betaadrenoceptor agonist isoprenaline beta 1adrenoceptor cardiovascular function was assessed by exerciseinduced tachycardia", "relationMentions": [{"em1Text": "betaadrenoceptor", "em2Text": "isoprenaline", "label": "CPR:5"}]}
{"sentText": "OBJECTIVES This study examined the effect of a smallmolecule direct thrombin inhibitor argatroban on reperfusion induced by tissue plasminogen activator TPA in patients with acute myocardial infarction AMI", "relationMentions": [{"em1Text": "thrombin", "em2Text": "argatroban", "label": "CPR:4"}]}
{"sentText": "In vitro and in vivo studies have shown that argatroban has advantages over heparin for the inhibition of clotbound thrombin and for the enhancement of thrombolysis with TPA", "relationMentions": [{"em1Text": "argatroban", "em2Text": "thrombin", "label": "CPR:4"}]}
{"sentText": "At clinically relevant concentrations candesartan is an insurmountable and longlasting antagonist of the vascular contractile responses to Ang II", "relationMentions": [{"em1Text": "candesartan", "em2Text": "Ang II", "label": "CPR:4"}]}
{"sentText": "In both vascular preparations candesartan caused a marked decrease in the maximal contractile response of the angiotensin II Ang II concentrationresponse curve", "relationMentions": [{"em1Text": "candesartan", "em2Text": "angiotensin II", "label": "CPR:4"}, {"em1Text": "candesartan", "em2Text": "Ang II", "label": "CPR:4"}]}
{"sentText": "The functional inhibitory characteristics of the angiotensin II type 1 receptor blockers ARB candesartan irbesartan and losartan and its active metabolite EXP 3174 EXP were studied in rabbit aortic strips and rat portal vein preparations in vitro", "relationMentions": [{"em1Text": "angiotensin II type 1 receptor", "em2Text": "irbesartan", "label": "CPR:4"}, {"em1Text": "angiotensin II type 1 receptor", "em2Text": "candesartan", "label": "CPR:4"}, {"em1Text": "angiotensin II type 1 receptor", "em2Text": "losartan", "label": "CPR:4"}, {"em1Text": "angiotensin II type 1 receptor", "em2Text": "EXP 3174", "label": "CPR:4"}, {"em1Text": "angiotensin II type 1 receptor", "em2Text": "EXP", "label": "CPR:4"}]}
{"sentText": "In addition when candesartan was given to conscious rats the inhibitory effect on Ang II induced blood pressure responses persisted during the 24hour period despite nondetectable plasma concentrations of candesartan at 24 hours", "relationMentions": [{"em1Text": "candesartan", "em2Text": "Ang II", "label": "CPR:4"}]}
{"sentText": "Dosedependent inhibition of platelet cyclooxygenase1 and monocyte cyclooxygenase2 by meloxicam in healthy subjects", "relationMentions": [{"em1Text": "cyclooxygenase1", "em2Text": "meloxicam", "label": "CPR:4"}, {"em1Text": "cyclooxygenase2", "em2Text": "meloxicam", "label": "CPR:4"}]}
{"sentText": "In contrast the administration of 75 and 15 mg of meloxicam caused dosedependent reductions in monocyte COX2 activity by 51 and 70 respectively and in platelet COX1 activity by 25 and 35 respectively", "relationMentions": [{"em1Text": "meloxicam", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "meloxicam", "em2Text": "COX1", "label": "CPR:4"}]}
{"sentText": "Although the IC50 value of meloxicam for inhibition of COX1 was 10fold higher than the IC50 value of COX2 in vitro this biochemical selectivity was inadequate to clearly separate the effects of meloxicam on the two isozymes after oral dosing as a function of the daily dose and interindividual variation in steadystate plasma levels", "relationMentions": [{"em1Text": "meloxicam", "em2Text": "COX1", "label": "CPR:4"}, {"em1Text": "meloxicam", "em2Text": "COX2", "label": "CPR:4"}]}
{"sentText": "Concentrationresponse curves for the inhibition of monocyte COX2 and platelet COX1 were obtained in vitro after the incubation of meloxicam with whole blood samples", "relationMentions": [{"em1Text": "COX2", "em2Text": "meloxicam", "label": "CPR:4"}, {"em1Text": "COX1", "em2Text": "meloxicam", "label": "CPR:4"}]}
{"sentText": "Before dosing and 24 h after the seventh dose of each regimen heparinized whole blood samples were incubated with lipopolysaccharide 10 microgramml for 24 h at 37 degrees C and prostaglandin E2 was measured in plasma as an index of monocyte COX2 activity", "relationMentions": [{"em1Text": "prostaglandin E2", "em2Text": "COX2", "label": "CPR:9"}]}
{"sentText": "The production of thromboxane B2 in whole blood allowed to clot at 37 degrees C for 60 min was assessed as an index of platelet COX1 activity", "relationMentions": [{"em1Text": "thromboxane B2", "em2Text": "COX1", "label": "CPR:9"}]}
{"sentText": "In distinction the preferential beta 1AR antagonist betaxolol and the preferential beta 2AR antagonist ICI118551 did not increase basal levels of DA NAD or 5HT", "relationMentions": [{"em1Text": "beta 1AR", "em2Text": "betaxolol", "label": "CPR:6"}, {"em1Text": "beta 2AR", "em2Text": "ICI118551", "label": "CPR:6"}]}
{"sentText": "The selective 5HT1A receptor antagonist WAY100635 slightly attenuated the pindololinduced increase in DA and NAD levels while the selective 5HT1B antagonist SB224289 was ineffective", "relationMentions": [{"em1Text": "5HT1A", "em2Text": "WAY100635", "label": "CPR:6"}, {"em1Text": "5HT1B", "em2Text": "SB224289", "label": "CPR:6"}]}
{"sentText": "UNLABELLED Entacapone is a potent and specific peripheral catecholOmethyltransferase COMT inhibitor", "relationMentions": [{"em1Text": "Entacapone", "em2Text": "catecholOmethyltransferase", "label": "CPR:4"}, {"em1Text": "Entacapone", "em2Text": "COMT", "label": "CPR:4"}]}
{"sentText": "We found that 5HT stimulated the conversion of 3HLarginine 3HLArg to 3HLCit indicating eNOS activation", "relationMentions": [{"em1Text": "5HT", "em2Text": "eNOS", "label": "CPR:3"}, {"em1Text": "3HLarginine", "em2Text": "eNOS", "label": "CPR:9"}, {"em1Text": "3HLArg", "em2Text": "eNOS", "label": "CPR:9"}, {"em1Text": "3HLCit", "em2Text": "eNOS", "label": "CPR:9"}]}
{"sentText": "5hydroxytryptamine evokes endothelial nitric oxide synthase activation in bovine aortic endothelial cell cultures", "relationMentions": [{"em1Text": "5hydroxytryptamine", "em2Text": "endothelial nitric oxide synthase", "label": "CPR:3"}]}
{"sentText": "These findings lend evidence of a 5HT 1B receptoreNOS pathway accounting in part for the activation of eNOS by 5HT", "relationMentions": [{"em1Text": "5HT", "em2Text": "eNOS", "label": "CPR:3"}]}
{"sentText": "The high affinity 5HT1B receptor agonist 5nonyloxytryptamine 5NOTstimulated 3HLCit turnover responses were concentration001 nM to 100 microM and timedependent", "relationMentions": [{"em1Text": "5HT1B", "em2Text": "5nonyloxytryptamine", "label": "CPR:5"}]}
{"sentText": "These responses were effectively blocked by the 5HT1B receptor antagonist isamoltane the 5HT1B 5HT2 receptor antagonist methiothepin and the eNOS selective antagonists 00110 microM LNomega monomethylLarginine LNMMA and LN omegaiminoethylLornithine LNIO", "relationMentions": [{"em1Text": "eNOS", "em2Text": "LNomega monomethylLarginine", "label": "CPR:6"}, {"em1Text": "5HT1B", "em2Text": "methiothepin", "label": "CPR:6"}, {"em1Text": "5HT2 receptor", "em2Text": "methiothepin", "label": "CPR:6"}, {"em1Text": "eNOS", "em2Text": "LNMMA", "label": "CPR:6"}, {"em1Text": "eNOS", "em2Text": "LN omegaiminoethylLornithine", "label": "CPR:6"}, {"em1Text": "eNOS", "em2Text": "LNIO", "label": "CPR:6"}]}
{"sentText": "Here we tested the hypothesis that 5HT receptors mediate eNOS activation by measuring agoniststimulated 3HLcitrulline 3HLCit formation in BAEC cultures", "relationMentions": [{"em1Text": "eNOS", "em2Text": "3HLcitrulline", "label": "CPR:9"}, {"em1Text": "eNOS", "em2Text": "3HLCit", "label": "CPR:9"}]}
{"sentText": "Activation of endothelial nitric oxide synthase eNOS results in the production of nitric oxide NO that mediates the vasorelaxing properties of endothelial cells", "relationMentions": [{"em1Text": "endothelial nitric oxide synthase", "em2Text": "nitric oxide", "label": "CPR:9"}, {"em1Text": "nitric oxide", "em2Text": "eNOS", "label": "CPR:9"}, {"em1Text": "endothelial nitric oxide synthase", "em2Text": "NO", "label": "CPR:9"}, {"em1Text": "eNOS", "em2Text": "NO", "label": "CPR:9"}]}
{"sentText": "We report that the radiationinduced activation of the kinase Cds1 4 also known as Chk2 5 is inhibited by caffeine in vivo and that ATM kinase activity is directly inhibited by caffeine in vitro", "relationMentions": [{"em1Text": "caffeine", "em2Text": "ATM", "label": "CPR:4"}, {"em1Text": "kinase", "em2Text": "caffeine", "label": "CPR:4"}, {"em1Text": "kinase", "em2Text": "caffeine", "label": "CPR:4"}, {"em1Text": "Cds1", "em2Text": "caffeine", "label": "CPR:4"}, {"em1Text": "Chk2", "em2Text": "caffeine", "label": "CPR:4"}]}
{"sentText": "Inhibition of ATM provides a molecular explanation of the attenuation of DNAdamage checkpoint responses and for the increased radiosensitivity of caffeine treated cells 6 7 8", "relationMentions": [{"em1Text": "ATM", "em2Text": "caffeine", "label": "CPR:4"}]}
{"sentText": "Caffeine inhibits the checkpoint kinase ATM", "relationMentions": [{"em1Text": "Caffeine", "em2Text": "kinase", "label": "CPR:4"}, {"em1Text": "Caffeine", "em2Text": "ATM", "label": "CPR:4"}]}
{"sentText": "The turnover of SERT was determined from the rate of recovery of binding after administration of RTI76 an irreversible inhibitor of ligand binding", "relationMentions": [{"em1Text": "SERT", "em2Text": "RTI76", "label": "CPR:4"}]}
{"sentText": "In preliminary studies in vitro incubation of rat cerebral cortex with RTI76 produced a wash and temperature resistant inhibition of SERT binding densities Bmax", "relationMentions": [{"em1Text": "RTI76", "em2Text": "SERT", "label": "CPR:4"}]}
{"sentText": "Citalopram protected against the RTI76 induced inhibition of SERT binding", "relationMentions": [{"em1Text": "RTI76", "em2Text": "SERT", "label": "CPR:4"}]}
{"sentText": "The decrease and recovery of 3H5HT uptake correlated highly r = 093 with the recovery of SERT binding", "relationMentions": [{"em1Text": "3H5HT", "em2Text": "SERT", "label": "CPR:9"}]}
{"sentText": "The mode of functional AT1 receptor antagonism has been characterized as surmountablenoncompetitive losartan tasosartan eprosartan or insurmountablenoncompetitive candesartan saprisartan zolasartan irbesartan valsartan telmisartan E3174", "relationMentions": [{"em1Text": "AT1", "em2Text": "saprisartan", "label": "CPR:6"}, {"em1Text": "AT1", "em2Text": "zolasartan", "label": "CPR:6"}, {"em1Text": "AT1", "em2Text": "irbesartan", "label": "CPR:6"}, {"em1Text": "AT1", "em2Text": "valsartan", "label": "CPR:6"}, {"em1Text": "AT1", "em2Text": "telmisartan", "label": "CPR:6"}, {"em1Text": "AT1", "em2Text": "E3174", "label": "CPR:6"}, {"em1Text": "AT1", "em2Text": "losartan", "label": "CPR:6"}, {"em1Text": "AT1", "em2Text": "tasosartan", "label": "CPR:6"}, {"em1Text": "AT1", "em2Text": "eprosartan", "label": "CPR:6"}, {"em1Text": "AT1", "em2Text": "candesartan", "label": "CPR:6"}]}
{"sentText": "Among the current AT1 receptor antagonists the rank order of the relative binding affinities highest affinity = 1 is candesartan 1 telmisartan 10 E3174 the active metabolite of losartan 10 tasosartan 20 losartan 50 eprosartan 100 and the prodrug candesartan cilexetil 280", "relationMentions": [{"em1Text": "AT1", "em2Text": "losartan", "label": "CPR:6"}, {"em1Text": "AT1", "em2Text": "tasosartan", "label": "CPR:6"}, {"em1Text": "AT1", "em2Text": "candesartan", "label": "CPR:6"}, {"em1Text": "AT1", "em2Text": "telmisartan", "label": "CPR:6"}, {"em1Text": "AT1", "em2Text": "E3174", "label": "CPR:6"}, {"em1Text": "AT1", "em2Text": "losartan", "label": "CPR:6"}, {"em1Text": "AT1", "em2Text": "eprosartan", "label": "CPR:6"}, {"em1Text": "AT1", "em2Text": "candesartan cilexetil", "label": "CPR:6"}]}
{"sentText": "Losartan was the first but by no means remained the only AT1 receptor antagonist", "relationMentions": [{"em1Text": "Losartan", "em2Text": "AT1", "label": "CPR:6"}]}
{"sentText": "The mNQO activity was insensitive to dicoumarol a potent inhibitor of cytosolic NQO1", "relationMentions": [{"em1Text": "dicoumarol", "em2Text": "NQO1", "label": "CPR:4"}]}
{"sentText": "A role of cytosolic NQO1 in protection of cells from oxidative stress cytotoxicity and mutagenicity of quinones was established", "relationMentions": [{"em1Text": "NQO1", "em2Text": "quinones", "label": "CPR:9"}]}
{"sentText": "The mNQO activity showed significantly higher affinity for NADH than NADPH as electron donors and catalyzed reduction of 26dichlorophenolindophenol and menadione", "relationMentions": [{"em1Text": "mNQO", "em2Text": "26dichlorophenolindophenol", "label": "CPR:9"}, {"em1Text": "mNQO", "em2Text": "menadione", "label": "CPR:9"}]}
{"sentText": "Quinone oxidoreductases are flavoproteins that catalyze twoelectron reduction and detoxification of quinones", "relationMentions": [{"em1Text": "Quinone oxidoreductases", "em2Text": "quinones", "label": "CPR:9"}]}
{"sentText": "The related piperidines ohmefentanyl and sufentanil and the nonselective opioid receptor agonist etorphine were less potent nociceptin receptor agonists", "relationMentions": [{"em1Text": "sufentanil", "em2Text": "nociceptin receptor", "label": "CPR:5"}, {"em1Text": "opioid receptor", "em2Text": "etorphine", "label": "CPR:5"}, {"em1Text": "etorphine", "em2Text": "nociceptin receptor", "label": "CPR:5"}, {"em1Text": "piperidines", "em2Text": "nociceptin receptor", "label": "CPR:5"}, {"em1Text": "ohmefentanyl", "em2Text": "nociceptin receptor", "label": "CPR:5"}]}
{"sentText": "The nonselective opioid receptor partial agonist buprenorphine and the nonselective opioid receptor antagonist quadazocine exhibited pure antagonism at rat brain receptors but displayed partial agonism at human ORL1 receptors", "relationMentions": [{"em1Text": "opioid receptor", "em2Text": "buprenorphine", "label": "CPR:5"}, {"em1Text": "quadazocine", "em2Text": "human ORL1", "label": "CPR:5"}, {"em1Text": "opioid receptor", "em2Text": "quadazocine", "label": "CPR:6"}]}
{"sentText": "The muopioid receptor selective agonist lofentanil potently and competitively displaced 3Hnociceptin at rat brain receptors IC50 62 nM", "relationMentions": [{"em1Text": "muopioid receptor", "em2Text": "lofentanil", "label": "CPR:5"}]}
{"sentText": "Lofentanil exhibited full agonism for enhancement of 35SGTPgammaS binding to human recombinant ORL1 receptors EC50 50 nM", "relationMentions": [{"em1Text": "Lofentanil", "em2Text": "ORL1", "label": "CPR:5"}]}
{"sentText": "The kappa1kappa3opioid receptor agonist muopioid receptor antagonist naloxone benzoylhydrazone was a pure antagonist at both rat brain and human ORL1 receptors", "relationMentions": [{"em1Text": "naloxone benzoylhydrazone", "em2Text": "ORL1", "label": "CPR:6"}, {"em1Text": "muopioid receptor", "em2Text": "naloxone benzoylhydrazone", "label": "CPR:6"}]}
{"sentText": "Thirtyweek administration of UFT with or without leucovorin markedly suppressed both colorectal carcinogenesis and tumor growth resulted in the increase of thymidylate synthase inhibition and the decrease of thymidine kinase activity in the tumor cells", "relationMentions": [{"em1Text": "UFT", "em2Text": "thymidylate synthase", "label": "CPR:4"}, {"em1Text": "UFT", "em2Text": "thymidine kinase", "label": "CPR:4"}, {"em1Text": "leucovorin", "em2Text": "thymidylate synthase", "label": "CPR:4"}, {"em1Text": "leucovorin", "em2Text": "thymidine kinase", "label": "CPR:4"}]}
{"sentText": "Thymidylate synthase is inhibited by 5fluorodeoxyuridine monophosphate forming an inactive ternary complex with intracellular folate", "relationMentions": [{"em1Text": "Thymidylate synthase", "em2Text": "5fluorodeoxyuridine monophosphate", "label": "CPR:4"}]}
{"sentText": "Thymidylate synthase and thymidine kinase are key enzymes involved in the de novo and salvage pathways for pyrimidine nucleotide synthesis respectively", "relationMentions": [{"em1Text": "Thymidylate synthase", "em2Text": "pyrimidine nucleotide", "label": "CPR:9"}, {"em1Text": "thymidine kinase", "em2Text": "pyrimidine nucleotide", "label": "CPR:9"}]}
{"sentText": "Ornithine decarboxylase ODC catalyses the first step in the synthesis of the polyamines putrescine spermidine and spermine", "relationMentions": [{"em1Text": "ODC", "em2Text": "spermidine", "label": "CPR:9"}, {"em1Text": "Ornithine decarboxylase", "em2Text": "spermidine", "label": "CPR:9"}, {"em1Text": "ODC", "em2Text": "spermine", "label": "CPR:9"}, {"em1Text": "Ornithine decarboxylase", "em2Text": "spermine", "label": "CPR:9"}, {"em1Text": "ODC", "em2Text": "putrescine", "label": "CPR:9"}, {"em1Text": "Ornithine decarboxylase", "em2Text": "putrescine", "label": "CPR:9"}]}
{"sentText": "In alpha2Aadrenoceptor transfected cells the rank order of agonist potency was A54741 mean pEC50=896 dexmedetomidine 888 UK14304 842 BHT 920 705 noradrenaline 692", "relationMentions": [{"em1Text": "alpha2Aadrenoceptor", "em2Text": "A54741", "label": "CPR:5"}, {"em1Text": "alpha2Aadrenoceptor", "em2Text": "dexmedetomidine", "label": "CPR:5"}, {"em1Text": "alpha2Aadrenoceptor", "em2Text": "UK14304", "label": "CPR:5"}, {"em1Text": "alpha2Aadrenoceptor", "em2Text": "BHT 920", "label": "CPR:5"}, {"em1Text": "alpha2Aadrenoceptor", "em2Text": "noradrenaline", "label": "CPR:5"}]}
{"sentText": "Glucocorticoid receptors were activated by dexamethasone as assessed using a glucocorticoidresponsive reporter plasmid pTAT3CAT", "relationMentions": [{"em1Text": "Glucocorticoid receptors", "em2Text": "dexamethasone", "label": "CPR:3"}]}
{"sentText": "The glucocorticoid receptor antagonist RU486 mifepristone significantly counteracted the effect of dexamethasone on glucocorticoid receptor activation indicating that the dexamethasone effect is specific and is mediated through the glucocorticoid receptor", "relationMentions": [{"em1Text": "glucocorticoid receptor", "em2Text": "RU486", "label": "CPR:6"}, {"em1Text": "glucocorticoid receptor", "em2Text": "mifepristone", "label": "CPR:6"}]}
{"sentText": "RESULTS Quetiapine was an effective antipsychotic and improved the extrapyramidal symptoms and prolactin level elevation noted at baseline", "relationMentions": [{"em1Text": "Quetiapine", "em2Text": "prolactin", "label": "CPR:3"}]}
{"sentText": "In a physiological K gradient TWIK2 is half inhibited by 01 mm Ba2 quinine and quinidine", "relationMentions": [{"em1Text": "TWIK2", "em2Text": "Ba2", "label": "CPR:4"}, {"em1Text": "TWIK2", "em2Text": "quinine", "label": "CPR:4"}, {"em1Text": "TWIK2", "em2Text": "quinidine", "label": "CPR:4"}]}
{"sentText": "Initial in vitro studies utilizing HEPG2 liver cells revealed that addition of eicosapentaenoic acid EPA blocked Delta5desaturase activity the terminal enzymatic step in AA synthesis", "relationMentions": [{"em1Text": "eicosapentaenoic acid", "em2Text": "Delta5desaturase", "label": "CPR:4"}, {"em1Text": "EPA", "em2Text": "Delta5desaturase", "label": "CPR:4"}]}
{"sentText": "BACKGROUND This study examines the effects of nicorandil a K channel opener on transmural dispersion of repolarization TDR and induction of torsade de pointes TdP under conditions mimicking the LQT1 LQT2 and LQT3 forms of the congenital longQT syndrome LQTS", "relationMentions": [{"em1Text": "nicorandil", "em2Text": "K channel", "label": "CPR:3"}]}
{"sentText": "Isoproterenol 50 to 100 nmolL was used to mimic an increase in betaadrenergic tone dsotalol 100 micromolL to block IKr LQT2 model and ATXII 20 nmolL to augment late INa LQT3 model", "relationMentions": [{"em1Text": "dsotalol", "em2Text": "IKr", "label": "CPR:4"}, {"em1Text": "dsotalol", "em2Text": "ATXII", "label": "CPR:4"}, {"em1Text": "Isoproterenol", "em2Text": "IKr", "label": "CPR:4"}, {"em1Text": "Isoproterenol", "em2Text": "ATXII", "label": "CPR:4"}]}
{"sentText": "Peroxisome proliferatoractivated receptor alpha PPARalpha activators bezafibrate and Wy14643 increase uncoupling protein3 mRNA levels without modifying the mitochondrial membrane potential in primary culture of rat preadipocytes", "relationMentions": [{"em1Text": "Peroxisome proliferatoractivated receptor alpha", "em2Text": "bezafibrate", "label": "CPR:3"}, {"em1Text": "bezafibrate", "em2Text": "uncoupling protein3", "label": "CPR:3"}, {"em1Text": "PPARalpha", "em2Text": "bezafibrate", "label": "CPR:3"}, {"em1Text": "Peroxisome proliferatoractivated receptor alpha", "em2Text": "Wy14643", "label": "CPR:3"}, {"em1Text": "Wy14643", "em2Text": "uncoupling protein3", "label": "CPR:3"}, {"em1Text": "PPARalpha", "em2Text": "Wy14643", "label": "CPR:3"}]}
{"sentText": "The induction in UCP3 expression was not accompanied by changes in the mitochondrial membrane potential of rat primary preadipocytes after bezafibrate or Wy14643 treatment", "relationMentions": [{"em1Text": "UCP3", "em2Text": "bezafibrate", "label": "CPR:3"}, {"em1Text": "UCP3", "em2Text": "Wy14643", "label": "CPR:3"}]}
{"sentText": "Since it has been proposed that UCP3 could be involved in the regulation of the use of fatty acids as fuel substrates the UCP3 induction achieved after bezafibrate and Wy14 643 treatment may indicate a higher oxidation of fatty acids limiting their availability to be stored as triglycerides", "relationMentions": [{"em1Text": "UCP3", "em2Text": "bezafibrate", "label": "CPR:3"}, {"em1Text": "UCP3", "em2Text": "Wy14 643", "label": "CPR:3"}]}
{"sentText": "Thus bezafibrate treatment resulted in an 8fold induction in UCP3 mRNA levels in preadipocytes compared with the 35fold induction observed in adipocytes", "relationMentions": [{"em1Text": "bezafibrate", "em2Text": "UCP3", "label": "CPR:3"}]}
{"sentText": "Uncoupling proteins UCPs are inner mitochondrial membrane transporters which act as pores for H ions dissipating the electrochemical gradient that develops during mitochondrial respiration at the expense of ATP synthesis", "relationMentions": [{"em1Text": "Uncoupling proteins", "em2Text": "H", "label": "CPR:9"}, {"em1Text": "UCPs", "em2Text": "H", "label": "CPR:9"}]}
{"sentText": "The ensemble of results suggests that the ability of Sch B pretreatment to enhance hepatocellular DTD activity may at least in part be attributed to the protection against menadione hepatotoxicity", "relationMentions": [{"em1Text": "Sch B", "em2Text": "DTD", "label": "CPR:3"}]}
{"sentText": "Schisandrin B protects against menadioneinduced hepatotoxicity by enhancing DTdiaphorase activity", "relationMentions": [{"em1Text": "Schisandrin B", "em2Text": "DTdiaphorase", "label": "CPR:3"}]}
{"sentText": "Hepatocytes isolated from Sch B pretreated a daily dose of 1 mmolkg for 3 days rats showed a significant increase 25 in DTD activity", "relationMentions": [{"em1Text": "Sch B", "em2Text": "DTD", "label": "CPR:3"}]}
{"sentText": "Pretreating mice with schisandrin B Sch B a dibenzocyclooctadiene derivative isolated from the fruit of Schisandra chinensis at a daily dose of 1 mmolkg for 3 days protected against menadione induced hepatic oxidative damage in mice as evidenced by decreases in plasma alanine aminotransferase activity 78 and hepatic malondialdehyde level 70 when compared with the menadione intoxicated control", "relationMentions": [{"em1Text": "menadione", "em2Text": "alanine aminotransferase", "label": "CPR:4"}]}
{"sentText": "Creatine phosphokinase activity in plasma increased slightly compared to control pyridostigmine or exercise group in mice treated with pyridostigmine plus exercise which may be indicative of perturbation in the integrity of the skeletal muscle due to combination", "relationMentions": [{"em1Text": "Creatine phosphokinase", "em2Text": "pyridostigmine", "label": "CPR:3"}, {"em1Text": "Creatine phosphokinase", "em2Text": "pyridostigmine", "label": "CPR:3"}]}
{"sentText": "The group treated with pyridostigmine alone showed decreased plasma butyrylcholinesterase BChE activity 87 of control whereas pyridostigmine plus exercise significantly decreased the BChE activity 79 of control indicating an interactive effect of the combination", "relationMentions": [{"em1Text": "pyridostigmine", "em2Text": "butyrylcholinesterase", "label": "CPR:4"}, {"em1Text": "pyridostigmine", "em2Text": "BChE", "label": "CPR:4"}, {"em1Text": "pyridostigmine", "em2Text": "BChE", "label": "CPR:4"}]}
{"sentText": "However AChE activity in triceps muscle decreased significantly 78 of control in the group treated with pyridostigmine plus exercise", "relationMentions": [{"em1Text": "AChE", "em2Text": "pyridostigmine", "label": "CPR:4"}]}
{"sentText": "RESULTS Buserelin acetate a GnRH agonist 0110 ngmL had no significant effect on MCP1 expression whereas danazol 107105 M a testosterone analog and dexamethasone an antiinflammatory glucocorticoid hormone 1012106M showed a direct and a dosedependent inhibitory effect on MCP1 expression", "relationMentions": [{"em1Text": "MCP1", "em2Text": "danazol", "label": "CPR:4"}, {"em1Text": "MCP1", "em2Text": "testosterone", "label": "CPR:4"}, {"em1Text": "MCP1", "em2Text": "dexamethasone", "label": "CPR:4"}, {"em1Text": "Buserelin acetate", "em2Text": "GnRH", "label": "CPR:5"}]}
{"sentText": "Mobility shift assays on whole cell extracts showed that clenbuterol increased AP1 binding in 3T3 cells prior to increasing NGF synthesis", "relationMentions": [{"em1Text": "clenbuterol", "em2Text": "NGF", "label": "CPR:3"}]}
{"sentText": "Clenbuterol was without effect on NGF mRNA levels in L929 cells whereas CB1093 caused significant increases in both NGF mRNA and protein levels in both 3T3 and L929 cells", "relationMentions": [{"em1Text": "NGF", "em2Text": "CB1093", "label": "CPR:3"}]}
{"sentText": "This study demonstrates that CB1093 and clenbuterol stimulate NGF levels in vitro and that AP1 binding could be a commonality between the mechanism of NGF induction of these two compounds", "relationMentions": [{"em1Text": "CB1093", "em2Text": "NGF", "label": "CPR:3"}, {"em1Text": "CB1093", "em2Text": "NGF", "label": "CPR:3"}, {"em1Text": "clenbuterol", "em2Text": "NGF", "label": "CPR:3"}, {"em1Text": "clenbuterol", "em2Text": "NGF", "label": "CPR:3"}]}
{"sentText": "The present studies were undertaken to compare two compounds a vitamin D3 analogue CB1093 with minimal calcaemic effects and clenbuterol a longacting beta2adrenoceptor agonist both of which induce NGF synthesis in vivo", "relationMentions": [{"em1Text": "CB1093", "em2Text": "NGF", "label": "CPR:3"}, {"em1Text": "clenbuterol", "em2Text": "NGF", "label": "CPR:3"}, {"em1Text": "vitamin D3", "em2Text": "NGF", "label": "CPR:4"}, {"em1Text": "clenbuterol", "em2Text": "beta2adrenoceptor", "label": "CPR:5"}]}
{"sentText": "Clenbuterol caused significant increases in both NGF mRNA and protein in 3T3 cells with maxima at 10 nM and at 812 h exposure", "relationMentions": [{"em1Text": "Clenbuterol", "em2Text": "NGF", "label": "CPR:3"}]}
{"sentText": "CONCLUSIONS After the initial bleach halothane impeded photon absorption by rhodopsin by inhibiting metabolic rhodopsin regeneration", "relationMentions": [{"em1Text": "halothane", "em2Text": "rhodopsin", "label": "CPR:4"}]}
{"sentText": "RESULTS Halothane anesthesia reversibly inhibited metabolic rhodopsin regeneration and thus prevented rhodopsin from absorbing high numbers of photons during light exposure", "relationMentions": [{"em1Text": "Halothane", "em2Text": "rhodopsin", "label": "CPR:4"}, {"em1Text": "Halothane", "em2Text": "rhodopsin", "label": "CPR:4"}]}
{"sentText": "Protective effect of halothane anesthesia on retinal light damage inhibition of metabolic rhodopsin regeneration", "relationMentions": [{"em1Text": "halothane", "em2Text": "rhodopsin", "label": "CPR:4"}]}
{"sentText": "METHODS Different classes of antidepressants imipramine tricyclic maprotiline noradrenline reuptake inhibitor venlafaxine mixed serotonin and noradrenaline reuptake inhibitors fluvoxamine and sertraline selective serotonin reuptake inhibitor were tested in the same randomised experimental session alone and in combination with 5HT1A and 5HT1B receptor agonists buspirone partial 5HT1A agonist anpirtoline 5HT1B agonist in the mouse forced swimming test", "relationMentions": [{"em1Text": "5HT1A", "em2Text": "buspirone", "label": "CPR:5"}, {"em1Text": "5HT1B", "em2Text": "anpirtoline", "label": "CPR:5"}]}
{"sentText": "Pemetrexed disodium Alimta LY231514 is a novel multitargeted antifolate that inhibits thymidylate synthase dihydrofolate reductase and glycinamide ribonucleotide formyl transferase", "relationMentions": [{"em1Text": "Pemetrexed disodium", "em2Text": "dihydrofolate reductase", "label": "CPR:4"}, {"em1Text": "Pemetrexed disodium", "em2Text": "glycinamide ribonucleotide formyl transferase", "label": "CPR:4"}, {"em1Text": "Pemetrexed disodium", "em2Text": "thymidylate synthase", "label": "CPR:4"}, {"em1Text": "Alimta", "em2Text": "dihydrofolate reductase", "label": "CPR:4"}, {"em1Text": "Alimta", "em2Text": "glycinamide ribonucleotide formyl transferase", "label": "CPR:4"}, {"em1Text": "Alimta", "em2Text": "thymidylate synthase", "label": "CPR:4"}, {"em1Text": "LY231514", "em2Text": "dihydrofolate reductase", "label": "CPR:4"}, {"em1Text": "LY231514", "em2Text": "glycinamide ribonucleotide formyl transferase", "label": "CPR:4"}, {"em1Text": "LY231514", "em2Text": "thymidylate synthase", "label": "CPR:4"}]}
{"sentText": "To mechanistically evaluate this regional selectivity we assessed cyclooxygenase2 COX2 expression in the uninvolved mucosa and demonstrated a 3 to 4fold excess in the distal relative to the proximal bowel in both MIN mice and AOM treated rats", "relationMentions": [{"em1Text": "cyclooxygenase2", "em2Text": "AOM", "label": "CPR:3"}, {"em1Text": "COX2", "em2Text": "AOM", "label": "CPR:3"}]}
{"sentText": "We took advantage of the previous observations that phosphatidylserine inhibits DGKdelta reviewed by Sakane F Imai S Kai M Wada I and Kanoh H 1996 J Biol", "relationMentions": [{"em1Text": "phosphatidylserine", "em2Text": "DGKdelta", "label": "CPR:4"}]}
{"sentText": "Diacylglycerol kinase DGK catalyzes the conversion of diacylglycerol to phosphatidic acid making it an attractive candidate for a signal transduction component", "relationMentions": [{"em1Text": "Diacylglycerol kinase", "em2Text": "diacylglycerol", "label": "CPR:9"}, {"em1Text": "DGK", "em2Text": "diacylglycerol", "label": "CPR:9"}, {"em1Text": "Diacylglycerol kinase", "em2Text": "phosphatidic acid", "label": "CPR:9"}, {"em1Text": "DGK", "em2Text": "phosphatidic acid", "label": "CPR:9"}]}
{"sentText": "Nordihydroguaiaretic acid NDGA has been shown to inhibit both 5lipoxygenase and ornithine decarboxylase and is active against several cancer cell lines and at least one mouse tumor model", "relationMentions": [{"em1Text": "Nordihydroguaiaretic acid", "em2Text": "ornithine decarboxylase", "label": "CPR:4"}, {"em1Text": "Nordihydroguaiaretic acid", "em2Text": "5lipoxygenase", "label": "CPR:4"}, {"em1Text": "NDGA", "em2Text": "ornithine decarboxylase", "label": "CPR:4"}, {"em1Text": "NDGA", "em2Text": "5lipoxygenase", "label": "CPR:4"}]}
{"sentText": "Carbonic anhydrase CA is a zinc enzyme that catalyses the reversible hydration reaction of CO2 and plays a major role in the acidbase balance", "relationMentions": [{"em1Text": "Carbonic anhydrase", "em2Text": "CO2", "label": "CPR:9"}, {"em1Text": "CA", "em2Text": "CO2", "label": "CPR:9"}]}
{"sentText": "The temporal profile of butyrylcholinesterase BuChE and in vitro pralidoxime reactivated BuChE was studied in a cohort of 25 organophosphatepoisoned patients to examine their relationship to the development of intermediate syndrome and to understand reasons for lack of efficacy of oxime treatment", "relationMentions": [{"em1Text": "BuChE", "em2Text": "pralidoxime", "label": "CPR:3"}]}
{"sentText": "Reactivation potentials of BuChE the difference between oxime reactivated and unreactivated enzyme activity declined significantly with time after organophosphate ingestion", "relationMentions": [{"em1Text": "BuChE", "em2Text": "oxime", "label": "CPR:3"}, {"em1Text": "BuChE", "em2Text": "organophosphate", "label": "CPR:4"}]}
{"sentText": "Patients who received oxime prior to hospitalization had a higher rate of intermediate syndrome and lower levels of BuChE at admission than those who had not", "relationMentions": [{"em1Text": "oxime", "em2Text": "BuChE", "label": "CPR:4"}]}
{"sentText": "CONCLUSIONS The alpha2adrenoceptor agonists brimonidine apraclonidine and oxymetazoline are potent vasoconstrictors in the porcine ciliary artery", "relationMentions": [{"em1Text": "alpha2adrenoceptor", "em2Text": "brimonidine", "label": "CPR:5"}, {"em1Text": "alpha2adrenoceptor", "em2Text": "apraclonidine", "label": "CPR:5"}, {"em1Text": "alpha2adrenoceptor", "em2Text": "oxymetazoline", "label": "CPR:5"}]}
{"sentText": "The segments were contracted with the alpha2adrenoceptor agonists brimonidine apraclonidine and oxymetazoline", "relationMentions": [{"em1Text": "alpha2adrenoceptor", "em2Text": "brimonidine", "label": "CPR:5"}, {"em1Text": "alpha2adrenoceptor", "em2Text": "apraclonidine", "label": "CPR:5"}, {"em1Text": "alpha2adrenoceptor", "em2Text": "oxymetazoline", "label": "CPR:5"}]}
{"sentText": "RESULTS The alpha2adrenoceptor agonists induced vasoconstriction in the porcine ciliary artery with the following potency order EC50 expressed in nanomolar brimonidine 211 oxymetazoline 526 and apraclonidine 130", "relationMentions": [{"em1Text": "alpha2adrenoceptor", "em2Text": "brimonidine", "label": "CPR:5"}, {"em1Text": "alpha2adrenoceptor", "em2Text": "oxymetazoline", "label": "CPR:5"}, {"em1Text": "alpha2adrenoceptor", "em2Text": "apraclonidine", "label": "CPR:5"}]}
{"sentText": "Schild analyses for the antagonists against brimonidine yielded regression lines with slopes of unity and functional antagonist potencies pKB for BRL44408 78 ARC 239 58 and for prazosin 60 suggesting the presence of functional alpha2Aadrenoceptors", "relationMentions": [{"em1Text": "BRL44408", "em2Text": "alpha2Aadrenoceptors", "label": "CPR:6"}, {"em1Text": "ARC 239", "em2Text": "alpha2Aadrenoceptors", "label": "CPR:6"}, {"em1Text": "prazosin", "em2Text": "alpha2Aadrenoceptors", "label": "CPR:6"}]}
{"sentText": "The following alpha2adrenoceptor antagonists were applied BRL44408 alpha2A selective ARC239 alpha2B and alpha2Cselective and prazosin alpha2B and alpha2C selective", "relationMentions": [{"em1Text": "BRL44408", "em2Text": "alpha2A", "label": "CPR:6"}, {"em1Text": "ARC239", "em2Text": "alpha2B", "label": "CPR:6"}, {"em1Text": "ARC239", "em2Text": "alpha2C", "label": "CPR:6"}, {"em1Text": "alpha2B", "em2Text": "prazosin", "label": "CPR:6"}, {"em1Text": "alpha2C", "em2Text": "prazosin", "label": "CPR:6"}]}
{"sentText": "Pemetrexed disodium ALIMTA is a novel antimetabolite that inhibits at least three folatedependent enzymes thymidylate synthase dihydrofolate reductase and glycinamide ribonucleotide formyltransferase", "relationMentions": [{"em1Text": "Pemetrexed disodium", "em2Text": "thymidylate synthase", "label": "CPR:4"}, {"em1Text": "Pemetrexed disodium", "em2Text": "dihydrofolate reductase", "label": "CPR:4"}, {"em1Text": "Pemetrexed disodium", "em2Text": "glycinamide ribonucleotide formyltransferase", "label": "CPR:4"}, {"em1Text": "ALIMTA", "em2Text": "thymidylate synthase", "label": "CPR:4"}, {"em1Text": "ALIMTA", "em2Text": "dihydrofolate reductase", "label": "CPR:4"}, {"em1Text": "ALIMTA", "em2Text": "glycinamide ribonucleotide formyltransferase", "label": "CPR:4"}]}
{"sentText": "DHFS is present exclusively in the mitochondria making this compartment the sole site of synthesis of dihydrofolate in the plant cell", "relationMentions": [{"em1Text": "DHFS", "em2Text": "dihydrofolate", "label": "CPR:9"}]}
{"sentText": "CONCLUSION Rabeprazole is a well tolerated proton pump inhibitor", "relationMentions": [{"em1Text": "Rabeprazole", "em2Text": "proton pump", "label": "CPR:4"}]}
{"sentText": "UNLABELLED Rabeprazole is an inhibitor of the gastric proton pump", "relationMentions": [{"em1Text": "Rabeprazole", "em2Text": "gastric proton pump", "label": "CPR:4"}]}
{"sentText": "At the same time mean plasma active renin was increased 16 and 34fold at the highest dose of Aliskiren", "relationMentions": [{"em1Text": "renin", "em2Text": "Aliskiren", "label": "CPR:3"}]}
{"sentText": "In conclusion the renin inhibitor Aliskiren dosedependently decreases Ang II levels in humans following oral administration", "relationMentions": [{"em1Text": "renin", "em2Text": "Aliskiren", "label": "CPR:4"}, {"em1Text": "Aliskiren", "em2Text": "Ang II", "label": "CPR:4"}]}
{"sentText": "Aliskiren has the potential to become the first orally active renin inhibitor that provides a true alternative to ACE inhibitors and Ang II receptor antagonists in therapy for hypertension and other cardiovascular and renal diseases", "relationMentions": [{"em1Text": "Aliskiren", "em2Text": "renin", "label": "CPR:4"}, {"em1Text": "Aliskiren", "em2Text": "ACE", "label": "CPR:4"}, {"em1Text": "Aliskiren", "em2Text": "Ang II receptor", "label": "CPR:6"}]}
{"sentText": "We tested the new orally active nonpeptidic renin inhibitor SPP100 Aliskiren an octanamide with a 50 inhibitory concentration IC50 in the low nanomolar range in 18 healthy volunteers on a constant 100 mmold sodium diet using a doubleblind 3way crossover protocol", "relationMentions": [{"em1Text": "renin", "em2Text": "SPP100", "label": "CPR:4"}, {"em1Text": "renin", "em2Text": "Aliskiren", "label": "CPR:4"}, {"em1Text": "renin", "em2Text": "octanamide", "label": "CPR:4"}]}
{"sentText": "There was a dosedependent decrease in plasma renin activity Ang I and Ang II following single doses of Aliskiren starting with 40 mg Inhibition was still marked and significant after repeated dosing with maximal decreases in Ang II levels by 89 and 75 on Days 1 and 8 respectively when the highest dose of Aliskiren was compared with placebo", "relationMentions": [{"em1Text": "renin", "em2Text": "Aliskiren", "label": "CPR:4"}, {"em1Text": "Ang I", "em2Text": "Aliskiren", "label": "CPR:4"}, {"em1Text": "Ang II", "em2Text": "Aliskiren", "label": "CPR:4"}, {"em1Text": "Ang II", "em2Text": "Aliskiren", "label": "CPR:4"}]}
{"sentText": "Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren SPP100 comparison with enalapril", "relationMentions": [{"em1Text": "Angiotensin II", "em2Text": "Aliskiren", "label": "CPR:4"}, {"em1Text": "renin", "em2Text": "Aliskiren", "label": "CPR:4"}, {"em1Text": "Angiotensin II", "em2Text": "SPP100", "label": "CPR:4"}, {"em1Text": "renin", "em2Text": "SPP100", "label": "CPR:4"}]}
{"sentText": "The earliest known AChE inhibitors namely physostigmine and tacrine performed poorly in clinical trials eg poor oral activity brain penetration and hepatotoxic liability", "relationMentions": [{"em1Text": "AChE", "em2Text": "physostigmine", "label": "CPR:4"}, {"em1Text": "AChE", "em2Text": "tacrine", "label": "CPR:4"}]}
{"sentText": "Donepezil hydrochloride inaugurates a new class of AChE inhibitors with longer and more selective action and with manageable adverse effects", "relationMentions": [{"em1Text": "Donepezil hydrochloride", "em2Text": "AChE", "label": "CPR:4"}]}
{"sentText": "Thalidomide removed from widespread clinical use by 1962 because of severe teratogenicityhas antiangiogenic and immunomodulatory effects including the inhibition of TNF alpha", "relationMentions": [{"em1Text": "Thalidomide", "em2Text": "TNF alpha", "label": "CPR:4"}]}
{"sentText": "As a prodrug leflunomide is completely converted to its active metabolite A 77 1726 M1 which blocks the dihydroorotate dehydrogenase a key enzyme of the pyrimidine de novo synthesis", "relationMentions": [{"em1Text": "leflunomide", "em2Text": "dihydroorotate dehydrogenase", "label": "CPR:4"}, {"em1Text": "A 77 1726", "em2Text": "dihydroorotate dehydrogenase", "label": "CPR:4"}]}
{"sentText": "A recent study showed that anastrozole an aromatase inhibitor is as effective or even superior to tamoxifen when used as a firstline therapy", "relationMentions": [{"em1Text": "anastrozole", "em2Text": "aromatase", "label": "CPR:4"}]}
{"sentText": "Fulvestrant the first agent in this new class not only induces the degradation of the estrogen receptor but also is an estrogen antagonist further its lack of agonist activity provides a better safety profile", "relationMentions": [{"em1Text": "Fulvestrant", "em2Text": "estrogen receptor", "label": "CPR:4"}]}
{"sentText": "Lovastatin a specific inhibitor of HMGCoA reductase induces a pronounced apoptotic response in a specific subset of tumor types including HNSCC and CC", "relationMentions": [{"em1Text": "Lovastatin", "em2Text": "HMGCoA reductase", "label": "CPR:4"}]}
{"sentText": "Chronic treatment with the NET inhibitor desipramine DMI reduced NET levels in both control and Dbh mice demonstrating that NE is not required for the regulation of NET by antidepressant drugs", "relationMentions": [{"em1Text": "NET", "em2Text": "desipramine", "label": "CPR:4"}, {"em1Text": "NET", "em2Text": "desipramine", "label": "CPR:4"}]}
{"sentText": "Probes were perfused with artificial cerebrospinal fluid containing nicotine the specific alpha4beta2 nAChR agonist metanicotine or nicotine plus nAChR antagonists and norepinephrine measured in the microdialysates", "relationMentions": [{"em1Text": "alpha4beta2 nAChR", "em2Text": "metanicotine", "label": "CPR:5"}, {"em1Text": "nicotine", "em2Text": "alpha4beta2 nAChR", "label": "CPR:5"}]}
{"sentText": "Cilostazol decreases levels of serum triglycerides and causes some increase in HDL cholesterol levels", "relationMentions": [{"em1Text": "Cilostazol", "em2Text": "HDL", "label": "CPR:3"}]}
{"sentText": "Cilostazol undergoes intensive and finally complete hepatic metabolism via the cytochrome P450 systems", "relationMentions": [{"em1Text": "Cilostazol", "em2Text": "cytochrome P450", "label": "CPR:9"}]}
{"sentText": "In contrast the mutants T844A F972A and Q975A showed increased Ki for cilostazol but no difference for milrinone from the recombinant PDE3A", "relationMentions": [{"em1Text": "cilostazol", "em2Text": "PDE3A", "label": "CPR:4"}, {"em1Text": "T844A", "em2Text": "cilostazol", "label": "CPR:4"}, {"em1Text": "F972A", "em2Text": "cilostazol", "label": "CPR:4"}, {"em1Text": "Q975A", "em2Text": "cilostazol", "label": "CPR:4"}, {"em1Text": "milrinone", "em2Text": "PDE3A", "label": "CPR:4"}, {"em1Text": "T844A", "em2Text": "milrinone", "label": "CPR:4"}, {"em1Text": "F972A", "em2Text": "milrinone", "label": "CPR:4"}, {"em1Text": "Q975A", "em2Text": "milrinone", "label": "CPR:4"}]}
{"sentText": "Molecular models show that the PDE3 inhibitors cilostazol and milrinone share some of common residues but interact with distinct residues at the active site suggesting that selective inhibitors can be designed with flexible size against PDE3 active site", "relationMentions": [{"em1Text": "PDE3", "em2Text": "cilostazol", "label": "CPR:4"}, {"em1Text": "PDE3", "em2Text": "milrinone", "label": "CPR:4"}]}
{"sentText": "Our study implies that highly conserved residuals Y751 D950 and F1004 in the PDE families are key residues for binding of both substrate and inhibitors and nonconserved T844 may be responsible for the cilostazol selectivity of PDE3A", "relationMentions": [{"em1Text": "PDE", "em2Text": "cilostazol", "label": "CPR:4"}, {"em1Text": "cilostazol", "em2Text": "PDE3A", "label": "CPR:4"}]}
{"sentText": "We changed the residues to alanine using sitedirected mutagenesis technique expressed the mutants in a baculovirusSf9 cell system and analyzed the kinetic characteristics of inhibition of the mutant enzymes by milrinone and cilostazol specific inhibitors of PDE3", "relationMentions": [{"em1Text": "milrinone", "em2Text": "PDE3", "label": "CPR:4"}, {"em1Text": "cilostazol", "em2Text": "PDE3", "label": "CPR:4"}]}
{"sentText": "Mutants Y751A D950A and F1004A had reduced sensitivity to milrinone Ki changed from 066 microM for the recombinant PDE3A to 75 to 156 microM for the mutants and diminished sensitivity to cilostazol Ki of the mutants were 18 to 371fold higher than that of the recombinant PDE3A", "relationMentions": [{"em1Text": "Y751A", "em2Text": "milrinone", "label": "CPR:4"}, {"em1Text": "D950A", "em2Text": "milrinone", "label": "CPR:4"}, {"em1Text": "F1004A", "em2Text": "milrinone", "label": "CPR:4"}, {"em1Text": "milrinone", "em2Text": "PDE3A", "label": "CPR:4"}, {"em1Text": "PDE3A", "em2Text": "cilostazol", "label": "CPR:4"}]}
{"sentText": "The bacterial enzyme maltodextrin phosphorylase MalP catalyses the phosphorolysis of an alpha14glycosidic bond in maltodextrins removing the nonreducing glucosyl residues of linear oligosaccharides as glucose1phosphate Glc1P", "relationMentions": [{"em1Text": "maltodextrin phosphorylase", "em2Text": "glucose1phosphate", "label": "CPR:9"}, {"em1Text": "MalP", "em2Text": "glucose1phosphate", "label": "CPR:9"}, {"em1Text": "maltodextrin phosphorylase", "em2Text": "Glc1P", "label": "CPR:9"}, {"em1Text": "MalP", "em2Text": "Glc1P", "label": "CPR:9"}]}
{"sentText": "OBJECTIVE Fondaparinux sodium is the first in a new class of synthetic factor Xa inhibitors that binds reversibly with high affinity to antithrombin III", "relationMentions": [{"em1Text": "Fondaparinux sodium", "em2Text": "factor Xa", "label": "CPR:4"}]}
{"sentText": "It is caused by a deficiency of propionylCoA carboxylase PCC EC 6413 a biotindependent enzyme that catalyzes the carboxylation of propionylCoA to DmethylmalonylCoA", "relationMentions": [{"em1Text": "propionylCoA", "em2Text": "propionylCoA carboxylase", "label": "CPR:9"}, {"em1Text": "propionylCoA", "em2Text": "PCC", "label": "CPR:9"}, {"em1Text": "propionylCoA", "em2Text": "EC 6413", "label": "CPR:9"}, {"em1Text": "propionylCoA carboxylase", "em2Text": "DmethylmalonylCoA", "label": "CPR:9"}, {"em1Text": "PCC", "em2Text": "DmethylmalonylCoA", "label": "CPR:9"}, {"em1Text": "EC 6413", "em2Text": "DmethylmalonylCoA", "label": "CPR:9"}]}
{"sentText": "Although only clozapine and ziprasidone are directly acting 5HT1A agonists WAY100635 a selective 5HT1A antagonist partially attenuates these atypical APDinduced increases in cortical DA release that may be due to combined 5HT2A and D2 blockade", "relationMentions": [{"em1Text": "clozapine", "em2Text": "5HT2A", "label": "CPR:4"}, {"em1Text": "clozapine", "em2Text": "D2", "label": "CPR:4"}, {"em1Text": "ziprasidone", "em2Text": "5HT2A", "label": "CPR:4"}, {"em1Text": "ziprasidone", "em2Text": "D2", "label": "CPR:4"}, {"em1Text": "WAY100635", "em2Text": "5HT2A", "label": "CPR:4"}, {"em1Text": "WAY100635", "em2Text": "D2", "label": "CPR:4"}, {"em1Text": "clozapine", "em2Text": "5HT1A", "label": "CPR:5"}, {"em1Text": "ziprasidone", "em2Text": "5HT1A", "label": "CPR:5"}, {"em1Text": "5HT1A", "em2Text": "WAY100635", "label": "CPR:6"}]}
{"sentText": "However 5HT1A agonism may be important only for quetiapine induced ACh release", "relationMentions": [{"em1Text": "5HT1A", "em2Text": "quetiapine", "label": "CPR:5"}]}
{"sentText": "BACKGROUND The novel antiepileptic drug retigabine is the first selective Mcurrent potassium channel opener for KCNQ23 and KCNQ35 channels", "relationMentions": [{"em1Text": "retigabine", "em2Text": "KCNQ23", "label": "CPR:3"}, {"em1Text": "retigabine", "em2Text": "KCNQ35", "label": "CPR:3"}, {"em1Text": "retigabine", "em2Text": "Mcurrent potassium channel", "label": "CPR:3"}]}
{"sentText": "OBJECTIVE Because of these physiological effects and the widespread use of the selective COX2 inhibitor celecoxib we wanted to determine if inhibition of COX2 would affect incisional skin wound healing", "relationMentions": [{"em1Text": "COX2", "em2Text": "celecoxib", "label": "CPR:4"}]}
{"sentText": "METHODS Using a cutaneous fullthickness sutured incisional wound model in hairless SKH1 mice we evaluated the role of COX2 in the wound healing process by comparing the effects of a nonselective COX inhibitor diclofenac with a selective COX2 inhibitor SC791", "relationMentions": [{"em1Text": "COX", "em2Text": "diclofenac", "label": "CPR:4"}]}
{"sentText": "The effects of histamine H1receptor antagonists promethazine and homochlorcyclizine both of which are inhibitors of CYP2D6 on the steadystate plasma concentrations Css of haloperidol and reduced haloperidol were studied in 23 schizophrenic inpatients receiving haloperidol 12 to 36 mgd for 2 to 29 weeks", "relationMentions": [{"em1Text": "promethazine", "em2Text": "CYP2D6", "label": "CPR:4"}, {"em1Text": "homochlorcyclizine", "em2Text": "CYP2D6", "label": "CPR:4"}, {"em1Text": "histamine H1receptor", "em2Text": "promethazine", "label": "CPR:6"}, {"em1Text": "histamine H1receptor", "em2Text": "homochlorcyclizine", "label": "CPR:6"}]}
{"sentText": "Thus the current study suggests that coadministration of clinical doses of promethazine and homochlorcyclizine increases the Css of haloperidol and reduced haloperidol via the inhibitory effects on the CYP2D6 catalyzed metabolism of haloperidol and reduced haloperidol", "relationMentions": [{"em1Text": "promethazine", "em2Text": "CYP2D6", "label": "CPR:4"}, {"em1Text": "homochlorcyclizine", "em2Text": "CYP2D6", "label": "CPR:4"}, {"em1Text": "haloperidol", "em2Text": "CYP2D6", "label": "CPR:9"}, {"em1Text": "haloperidol", "em2Text": "CYP2D6", "label": "CPR:9"}]}
{"sentText": "Histamine H1receptor antagonists promethazine and homochlorcyclizine increase the steadystate plasma concentrations of haloperidol and reduced haloperidol", "relationMentions": [{"em1Text": "Histamine H1receptor", "em2Text": "promethazine", "label": "CPR:6"}, {"em1Text": "Histamine H1receptor", "em2Text": "homochlorcyclizine", "label": "CPR:6"}]}
{"sentText": "The four lysine residues located in the SMG loop Lys260 Lys263 Lys265 and Lys268 also play an important role in mediating the sensitivity of OTCase to ornithine and to arginase and appear to be involved in transducing and enhancing the signal given by ornithine for the closure of the catalytic domain", "relationMentions": [{"em1Text": "OTCase", "em2Text": "ornithine", "label": "CPR:4"}]}
{"sentText": "Inhibition of binding of both plasminogen and plasmin to gp330 by benzamidine was similar although EACA inhibited the binding of plasmin to gp330 slightly more than the binding of plasminogen to gp330", "relationMentions": [{"em1Text": "plasminogen", "em2Text": "benzamidine", "label": "CPR:4"}, {"em1Text": "plasmin", "em2Text": "benzamidine", "label": "CPR:4"}, {"em1Text": "plasmin", "em2Text": "EACA", "label": "CPR:4"}, {"em1Text": "plasminogen", "em2Text": "EACA", "label": "CPR:4"}]}
{"sentText": "Involvement of alpha1adrenoceptors was established as mydriatic responses were inhibited by systemic administration of nonselective alphaadrenoceptor antagonists phentolamine 033 mgkg and phenoxybenzamine 00303 mgkg as well as by the selective alpha1adrenoceptor antagonist prazosin 03 mgkg", "relationMentions": [{"em1Text": "alphaadrenoceptor", "em2Text": "phentolamine", "label": "CPR:6"}, {"em1Text": "alphaadrenoceptor", "em2Text": "phenoxybenzamine", "label": "CPR:6"}, {"em1Text": "alpha1adrenoceptor", "em2Text": "prazosin", "label": "CPR:6"}]}
{"sentText": "The alpha2adrenoceptor antagonist rauwolscine 05 mgkg was without antagonistic effects", "relationMentions": [{"em1Text": "alpha2adrenoceptor", "em2Text": "rauwolscine", "label": "CPR:6"}]}
{"sentText": "alpha1AAdrenoceptor selective antagonists 226dimethoxyphenoxyethylaminomethyl14benzodioxane WB4101 011 mgkg and 5methylurapidil 011 mgkg the alpha1Badrenoceptor selective antagonist 4amino241benzyloxycarbonyl2S 11dimethylethylaminocarbonylpiperazinyl67dimethoxyquinazoline L765314 031 mgkg as well as the alpha1Dadrenoceptor selective antagonist 8242methoxyphenyl1piperazinylethyl8azaspiro45decane79dione BMY7378 1 mgkg were used to delineate the adrenoceptor subtypes involved", "relationMentions": [{"em1Text": "alpha1AAdrenoceptor", "em2Text": "226dimethoxyphenoxyethylaminomethyl14benzodioxane", "label": "CPR:6"}, {"em1Text": "alpha1AAdrenoceptor", "em2Text": "WB4101", "label": "CPR:6"}, {"em1Text": "alpha1AAdrenoceptor", "em2Text": "5methylurapidil", "label": "CPR:6"}, {"em1Text": "alpha1Badrenoceptor", "em2Text": "4amino241benzyloxycarbonyl2S 11dimethylethylaminocarbonylpiperazinyl67dimethoxyquinazoline", "label": "CPR:6"}, {"em1Text": "alpha1Badrenoceptor", "em2Text": "L765314", "label": "CPR:6"}, {"em1Text": "alpha1Dadrenoceptor", "em2Text": "8242methoxyphenyl1piperazinylethyl8azaspiro45decane79dione", "label": "CPR:6"}, {"em1Text": "alpha1Dadrenoceptor", "em2Text": "BMY7378", "label": "CPR:6"}]}
{"sentText": "To further investigate this positive correlation and its possible therapeutic implications a selective COX2 inhibitor etodolac was tested on three variants of HT29 colon cancer cell lines HT29Inv1 HT29Inv2 and HT29Inv3 with graded increases of in vitro Matrigel invasive potential and COX2 expression levels", "relationMentions": [{"em1Text": "COX2", "em2Text": "etodolac", "label": "CPR:4"}]}
{"sentText": "However other alpha1adrenoceptor antagonists tamsulosin WB4101 and corynanthine did not inhibit the binding at a range of concentrations that generally exhibit alpha1adrenoceptor antagonism and noradrenaline rauwolscine and propranolol were without effect on the 3Hprazosin binding", "relationMentions": [{"em1Text": "alpha1adrenoceptor", "em2Text": "tamsulosin", "label": "CPR:6"}, {"em1Text": "alpha1adrenoceptor", "em2Text": "WB4101", "label": "CPR:6"}, {"em1Text": "alpha1adrenoceptor", "em2Text": "corynanthine", "label": "CPR:6"}]}
{"sentText": "A comparison of the results with previous data for desipramine and cocaine inhibition of norepinephrine uptake by the mutant hNETs reveals that MrIA binding to hNET occurs at a site that is distinct from but overlaps with the binding sites for tricyclic antidepressants and cocaine", "relationMentions": [{"em1Text": "norepinephrine", "em2Text": "hNETs", "label": "CPR:9"}]}
{"sentText": "The potency of MrIA was greater for inhibition of uptake by hNET of 3Hnorepinephrine Ki 189 microM than 3Hdopamine Ki 433 microM and the human dopamine transporter and serotonin transporter were not inhibited by MrIA to 7 microM", "relationMentions": [{"em1Text": "hNET", "em2Text": "3Hnorepinephrine", "label": "CPR:9"}, {"em1Text": "hNET", "em2Text": "3Hdopamine", "label": "CPR:9"}]}
{"sentText": "A cDNA encoding the complete amino acid sequence of aminoacylase 1 Nacylamino acid aminohydrolase ACY1 EC 35114 a dimeric metalloprotein having two Zn2 in the molecule which catalyzes the deacylation of Nacylated Lamino acids except Laspartic acid has been isolated from porcine kidney lambda gt10 cDNA library and sequenced", "relationMentions": [{"em1Text": "ACY1", "em2Text": "Nacylated Lamino acids", "label": "CPR:9"}, {"em1Text": "EC 35114", "em2Text": "Nacylated Lamino acids", "label": "CPR:9"}, {"em1Text": "metalloprotein", "em2Text": "Nacylated Lamino acids", "label": "CPR:9"}, {"em1Text": "aminoacylase 1", "em2Text": "Nacylated Lamino acids", "label": "CPR:9"}, {"em1Text": "Nacylamino acid aminohydrolase", "em2Text": "Nacylated Lamino acids", "label": "CPR:9"}]}
{"sentText": "Patients stable on warfarin therapy and concurrently taking a cyclooxygenase2 COX2 inhibitor comparator traditional nonsteroidal antiinflammatory medications salsalate or acetaminophen randomly received celecoxib 200 mgday or rofecoxib 25 mgday for three weeks", "relationMentions": [{"em1Text": "cyclooxygenase2", "em2Text": "salsalate", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "salsalate", "label": "CPR:4"}, {"em1Text": "cyclooxygenase2", "em2Text": "acetaminophen", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "acetaminophen", "label": "CPR:4"}, {"em1Text": "cyclooxygenase2", "em2Text": "celecoxib", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "celecoxib", "label": "CPR:4"}, {"em1Text": "cyclooxygenase2", "em2Text": "rofecoxib", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "rofecoxib", "label": "CPR:4"}]}
{"sentText": "RESULTS Eprosartan tended to lower mean AP it slightly increased heart rate HR p005 and markedly increased circulating AngII levels p001", "relationMentions": [{"em1Text": "Eprosartan", "em2Text": "AngII", "label": "CPR:3"}]}
{"sentText": "We sought to assess the effects of the angiotensin type 1 AT1 receptor blocker eprosartan on HRV and BRG", "relationMentions": [{"em1Text": "angiotensin type 1 AT1 receptor", "em2Text": "eprosartan", "label": "CPR:4"}]}
{"sentText": "AT1 antagonism by eprosartan lowers heart rate variability and baroreflex gain", "relationMentions": [{"em1Text": "AT1", "em2Text": "eprosartan", "label": "CPR:6"}]}
{"sentText": "CONCLUSIONS AT1 antagonism by eprosartan lowers heart rate variability and baroreflex gain", "relationMentions": [{"em1Text": "AT1", "em2Text": "eprosartan", "label": "CPR:6"}]}
{"sentText": "The antinociceptive activity of the alpha 2adrenoceptor agonist clonidine was also increased in mice treated with alpha Nacetyl betaendorphin131", "relationMentions": [{"em1Text": "alpha 2adrenoceptor", "em2Text": "clonidine", "label": "CPR:5"}]}
{"sentText": "In seven normal subjects basal ACTH plasma levels were significantly suppressed 3 h after loperamide administration 16 mg orally from 5 1 to 2 0 pmolL P less than 00001", "relationMentions": [{"em1Text": "ACTH", "em2Text": "loperamide", "label": "CPR:4"}]}
{"sentText": "After the combined pituitary stimulation test 100 micrograms human CRH 100 micrograms GnRH 100 micrograms GHreleasing hormone and 200 micrograms TRH the ACTH peak maximum increase at 30 min was significantly blunted by loperamide from 9 1 to 4 1 pmolL P less than 0001 and the area under the curve of ACTH from 0120 min was reduced from 35 5 to 23 4 pmolL2 h P less than 005", "relationMentions": [{"em1Text": "human CRH", "em2Text": "loperamide", "label": "CPR:4"}, {"em1Text": "GnRH", "em2Text": "loperamide", "label": "CPR:4"}, {"em1Text": "GHreleasing hormone", "em2Text": "loperamide", "label": "CPR:4"}, {"em1Text": "TRH", "em2Text": "loperamide", "label": "CPR:4"}, {"em1Text": "ACTH", "em2Text": "loperamide", "label": "CPR:4"}, {"em1Text": "ACTH", "em2Text": "loperamide", "label": "CPR:4"}]}
{"sentText": "Loperamide an opiate agonist of high specificity for mureceptors was recently reported to suppress ACTH and cortisol levels in normal subjects but not in patients with proven ACTHdependent Cushings disease", "relationMentions": [{"em1Text": "Loperamide", "em2Text": "ACTH", "label": "CPR:4"}]}
{"sentText": "In summary loperamide is able to reduce basal and CRH induced ACTH and cortisol levels in normal subjects but not in patients with Cushings disease or secondary adrenal failure of hypothalamic origin", "relationMentions": [{"em1Text": "loperamide", "em2Text": "CRH", "label": "CPR:4"}, {"em1Text": "loperamide", "em2Text": "ACTH", "label": "CPR:4"}]}
{"sentText": "We also examined the effects of WEB 2086 a plateletactivating factor PAF receptor antagonist in parallel", "relationMentions": [{"em1Text": "WEB 2086", "em2Text": "plateletactivating factor PAF receptor", "label": "CPR:6"}]}
{"sentText": "The compounds identified as 5LO inhibitors can be divided into antioxidants substrateanalogous and a large miscellaneous group of inhibitors where hydroxamic acids are potent and more selective inhibitors of 5LO", "relationMentions": [{"em1Text": "5LO", "em2Text": "hydroxamic acids", "label": "CPR:4"}]}
{"sentText": "The benzothiophene hydroxyurea zileuton is the first selective 5LO inhibitor evaluated for the treatment of patients with IBD", "relationMentions": [{"em1Text": "benzothiophene hydroxyurea", "em2Text": "5LO", "label": "CPR:4"}, {"em1Text": "zileuton", "em2Text": "5LO", "label": "CPR:4"}]}
{"sentText": "The unique role of the enzyme 5lipoxygenase 5LO in the production of leukotrienes LTs makes it a likely target for biochemical manipulation", "relationMentions": [{"em1Text": "5lipoxygenase", "em2Text": "leukotrienes", "label": "CPR:9"}, {"em1Text": "5LO", "em2Text": "leukotrienes", "label": "CPR:9"}, {"em1Text": "5lipoxygenase", "em2Text": "LTs", "label": "CPR:9"}, {"em1Text": "5LO", "em2Text": "LTs", "label": "CPR:9"}]}
{"sentText": "In PC3 cells hydroxyurea inhibited hRRM2 and resulted in increased sensitivity to UV irradiation", "relationMentions": [{"em1Text": "hydroxyurea", "em2Text": "hRRM2", "label": "CPR:4"}]}
{"sentText": "Ribonucleotide reductase RR is responsible for the de novo conversion of the ribonucleoside diphosphates to deoxyribonucleoside diphosphates which are essential for DNA synthesis and repair", "relationMentions": [{"em1Text": "RR", "em2Text": "deoxyribonucleoside diphosphates", "label": "CPR:9"}, {"em1Text": "Ribonucleotide reductase", "em2Text": "deoxyribonucleoside diphosphates", "label": "CPR:9"}, {"em1Text": "RR", "em2Text": "ribonucleoside diphosphates", "label": "CPR:9"}, {"em1Text": "Ribonucleotide reductase", "em2Text": "ribonucleoside diphosphates", "label": "CPR:9"}]}
{"sentText": "Furthermore RTPCR analyses revealed that minocycline treatment increased expression of interleukin10 mRNA but decreased tumor necrosis factoralpha expression", "relationMentions": [{"em1Text": "minocycline", "em2Text": "interleukin10", "label": "CPR:3"}, {"em1Text": "minocycline", "em2Text": "tumor necrosis factoralpha", "label": "CPR:4"}]}
{"sentText": "In addition minocycline treatment significantly reduced the specific caspase3 activity after SCI as compared to that of vehicle control", "relationMentions": [{"em1Text": "minocycline", "em2Text": "caspase3", "label": "CPR:4"}]}
{"sentText": "CONCLUSION Nandrolone phenylpropionate upregulated the density of AR in liver tissue whereas it had no significant effects on the density of AR in testis and ovary tissues", "relationMentions": [{"em1Text": "Nandrolone phenylpropionate", "em2Text": "AR", "label": "CPR:3"}]}
{"sentText": "RESULTS The density of AR in liver tissue in NP group was higher than that in control group P 005", "relationMentions": [{"em1Text": "AR", "em2Text": "NP", "label": "CPR:3"}]}
{"sentText": "The pretreatment with salbutamol induced a 59 downregulation of left ventricular beta2adrenoceptors compared to control", "relationMentions": [{"em1Text": "salbutamol", "em2Text": "beta2adrenoceptors", "label": "CPR:4"}]}
{"sentText": "or were chronically pretreated with the selective beta2adrenoceptor agonist salbutamol 40 microgkgh for 1 week to induce beta2adrenoceptor desensitization", "relationMentions": [{"em1Text": "beta2adrenoceptor", "em2Text": "salbutamol", "label": "CPR:5"}]}
{"sentText": "Rats received a concomitant treatment with the selective beta1adrenoceptor antagonist bisoprolol 50 mgkgday po", "relationMentions": [{"em1Text": "beta1adrenoceptor", "em2Text": "bisoprolol", "label": "CPR:6"}]}
{"sentText": "Known VR1 antagonists BCTC thioBCTC and capsazepine were also able to block the response of TRPM8 to menthol IC50 0810 3511 and 1811 microM respectively", "relationMentions": [{"em1Text": "TRPM8", "em2Text": "menthol", "label": "CPR:3"}, {"em1Text": "BCTC", "em2Text": "TRPM8", "label": "CPR:4"}, {"em1Text": "thioBCTC", "em2Text": "TRPM8", "label": "CPR:4"}, {"em1Text": "capsazepine", "em2Text": "TRPM8", "label": "CPR:4"}, {"em1Text": "VR1", "em2Text": "BCTC", "label": "CPR:6"}, {"em1Text": "VR1", "em2Text": "thioBCTC", "label": "CPR:6"}, {"em1Text": "VR1", "em2Text": "capsazepine", "label": "CPR:6"}]}
{"sentText": "The Ca2 response of hVR1 transfected HEK293 cells to the endogenous VR1 agonist Narachidonoyldopamine was potentiated by low pH", "relationMentions": [{"em1Text": "hVR1", "em2Text": "Narachidonoyldopamine", "label": "CPR:3"}, {"em1Text": "VR1", "em2Text": "Narachidonoyldopamine", "label": "CPR:5"}]}
{"sentText": "In contrast menthol and icilin activated TRPM8 currents were suppressed by low pH", "relationMentions": [{"em1Text": "menthol", "em2Text": "TRPM8", "label": "CPR:3"}, {"em1Text": "icilin", "em2Text": "TRPM8", "label": "CPR:3"}]}
{"sentText": "TRPM8 CMR1 is a Ca2permeable channel which can be activated by low temperatures menthol eucalyptol and icilin", "relationMentions": [{"em1Text": "CMR1", "em2Text": "eucalyptol", "label": "CPR:3"}, {"em1Text": "Ca2permeable channel", "em2Text": "eucalyptol", "label": "CPR:3"}, {"em1Text": "TRPM8", "em2Text": "eucalyptol", "label": "CPR:3"}, {"em1Text": "CMR1", "em2Text": "menthol", "label": "CPR:3"}, {"em1Text": "Ca2permeable channel", "em2Text": "menthol", "label": "CPR:3"}, {"em1Text": "TRPM8", "em2Text": "menthol", "label": "CPR:3"}, {"em1Text": "CMR1", "em2Text": "icilin", "label": "CPR:3"}, {"em1Text": "Ca2permeable channel", "em2Text": "icilin", "label": "CPR:3"}, {"em1Text": "TRPM8", "em2Text": "icilin", "label": "CPR:3"}]}
{"sentText": "The inhibitory effects of tranylcypromine a nonselective irreversible inhibitor of monoamine oxidase MAO on three cytochrome P450 CYP enzymes namely CYP2C9 CYP2C19 and CYP2D6 have been evaluated in vitro", "relationMentions": [{"em1Text": "tranylcypromine", "em2Text": "monoamine oxidase", "label": "CPR:4"}, {"em1Text": "tranylcypromine", "em2Text": "MAO", "label": "CPR:4"}]}
{"sentText": "The results demonstrated that tranylcypromine is a competitive inhibitor of CYP2C19 Ki = 32 microM and CYP2D6 Ki = 367 microM and a noncompetitive inhibitor of CYP2C9 Ki = 56 microM", "relationMentions": [{"em1Text": "tranylcypromine", "em2Text": "CYP2C19", "label": "CPR:4"}, {"em1Text": "tranylcypromine", "em2Text": "CYP2D6", "label": "CPR:4"}, {"em1Text": "tranylcypromine", "em2Text": "CYP2C9", "label": "CPR:4"}]}
{"sentText": "Inhibitory effects of the monoamine oxidase inhibitor tranylcypromine on the cytochrome P450 enzymes CYP2C19 CYP2C9 and CYP2D6", "relationMentions": [{"em1Text": "monoamine oxidase", "em2Text": "tranylcypromine", "label": "CPR:4"}]}
{"sentText": "Studies in rats mice and monkeys show that GC1 lowers cholesterol with 600 to 1400fold more potency and approximately two to threefold more efficacy than atorvastatin a compound that blocks HMGCoA reductase", "relationMentions": [{"em1Text": "atorvastatin", "em2Text": "HMGCoA reductase", "label": "CPR:4"}]}
{"sentText": "Compounds of several other structural families including the quinoxaline AG1296 the bis1H2indolyl1methanone D65476 the indolinones SU5416 and SU11248 the indolocarbazoles PKC412 and CEP701 and the piperazonyl quinazoline CT53518 are potent inhibitors of Flt3 kinase", "relationMentions": [{"em1Text": "quinoxaline", "em2Text": "Flt3", "label": "CPR:4"}, {"em1Text": "quinoxaline", "em2Text": "kinase", "label": "CPR:4"}, {"em1Text": "AG1296", "em2Text": "Flt3", "label": "CPR:4"}, {"em1Text": "AG1296", "em2Text": "kinase", "label": "CPR:4"}, {"em1Text": "bis1H2indolyl1methanone", "em2Text": "Flt3", "label": "CPR:4"}, {"em1Text": "bis1H2indolyl1methanone", "em2Text": "kinase", "label": "CPR:4"}, {"em1Text": "D65476", "em2Text": "Flt3", "label": "CPR:4"}, {"em1Text": "D65476", "em2Text": "kinase", "label": "CPR:4"}, {"em1Text": "indolinones", "em2Text": "Flt3", "label": "CPR:4"}, {"em1Text": "indolinones", "em2Text": "kinase", "label": "CPR:4"}, {"em1Text": "SU5416", "em2Text": "Flt3", "label": "CPR:4"}, {"em1Text": "SU5416", "em2Text": "kinase", "label": "CPR:4"}, {"em1Text": "SU11248", "em2Text": "Flt3", "label": "CPR:4"}, {"em1Text": "SU11248", "em2Text": "kinase", "label": "CPR:4"}, {"em1Text": "indolocarbazoles", "em2Text": "Flt3", "label": "CPR:4"}, {"em1Text": "indolocarbazoles", "em2Text": "kinase", "label": "CPR:4"}, {"em1Text": "PKC412", "em2Text": "Flt3", "label": "CPR:4"}, {"em1Text": "PKC412", "em2Text": "kinase", "label": "CPR:4"}, {"em1Text": "CEP701", "em2Text": "Flt3", "label": "CPR:4"}, {"em1Text": "CEP701", "em2Text": "kinase", "label": "CPR:4"}, {"em1Text": "piperazonyl quinazoline", "em2Text": "Flt3", "label": "CPR:4"}, {"em1Text": "piperazonyl quinazoline", "em2Text": "kinase", "label": "CPR:4"}, {"em1Text": "CT53518", "em2Text": "Flt3", "label": "CPR:4"}, {"em1Text": "CT53518", "em2Text": "kinase", "label": "CPR:4"}]}
{"sentText": "Although highly homologous to other class III RTKs Flt3 is resistant to the phenylaminopyrimidine STI571 Gleevec Imatinib a potent inhibitor of other RTKs in the family such as the PDGFbetareceptor or cKit", "relationMentions": [{"em1Text": "RTKs", "em2Text": "phenylaminopyrimidine", "label": "CPR:4"}, {"em1Text": "phenylaminopyrimidine", "em2Text": "PDGFbetareceptor", "label": "CPR:4"}, {"em1Text": "phenylaminopyrimidine", "em2Text": "cKit", "label": "CPR:4"}, {"em1Text": "RTKs", "em2Text": "STI571", "label": "CPR:4"}, {"em1Text": "STI571", "em2Text": "PDGFbetareceptor", "label": "CPR:4"}, {"em1Text": "STI571", "em2Text": "cKit", "label": "CPR:4"}, {"em1Text": "RTKs", "em2Text": "Gleevec", "label": "CPR:4"}, {"em1Text": "Gleevec", "em2Text": "PDGFbetareceptor", "label": "CPR:4"}, {"em1Text": "Gleevec", "em2Text": "cKit", "label": "CPR:4"}, {"em1Text": "RTKs", "em2Text": "Imatinib", "label": "CPR:4"}, {"em1Text": "Imatinib", "em2Text": "PDGFbetareceptor", "label": "CPR:4"}, {"em1Text": "Imatinib", "em2Text": "cKit", "label": "CPR:4"}]}
{"sentText": "STI571 binding to Flt3 is prevented by the phenylalanine 691 sidechain in the ATP binding center and mutating this site to threonine renders the corresponding Flt3 mutant sensitive to STI571", "relationMentions": [{"em1Text": "STI571", "em2Text": "Flt3", "label": "CPR:4"}]}
{"sentText": "Hydralazine induced rapid and transient expression of HIF1alpha and downstream targets of HIF endothelin1 adrenomedullin haem oxygenase 1 and vascular endothelial growth factor VEGF in endothelial and smooth muscle cells and induced endothelial cellspecific proliferation", "relationMentions": [{"em1Text": "Hydralazine", "em2Text": "HIF1alpha", "label": "CPR:3"}, {"em1Text": "Hydralazine", "em2Text": "HIF", "label": "CPR:3"}, {"em1Text": "Hydralazine", "em2Text": "endothelin1", "label": "CPR:3"}, {"em1Text": "Hydralazine", "em2Text": "adrenomedullin", "label": "CPR:3"}, {"em1Text": "Hydralazine", "em2Text": "haem oxygenase 1", "label": "CPR:3"}, {"em1Text": "Hydralazine", "em2Text": "vascular endothelial growth factor", "label": "CPR:3"}, {"em1Text": "Hydralazine", "em2Text": "VEGF", "label": "CPR:3"}]}
{"sentText": "Hydralazine dosedependently inhibited PHD activity and induced nonhydroxylated HIF1alpha evidence for HIF stabilization specifically by inhibition of PHD enzyme activity", "relationMentions": [{"em1Text": "Hydralazine", "em2Text": "HIF1alpha", "label": "CPR:3"}, {"em1Text": "Hydralazine", "em2Text": "PHD", "label": "CPR:4"}, {"em1Text": "Hydralazine", "em2Text": "PHD", "label": "CPR:4"}]}
{"sentText": "In vivo hydralazine induced HIF1alpha and VEGF protein in tissue extracts and elevated plasma VEGF levels", "relationMentions": [{"em1Text": "hydralazine", "em2Text": "VEGF", "label": "CPR:3"}, {"em1Text": "hydralazine", "em2Text": "HIF1alpha", "label": "CPR:3"}, {"em1Text": "hydralazine", "em2Text": "VEGF", "label": "CPR:3"}]}
{"sentText": "Novel mechanism of action for hydralazine induction of hypoxiainducible factor1alpha vascular endothelial growth factor and angiogenesis by inhibition of prolyl hydroxylases", "relationMentions": [{"em1Text": "hydralazine", "em2Text": "hypoxiainducible factor1alpha", "label": "CPR:3"}, {"em1Text": "hydralazine", "em2Text": "vascular endothelial growth factor", "label": "CPR:3"}, {"em1Text": "hydralazine", "em2Text": "prolyl hydroxylases", "label": "CPR:4"}]}
{"sentText": "Thus hydralazine activates the HIF pathway through inhibition of PHD activity and initiates a proangiogenic phenotype", "relationMentions": [{"em1Text": "hydralazine", "em2Text": "HIF", "label": "CPR:3"}, {"em1Text": "hydralazine", "em2Text": "PHD", "label": "CPR:4"}]}
{"sentText": "RESULTS Aspirin diclofenac indomethacin ketoprofen meclofenamic acid and piroxicam had little selectivity toward COX isozymes whereas NS398 carprofen tolfenamic acid nimesulide and etodolac had more than 5 times greater preference for inhibiting COX2 than COX1", "relationMentions": [{"em1Text": "NS398", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "NS398", "em2Text": "COX1", "label": "CPR:4"}, {"em1Text": "carprofen", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "carprofen", "em2Text": "COX1", "label": "CPR:4"}, {"em1Text": "tolfenamic acid", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "tolfenamic acid", "em2Text": "COX1", "label": "CPR:4"}, {"em1Text": "nimesulide", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "nimesulide", "em2Text": "COX1", "label": "CPR:4"}, {"em1Text": "etodolac", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "etodolac", "em2Text": "COX1", "label": "CPR:4"}]}
{"sentText": "CONCLUSIONS AND CLINICAL RELEVANCE Canine COX2 was selectively inhibited by etodolac nimesulide and NS398 tolfenamic acid and carprofen also appeared to be preferential COX2 inhibitors in dogs", "relationMentions": [{"em1Text": "Canine COX2", "em2Text": "etodolac", "label": "CPR:4"}, {"em1Text": "Canine COX2", "em2Text": "nimesulide", "label": "CPR:4"}, {"em1Text": "Canine COX2", "em2Text": "NS398", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "tolfenamic acid", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "carprofen", "label": "CPR:4"}]}
{"sentText": "Acarbose served as inhibitor of an interfering acid alphaglucosidase present in neutrophils which allowed the lysosomal enzyme implicated in Pompe disease to be selectively analyzed", "relationMentions": [{"em1Text": "Acarbose", "em2Text": "acid alphaglucosidase", "label": "CPR:4"}]}
{"sentText": "Univariate regression analyses showed that only the use of carvedilol was correlated with the decrease in plasma BNP concentration p 003", "relationMentions": [{"em1Text": "carvedilol", "em2Text": "plasma BNP", "label": "CPR:4"}]}
{"sentText": "Terbinafine is a potent noncompetitive inhibitor of squalene epoxidase from Candida Ki = 30 nM", "relationMentions": [{"em1Text": "Terbinafine", "em2Text": "squalene epoxidase", "label": "CPR:4"}]}
{"sentText": "Terbinafine mode of action and properties of the squalene epoxidase inhibition", "relationMentions": [{"em1Text": "Terbinafine", "em2Text": "squalene epoxidase", "label": "CPR:4"}]}
{"sentText": "Terbinafine Lamisil has primarily fungicidal action against many fungi as a result of its specific mechanism of squalene epoxidase inhibition", "relationMentions": [{"em1Text": "Terbinafine", "em2Text": "squalene epoxidase", "label": "CPR:4"}, {"em1Text": "Lamisil", "em2Text": "squalene epoxidase", "label": "CPR:4"}]}
{"sentText": "In contrast inhibition of rat liver squalene epoxidase only occurs at higher drug concentrations Ki = 77 microM and is competitive with squalene", "relationMentions": [{"em1Text": "rat liver squalene epoxidase", "em2Text": "squalene", "label": "CPR:4"}]}
{"sentText": "Based on HMGCoA reductase inhibition pitavastatin induced apoAI more efficiently than simvastatin and atorvastatin", "relationMentions": [{"em1Text": "apoAI", "em2Text": "simvastatin", "label": "CPR:3"}, {"em1Text": "apoAI", "em2Text": "atorvastatin", "label": "CPR:3"}, {"em1Text": "pitavastatin", "em2Text": "apoAI", "label": "CPR:3"}]}
{"sentText": "Further study revealed that pitavastatin increased ABCA1 mRNA in HMGCoA reductasedependent manner and that Rho and Rho kinase inhibitor C3T and Y27632 increased apoAI production in the HepG2 cells", "relationMentions": [{"em1Text": "pitavastatin", "em2Text": "ABCA1", "label": "CPR:3"}, {"em1Text": "Y27632", "em2Text": "apoAI", "label": "CPR:3"}, {"em1Text": "Rho", "em2Text": "Y27632", "label": "CPR:4"}, {"em1Text": "Rho kinase", "em2Text": "Y27632", "label": "CPR:4"}]}
{"sentText": "These results suggest that pitavastatin efficiently increases apoAI in the culture medium of HepG2 cells by promoting apoAI production through inhibition of HMGCoA reductase and suppression of Rho activity and by protecting apoAI from catabolism through ABCA1 induction and lipidation of apoAI", "relationMentions": [{"em1Text": "pitavastatin", "em2Text": "apoAI", "label": "CPR:3"}, {"em1Text": "pitavastatin", "em2Text": "apoAI", "label": "CPR:3"}, {"em1Text": "pitavastatin", "em2Text": "ABCA1", "label": "CPR:3"}, {"em1Text": "pitavastatin", "em2Text": "apoAI", "label": "CPR:3"}, {"em1Text": "pitavastatin", "em2Text": "HMGCoA reductase", "label": "CPR:4"}, {"em1Text": "pitavastatin", "em2Text": "Rho", "label": "CPR:4"}]}
{"sentText": "Each statin induced apoAI expression mRNA and protein dosedependently the rank order of the apoAI induction pitavastatin 3 microM simvastatin 10 microM atorvastatin 30 microM", "relationMentions": [{"em1Text": "apoAI", "em2Text": "pitavastatin", "label": "CPR:3"}, {"em1Text": "apoAI", "em2Text": "simvastatin", "label": "CPR:3"}, {"em1Text": "apoAI", "em2Text": "atorvastatin", "label": "CPR:3"}]}
{"sentText": "The induction of apoAI by statins disappeared with addition of mevalonate which indicates that the effect is HMGCoA reductase inhibitiondependent", "relationMentions": [{"em1Text": "apoAI", "em2Text": "mevalonate", "label": "CPR:4"}]}
{"sentText": "MATERIALS AND METHODS Seeking to improve efficacy against otherwise intractable endstage pancreatic islet tumors two receptor tyrosine kinase inhibitors imatinib and SU11248 were used to disrupt PDGFR mediated pericyte support of tumor endothelial cells in concert with maximumtolerated dose MTD or metronomic chemotherapy andor VEGFR inhibition", "relationMentions": [{"em1Text": "receptor tyrosine kinase", "em2Text": "imatinib", "label": "CPR:4"}, {"em1Text": "imatinib", "em2Text": "PDGFR", "label": "CPR:4"}, {"em1Text": "imatinib", "em2Text": "VEGFR", "label": "CPR:4"}, {"em1Text": "receptor tyrosine kinase", "em2Text": "SU11248", "label": "CPR:4"}, {"em1Text": "SU11248", "em2Text": "PDGFR", "label": "CPR:4"}, {"em1Text": "SU11248", "em2Text": "VEGFR", "label": "CPR:4"}]}
{"sentText": "RESULTS Imatinib despite equivocal efficacy as monotherapy reduced pericyte coverage of tumor vessels and enhanced efficacy in combination with metronomic chemotherapy or VEGFR inhibition", "relationMentions": [{"em1Text": "Imatinib", "em2Text": "VEGFR", "label": "CPR:4"}]}
{"sentText": "In addition both drugs significantly reduced PGE2 levels P005 6h following LPS injection whereas the probable COX1 prostanoid TXB2 was significantly reduced by phenylbutazone P005 but not etodolac", "relationMentions": [{"em1Text": "COX1", "em2Text": "phenylbutazone", "label": "CPR:4"}]}
{"sentText": "The objective of the present study was to compare the antiinflammatory effects of the preferential COX2 inhibitor etodolac with the nonselective COX inhibitor phenylbutazone in horses with lipopolysaccharide LPSinduced synovitis", "relationMentions": [{"em1Text": "COX", "em2Text": "phenylbutazone", "label": "CPR:4"}]}
{"sentText": "Effect of bosentan ETA ETB receptor antagonist on metabolic changes during stress and diabetes", "relationMentions": [{"em1Text": "bosentan", "em2Text": "ETA", "label": "CPR:6"}, {"em1Text": "bosentan", "em2Text": "ETB", "label": "CPR:6"}]}
{"sentText": "To test this we studied the possible effect of the endothelin receptor antagonist bosentan 50 and 100 mg kg1 on serum glucose and insulin levels as well as on liver glycogen contents in normoglycemic stressed animals", "relationMentions": [{"em1Text": "endothelin receptor", "em2Text": "bosentan", "label": "CPR:6"}]}
{"sentText": "Preirradiation administration of RP1 enhanced levels of GSH induced increase in complex I upto 16 h complex IIII 4 h complex IIIII activity upto 24 h p 001 and inhibited the radiationinduced decrease in MMP significantly 24 h p 001", "relationMentions": [{"em1Text": "GSH", "em2Text": "complex I", "label": "CPR:3"}, {"em1Text": "GSH", "em2Text": "complex IIII", "label": "CPR:3"}, {"em1Text": "GSH", "em2Text": "complex IIIII", "label": "CPR:3"}]}
{"sentText": "Moreover minocycline efficiently suppressed the release of cytochrome c from mitochondria of the liver tissues from Jo2challenged mice", "relationMentions": [{"em1Text": "minocycline", "em2Text": "cytochrome c", "label": "CPR:4"}]}
{"sentText": "Our results suggest that easing of Fastriggered fulminant hepatitis by minocycline may involve a mitochondrial apoptotic pathway probably through preventing cytochrome c release and thereby blocking downstream caspase activation", "relationMentions": [{"em1Text": "minocycline", "em2Text": "cytochrome c", "label": "CPR:4"}, {"em1Text": "minocycline", "em2Text": "caspase", "label": "CPR:4"}]}
{"sentText": "placebo n=24 animals in each group 2 neutrophil sequestration in the pancreas pancreatic myeloperoxidase oxidase MPO activity fold increase over control prophylactic treatment placebo 578063 PAG 297039 therapeutic treatment placebo 548052 PAG 303047 P005 PAG cf", "relationMentions": [{"em1Text": "myeloperoxidase oxidase", "em2Text": "PAG", "label": "CPR:3"}, {"em1Text": "MPO", "em2Text": "PAG", "label": "CPR:3"}]}
{"sentText": "Also prophylactic as well as therapeutic treatment with the CSE inhibitor DLpropargylglycine PAG significantly reduced the severity of caeruleininduced pancreatitis and associated lung injury as determined by 1 hyperamylasemia plasma amylase UL control 120459 prophylactic treatment placebo 10635305 PAG 7904495 therapeutic treatment placebo 10427470 PAG 7811428 P005 PAG cf", "relationMentions": [{"em1Text": "CSE", "em2Text": "DLpropargylglycine", "label": "CPR:4"}, {"em1Text": "CSE", "em2Text": "PAG", "label": "CPR:4"}]}
{"sentText": "Cystathioninegammalyase CSE and cystathioninebetasynthase CBS utilize Lcysteine as substrate to form H2S", "relationMentions": [{"em1Text": "CSE", "em2Text": "Lcysteine", "label": "CPR:9"}, {"em1Text": "cystathioninebetasynthase", "em2Text": "Lcysteine", "label": "CPR:9"}, {"em1Text": "CBS", "em2Text": "Lcysteine", "label": "CPR:9"}, {"em1Text": "Cystathioninegammalyase", "em2Text": "Lcysteine", "label": "CPR:9"}, {"em1Text": "CSE", "em2Text": "H2S", "label": "CPR:9"}, {"em1Text": "cystathioninebetasynthase", "em2Text": "H2S", "label": "CPR:9"}, {"em1Text": "CBS", "em2Text": "H2S", "label": "CPR:9"}, {"em1Text": "Cystathioninegammalyase", "em2Text": "H2S", "label": "CPR:9"}]}
{"sentText": "Of these two enzymes cystathioninegammalyase CSE is believed to be the key enzyme that forms H2S in the cardiovascular system", "relationMentions": [{"em1Text": "cystathioninegammalyase", "em2Text": "H2S", "label": "CPR:9"}, {"em1Text": "CSE", "em2Text": "H2S", "label": "CPR:9"}]}
{"sentText": "ABCG5 and ABCG8 themselves are regulated by cholesterol via liver X receptors LXRs which are also activated by oxy sterols and some derivatives of plant sterols", "relationMentions": [{"em1Text": "LXRs", "em2Text": "sterols", "label": "CPR:3"}]}
{"sentText": "NPC1L1 could recently be identified as a major sterol transporter for the intestinal uptake of cholesterol as well as plant sterols", "relationMentions": [{"em1Text": "NPC1L1", "em2Text": "cholesterol", "label": "CPR:9"}, {"em1Text": "sterol transporter", "em2Text": "cholesterol", "label": "CPR:9"}, {"em1Text": "NPC1L1", "em2Text": "sterols", "label": "CPR:9"}, {"em1Text": "sterol transporter", "em2Text": "sterols", "label": "CPR:9"}]}
{"sentText": "Bupropion has an antidepressant effect through blocking the dopamine transporter", "relationMentions": [{"em1Text": "Bupropion", "em2Text": "dopamine transporter", "label": "CPR:4"}]}
{"sentText": "Our results demonstrate that the combination of denileukin diftitox and bexarotene is well tolerated and that even low doses 150 mgday of bexarotene are capable of in vivo upregulation of CD25 expression on circulating leukemia cells", "relationMentions": [{"em1Text": "bexarotene", "em2Text": "CD25", "label": "CPR:3"}]}
{"sentText": "In vitro studies demonstrated that the retinoid X receptor RXR retinoid bexarotene at biologically relevant concentrations of 106 M to 108 M upregulated both the p55 and p75 subunits of the IL2R and enhanced 5 to 10fold the susceptibility of Tcell leukemia cells to denileukin diftitox", "relationMentions": [{"em1Text": "bexarotene", "em2Text": "p55", "label": "CPR:3"}, {"em1Text": "bexarotene", "em2Text": "p75", "label": "CPR:3"}, {"em1Text": "bexarotene", "em2Text": "IL2R", "label": "CPR:3"}]}
{"sentText": "PSMA acts as a glutamate carboxypeptidase GCPII on small molecule substrates including folate the anticancer drug methotrexate and the neuropeptide Nacetyllaspartyllglutamate", "relationMentions": [{"em1Text": "PSMA", "em2Text": "folate", "label": "CPR:9"}, {"em1Text": "glutamate carboxypeptidase", "em2Text": "folate", "label": "CPR:9"}, {"em1Text": "GCPII", "em2Text": "folate", "label": "CPR:9"}, {"em1Text": "PSMA", "em2Text": "methotrexate", "label": "CPR:9"}, {"em1Text": "glutamate carboxypeptidase", "em2Text": "methotrexate", "label": "CPR:9"}, {"em1Text": "GCPII", "em2Text": "methotrexate", "label": "CPR:9"}, {"em1Text": "PSMA", "em2Text": "Nacetyllaspartyllglutamate", "label": "CPR:9"}, {"em1Text": "glutamate carboxypeptidase", "em2Text": "Nacetyllaspartyllglutamate", "label": "CPR:9"}]}
{"sentText": "Elucidation of the PSMA structure combined with docking studies and a proposed catalytic mechanism provides insight into the recognition of inhibitors and the natural substrate Nacetyllaspartyllglutamate", "relationMentions": [{"em1Text": "PSMA", "em2Text": "Nacetyllaspartyllglutamate", "label": "CPR:9"}]}
{"sentText": "While the substituted benzamide prokinetics for example metoclopramide cisapride also block 5HT3 receptors in high concentrations their prokinetic action is believed to be on the basis of their agonist effects on the putative 5HT4 receptor", "relationMentions": [{"em1Text": "benzamide", "em2Text": "5HT3", "label": "CPR:4"}, {"em1Text": "metoclopramide", "em2Text": "5HT3", "label": "CPR:4"}, {"em1Text": "cisapride", "em2Text": "5HT3", "label": "CPR:4"}, {"em1Text": "benzamide", "em2Text": "5HT4", "label": "CPR:5"}, {"em1Text": "metoclopramide", "em2Text": "5HT4", "label": "CPR:5"}, {"em1Text": "cisapride", "em2Text": "5HT4", "label": "CPR:5"}]}
{"sentText": "Some 5HT3 antagonists have 5HT4 agonist activity for example renzapride zacopride and others do not for example ondansetron granisetron while tropisetron in high concentrations is a 5HT4 antagonist", "relationMentions": [{"em1Text": "5HT4", "em2Text": "renzapride", "label": "CPR:5"}, {"em1Text": "5HT4", "em2Text": "zacopride", "label": "CPR:5"}, {"em1Text": "5HT3", "em2Text": "renzapride", "label": "CPR:6"}, {"em1Text": "5HT3", "em2Text": "zacopride", "label": "CPR:6"}, {"em1Text": "5HT4", "em2Text": "tropisetron", "label": "CPR:6"}]}
{"sentText": "A number of selective 5HT3 antagonists have been developed including ondansetron granisetron tropisetron renzapride and zacopride", "relationMentions": [{"em1Text": "5HT3", "em2Text": "zacopride", "label": "CPR:6"}, {"em1Text": "5HT3", "em2Text": "ondansetron", "label": "CPR:6"}, {"em1Text": "5HT3", "em2Text": "granisetron", "label": "CPR:6"}, {"em1Text": "5HT3", "em2Text": "tropisetron", "label": "CPR:6"}, {"em1Text": "5HT3", "em2Text": "renzapride", "label": "CPR:6"}]}
{"sentText": "We present our studies to demonstrate that HM74A but not HM74 binds niacin at high affinities and effectively mediates Gi signaling events in human embryonic kidney HEK293 cells as well as in 3T3L1 adipocytes expressing HM74A", "relationMentions": [{"em1Text": "niacin", "em2Text": "Gi", "label": "CPR:3"}]}
{"sentText": "When cultured in YPD medium containing 15 glucose under aerobic conditions the KGD1 alphaketoglutarate dehydrogenase gene disrupted mutant produced a lower level of succinate than the wildtype strain while the SDH1 succinate dehydrogenase genedisrupted mutant produced an increased level of succinate", "relationMentions": [{"em1Text": "KGD1", "em2Text": "succinate", "label": "CPR:9"}, {"em1Text": "alphaketoglutarate dehydrogenase", "em2Text": "succinate", "label": "CPR:9"}, {"em1Text": "succinate", "em2Text": "SDH1", "label": "CPR:9"}, {"em1Text": "succinate", "em2Text": "succinate dehydrogenase", "label": "CPR:9"}]}
{"sentText": "On the other hand the FUM1 fumarase gene disrupted mutant produced significantly higher levels of fumarate but did not form malate at all", "relationMentions": [{"em1Text": "FUM1", "em2Text": "fumarate", "label": "CPR:9"}, {"em1Text": "fumarase", "em2Text": "fumarate", "label": "CPR:9"}]}
{"sentText": "When the growth condition was shifted from aerobic to anaerobic the increased level of succinate in SDH1 disruptants was no longer observed whereas the decreased level of succinate in the KGD1 diruptant was still observed", "relationMentions": [{"em1Text": "succinate", "em2Text": "SDH1", "label": "CPR:9"}, {"em1Text": "succinate", "em2Text": "KGD1", "label": "CPR:9"}]}
{"sentText": "A double mutant of the two fumarate reductase isozyme genes OSM1 and FRDS showed a succinate productivity of 50 as compared to the parent when cells were incubated in glucosebuffered solution", "relationMentions": [{"em1Text": "fumarate reductase", "em2Text": "succinate", "label": "CPR:9"}, {"em1Text": "OSM1", "em2Text": "succinate", "label": "CPR:9"}, {"em1Text": "FRDS", "em2Text": "succinate", "label": "CPR:9"}]}
{"sentText": "However plasma highdensity lipoprotein cholesterol HDL C and HDL CtotalC ratio levels and plasma paraoxonase activity were only significantly higher in vitamin E group after 8 weeks", "relationMentions": [{"em1Text": "highdensity lipoprotein", "em2Text": "vitamin E", "label": "CPR:3"}, {"em1Text": "HDL", "em2Text": "vitamin E", "label": "CPR:3"}, {"em1Text": "HDL", "em2Text": "vitamin E", "label": "CPR:3"}, {"em1Text": "paraoxonase", "em2Text": "vitamin E", "label": "CPR:3"}]}
{"sentText": "Hepatic ACAT activity was significantly lower in both vitamin E and probucol groups than in HCcontrol group while HMGCoA reductase activity was the highest only in the probucol group", "relationMentions": [{"em1Text": "probucol", "em2Text": "HMGCoA reductase", "label": "CPR:3"}, {"em1Text": "ACAT", "em2Text": "vitamin E", "label": "CPR:4"}, {"em1Text": "ACAT", "em2Text": "probucol", "label": "CPR:4"}]}
{"sentText": "Vitamin E and probucol significantly suppressed an increase in plasma totalcholesterol totalC and lowdensity lipoprotein cholesterol compared to HCcontrol group", "relationMentions": [{"em1Text": "Vitamin E", "em2Text": "lowdensity lipoprotein", "label": "CPR:4"}, {"em1Text": "probucol", "em2Text": "lowdensity lipoprotein", "label": "CPR:4"}]}
{"sentText": "Hepatic mRNA expressions of apo B100 and apo CIII were significantly lower in probucol group than in other groups", "relationMentions": [{"em1Text": "apo B100", "em2Text": "probucol", "label": "CPR:4"}, {"em1Text": "apo CIII", "em2Text": "probucol", "label": "CPR:4"}]}
{"sentText": "Vitamin E supplementation was found to alter the plasma HDLCrelated factors meanwhile probucol supplementation was very effective in enhancing cholesterol metabolism except for a negative effect that reduced plasma HDL C concentration", "relationMentions": [{"em1Text": "HDL", "em2Text": "probucol", "label": "CPR:4"}]}
{"sentText": "However as with the human receptor maraviroc was shown to be a high affinity potent functional antagonist of macaque CCR5 thereby indicating that the macaque should be a suitable species in which to evaluate the pharmacology safety and potential mechanismrelated toxicology of novel CCR5 antagonists", "relationMentions": [{"em1Text": "maraviroc", "em2Text": "macaque CCR5", "label": "CPR:6"}, {"em1Text": "maraviroc", "em2Text": "CCR5", "label": "CPR:6"}]}
{"sentText": "The aim of this study was to determine if macaque represents a suitable species for the preclinical evaluation of novel CCR5 antagonists such as maraviroc UK427857", "relationMentions": [{"em1Text": "CCR5", "em2Text": "maraviroc", "label": "CPR:6"}, {"em1Text": "CCR5", "em2Text": "UK427857", "label": "CPR:6"}]}
{"sentText": "Maraviroc inhibited binding of 125IMIP1beta to CCR5 from macaque and human with similar potency IC50 = 1750 124 nM and 718 093 nM respectively and antagonised MIP1beta induced intracellular calcium release mediated through CCR5 from macaque and human with similar potency IC50 = 1750 330 nM and 1207 189 respectively", "relationMentions": [{"em1Text": "Maraviroc", "em2Text": "CCR5", "label": "CPR:6"}]}
{"sentText": "Hence reexpression of the p75NTR appears to partially reverse dedifferentiation of prostate cancer cells by upregulating the expression of CRABPI for localized sequestration of retinoids that are available to newly upregulated RARbeta RXRalpha and RXRbeta", "relationMentions": [{"em1Text": "CRABPI", "em2Text": "retinoids", "label": "CPR:3"}]}
{"sentText": "Its special profile of actions especially the rise in HDL cholesterol levels induced by nicotinic acid is unique among the currently available pharmacological tools to treat lipid disorders", "relationMentions": [{"em1Text": "HDL", "em2Text": "nicotinic acid", "label": "CPR:3"}]}
{"sentText": "RATIONALE Several drugs used to treat bipolar disorder lithium and carbamazepine when administered chronically to rats reduce the turnover of arachidonic acid but not docosahexaenoic acid in brain phospholipids by decreasing the activity of an arachidonic acidselective phospholipase A2", "relationMentions": [{"em1Text": "lithium", "em2Text": "phospholipase A2", "label": "CPR:4"}, {"em1Text": "carbamazepine", "em2Text": "phospholipase A2", "label": "CPR:4"}]}
{"sentText": "MATERIALS AND METHODSRESULTS By isolating rat brain microsomal longchain fatty acylCoA synthetases Acsl we show in vitro that valproic acid is a noncompetitive inhibitor of Acsl as it reduces the maximal velocity of the reaction without changing the affinity of the substrate for the enzyme", "relationMentions": [{"em1Text": "Acsl", "em2Text": "valproic acid", "label": "CPR:4"}]}
{"sentText": "Valproic acid selectively inhibits conversion of arachidonic acid to arachidonoylCoA by brain microsomal longchain fatty acylCoA synthetases relevance to bipolar disorder", "relationMentions": [{"em1Text": "Valproic acid", "em2Text": "brain microsomal longchain fatty acylCoA synthetases", "label": "CPR:4"}, {"em1Text": "arachidonic acid", "em2Text": "brain microsomal longchain fatty acylCoA synthetases", "label": "CPR:9"}, {"em1Text": "arachidonoylCoA", "em2Text": "brain microsomal longchain fatty acylCoA synthetases", "label": "CPR:9"}]}
{"sentText": "CONCLUSIONS This study shows that valproic acid acts as a noncompetitive inhibitor of brain microsomal Acsl and that inhibition is substrateselective", "relationMentions": [{"em1Text": "valproic acid", "em2Text": "brain microsomal Acsl", "label": "CPR:4"}]}
{"sentText": "On the other hand holocarboxylase synthetase HCS mRNA levels were markedly low in the deficient animals and increased upon biotin injection", "relationMentions": [{"em1Text": "HCS", "em2Text": "biotin", "label": "CPR:3"}, {"em1Text": "holocarboxylase synthetase", "em2Text": "biotin", "label": "CPR:3"}]}
{"sentText": "Furthermore PS liposomeinduced PGE2 production was significantly suppressed by indomethacin a preferential COX1 inhibitor but not by NS398 a selective COX2 inhibitor", "relationMentions": [{"em1Text": "indomethacin", "em2Text": "COX1", "label": "CPR:4"}, {"em1Text": "NS398", "em2Text": "COX2", "label": "CPR:4"}]}
{"sentText": "Involvement of COX1 and upregulated prostaglandin E synthases in phosphatidylserine liposomeinduced prostaglandin E2 production by microglia", "relationMentions": [{"em1Text": "COX1", "em2Text": "prostaglandin E2", "label": "CPR:9"}, {"em1Text": "prostaglandin E synthases", "em2Text": "prostaglandin E2", "label": "CPR:9"}]}
{"sentText": "These observations strongly suggest that the upregulation of terminal PGESs that are preferentially coupled with COX1 especially mPGES2 plays the pivotal role in PS liposomeinduced PGE2 production by microglia", "relationMentions": [{"em1Text": "PGESs", "em2Text": "PGE2", "label": "CPR:9"}, {"em1Text": "COX1", "em2Text": "PGE2", "label": "CPR:9"}, {"em1Text": "mPGES2", "em2Text": "PGE2", "label": "CPR:9"}]}
{"sentText": "Significant advances in the treatment of clearcell RCC have been derived from agents that target these pathways including the multiple kinase inhibitors MKIs sorafenib sunitinib and AG013736 which target multiple VEGFRs as well as PDGFRbeta", "relationMentions": [{"em1Text": "kinase", "em2Text": "sorafenib", "label": "CPR:4"}, {"em1Text": "sorafenib", "em2Text": "VEGFRs", "label": "CPR:4"}, {"em1Text": "sorafenib", "em2Text": "PDGFRbeta", "label": "CPR:4"}, {"em1Text": "kinase", "em2Text": "sunitinib", "label": "CPR:4"}, {"em1Text": "sunitinib", "em2Text": "VEGFRs", "label": "CPR:4"}, {"em1Text": "sunitinib", "em2Text": "PDGFRbeta", "label": "CPR:4"}, {"em1Text": "kinase", "em2Text": "AG013736", "label": "CPR:4"}, {"em1Text": "AG013736", "em2Text": "VEGFRs", "label": "CPR:4"}, {"em1Text": "AG013736", "em2Text": "PDGFRbeta", "label": "CPR:4"}]}
{"sentText": "Sorafenib has the added advantage of inhibiting multiple different Raf isoforms which enables it to target TGFalpha EGFR signaling and may also enhance its inhibition of VEGFR and PDGFRbeta", "relationMentions": [{"em1Text": "Sorafenib", "em2Text": "Raf", "label": "CPR:4"}, {"em1Text": "Sorafenib", "em2Text": "TGFalpha", "label": "CPR:4"}, {"em1Text": "Sorafenib", "em2Text": "EGFR", "label": "CPR:4"}, {"em1Text": "Sorafenib", "em2Text": "VEGFR", "label": "CPR:4"}, {"em1Text": "Sorafenib", "em2Text": "PDGFRbeta", "label": "CPR:4"}]}
{"sentText": "Low TS expression levels cytoplasmic expression pattern and C SNP arose as variables associated to longer progressionfree survival PFS in patients treated with 5FU", "relationMentions": [{"em1Text": "TS", "em2Text": "5FU", "label": "CPR:4"}]}
{"sentText": "Our conclusion is that chronic DPDPE treatment preferentially reduces deltaopioid receptor binding activity", "relationMentions": [{"em1Text": "DPDPE", "em2Text": "deltaopioid receptor", "label": "CPR:4"}]}
{"sentText": "Therefore in the present studies animals were rendered tolerant to the deltaopioid receptor selective agonist DPen2DPen5enkephalin DPDPE and receptor binding activities were measured", "relationMentions": [{"em1Text": "deltaopioid receptor", "em2Text": "DPDPE", "label": "CPR:5"}, {"em1Text": "deltaopioid receptor", "em2Text": "DPen2DPen5enkephalin", "label": "CPR:5"}]}
{"sentText": "Complementary experiments using the 5HT3dependent BezoldJarisch reflex confirmed that amoxapine really acts in vivo as a 5HT3 antagonist IC50 = 50 microgramskg iv", "relationMentions": [{"em1Text": "5HT3", "em2Text": "amoxapine", "label": "CPR:6"}]}
{"sentText": "Competitive radioligand binding assays were performed using cells expressing either the human serotonin 5HT transporter hSERT or norepinephrine NE transporter hNET with Ki values for DVS of 402 16 and 5584 1216 nM respectively", "relationMentions": [{"em1Text": "human serotonin 5HT transporter", "em2Text": "DVS", "label": "CPR:4"}, {"em1Text": "hSERT", "em2Text": "DVS", "label": "CPR:4"}, {"em1Text": "norepinephrine NE transporter", "em2Text": "DVS", "label": "CPR:4"}, {"em1Text": "hNET", "em2Text": "DVS", "label": "CPR:4"}]}
{"sentText": "To mimic chronic selective serotonin reuptake inhibitor treatment and to block the inhibitory 5HT1A autoreceptors a 5HT1A antagonist N242methoxyphenyl1piperazinylethylN2pyridinylcyclo hexanecarboxamide maleate salt WAY100635 03 mgkg sc was administered with DVS 30 mgkg orally", "relationMentions": [{"em1Text": "5HT1A", "em2Text": "N242methoxyphenyl1piperazinylethylN2pyridinylcyclo hexanecarboxamide maleate salt", "label": "CPR:6"}, {"em1Text": "5HT1A", "em2Text": "WAY100635", "label": "CPR:6"}]}
{"sentText": "Inhibition of 3H5HT or 3HNE uptake by DVS for the hSERT or hNET produced IC50 values of 473 194 and 5313 1130 nM respectively", "relationMentions": [{"em1Text": "3H5HT", "em2Text": "hSERT", "label": "CPR:9"}, {"em1Text": "3HNE", "em2Text": "hNET", "label": "CPR:9"}]}
{"sentText": "Further cholesterol metabolites predominantly the oxysterols the natural ligands for liver X receptor LXR induced these genes via upregulation of sterol regulatory element binding protein1c SREBP1c that bound to the regulatory regions of these genes", "relationMentions": [{"em1Text": "cholesterol", "em2Text": "sterol regulatory element binding protein1c", "label": "CPR:3"}, {"em1Text": "cholesterol", "em2Text": "SREBP1c", "label": "CPR:3"}, {"em1Text": "oxysterols", "em2Text": "sterol regulatory element binding protein1c", "label": "CPR:3"}, {"em1Text": "oxysterols", "em2Text": "SREBP1c", "label": "CPR:3"}]}
{"sentText": "The tissue RA level is maintained through a cascade of metabolic reactions where retinal dehydrogenases RALDHs catalyze the terminal reaction of RA biosynthesis from retinal a ratelimiting step", "relationMentions": [{"em1Text": "RA", "em2Text": "retinal dehydrogenases", "label": "CPR:9"}, {"em1Text": "RA", "em2Text": "RALDHs", "label": "CPR:9"}, {"em1Text": "retinal", "em2Text": "retinal dehydrogenases", "label": "CPR:9"}, {"em1Text": "retinal", "em2Text": "RALDHs", "label": "CPR:9"}]}
{"sentText": "Hypermethlyation of RELN and GAD67 promoters can be induced by treating mice with methionine and these mice display brain and behavioral abnormalities similar to rl", "relationMentions": [{"em1Text": "RELN and GAD67 promoters", "em2Text": "methionine", "label": "CPR:3"}]}
{"sentText": "Thus severe LV dysfunction and accompanying abnormal myocardial bioenergetic phenotype were prevented by the AT1 antagonist olmesartan medoxomil", "relationMentions": [{"em1Text": "AT1", "em2Text": "olmesartan medoxomil", "label": "CPR:6"}]}
{"sentText": "Functional and bioenergetic consequences of AT1 antagonist olmesartan medoxomil in hearts with postinfarction LV remodeling", "relationMentions": [{"em1Text": "AT1", "em2Text": "olmesartan medoxomil", "label": "CPR:6"}]}
{"sentText": "RESULTS Imatinib inhibited RET Y1062 phosphorylation in a dosedependent manner after 15 hours of exposure", "relationMentions": [{"em1Text": "Imatinib", "em2Text": "RET", "label": "CPR:4"}, {"em1Text": "Imatinib", "em2Text": "Y1062", "label": "CPR:4"}]}
{"sentText": "CONCLUSIONS Imatinib inhibits RETmediated MTC cell growth affecting RET protein levels in vitro in a dosedependent manner", "relationMentions": [{"em1Text": "Imatinib", "em2Text": "RET", "label": "CPR:4"}, {"em1Text": "Imatinib", "em2Text": "RET", "label": "CPR:4"}]}
{"sentText": "The concentration of imatinib necessary to inhibit RET in vitro however makes it impossible to conclude that imatinib monotherapy will be a good option for systemic therapy of MTC", "relationMentions": [{"em1Text": "imatinib", "em2Text": "RET", "label": "CPR:4"}]}
{"sentText": "We evaluated imatinib a tyrosine kinase inhibitor currently used to treat chronic myelogenous leukemia and gastrointestinal stromal tumors as a potential drug for systemic treatment of MTC in 2 MTCderived cell lines expressing multiple endocrine neoplasiaassociated mutant RET receptors", "relationMentions": [{"em1Text": "imatinib", "em2Text": "tyrosine kinase", "label": "CPR:4"}]}
{"sentText": "Retinoid is a collective term for compounds which bind to and activate retinoic acid receptors RARalpha beta gamma and RXRalpha beta gamma members of nuclear hormone receptor superfamily", "relationMentions": [{"em1Text": "Retinoid", "em2Text": "nuclear hormone receptor", "label": "CPR:3"}, {"em1Text": "Retinoid", "em2Text": "retinoic acid receptors", "label": "CPR:3"}]}
{"sentText": "Simvastatin abolished these anti CD11a mAbinduced increases in lymphocytic cholinergic activity in a manner independent of its cholesterollowering activity", "relationMentions": [{"em1Text": "Simvastatin", "em2Text": "CD11a", "label": "CPR:4"}]}
{"sentText": "The cholesterollowering drug simvastatin inhibits LFA1 signaling by binding to an allosteric site on CD11a LFA1 alpha chain which leads to immunomodulation", "relationMentions": [{"em1Text": "simvastatin", "em2Text": "LFA1", "label": "CPR:4"}]}
{"sentText": "Menthol popularly known for its cooling effect activates TRPM8 a coldactivated thermoTRP ion channel", "relationMentions": [{"em1Text": "Menthol", "em2Text": "TRPM8", "label": "CPR:3"}, {"em1Text": "Menthol", "em2Text": "thermoTRP ion channel", "label": "CPR:3"}]}
{"sentText": "However human physiological studies demonstrate a paradoxical role of menthol in modulation of warm sensation and here we show that menthol also activates heatactivated TRPV3", "relationMentions": [{"em1Text": "menthol", "em2Text": "TRPV3", "label": "CPR:3"}]}
{"sentText": "Similar to menthol both camphor and cinnamaldehyde initially reported to be specific activators of TRPV3 and TRPA1 respectively also modulate other thermoTRPs", "relationMentions": [{"em1Text": "menthol", "em2Text": "TRPV3", "label": "CPR:3"}, {"em1Text": "menthol", "em2Text": "TRPA1", "label": "CPR:3"}, {"em1Text": "camphor", "em2Text": "TRPV3", "label": "CPR:3"}, {"em1Text": "camphor", "em2Text": "TRPA1", "label": "CPR:3"}, {"em1Text": "cinnamaldehyde", "em2Text": "TRPV3", "label": "CPR:3"}, {"em1Text": "cinnamaldehyde", "em2Text": "TRPA1", "label": "CPR:3"}]}
{"sentText": "We further show that menthol inhibits TRPA1 potentially explaining the use of menthol as an analgesic", "relationMentions": [{"em1Text": "menthol", "em2Text": "TRPA1", "label": "CPR:4"}]}
{"sentText": "These currents were produced by glutamateaspartate transporters GLAST excitatory amino acid transporter 1 because they were weakly inhibited by dihydrokainate an antagonist of glutamate transporter1 excitatory amino acid transporter 2 and were absent from IPCs in GLAST cochleas", "relationMentions": [{"em1Text": "glutamateaspartate transporters", "em2Text": "dihydrokainate", "label": "CPR:4"}, {"em1Text": "GLAST", "em2Text": "dihydrokainate", "label": "CPR:4"}, {"em1Text": "excitatory amino acid transporter 1", "em2Text": "dihydrokainate", "label": "CPR:4"}, {"em1Text": "dihydrokainate", "em2Text": "glutamate transporter1", "label": "CPR:6"}, {"em1Text": "dihydrokainate", "em2Text": "excitatory amino acid transporter 2", "label": "CPR:6"}]}
{"sentText": "Focal application of the transporter substrate Daspartate elicited inward currents in IPCs which were larger in the presence of anions that permeate the transporterassociated anion channel and blocked by the transporter antagonist DLthreobetabenzyloxyaspartate", "relationMentions": [{"em1Text": "anion channel", "em2Text": "DLthreobetabenzyloxyaspartate", "label": "CPR:6"}]}
{"sentText": "The glutamateaspartate transporter GLAST mediates glutamate uptake at inner hair cell afferent synapses in the mammalian cochlea", "relationMentions": [{"em1Text": "glutamate", "em2Text": "GLAST", "label": "CPR:9"}, {"em1Text": "glutamate", "em2Text": "glutamateaspartate transporter", "label": "CPR:9"}]}
{"sentText": "Furthermore Daspartateinduced currents in outsideout patches from IPCs exhibited larger steadystate currents than responses elicited by Lglutamate a prominent feature of GLAST and examination of cochlea from GLASTDiscosoma red DsRed promoter reporter mice revealed that DsRed expression was restricted to IPCs and other supporting cells surrounding IHCs", "relationMentions": [{"em1Text": "Lglutamate", "em2Text": "GLAST", "label": "CPR:9"}]}
{"sentText": "Overexpression of proline oxidase induces proline dependent and mitochondriamediated apoptosis", "relationMentions": [{"em1Text": "proline", "em2Text": "proline oxidase", "label": "CPR:9"}]}
{"sentText": "We conclude that in the presence of proline high POX activity is sufficient to induce mitochondriamediated apoptosis", "relationMentions": [{"em1Text": "proline", "em2Text": "POX", "label": "CPR:9"}]}
{"sentText": "Proline oxidase POX a mitochondrial innermembrane protein catalyzes the ratelimiting oxidation of proline to pyrroline 5carboxylate P5C", "relationMentions": [{"em1Text": "Proline oxidase", "em2Text": "proline", "label": "CPR:9"}, {"em1Text": "POX", "em2Text": "proline", "label": "CPR:9"}, {"em1Text": "Proline oxidase", "em2Text": "pyrroline 5carboxylate", "label": "CPR:9"}, {"em1Text": "POX", "em2Text": "pyrroline 5carboxylate", "label": "CPR:9"}, {"em1Text": "Proline oxidase", "em2Text": "P5C", "label": "CPR:9"}, {"em1Text": "POX", "em2Text": "P5C", "label": "CPR:9"}]}
{"sentText": "To further investigate the molecular basis of POXinduced apoptosis we utilized the DLD1POX cells to show that cells overproducing POX exhibit an Lproline dependent apoptotic response", "relationMentions": [{"em1Text": "POX", "em2Text": "Lproline", "label": "CPR:9"}]}
{"sentText": "The apoptotic effect is specific for Lproline detectable at 02 mM maximal at 1 mM and occurs during 4872 h following the addition of Lproline to cells with maximally induced POX", "relationMentions": [{"em1Text": "Lproline", "em2Text": "POX", "label": "CPR:9"}]}
{"sentText": "The exception was bupropion a dual norepinephrine transporter dopamine transporter blocker which tended to increase spontaneous locomotor activity", "relationMentions": [{"em1Text": "bupropion", "em2Text": "norepinephrine transporter", "label": "CPR:4"}, {"em1Text": "bupropion", "em2Text": "dopamine transporter", "label": "CPR:4"}]}
{"sentText": "Coadministration of reboxetine and the dopamine transporter blocker GBR 12909 also increased spontaneous locomotor activity", "relationMentions": [{"em1Text": "dopamine transporter", "em2Text": "GBR 12909", "label": "CPR:4"}]}
{"sentText": "Fulvestrant is a novel ER antagonist that destroys the ER and its signaling pathway and is not associated with tamoxifenlike agonist effects", "relationMentions": [{"em1Text": "Fulvestrant", "em2Text": "ER", "label": "CPR:4"}, {"em1Text": "Fulvestrant", "em2Text": "ER", "label": "CPR:6"}]}
{"sentText": "Tamoxifen blocks the action of estrogen by binding to the ER and possesses both ER agonist and antagonist properties", "relationMentions": [{"em1Text": "Tamoxifen", "em2Text": "ER", "label": "CPR:5"}, {"em1Text": "Tamoxifen", "em2Text": "ER", "label": "CPR:6"}]}
{"sentText": "Binding of cGMP to GAFA increases cNPK phosphorylation of PDE5 and improves catalytic site affinity for cGMP or inhibitors", "relationMentions": [{"em1Text": "cGMP", "em2Text": "cNPK", "label": "CPR:3"}, {"em1Text": "cGMP", "em2Text": "PDE5", "label": "CPR:3"}]}
{"sentText": "Phosphodiesterase5 PDE5 contains a catalytic domain C domain that hydrolyzes cGMP and a regulatory domain R domain that contains two mammalian cGMPbinding phosphodiesterase Anabaena adenylyl cyclases Escherichia coli FhlAs GAFs A and B and a phosphorylation site for cyclic nucleotidedependent protein kinases cNPKs", "relationMentions": [{"em1Text": "Phosphodiesterase5", "em2Text": "cGMP", "label": "CPR:9"}, {"em1Text": "PDE5", "em2Text": "cGMP", "label": "CPR:9"}]}
{"sentText": "Km values of the mutants for cGMP were similar to that of fulllength PDE5", "relationMentions": [{"em1Text": "cGMP", "em2Text": "PDE5", "label": "CPR:9"}]}
{"sentText": "Telmisartan downregulates angiotensin II type 1 receptor through activation of peroxisome proliferatoractivated receptor gamma", "relationMentions": [{"em1Text": "Telmisartan", "em2Text": "peroxisome proliferatoractivated receptor gamma", "label": "CPR:3"}, {"em1Text": "Telmisartan", "em2Text": "angiotensin II type 1 receptor", "label": "CPR:4"}]}
{"sentText": "Since the suppression of AT1R expression was prevented by pretreatment with GW9662 a PPARgamma antagonist PPARgamma should have participated in the process", "relationMentions": [{"em1Text": "AT1R", "em2Text": "GW9662", "label": "CPR:3"}, {"em1Text": "GW9662", "em2Text": "PPARgamma", "label": "CPR:6"}]}
{"sentText": "CONCLUSION Our data provides a novel insight into an effect of telmisartan telmisartan inhibits AT1R gene expression through PPARgamma activation", "relationMentions": [{"em1Text": "telmisartan", "em2Text": "PPARgamma", "label": "CPR:3"}, {"em1Text": "telmisartan", "em2Text": "AT1R", "label": "CPR:4"}]}
{"sentText": "Decreased AT1R promoter activity with unchanged mRNA stability suggested that telmisartan suppressed AT1R gene expression at the transcriptional level", "relationMentions": [{"em1Text": "AT1R", "em2Text": "telmisartan", "label": "CPR:4"}]}
{"sentText": "The deletion and mutation analysis of the AT1R gene promoter indicated that a GC box located in the proximal promoter region is responsible for the telmisartan induced downregulation", "relationMentions": [{"em1Text": "AT1R", "em2Text": "telmisartan", "label": "CPR:4"}, {"em1Text": "GC box", "em2Text": "telmisartan", "label": "CPR:4"}]}
{"sentText": "RESULTS Telmisartan decreased the expression of AT1R at the mRNA and protein levels in a dose and timedependent manner", "relationMentions": [{"em1Text": "Telmisartan", "em2Text": "AT1R", "label": "CPR:4"}]}
{"sentText": "OBJECTIVE Telmisartan an angiotensin II type 1 receptor AT1R antagonist was found to have a unique property it is a partial agonist of peroxisome proliferatoractivated receptor gamma PPARgamma", "relationMentions": [{"em1Text": "Telmisartan", "em2Text": "peroxisome proliferatoractivated receptor gamma", "label": "CPR:5"}, {"em1Text": "Telmisartan", "em2Text": "PPARgamma", "label": "CPR:5"}, {"em1Text": "Telmisartan", "em2Text": "angiotensin II type 1 receptor", "label": "CPR:6"}, {"em1Text": "Telmisartan", "em2Text": "AT1R", "label": "CPR:6"}]}
{"sentText": "However the expression of AT1R was not suppressed by other AT1R antagonists such as candesartan or olmesartan", "relationMentions": [{"em1Text": "AT1R", "em2Text": "candesartan", "label": "CPR:6"}, {"em1Text": "AT1R", "em2Text": "olmesartan", "label": "CPR:6"}]}
{"sentText": "Upon differentiation osteoclasts express vesicular glutamate transporter 1 VGLUT1 which is essential for vesicular storage and subsequent exocytosis of glutamate in neurons", "relationMentions": [{"em1Text": "vesicular glutamate transporter 1", "em2Text": "glutamate", "label": "CPR:9"}, {"em1Text": "glutamate", "em2Text": "VGLUT1", "label": "CPR:9"}]}
{"sentText": "VGLUT1 is localized in transcytotic vesicles and accumulates Lglutamate", "relationMentions": [{"em1Text": "VGLUT1", "em2Text": "Lglutamate", "label": "CPR:9"}]}
{"sentText": "In order to produce potent new leads for anticancer drugs a new series of quinazoline analogs was designed to resemble methotrexate MTX 1 structure features and fitted with functional groups believed to enhance inhibition of mammalian DHFR activity", "relationMentions": [{"em1Text": "methotrexate", "em2Text": "mammalian DHFR", "label": "CPR:4"}, {"em1Text": "MTX", "em2Text": "mammalian DHFR", "label": "CPR:4"}, {"em1Text": "quinazoline", "em2Text": "mammalian DHFR", "label": "CPR:4"}]}
{"sentText": "Synthesis dihydrofolate reductase inhibition antitumor testing and molecular modeling study of some new 43Hquinazolinone analogs", "relationMentions": [{"em1Text": "dihydrofolate reductase", "em2Text": "43Hquinazolinone", "label": "CPR:4"}]}
{"sentText": "CONCLUSION Intake of high SFAs and MUFAs appears to increase expression of PBMC D6D and D5D genes whilst high EFAs intake appears to decrease expression of PBMC D6D and D5D genes", "relationMentions": [{"em1Text": "SFAs", "em2Text": "D6D", "label": "CPR:3"}, {"em1Text": "SFAs", "em2Text": "D5D", "label": "CPR:3"}, {"em1Text": "MUFAs", "em2Text": "D6D", "label": "CPR:3"}, {"em1Text": "MUFAs", "em2Text": "D5D", "label": "CPR:3"}, {"em1Text": "D6D", "em2Text": "EFAs", "label": "CPR:4"}, {"em1Text": "D5D", "em2Text": "EFAs", "label": "CPR:4"}]}
{"sentText": "A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC D6D and D5D genes but a significant negative correlation between dietary intake of linoleic acid LA and alphalinolenic acid LNA and the expression of PBMC D6D and D5D genes", "relationMentions": [{"em1Text": "D6D", "em2Text": "linoleic acid", "label": "CPR:4"}, {"em1Text": "D5D", "em2Text": "linoleic acid", "label": "CPR:4"}, {"em1Text": "D6D", "em2Text": "LA", "label": "CPR:4"}, {"em1Text": "D5D", "em2Text": "LA", "label": "CPR:4"}, {"em1Text": "D6D", "em2Text": "alphalinolenic acid", "label": "CPR:4"}, {"em1Text": "D5D", "em2Text": "alphalinolenic acid", "label": "CPR:4"}, {"em1Text": "D6D", "em2Text": "LNA", "label": "CPR:4"}, {"em1Text": "D5D", "em2Text": "LNA", "label": "CPR:4"}]}
{"sentText": "Decitabine inhibits DNA methyltransferase and has shown therapeutic effects in patients with hematologic malignancies", "relationMentions": [{"em1Text": "Decitabine", "em2Text": "DNA methyltransferase", "label": "CPR:4"}]}
{"sentText": "Our data suggest that larginine is taken up by Sertoli cells and peritubular cells principally via system yL SLC3A2 SLC7A6 and system y SLC7A1 and SLC7A2 with system B0 making a minor contribution", "relationMentions": [{"em1Text": "larginine", "em2Text": "SLC3A2", "label": "CPR:9"}]}
{"sentText": "KIEs were measured on the arsenolysis of 5methylthioadenosine MTA catalyzed by MTAP and were corrected for the forward commitment to catalysis", "relationMentions": [{"em1Text": "5methylthioadenosine", "em2Text": "MTAP", "label": "CPR:9"}, {"em1Text": "MTA", "em2Text": "MTAP", "label": "CPR:9"}]}
{"sentText": "Blocking retinyl ester formation by a targeted knock down of Lratb results in significantly increased retinoic acid levels which lead to severe embryonic patterning defects", "relationMentions": [{"em1Text": "retinyl ester", "em2Text": "Lratb", "label": "CPR:9"}]}
{"sentText": "During embryogenesis lratb is expressed in mostly nonoverlapping domains opposite to retinal dehydrogenase 2 raldh2 the key enzyme for retinoic acid synthesis", "relationMentions": [{"em1Text": "retinal dehydrogenase 2", "em2Text": "retinoic acid", "label": "CPR:9"}, {"em1Text": "raldh2", "em2Text": "retinoic acid", "label": "CPR:9"}]}
{"sentText": "ADP initiates platelet aggregation by simultaneous activation of two G proteincoupled receptors P2Y1 and P2Y12", "relationMentions": [{"em1Text": "ADP", "em2Text": "G proteincoupled receptors", "label": "CPR:3"}, {"em1Text": "ADP", "em2Text": "P2Y1", "label": "CPR:3"}, {"em1Text": "ADP", "em2Text": "P2Y12", "label": "CPR:3"}]}
{"sentText": "Our results imply that P2Y12 has the potential to be inhibited by ADP ATP analogs and it suggests that P2Y12 acts as a target of new drugs that inhibit platelet aggregation", "relationMentions": [{"em1Text": "P2Y12", "em2Text": "ADP", "label": "CPR:4"}, {"em1Text": "P2Y12", "em2Text": "ATP", "label": "CPR:4"}]}
{"sentText": "Cd rapidly increased cjun cfos and PDGFA expression", "relationMentions": [{"em1Text": "Cd", "em2Text": "cjun", "label": "CPR:3"}, {"em1Text": "Cd", "em2Text": "cfos", "label": "CPR:3"}, {"em1Text": "Cd", "em2Text": "PDGFA", "label": "CPR:3"}]}
{"sentText": "In conclusion our results indicate that Cd increases BC cell proliferation in vitro by stimulating Akt ERK12 and PDGFRalpha kinases activity likely by activating cfos cjun and PDGFA by an ERalphadependent mechanism", "relationMentions": [{"em1Text": "Cd", "em2Text": "Akt", "label": "CPR:3"}, {"em1Text": "Cd", "em2Text": "PDGFRalpha", "label": "CPR:3"}, {"em1Text": "Cd", "em2Text": "kinases", "label": "CPR:3"}, {"em1Text": "Cd", "em2Text": "cfos", "label": "CPR:3"}, {"em1Text": "Cd", "em2Text": "cjun", "label": "CPR:3"}, {"em1Text": "Cd", "em2Text": "PDGFA", "label": "CPR:3"}]}
{"sentText": "Cd also increased ERK12 Akt and PDGFRalpha phosphorylation while ICI blocked it", "relationMentions": [{"em1Text": "Cd", "em2Text": "Akt", "label": "CPR:3"}, {"em1Text": "Cd", "em2Text": "PDGFRalpha", "label": "CPR:3"}]}
{"sentText": "Cd decreased ERalpha expression but not ERbeta", "relationMentions": [{"em1Text": "Cd", "em2Text": "ERalpha", "label": "CPR:4"}]}
{"sentText": "Gonadotropinreleasing hormone functionally antagonizes testosterone activation of the human androgen receptor in prostate cells through focal adhesion complexes involving Hic5", "relationMentions": [{"em1Text": "testosterone", "em2Text": "human androgen receptor", "label": "CPR:3"}, {"em1Text": "Gonadotropinreleasing hormone", "em2Text": "human androgen receptor", "label": "CPR:6"}]}
{"sentText": "GnRH induced Pyk2 activation opposed the association of Hic5 with androgen receptor as overexpression of a dominant negative Pyk2 enhanced the GnRH induced nuclear translocation of a green fluorescent proteintagged human androgen receptor", "relationMentions": [{"em1Text": "GnRH", "em2Text": "Pyk2", "label": "CPR:3"}, {"em1Text": "GnRH", "em2Text": "Hic5", "label": "CPR:4"}, {"em1Text": "GnRH", "em2Text": "androgen receptor", "label": "CPR:4"}]}
{"sentText": "GnRH induced cSrc activation resulted in the phosphorylation of expressed Hic5 and promoted its association with the human androgen receptor", "relationMentions": [{"em1Text": "GnRH", "em2Text": "cSrc", "label": "CPR:3"}]}
{"sentText": "In contrast to testosterone GnRHinduced nuclear translocation did not transcriptionally activate the androgen receptor", "relationMentions": [{"em1Text": "testosterone", "em2Text": "androgen receptor", "label": "CPR:3"}]}
{"sentText": "EC50 values for SMETH were 089 092 and 444 microM for rTAAR1 mTAAR1 and hrChTAAR1 respectively", "relationMentions": [{"em1Text": "SMETH", "em2Text": "rTAAR1", "label": "CPR:3"}, {"em1Text": "SMETH", "em2Text": "mTAAR1", "label": "CPR:3"}, {"em1Text": "SMETH", "em2Text": "hrChTAAR1", "label": "CPR:3"}]}
{"sentText": "The discovery that METH and AMPH activate the rTAAR1 motivated us to study the effect of these drugs on the mouse TAAR1 mTAAR1 and a humanrat chimera hrChTAAR1", "relationMentions": [{"em1Text": "METH", "em2Text": "rTAAR1", "label": "CPR:3"}, {"em1Text": "AMPH", "em2Text": "rTAAR1", "label": "CPR:3"}]}
{"sentText": "Furthermore because Sisomers of METH and AMPH are reported to be more potent and efficacious in vivo than R we determined the enantiomeric selectivity of all three species of TAAR1", "relationMentions": [{"em1Text": "METH", "em2Text": "TAAR1", "label": "CPR:3"}, {"em1Text": "AMPH", "em2Text": "TAAR1", "label": "CPR:3"}]}
{"sentText": "PEA was a potent and full agonist at each species of TAAR1 whereas TYR was a full agonist for the rodent TAAR1s but was a partial agonist at hrChTAAR1", "relationMentions": [{"em1Text": "PEA", "em2Text": "TAAR1", "label": "CPR:5"}, {"em1Text": "TYR", "em2Text": "rodent TAAR1s", "label": "CPR:5"}, {"em1Text": "TYR", "em2Text": "hrChTAAR1", "label": "CPR:5"}]}
{"sentText": "Interestingly both isomers of METH were full agonists at mTAAR1 and hrChTAAR1 whereas both were partial agonists at rTAAR1", "relationMentions": [{"em1Text": "METH", "em2Text": "mTAAR1", "label": "CPR:5"}, {"em1Text": "METH", "em2Text": "hrChTAAR1", "label": "CPR:5"}, {"em1Text": "METH", "em2Text": "rTAAR1", "label": "CPR:5"}]}
{"sentText": "Finally we showed that chlorate activated endocrine cell development by inducing neurogenin 3 Neurog3 expression in early endocrine progenitor cells", "relationMentions": [{"em1Text": "chlorate", "em2Text": "neurogenin 3", "label": "CPR:3"}, {"em1Text": "chlorate", "em2Text": "Neurog3", "label": "CPR:3"}]}
{"sentText": "The metallic taste reported as a side effect after the treatment with systemic sulfonamides may be due to the inhibition of the salivary CA VI", "relationMentions": [{"em1Text": "sulfonamides", "em2Text": "salivary CA VI", "label": "CPR:4"}]}
{"sentText": "Some clinically used compounds such as acetazolamide methazolamide ethoxzolamide dichlorophenamide dorzolamide brinzolamide topiramate sulpiride and indisulam or the orphan drug benzolamide showed effective hCA VI inhibitory activity with inhibition constants of 0879 nM", "relationMentions": [{"em1Text": "dichlorophenamide", "em2Text": "hCA VI", "label": "CPR:4"}, {"em1Text": "acetazolamide", "em2Text": "hCA VI", "label": "CPR:4"}, {"em1Text": "methazolamide", "em2Text": "hCA VI", "label": "CPR:4"}, {"em1Text": "ethoxzolamide", "em2Text": "hCA VI", "label": "CPR:4"}, {"em1Text": "dorzolamide", "em2Text": "hCA VI", "label": "CPR:4"}, {"em1Text": "brinzolamide", "em2Text": "hCA VI", "label": "CPR:4"}, {"em1Text": "topiramate", "em2Text": "hCA VI", "label": "CPR:4"}, {"em1Text": "sulpiride", "em2Text": "hCA VI", "label": "CPR:4"}, {"em1Text": "indisulam", "em2Text": "hCA VI", "label": "CPR:4"}, {"em1Text": "benzolamide", "em2Text": "hCA VI", "label": "CPR:4"}]}
{"sentText": "DNA cloning characterization and inhibition studies of the human secretory isoform VI a new target for sulfonamide and sulfamate inhibitors", "relationMentions": [{"em1Text": "human secretory isoform VI", "em2Text": "sulfonamide", "label": "CPR:4"}, {"em1Text": "human secretory isoform VI", "em2Text": "sulfamate", "label": "CPR:4"}]}
{"sentText": "The best inhibitors were brinzolamide and sulpiride KI values of 0809 nM the latter compound being also a CA VI selective inhibitor", "relationMentions": [{"em1Text": "brinzolamide", "em2Text": "CA VI", "label": "CPR:4"}, {"em1Text": "sulpiride", "em2Text": "CA VI", "label": "CPR:4"}]}
{"sentText": "Some of the compounds investigated in this study might be used as additives in toothpastes for reducing the acidification produced by the relevant CO2 hydrase activity of enamel CA VI which leads to the formation of protons and bicarbonate and may have a role in cariogenesis", "relationMentions": [{"em1Text": "CO2", "em2Text": "CA VI", "label": "CPR:9"}, {"em1Text": "CA VI", "em2Text": "bicarbonate", "label": "CPR:9"}]}
{"sentText": "The kinetic parameters for the CO2 hydration reaction proved hCA VI to possess a kcat of 34 x 105 s1 and kcatKM of 49 x 107 M1 s1 at pH 75 and 20 degrees C", "relationMentions": [{"em1Text": "CO2", "em2Text": "hCA VI", "label": "CPR:9"}]}
{"sentText": "Transmembrane isoforms of adenylate cyclases AC integrate a wide variety of extracellular signals from neurotransmitters to morphogens and can also regulate cAMP production in response to calcium entry", "relationMentions": [{"em1Text": "adenylate cyclases", "em2Text": "cAMP", "label": "CPR:9"}, {"em1Text": "AC", "em2Text": "cAMP", "label": "CPR:9"}]}
{"sentText": "Here we report that the antifibrotic drug 5methyl1phenyl21Hpyridone pirfenidone PFD elicits growthinhibitory effects and reduces TGFbeta2 protein levels in human glioma cell lines", "relationMentions": [{"em1Text": "5methyl1phenyl21Hpyridone", "em2Text": "TGFbeta2", "label": "CPR:4"}, {"em1Text": "pirfenidone", "em2Text": "TGFbeta2", "label": "CPR:4"}, {"em1Text": "PFD", "em2Text": "TGFbeta2", "label": "CPR:4"}]}
{"sentText": "This reduction in TGFbeta 2 is biologically relevant since PFD treatment reduces the growth inhibition of TGFbeta sensitive CCL64 cells mediated by conditioned media of glioma cells", "relationMentions": [{"em1Text": "TGFbeta", "em2Text": "PFD", "label": "CPR:4"}]}
{"sentText": "PFD leads to a reduction of TGFbeta2 mRNA levels and of the mature TGFbeta2 protein due to decreased expression and direct inhibition of the TGFbeta proprotein convertase furin", "relationMentions": [{"em1Text": "PFD", "em2Text": "TGFbeta2", "label": "CPR:4"}, {"em1Text": "PFD", "em2Text": "TGFbeta2", "label": "CPR:4"}, {"em1Text": "PFD", "em2Text": "TGFbeta", "label": "CPR:4"}, {"em1Text": "PFD", "em2Text": "proprotein convertase", "label": "CPR:4"}, {"em1Text": "PFD", "em2Text": "furin", "label": "CPR:4"}]}
{"sentText": "In addition PFD reduces the protein levels of the matrix metalloproteinase MMP11 a TGFbeta target gene and furin substrate involved in carcinogenesis", "relationMentions": [{"em1Text": "PFD", "em2Text": "matrix metalloproteinase MMP11", "label": "CPR:4"}, {"em1Text": "PFD", "em2Text": "TGFbeta", "label": "CPR:4"}]}
{"sentText": "Pirfenidone inhibits TGFbeta expression in malignant glioma cells", "relationMentions": [{"em1Text": "Pirfenidone", "em2Text": "TGFbeta", "label": "CPR:4"}]}
{"sentText": "UNLABELLED Bile acidcoenzyme Aamino acid Nacyltransferase BAAT is the sole enzyme responsible for conjugation of primary and secondary bile acids to taurine and glycine", "relationMentions": [{"em1Text": "Bile acidcoenzyme Aamino acid Nacyltransferase", "em2Text": "bile acids", "label": "CPR:9"}, {"em1Text": "BAAT", "em2Text": "bile acids", "label": "CPR:9"}, {"em1Text": "Bile acidcoenzyme Aamino acid Nacyltransferase", "em2Text": "taurine", "label": "CPR:9"}, {"em1Text": "BAAT", "em2Text": "taurine", "label": "CPR:9"}, {"em1Text": "Bile acidcoenzyme Aamino acid Nacyltransferase", "em2Text": "glycine", "label": "CPR:9"}, {"em1Text": "BAAT", "em2Text": "glycine", "label": "CPR:9"}]}
{"sentText": "The absence or presence of a cytosolic pool of BAAT has important implications for the intracellular transport of unconjugateddeconjugated bile salts", "relationMentions": [{"em1Text": "BAAT", "em2Text": "bile salts", "label": "CPR:9"}]}
{"sentText": "The recombinant strains of the flavinogenic yeast Candida famata which contain the DNA fragment consisting of the FMN1 gene encoding the riboflavin kinase enzyme that converts riboflavin to flavinmononucleotide driven by the strong promoters the regulated RIB1 or constitutive TEF1 promoter were isolated", "relationMentions": [{"em1Text": "riboflavin", "em2Text": "riboflavin kinase", "label": "CPR:9"}, {"em1Text": "riboflavin kinase", "em2Text": "flavinmononucleotide", "label": "CPR:9"}]}
{"sentText": "Mouse ornithine decarboxylase ODC was expressed in Escherichia coli and the purified recombinant enzyme used for determination of the binding site for pyridoxal 5phosphate and of the residues modified in the inactivation of the enzyme by the enzymeactivated irreversible inhibitor alphadifluoromethylornithine DFMO", "relationMentions": [{"em1Text": "Mouse ornithine decarboxylase", "em2Text": "alphadifluoromethylornithine", "label": "CPR:4"}, {"em1Text": "ODC", "em2Text": "alphadifluoromethylornithine", "label": "CPR:4"}, {"em1Text": "Mouse ornithine decarboxylase", "em2Text": "DFMO", "label": "CPR:4"}, {"em1Text": "ODC", "em2Text": "DFMO", "label": "CPR:4"}]}
{"sentText": "Mechanism of the irreversible inactivation of mouse ornithine decarboxylase by alphadifluoromethylornithine", "relationMentions": [{"em1Text": "mouse ornithine decarboxylase", "em2Text": "alphadifluoromethylornithine", "label": "CPR:4"}]}
{"sentText": "Here we describe a new photolabile alanine derivative based on protection of alanine with the 4methoxy7nitroindolinyl MNI caging group which we use for presteadystate kinetic analysis of alanine transport by ASCT2 SNAT1 and SNAT2", "relationMentions": [{"em1Text": "alanine", "em2Text": "ASCT2", "label": "CPR:9"}, {"em1Text": "alanine", "em2Text": "SNAT1", "label": "CPR:9"}, {"em1Text": "alanine", "em2Text": "SNAT2", "label": "CPR:9"}, {"em1Text": "alanine", "em2Text": "ASCT2", "label": "CPR:9"}, {"em1Text": "alanine", "em2Text": "SNAT1", "label": "CPR:9"}, {"em1Text": "alanine", "em2Text": "SNAT2", "label": "CPR:9"}, {"em1Text": "4methoxy7nitroindolinyl", "em2Text": "ASCT2", "label": "CPR:9"}, {"em1Text": "4methoxy7nitroindolinyl", "em2Text": "SNAT1", "label": "CPR:9"}, {"em1Text": "4methoxy7nitroindolinyl", "em2Text": "SNAT2", "label": "CPR:9"}, {"em1Text": "MNI", "em2Text": "ASCT2", "label": "CPR:9"}, {"em1Text": "MNI", "em2Text": "SNAT1", "label": "CPR:9"}, {"em1Text": "MNI", "em2Text": "SNAT2", "label": "CPR:9"}]}
{"sentText": "NaDependent transmembrane transport of small neutral amino acids such as glutamine and alanine is mediated among others by the neutral amino acid transporters of the solute carrier 1 SLC1 alanine serine cysteine transporter 1 ASCT1 and ASCT2 and SLC38 families sodiumcoupled neutral amino acid transporter 1 SNAT1 SNAT2 and SNAT4", "relationMentions": [{"em1Text": "amino acids", "em2Text": "neutral amino acid transporters", "label": "CPR:9"}, {"em1Text": "amino acids", "em2Text": "solute carrier 1", "label": "CPR:9"}, {"em1Text": "amino acids", "em2Text": "SLC1", "label": "CPR:9"}, {"em1Text": "amino acids", "em2Text": "alanine serine cysteine transporter 1", "label": "CPR:9"}, {"em1Text": "amino acids", "em2Text": "ASCT1", "label": "CPR:9"}, {"em1Text": "amino acids", "em2Text": "ASCT2", "label": "CPR:9"}, {"em1Text": "amino acids", "em2Text": "SLC38", "label": "CPR:9"}, {"em1Text": "amino acids", "em2Text": "sodiumcoupled neutral amino acid transporter 1", "label": "CPR:9"}, {"em1Text": "amino acids", "em2Text": "SNAT1", "label": "CPR:9"}, {"em1Text": "amino acids", "em2Text": "SNAT2", "label": "CPR:9"}, {"em1Text": "amino acids", "em2Text": "SNAT4", "label": "CPR:9"}, {"em1Text": "glutamine", "em2Text": "neutral amino acid transporters", "label": "CPR:9"}, {"em1Text": "glutamine", "em2Text": "solute carrier 1", "label": "CPR:9"}, {"em1Text": "glutamine", "em2Text": "SLC1", "label": "CPR:9"}, {"em1Text": "glutamine", "em2Text": "alanine serine cysteine transporter 1", "label": "CPR:9"}, {"em1Text": "glutamine", "em2Text": "ASCT1", "label": "CPR:9"}, {"em1Text": "glutamine", "em2Text": "ASCT2", "label": "CPR:9"}, {"em1Text": "glutamine", "em2Text": "SLC38", "label": "CPR:9"}, {"em1Text": "glutamine", "em2Text": "sodiumcoupled neutral amino acid transporter 1", "label": "CPR:9"}, {"em1Text": "glutamine", "em2Text": "SNAT1", "label": "CPR:9"}, {"em1Text": "glutamine", "em2Text": "SNAT2", "label": "CPR:9"}, {"em1Text": "glutamine", "em2Text": "SNAT4", "label": "CPR:9"}, {"em1Text": "alanine", "em2Text": "neutral amino acid transporters", "label": "CPR:9"}, {"em1Text": "alanine", "em2Text": "solute carrier 1", "label": "CPR:9"}, {"em1Text": "alanine", "em2Text": "SLC1", "label": "CPR:9"}, {"em1Text": "alanine", "em2Text": "alanine serine cysteine transporter 1", "label": "CPR:9"}, {"em1Text": "alanine", "em2Text": "ASCT1", "label": "CPR:9"}, {"em1Text": "alanine", "em2Text": "ASCT2", "label": "CPR:9"}, {"em1Text": "alanine", "em2Text": "sodiumcoupled neutral amino acid transporter 1", "label": "CPR:9"}, {"em1Text": "alanine", "em2Text": "SNAT1", "label": "CPR:9"}, {"em1Text": "alanine", "em2Text": "SNAT2", "label": "CPR:9"}, {"em1Text": "alanine", "em2Text": "SNAT4", "label": "CPR:9"}]}
{"sentText": "Stimulated Pselectin and integrin alphaIIbbeta3 expression were also higher in the upper tertile both before and after aspirin", "relationMentions": [{"em1Text": "Pselectin", "em2Text": "aspirin", "label": "CPR:3"}, {"em1Text": "integrin alphaIIbbeta3", "em2Text": "aspirin", "label": "CPR:3"}]}
{"sentText": "Moreover ERalpha mediated the protection afforded by estrogen since only the ERalpha agonist HPTE but not the ERbeta agonist DPN protected against dopamine cell loss", "relationMentions": [{"em1Text": "ERbeta", "em2Text": "DPN", "label": "CPR:5"}]}
{"sentText": "At least 4 h of estrogen pretreatment was required to elicit protection an effect that was blocked by the ER antagonist ICI 182780", "relationMentions": [{"em1Text": "ER", "em2Text": "ICI 182780", "label": "CPR:6"}]}
{"sentText": "Differential activation of cAMP response element binding protein in discrete nucleus accumbens subregions during early and late cocaine sensitization", "relationMentions": [{"em1Text": "cAMP response element binding protein", "em2Text": "cocaine", "label": "CPR:3"}]}
{"sentText": "The temporal and anatomical determinants of cocaine induced CREB activity may indicate functional differences among NAc shell subregions and suggest the involvement of CREB in early and late cocaine effects", "relationMentions": [{"em1Text": "cocaine", "em2Text": "CREB", "label": "CPR:3"}]}
{"sentText": "The present study examined the differential cocaine induced activation of the cyclic adenosine monophosphate cAMP response element binding protein CREB throughout discrete zones of analysis of the nucleus accumbens NAc in rats", "relationMentions": [{"em1Text": "cocaine", "em2Text": "CREB", "label": "CPR:3"}, {"em1Text": "cocaine", "em2Text": "cyclic adenosine monophosphate cAMP response element binding protein", "label": "CPR:3"}]}
{"sentText": "Using immunohistochemistry the authors analyzed changes in CREB phosphorylation in the NAc after 5 days of cocaine a short or long drugfree period and a subsequent challenge injection", "relationMentions": [{"em1Text": "CREB", "em2Text": "cocaine", "label": "CPR:3"}]}
{"sentText": "Repeated cocaine resulted in CREB phosphorylation in all analyzed subregions of the NAc excluding the most ventrolateral region of the shell 2 weeks after cessation of repeated cocaine but rats challenged after 2 drugfree days yielded a more localized activation of CREB in the 3 most dorsomedial zones of the shell", "relationMentions": [{"em1Text": "cocaine", "em2Text": "CREB", "label": "CPR:3"}, {"em1Text": "cocaine", "em2Text": "CREB", "label": "CPR:3"}]}
{"sentText": "The carboxylation of glutamic acid residues to gammacarboxyglutamic acid Gla by the vitamin Kdependent gammaglutamyl carboxylase gammacarboxylase is an essential posttranslational modification required for the biological activity of a number of proteins including proteins involved in blood coagulation and its regulation", "relationMentions": [{"em1Text": "glutamic acid", "em2Text": "vitamin Kdependent gammaglutamyl carboxylase", "label": "CPR:9"}, {"em1Text": "glutamic acid", "em2Text": "gammacarboxylase", "label": "CPR:9"}, {"em1Text": "gammacarboxyglutamic acid", "em2Text": "vitamin Kdependent gammaglutamyl carboxylase", "label": "CPR:9"}, {"em1Text": "gammacarboxyglutamic acid", "em2Text": "gammacarboxylase", "label": "CPR:9"}, {"em1Text": "Gla", "em2Text": "vitamin Kdependent gammaglutamyl carboxylase", "label": "CPR:9"}, {"em1Text": "Gla", "em2Text": "gammacarboxylase", "label": "CPR:9"}]}
{"sentText": "RAMH inhibition of cholangiocyte growth was associated with decreased cAMP levels and PKA ERK12 Elk1 phosphorylation", "relationMentions": [{"em1Text": "RAMH", "em2Text": "PKA", "label": "CPR:4"}, {"em1Text": "RAMH", "em2Text": "ERK12", "label": "CPR:4"}, {"em1Text": "RAMH", "em2Text": "Elk1", "label": "CPR:4"}]}
{"sentText": "2 Does in vivo administration of Ralphamethylhistamine dihydrobromide RAMH H3R agonist thioperamide maleate H3R antagonist or histamine in the absencepresence of thioperamide maleate to bile duct ligated BDL rats regulate cholangiocyte proliferation", "relationMentions": [{"em1Text": "Ralphamethylhistamine dihydrobromide", "em2Text": "H3R", "label": "CPR:5"}, {"em1Text": "RAMH", "em2Text": "H3R", "label": "CPR:5"}, {"em1Text": "H3R", "em2Text": "thioperamide maleate", "label": "CPR:6"}]}
{"sentText": "Proline dehydrogenase PRODH and Delta1pyrroline5carboxylate dehydrogenase P5CDH catalyze the twostep oxidation of proline to glutamate", "relationMentions": [{"em1Text": "Proline dehydrogenase", "em2Text": "proline", "label": "CPR:9"}, {"em1Text": "PRODH", "em2Text": "proline", "label": "CPR:9"}, {"em1Text": "Delta1pyrroline5carboxylate dehydrogenase", "em2Text": "proline", "label": "CPR:9"}, {"em1Text": "P5CDH", "em2Text": "proline", "label": "CPR:9"}, {"em1Text": "Proline dehydrogenase", "em2Text": "glutamate", "label": "CPR:9"}, {"em1Text": "PRODH", "em2Text": "glutamate", "label": "CPR:9"}, {"em1Text": "Delta1pyrroline5carboxylate dehydrogenase", "em2Text": "glutamate", "label": "CPR:9"}, {"em1Text": "P5CDH", "em2Text": "glutamate", "label": "CPR:9"}]}
{"sentText": "Finally we demonstrate that T thermophilus PRODH reacts with O2 producing superoxide", "relationMentions": [{"em1Text": "T thermophilus PRODH", "em2Text": "O2", "label": "CPR:9"}, {"em1Text": "T thermophilus PRODH", "em2Text": "superoxide", "label": "CPR:9"}]}
{"sentText": "This is significant because superoxide production underlies the role of human PRODH in p53mediated apoptosis implying commonalities between eukaryotic and bacterial monofunctional PRODHs", "relationMentions": [{"em1Text": "superoxide", "em2Text": "human PRODH", "label": "CPR:9"}]}
{"sentText": "Results of early clinical trials with both topically cipamfylline CP80633 and systemically CC10004 active PDE4 inhibitors demonstrated efficacy in atopic dermatitis and in the case of CC10004 also in psoriasis", "relationMentions": [{"em1Text": "cipamfylline", "em2Text": "PDE4", "label": "CPR:4"}, {"em1Text": "CP80633", "em2Text": "PDE4", "label": "CPR:4"}]}
{"sentText": "Consequently PDE4 inhibitors including cilomilast and AWD 12281 have been tested in several models of allergic and irritant skin inflammation", "relationMentions": [{"em1Text": "PDE4", "em2Text": "cilomilast", "label": "CPR:4"}, {"em1Text": "PDE4", "em2Text": "AWD 12281", "label": "CPR:4"}]}
{"sentText": "The phosphodiesterase PDE 4 is the predominant cyclic AMP degrading enzyme in a variety of inflammatory cells including eosinophils neutrophils macrophages T cells and monocytes", "relationMentions": [{"em1Text": "phosphodiesterase PDE 4", "em2Text": "cyclic AMP", "label": "CPR:9"}]}
{"sentText": "Although considerable functional diversity exists most C2 domains are activated by Ca2 binding and then dock to a specific cellular membrane", "relationMentions": [{"em1Text": "C2 domains", "em2Text": "Ca2", "label": "CPR:3"}]}
{"sentText": "Bile acid coenzyme Aamino acid Nacyltransferase BAT is responsible for the amidation of bile acids with the amino acids glycine and taurine", "relationMentions": [{"em1Text": "Bile acid coenzyme Aamino acid Nacyltransferase", "em2Text": "bile acids", "label": "CPR:9"}, {"em1Text": "BAT", "em2Text": "bile acids", "label": "CPR:9"}]}
{"sentText": "Asparagine secretion by MSCs was directly related to their ASNS expression levels suggesting a mechanism increased concentrations of asparagine in the leukemic cell microenvironment for the protective effects we observed", "relationMentions": [{"em1Text": "Asparagine", "em2Text": "ASNS", "label": "CPR:9"}]}
{"sentText": "Because of their low asparagine synthetase ASNS expression and asparagine biosynthesis acute lymphoblastic leukemia ALL cells are exquisitely sensitive to asparagine depletion", "relationMentions": [{"em1Text": "asparagine", "em2Text": "ASNS", "label": "CPR:9"}, {"em1Text": "asparagine", "em2Text": "asparagine synthetase", "label": "CPR:9"}]}
{"sentText": "MK801 5methyl1011dihydro5Hdibenzoadcyclohepten510imine maleate a noncompetitive NMDA receptor antagonist partially prevented the decrease in cell viability and the energy impairment", "relationMentions": [{"em1Text": "MK801", "em2Text": "NMDA receptor", "label": "CPR:6"}, {"em1Text": "5methyl1011dihydro5Hdibenzoadcyclohepten510imine maleate", "em2Text": "NMDA receptor", "label": "CPR:6"}]}
{"sentText": "The parallel pattern of accumulation of 246n3 and DHA in response to increasing concentrations of ALA suggests that the competition between 245n3 and ALA for D6D may contribute to the limited accumulation of DHA in cell membranes", "relationMentions": [{"em1Text": "DHA", "em2Text": "D6D", "label": "CPR:9"}, {"em1Text": "ALA", "em2Text": "D6D", "label": "CPR:9"}]}
{"sentText": "The use of Delta 6 desaturase D6D twice in the conversion of alphalinolenic acid ALA 183n3 to docosahexaenoic acid DHA 226n3 suggests that this enzyme may play a key regulatory role in the synthesis and accumulation of DHA from ALA We examined this using an in vitro model of fatty acid metabolism to measure the accumulation of the longchain metabolites of ALA in HepG2 cell phospholipids", "relationMentions": [{"em1Text": "Delta 6 desaturase", "em2Text": "DHA", "label": "CPR:9"}, {"em1Text": "D6D", "em2Text": "DHA", "label": "CPR:9"}, {"em1Text": "Delta 6 desaturase", "em2Text": "ALA", "label": "CPR:9"}, {"em1Text": "D6D", "em2Text": "ALA", "label": "CPR:9"}, {"em1Text": "Delta 6 desaturase", "em2Text": "alphalinolenic acid", "label": "CPR:9"}, {"em1Text": "D6D", "em2Text": "alphalinolenic acid", "label": "CPR:9"}, {"em1Text": "Delta 6 desaturase", "em2Text": "ALA", "label": "CPR:9"}, {"em1Text": "D6D", "em2Text": "ALA", "label": "CPR:9"}, {"em1Text": "Delta 6 desaturase", "em2Text": "docosahexaenoic acid", "label": "CPR:9"}, {"em1Text": "D6D", "em2Text": "docosahexaenoic acid", "label": "CPR:9"}, {"em1Text": "Delta 6 desaturase", "em2Text": "DHA", "label": "CPR:9"}, {"em1Text": "D6D", "em2Text": "DHA", "label": "CPR:9"}]}
{"sentText": "The accumulation of the post D6D products of 225n3 246n3 and DHA in cell phospholipids was saturated at concentrations of 18 microM ALA Supplementation of HepG2 cells with preformed DHA revealed that although the accumulation of DHA in cell phospholipids approached saturation the level of DHA in cell phospholipids was significantly greater compared with the accumulation of DHA from ALA indicating that the accumulation of DHA from ALA was not limited by incorporation", "relationMentions": [{"em1Text": "D6D", "em2Text": "DHA", "label": "CPR:9"}]}
{"sentText": "Dopamine D1 receptor agonist and D2 receptor antagonist effects of the natural product stepholidine molecular modeling and dynamics simulations", "relationMentions": [{"em1Text": "Dopamine D1 receptor", "em2Text": "stepholidine", "label": "CPR:5"}, {"em1Text": "D2 receptor", "em2Text": "stepholidine", "label": "CPR:6"}]}
{"sentText": "Stepholidine SPD an active ingredient of the Chinese herb Stephania is the first compound found to have dual function as a dopamine receptor D1 agonist and D2 antagonist", "relationMentions": [{"em1Text": "Stepholidine", "em2Text": "dopamine receptor D1", "label": "CPR:5"}, {"em1Text": "SPD", "em2Text": "dopamine receptor D1", "label": "CPR:5"}, {"em1Text": "Stepholidine", "em2Text": "D2", "label": "CPR:6"}, {"em1Text": "SPD", "em2Text": "D2", "label": "CPR:6"}]}
{"sentText": "The Ki for mycophenolic acid inhibition of the L263F variant was comparable with the wildtype and the variant Km for inosine 5monophosphate and nicotinamide adenine dinucleotide did not change significantly", "relationMentions": [{"em1Text": "mycophenolic acid", "em2Text": "L263F", "label": "CPR:4"}]}
{"sentText": "Ovariectomy downregulates glutaredoxin and renders female mice vulnerable to LBOAA toxicity as evidenced by activation of AP1 loss of GSH and complex I activity indicating the important role of glutaredoxin in neuroprotection", "relationMentions": [{"em1Text": "LBOAA", "em2Text": "AP1", "label": "CPR:3"}, {"em1Text": "LBOAA", "em2Text": "complex I", "label": "CPR:3"}]}
{"sentText": "Estrogen protects against mitochondrial dysfunction caused by excitotoxicity by maintaining cellular redox status through higher constitutive expression of glutaredoxin in the CNS", "relationMentions": [{"em1Text": "Estrogen", "em2Text": "glutaredoxin", "label": "CPR:3"}]}
{"sentText": "LBOAA causes loss of GSH and inhibition of mitochondrial complex I in lumbosacral cord of male mice through oxidation of thiol groups while female mice are resistant", "relationMentions": [{"em1Text": "LBOAA", "em2Text": "mitochondrial complex I", "label": "CPR:4"}]}
{"sentText": "Female mice express higher levels of glutaredoxin in certain CNS regions and downregulation of glutaredoxin using antisense oligonucleotides sensitizes them to LBOAA toxicity seen as mitochondrial complex I loss", "relationMentions": [{"em1Text": "LBOAA", "em2Text": "mitochondrial complex I", "label": "CPR:4"}]}
{"sentText": "We have expressed VIAAT and the plasmalemmal transporters for glycine and GABA in a neuroendocrine cell line and measured the quantal release of glycine and GABA using a novel doublesniffer patchclamp technique", "relationMentions": [{"em1Text": "VIAAT", "em2Text": "GABA", "label": "CPR:9"}, {"em1Text": "plasmalemmal transporters", "em2Text": "GABA", "label": "CPR:9"}, {"em1Text": "VIAAT", "em2Text": "glycine", "label": "CPR:9"}, {"em1Text": "plasmalemmal transporters", "em2Text": "glycine", "label": "CPR:9"}]}
{"sentText": "We found that glycine is released from vesicles when VIAAT is coexpressed with either the neuronal transporter GlyT2 or the glial transporter GlyT1", "relationMentions": [{"em1Text": "glycine", "em2Text": "VIAAT", "label": "CPR:9"}]}
{"sentText": "However GlyT2 was more effective than GlyT1 probably because GlyT2 is unable to operate in the reverse mode which gives it an advantage in maintaining the high cytosolic glycine concentration required for efficient vesicular loading by VIAAT", "relationMentions": [{"em1Text": "glycine", "em2Text": "VIAAT", "label": "CPR:9"}]}
{"sentText": "The vesicular inhibitory phenotype was gradually altered from glycinergic to GABAergic through mixed events when GABA is introduced into the secretory cell and competes for uptake by VIAAT", "relationMentions": [{"em1Text": "GABA", "em2Text": "VIAAT", "label": "CPR:9"}]}
{"sentText": "Interestingly the VIAAT ortholog from Caenorhabditis elegans UNC47 a species lacking glycine transmission also supports glycine exocytosis in the presence of GlyT2 and a point mutation of UNC47 that abolishes GABA transmission in the worm confers glycine specificity", "relationMentions": [{"em1Text": "glycine", "em2Text": "GlyT2", "label": "CPR:9"}]}
{"sentText": "Together these results suggest that an increased cytosolic availability of glycine in VIAAT containing terminals was crucial for the emergence of glycinergic transmission in vertebrates", "relationMentions": [{"em1Text": "glycine", "em2Text": "VIAAT", "label": "CPR:9"}]}
{"sentText": "The mechanisms that specify the vesicular phenotype of inhibitory interneurons in vertebrates are poorly understood because the two main inhibitory transmitters glycine and GABA share the same vesicular inhibitory amino acid transporter VIAAT and are both present in neurons during postnatal development", "relationMentions": [{"em1Text": "glycine", "em2Text": "vesicular inhibitory amino acid transporter", "label": "CPR:9"}, {"em1Text": "glycine", "em2Text": "VIAAT", "label": "CPR:9"}, {"em1Text": "GABA", "em2Text": "vesicular inhibitory amino acid transporter", "label": "CPR:9"}, {"em1Text": "GABA", "em2Text": "VIAAT", "label": "CPR:9"}]}
{"sentText": "Na Cl dipole couples agonist binding to kainate receptor activation", "relationMentions": [{"em1Text": "Na", "em2Text": "kainate receptor", "label": "CPR:3"}, {"em1Text": "Cl", "em2Text": "kainate receptor", "label": "CPR:3"}]}
{"sentText": "Kainateselective ionotropic glutamate receptors GluRs require external Na and Cl as well as the neurotransmitter Lglutamate for activation", "relationMentions": [{"em1Text": "Kainateselective ionotropic glutamate receptors", "em2Text": "Lglutamate", "label": "CPR:3"}, {"em1Text": "GluRs", "em2Text": "Lglutamate", "label": "CPR:3"}, {"em1Text": "Kainateselective ionotropic glutamate receptors", "em2Text": "Na", "label": "CPR:3"}, {"em1Text": "GluRs", "em2Text": "Na", "label": "CPR:3"}, {"em1Text": "Kainateselective ionotropic glutamate receptors", "em2Text": "Cl", "label": "CPR:3"}, {"em1Text": "GluRs", "em2Text": "Cl", "label": "CPR:3"}]}
{"sentText": "Additionally Na and Cl ions coactivate GluR6 receptors by establishing a dipole accounting for their common effect on KARs", "relationMentions": [{"em1Text": "Na", "em2Text": "GluR6", "label": "CPR:3"}, {"em1Text": "Cl", "em2Text": "GluR6", "label": "CPR:3"}]}
{"sentText": "Phenserine apparently reduces translational efficiency of APP mRNA into protein a process that may involve an interaction with iron andor an ironresponsive element", "relationMentions": [{"em1Text": "Phenserine", "em2Text": "APP", "label": "CPR:4"}]}
{"sentText": "As a consequence phenserine reduces betaamyloid peptide Abeta formation in vitro and in vivo", "relationMentions": [{"em1Text": "phenserine", "em2Text": "betaamyloid", "label": "CPR:4"}, {"em1Text": "phenserine", "em2Text": "Abeta", "label": "CPR:4"}]}
{"sentText": "Phenserine a derivative of physostigmine was first described as an inhibitor of acetylcholinesterase AChE and was shown to improve cognition in various experimental paradigms in rodents and dogs", "relationMentions": [{"em1Text": "Phenserine", "em2Text": "AChE", "label": "CPR:4"}, {"em1Text": "Phenserine", "em2Text": "acetylcholinesterase", "label": "CPR:4"}, {"em1Text": "physostigmine", "em2Text": "AChE", "label": "CPR:4"}, {"em1Text": "physostigmine", "em2Text": "acetylcholinesterase", "label": "CPR:4"}]}
{"sentText": "Phenserine is also unique because of differing actions of its enantiomers phenserine is the active enantiomer for inhibition of AChE whereas phenserine posiphen has weak activity as an AChE inhibitor and can be dosed much higher", "relationMentions": [{"em1Text": "phenserine", "em2Text": "AChE", "label": "CPR:4"}, {"em1Text": "phenserine", "em2Text": "AChE", "label": "CPR:4"}, {"em1Text": "AChE", "em2Text": "posiphen", "label": "CPR:4"}]}
{"sentText": "Phenserine deserves attention for an additional quality of action in addition to inhibiting AChE it modulates the amount of betaamyloid precursor protein APP in neuronal cell culture by reducing APP translation", "relationMentions": [{"em1Text": "Phenserine", "em2Text": "AChE", "label": "CPR:4"}, {"em1Text": "Phenserine", "em2Text": "APP", "label": "CPR:4"}]}
{"sentText": "Additional pharmacological effects evoked by AICAR and phenformin on I ouabain with potential secondary effects on apical Na conductance ENaC activity and monolayer resistance have important consequences for their use as pharmacological activators of AMPK in cell systems where NaKATPase is an important component", "relationMentions": [{"em1Text": "AICAR", "em2Text": "AMPK", "label": "CPR:3"}, {"em1Text": "phenformin", "em2Text": "AMPK", "label": "CPR:3"}, {"em1Text": "ouabain", "em2Text": "AMPK", "label": "CPR:3"}]}
{"sentText": "BACKGROUND AND PURPOSE AMPactivated protein kinase AMPK is activated by metformin phenformin and the AMP mimetic 5aminoimidazole4carboxamide1betaDribofuranoside AICAR", "relationMentions": [{"em1Text": "AMPactivated protein kinase", "em2Text": "AICAR", "label": "CPR:3"}, {"em1Text": "AMPK", "em2Text": "AICAR", "label": "CPR:3"}, {"em1Text": "AMPactivated protein kinase", "em2Text": "metformin", "label": "CPR:3"}, {"em1Text": "AMPK", "em2Text": "metformin", "label": "CPR:3"}, {"em1Text": "AMPactivated protein kinase", "em2Text": "phenformin", "label": "CPR:3"}, {"em1Text": "AMPK", "em2Text": "phenformin", "label": "CPR:3"}, {"em1Text": "AMPactivated protein kinase", "em2Text": "5aminoimidazole4carboxamide1betaDribofuranoside", "label": "CPR:3"}, {"em1Text": "AMPK", "em2Text": "5aminoimidazole4carboxamide1betaDribofuranoside", "label": "CPR:3"}]}
{"sentText": "KEY RESULTS Phenformin AICAR and metformin increased AMPK alpha1 activity and decreased Iamiloride", "relationMentions": [{"em1Text": "Phenformin", "em2Text": "AMPK alpha1", "label": "CPR:3"}, {"em1Text": "AICAR", "em2Text": "AMPK alpha1", "label": "CPR:3"}, {"em1Text": "metformin", "em2Text": "AMPK alpha1", "label": "CPR:3"}]}
{"sentText": "The AMPK inhibitor Compound C prevented the action of metformin and AICAR but not phenformin", "relationMentions": [{"em1Text": "AMPK", "em2Text": "phenformin", "label": "CPR:3"}]}
{"sentText": "Compared with normal control group PTZ kindled mice had significantly higher levels of malondialdehyde nitrite myeloperoxidase but had lower levels of reduced glutathione in the whole brain homogenate", "relationMentions": [{"em1Text": "PTZ", "em2Text": "myeloperoxidase", "label": "CPR:3"}]}
{"sentText": "Previous studies have explored the protective effect of naproxen nonselective COX inhibitor or rofecoxib selective COX 2 inhibitor against chemical kindling in mice", "relationMentions": [{"em1Text": "naproxen", "em2Text": "COX", "label": "CPR:4"}]}
{"sentText": "With this background the present study was designed to explore the possible effect of nimesulide a preferential COX2 inhibitor against pentylenetetrazol PTZinduced kindling epilepsy in mice", "relationMentions": [{"em1Text": "nimesulide", "em2Text": "COX2", "label": "CPR:4"}]}
{"sentText": "Neuroprotective effect of nimesulide a preferential COX2 inhibitor against pentylenetetrazol PTZinduced chemical kindling and associated biochemical parameters in mice", "relationMentions": [{"em1Text": "nimesulide", "em2Text": "COX2", "label": "CPR:4"}]}
{"sentText": "These results suggested that nimesulide a preferential COX2 inhibitor offered neuroprotection against PTZinduced kindling in mice", "relationMentions": [{"em1Text": "nimesulide", "em2Text": "COX2", "label": "CPR:4"}]}
{"sentText": "Brain cyclooxygenases COX the ratelimiting enzyme in prostaglandin synthesis is rapidly and transiently induced by convulsions in hippocampal and cortical neurons", "relationMentions": [{"em1Text": "COX", "em2Text": "prostaglandin", "label": "CPR:9"}, {"em1Text": "cyclooxygenases", "em2Text": "prostaglandin", "label": "CPR:9"}]}
{"sentText": "While vitamin C is essential for PHD activity in vitro NacetylLcysteine had no effect and gallic acid or npropyl gallate efficiently inhibited the activity of all three PHDs demonstrating different functions of these antioxidants", "relationMentions": [{"em1Text": "gallic acid", "em2Text": "PHDs", "label": "CPR:4"}, {"em1Text": "npropyl gallate", "em2Text": "PHDs", "label": "CPR:4"}]}
{"sentText": "LTC4 synthase LTC4S the pivotal enzyme for the biosynthesis of LTC4 ref", "relationMentions": [{"em1Text": "LTC4", "em2Text": "LTC4 synthase", "label": "CPR:9"}, {"em1Text": "LTC4", "em2Text": "LTC4S", "label": "CPR:9"}]}
{"sentText": "10 is an 18kDa integral nuclear membrane protein that belongs to a superfamily of membraneassociated proteins in eicosanoid and glutathione metabolism that includes 5lipoxygenaseactivating protein microsomal glutathione Stransferases MGSTs and microsomal prostaglandin E synthase 1 ref", "relationMentions": [{"em1Text": "eicosanoid", "em2Text": "microsomal glutathione Stransferases", "label": "CPR:9"}, {"em1Text": "eicosanoid", "em2Text": "MGSTs", "label": "CPR:9"}, {"em1Text": "eicosanoid", "em2Text": "microsomal prostaglandin E synthase 1", "label": "CPR:9"}, {"em1Text": "glutathione", "em2Text": "microsomal glutathione Stransferases", "label": "CPR:9"}, {"em1Text": "glutathione", "em2Text": "MGSTs", "label": "CPR:9"}, {"em1Text": "glutathione", "em2Text": "microsomal prostaglandin E synthase 1", "label": "CPR:9"}]}
{"sentText": "Phenelzine PLZ a nonselective irreversible inhibitor of monoamine oxidase MAO also inhibits GABAtransaminase GABAT markedly increasing brain GABA levels", "relationMentions": [{"em1Text": "Phenelzine", "em2Text": "GABAT", "label": "CPR:4"}, {"em1Text": "Phenelzine", "em2Text": "monoamine oxidase", "label": "CPR:4"}, {"em1Text": "Phenelzine", "em2Text": "MAO", "label": "CPR:4"}, {"em1Text": "Phenelzine", "em2Text": "GABAtransaminase", "label": "CPR:4"}, {"em1Text": "PLZ", "em2Text": "GABAT", "label": "CPR:4"}, {"em1Text": "PLZ", "em2Text": "monoamine oxidase", "label": "CPR:4"}, {"em1Text": "PLZ", "em2Text": "MAO", "label": "CPR:4"}, {"em1Text": "PLZ", "em2Text": "GABAtransaminase", "label": "CPR:4"}]}
{"sentText": "To determine whether a metabolite formed by the action of MAO on PLZ may be responsible for the elevation in brain ORN observed animals were pretreated with vehicle or the MAO inhibitor tranylcypromine TCP before vehicle or PLZ 15 mgkg and brains collected 3 h later", "relationMentions": [{"em1Text": "MAO", "em2Text": "tranylcypromine", "label": "CPR:4"}, {"em1Text": "MAO", "em2Text": "TCP", "label": "CPR:4"}]}
{"sentText": "Phenelzine causes an increase in brain ornithine that is prevented by prior monoamine oxidase inhibition", "relationMentions": [{"em1Text": "Phenelzine", "em2Text": "monoamine oxidase", "label": "CPR:4"}]}
{"sentText": "ORN levels measured by an HPLC procedure were dose and timedependently increased in PLZtreated animals with levels reaching approximately 650 of control at 6 and 12 h Pretreatment with TCP completely abolished the PLZinduced increase in brain ORN suggesting as with GABA that a metabolite of PLZ formed by the action of MAO is responsible for the elevation of brain ORN observed", "relationMentions": [{"em1Text": "PLZ", "em2Text": "MAO", "label": "CPR:9"}]}
{"sentText": "PLZ is also a substrate for MAO and studies suggest that a metabolite formed by the action of this enzyme on PLZ may be responsible for the increase in GABA observed", "relationMentions": [{"em1Text": "PLZ", "em2Text": "MAO", "label": "CPR:9"}]}
{"sentText": "As further support alphamethylDLaspartate an inhibitor of argininosuccinate synthase AS a component of the citrullineNO cycle inhibited NO production in a dosedependent manner", "relationMentions": [{"em1Text": "alphamethylDLaspartate", "em2Text": "argininosuccinate synthase", "label": "CPR:4"}, {"em1Text": "alphamethylDLaspartate", "em2Text": "AS", "label": "CPR:4"}]}
{"sentText": "Nitric oxide NO is an important vasorelaxant produced along with Lcitrulline from Larginine in a reaction catalyzed by endothelial nitric oxide synthase eNOS", "relationMentions": [{"em1Text": "NO", "em2Text": "endothelial nitric oxide synthase", "label": "CPR:9"}, {"em1Text": "NO", "em2Text": "eNOS", "label": "CPR:9"}, {"em1Text": "Nitric oxide", "em2Text": "endothelial nitric oxide synthase", "label": "CPR:9"}, {"em1Text": "Nitric oxide", "em2Text": "eNOS", "label": "CPR:9"}, {"em1Text": "Lcitrulline", "em2Text": "endothelial nitric oxide synthase", "label": "CPR:9"}, {"em1Text": "Lcitrulline", "em2Text": "eNOS", "label": "CPR:9"}, {"em1Text": "Larginine", "em2Text": "endothelial nitric oxide synthase", "label": "CPR:9"}, {"em1Text": "Larginine", "em2Text": "eNOS", "label": "CPR:9"}]}
{"sentText": "Caution is necessary only when it is coadministered with drugs metabolised by CYP2D6 such as metoprolol or administered to the elderly or patients with severe hepatic or renal impairment", "relationMentions": [{"em1Text": "CYP2D6", "em2Text": "metoprolol", "label": "CPR:9"}]}
{"sentText": "AZD6140 is a reversible oral P2Y12 receptor antagonist that has been studied in ACS patients in comparison with clopidogrel DISPERSE2 study", "relationMentions": [{"em1Text": "AZD6140", "em2Text": "P2Y12", "label": "CPR:6"}, {"em1Text": "P2Y12", "em2Text": "clopidogrel", "label": "CPR:6"}]}
{"sentText": "Inhibition of platelet aggregation by AZD6140 a reversible oral P2Y12 receptor antagonist compared with clopidogrel in patients with acute coronary syndromes", "relationMentions": [{"em1Text": "P2Y12", "em2Text": "clopidogrel", "label": "CPR:6"}, {"em1Text": "AZD6140", "em2Text": "P2Y12", "label": "CPR:6"}]}
{"sentText": "Oxybutynin 1 is a nonselective muscarinic receptor antagonist that is used clinically for the treatment of urinary incontinence", "relationMentions": [{"em1Text": "Oxybutynin", "em2Text": "muscarinic receptor", "label": "CPR:6"}]}
{"sentText": "Administration of cevimeline hydrochloride an M3 muscarinic receptor agonist 10 mgkg for 7 days po but not pilocarpine 03 mgkg for 7 days po recovered the AQP5 protein level reduced by CTD and increased the AQP1 protein level above the control one", "relationMentions": [{"em1Text": "cevimeline hydrochloride", "em2Text": "AQP5", "label": "CPR:3"}, {"em1Text": "cevimeline hydrochloride", "em2Text": "AQP1", "label": "CPR:3"}, {"em1Text": "cevimeline hydrochloride", "em2Text": "M3 muscarinic receptor", "label": "CPR:5"}]}
{"sentText": "Administration of chloroquine 50 mgkg for 7 days po a denaturant of lysosomes increased the AQP5 protein level reduced by CTD", "relationMentions": [{"em1Text": "chloroquine", "em2Text": "AQP5", "label": "CPR:3"}]}
{"sentText": "Degradation of submandibular gland AQP5 by parasympathetic denervation of chorda tympani and its recovery by cevimeline an M3 muscarinic receptor agonist", "relationMentions": [{"em1Text": "AQP5", "em2Text": "cevimeline", "label": "CPR:3"}, {"em1Text": "cevimeline", "em2Text": "M3 muscarinic receptor", "label": "CPR:5"}]}
{"sentText": "threomethylphenidate inhibits the dopamine transporter and the norepinephrine transporter resulting in elevations of these monoamines after impulse release", "relationMentions": [{"em1Text": "threomethylphenidate", "em2Text": "dopamine transporter", "label": "CPR:4"}, {"em1Text": "threomethylphenidate", "em2Text": "norepinephrine transporter", "label": "CPR:4"}, {"em1Text": "dopamine transporter", "em2Text": "monoamines", "label": "CPR:9"}, {"em1Text": "norepinephrine transporter", "em2Text": "monoamines", "label": "CPR:9"}]}
{"sentText": "The direct inhibition of stathmin by CCNU is likely a contributing factor", "relationMentions": [{"em1Text": "stathmin", "em2Text": "CCNU", "label": "CPR:4"}]}
{"sentText": "CONCLUSIONS AND IMPLICATIONS Amiodarone analogues with better hERG channel inhibition and cytotoxicity profiles than the parent compound have been identified demonstrating that cytotoxicity and hERG channel interaction are mechanistically distinct and separable properties of the compounds", "relationMentions": [{"em1Text": "Amiodarone", "em2Text": "hERG", "label": "CPR:4"}]}
{"sentText": "The principal aim of the study was to find amiodarone analogues that retained human etheragogorelated protein hERG channel inhibition but with reduced cytotoxicity", "relationMentions": [{"em1Text": "amiodarone", "em2Text": "human etheragogorelated protein hERG channel", "label": "CPR:4"}]}
{"sentText": "In addition to OT and to a lesser extent AVP pitressin a number of OT and AVP analogues such as carbetocin OT agonist dDAVP desmopressin V2 agonist terlipressin V1a agonist felypressin V1a agonist and atosiban Tractocile OT antagonist are also in clinical use", "relationMentions": [{"em1Text": "OT", "em2Text": "carbetocin", "label": "CPR:5"}, {"em1Text": "desmopressin", "em2Text": "V2", "label": "CPR:5"}, {"em1Text": "terlipressin", "em2Text": "V1a", "label": "CPR:5"}, {"em1Text": "V1a", "em2Text": "felypressin", "label": "CPR:5"}, {"em1Text": "OT", "em2Text": "atosiban", "label": "CPR:6"}, {"em1Text": "OT", "em2Text": "Tractocile", "label": "CPR:6"}]}
{"sentText": "While a number of orally active nonpeptide V2 antagonists Vaptans notably Tolvaptan Lixivaptan and Satavaptan are currently in Phase III clinical trials to date only the mixed V2 V1a antagonist Conivaptan Vaprisol has been approved by the US FDA for clinical use by iv", "relationMentions": [{"em1Text": "V2", "em2Text": "Tolvaptan", "label": "CPR:6"}, {"em1Text": "V2", "em2Text": "Lixivaptan", "label": "CPR:6"}, {"em1Text": "V2", "em2Text": "Satavaptan", "label": "CPR:6"}, {"em1Text": "V2", "em2Text": "Conivaptan", "label": "CPR:6"}, {"em1Text": "V1a", "em2Text": "Conivaptan", "label": "CPR:6"}, {"em1Text": "V2", "em2Text": "Vaprisol", "label": "CPR:6"}, {"em1Text": "V1a", "em2Text": "Vaprisol", "label": "CPR:6"}]}
{"sentText": "Absorbable drugs fibric acids nicotinic acid probucol HMGCoA reductase inhibitors reduce plasma verylowdensity lipoproteins VLDL andor lowdensity lipoproteins LDL by a variety of mechanisms", "relationMentions": [{"em1Text": "fibric acids", "em2Text": "plasma verylowdensity lipoproteins", "label": "CPR:4"}, {"em1Text": "fibric acids", "em2Text": "VLDL", "label": "CPR:4"}, {"em1Text": "fibric acids", "em2Text": "lowdensity lipoproteins", "label": "CPR:4"}, {"em1Text": "fibric acids", "em2Text": "LDL", "label": "CPR:4"}, {"em1Text": "nicotinic acid", "em2Text": "plasma verylowdensity lipoproteins", "label": "CPR:4"}, {"em1Text": "nicotinic acid", "em2Text": "VLDL", "label": "CPR:4"}, {"em1Text": "nicotinic acid", "em2Text": "lowdensity lipoproteins", "label": "CPR:4"}, {"em1Text": "nicotinic acid", "em2Text": "LDL", "label": "CPR:4"}, {"em1Text": "probucol", "em2Text": "plasma verylowdensity lipoproteins", "label": "CPR:4"}, {"em1Text": "probucol", "em2Text": "VLDL", "label": "CPR:4"}, {"em1Text": "probucol", "em2Text": "lowdensity lipoproteins", "label": "CPR:4"}, {"em1Text": "probucol", "em2Text": "LDL", "label": "CPR:4"}]}
{"sentText": "Fibric acids in particular act by stimulating the catabolism of VLDL and also as a consequence improving LDL delipidation thus favoring receptor uptake", "relationMentions": [{"em1Text": "Fibric acids", "em2Text": "VLDL", "label": "CPR:4"}]}
{"sentText": "accelerating reverse transport of cholesteryl esters from highdensity lipoproteins to lowerdensity lipoproteins", "relationMentions": [{"em1Text": "cholesteryl esters", "em2Text": "highdensity lipoproteins", "label": "CPR:9"}, {"em1Text": "cholesteryl esters", "em2Text": "lowerdensity lipoproteins", "label": "CPR:9"}]}
{"sentText": "CONCLUSIONS Lapatinib is a dual inhibitor of the EGFR and HER2 tyrosine kinases", "relationMentions": [{"em1Text": "Lapatinib", "em2Text": "EGFR", "label": "CPR:4"}, {"em1Text": "Lapatinib", "em2Text": "HER2", "label": "CPR:4"}, {"em1Text": "Lapatinib", "em2Text": "tyrosine kinases", "label": "CPR:4"}]}
{"sentText": "Lapatinib a dual inhibitor of human epidermal growth factor receptor tyrosine kinases", "relationMentions": [{"em1Text": "Lapatinib", "em2Text": "human epidermal growth factor receptor", "label": "CPR:4"}, {"em1Text": "Lapatinib", "em2Text": "tyrosine kinases", "label": "CPR:4"}]}
{"sentText": "BACKGROUND Lapatinib the first dual inhibitor of epidermal growth factor receptor EGFR and human epidermal growth factor receptor 2 HER2 tyrosine kinases was approved by the US Food and Drug Administration FDA in 2007", "relationMentions": [{"em1Text": "Lapatinib", "em2Text": "HER2", "label": "CPR:4"}, {"em1Text": "Lapatinib", "em2Text": "tyrosine kinases", "label": "CPR:4"}, {"em1Text": "Lapatinib", "em2Text": "epidermal growth factor receptor", "label": "CPR:4"}, {"em1Text": "Lapatinib", "em2Text": "EGFR", "label": "CPR:4"}, {"em1Text": "Lapatinib", "em2Text": "human epidermal growth factor receptor 2", "label": "CPR:4"}]}
{"sentText": "Lapatinib is metabolized primarily by the cytochrome P450 3A4 isozyme with 1 metabolite remaining active against EGFR but not HER2", "relationMentions": [{"em1Text": "Lapatinib", "em2Text": "cytochrome P450 3A4", "label": "CPR:9"}]}
{"sentText": "Phenelzine is a more potent monoamine oxidase inhibitor than is N2acetylphenelzine", "relationMentions": [{"em1Text": "monoamine oxidase", "em2Text": "N2acetylphenelzine", "label": "CPR:4"}, {"em1Text": "Phenelzine", "em2Text": "monoamine oxidase", "label": "CPR:4"}]}
{"sentText": "Acetylation of phenelzine at the N2 position presumably interferes with the inhibition of the transaminase enzymes for gammaaminobutyric acid and alanine", "relationMentions": [{"em1Text": "phenelzine", "em2Text": "transaminase", "label": "CPR:4"}, {"em1Text": "N2", "em2Text": "transaminase", "label": "CPR:4"}, {"em1Text": "transaminase", "em2Text": "gammaaminobutyric acid", "label": "CPR:4"}, {"em1Text": "transaminase", "em2Text": "alanine", "label": "CPR:4"}]}
{"sentText": "Quinpirole and 7OHDPAT also increased the phosphorylation of extracellular signalregulated kinase ERK within minutes an effect blocked by pretreatment with SB277011A", "relationMentions": [{"em1Text": "Quinpirole", "em2Text": "extracellular signalregulated kinase", "label": "CPR:3"}, {"em1Text": "Quinpirole", "em2Text": "ERK", "label": "CPR:3"}, {"em1Text": "7OHDPAT", "em2Text": "extracellular signalregulated kinase", "label": "CPR:3"}, {"em1Text": "7OHDPAT", "em2Text": "ERK", "label": "CPR:3"}, {"em1Text": "extracellular signalregulated kinase", "em2Text": "SB277011A", "label": "CPR:4"}, {"em1Text": "ERK", "em2Text": "SB277011A", "label": "CPR:4"}]}
{"sentText": "All neurotrophic effects were blocked by the unselective D2D3 receptor antagonist sulpiride 5 microm and by the selective D3 receptor antagonist SB277011A at a low dose 50 nm", "relationMentions": [{"em1Text": "D3 receptor", "em2Text": "SB277011A", "label": "CPR:6"}]}
{"sentText": "This study identified four clinically approved antihypertensive drugs efonidipine felodipine isradipine and nitrendipine as potent Tchannel blockers IC50 3 microM", "relationMentions": [{"em1Text": "efonidipine", "em2Text": "Tchannel", "label": "CPR:4"}, {"em1Text": "felodipine", "em2Text": "Tchannel", "label": "CPR:4"}, {"em1Text": "isradipine", "em2Text": "Tchannel", "label": "CPR:4"}, {"em1Text": "nitrendipine", "em2Text": "Tchannel", "label": "CPR:4"}]}
{"sentText": "Triphosphate nucleotides ATP GTP and UTP rapidly and reversibly inhibited Panx1 currents via mechanisms independent of purine receptors", "relationMentions": [{"em1Text": "UTP", "em2Text": "Panx1", "label": "CPR:4"}, {"em1Text": "Triphosphate nucleotides", "em2Text": "Panx1", "label": "CPR:4"}, {"em1Text": "ATP", "em2Text": "Panx1", "label": "CPR:4"}, {"em1Text": "GTP", "em2Text": "Panx1", "label": "CPR:4"}]}
{"sentText": "We found compounds that inhibited Panx1 currents with a rank order of potency carbenoxolone disodium 44diisothiocyanatostilbene22disulfonate DIDS approximately disodium 4acetamido4isothiocyanatostilben22disulfonate approximately 5nitro23phenylpropylaminobenzoic acid indanyloxyacetic acid 94 probenecid flufenamic acid = niflumic acid", "relationMentions": [{"em1Text": "Panx1", "em2Text": "carbenoxolone", "label": "CPR:4"}, {"em1Text": "Panx1", "em2Text": "disodium 44diisothiocyanatostilbene22disulfonate", "label": "CPR:4"}, {"em1Text": "Panx1", "em2Text": "DIDS", "label": "CPR:4"}, {"em1Text": "Panx1", "em2Text": "disodium 4acetamido4isothiocyanatostilben22disulfonate", "label": "CPR:4"}, {"em1Text": "Panx1", "em2Text": "5nitro23phenylpropylaminobenzoic acid", "label": "CPR:4"}, {"em1Text": "Panx1", "em2Text": "indanyloxyacetic acid 94", "label": "CPR:4"}, {"em1Text": "Panx1", "em2Text": "probenecid", "label": "CPR:4"}, {"em1Text": "Panx1", "em2Text": "flufenamic acid", "label": "CPR:4"}, {"em1Text": "Panx1", "em2Text": "niflumic acid", "label": "CPR:4"}]}
{"sentText": "When Panx1 was coexpressed with purinergic P2X7 receptor P2X7R DIDS was found to act as a P2X7R antagonist to inhibit ATPevoked currents but none of the other compounds inhibited P2X7R currents", "relationMentions": [{"em1Text": "P2X7R", "em2Text": "DIDS", "label": "CPR:6"}]}
{"sentText": "MMP2 and MMP9 expressions and activities in right ventricles increased significantly in monocrotaline injected rats and captopril inhibited them", "relationMentions": [{"em1Text": "MMP2", "em2Text": "monocrotaline", "label": "CPR:3"}, {"em1Text": "MMP9", "em2Text": "monocrotaline", "label": "CPR:3"}, {"em1Text": "MMP2", "em2Text": "captopril", "label": "CPR:4"}, {"em1Text": "MMP9", "em2Text": "captopril", "label": "CPR:4"}]}
{"sentText": "These findings indicate that captopril attenuates the development of monocrotaline induced right ventricular hypertrophy in association with inhibition of MMP2 and MMP9 in rats", "relationMentions": [{"em1Text": "monocrotaline", "em2Text": "MMP2", "label": "CPR:3"}, {"em1Text": "monocrotaline", "em2Text": "MMP9", "label": "CPR:3"}, {"em1Text": "captopril", "em2Text": "MMP2", "label": "CPR:4"}, {"em1Text": "captopril", "em2Text": "MMP9", "label": "CPR:4"}]}
{"sentText": "We investigated the effect of captopril an ACE inhibitor on MMP2 and MMP9 in monocrotalineinduced right ventricular hypertrophy", "relationMentions": [{"em1Text": "captopril", "em2Text": "ACE", "label": "CPR:4"}]}
{"sentText": "Some of these structurally related compounds have a very different behavior against the widespread isozyme CA II with chlorthalidone trichloromethiazide and furosemide being efficient inhibitors against CA II KIs of 65138 nM whereas indapamide is a much weaker one KI of 2520 nM", "relationMentions": [{"em1Text": "CA II", "em2Text": "chlorthalidone", "label": "CPR:4"}, {"em1Text": "CA II", "em2Text": "trichloromethiazide", "label": "CPR:4"}, {"em1Text": "CA II", "em2Text": "furosemide", "label": "CPR:4"}, {"em1Text": "CA II", "em2Text": "indapamide", "label": "CPR:4"}]}
{"sentText": "Thiazide and high ceiling diuretics were recently shown to inhibit all mammalian isoforms of carbonic anhydrase CA EC 4211 with a very different profile as compared to classical inhibitors such as acetazolamide methazolamide and ethoxzolamide", "relationMentions": [{"em1Text": "Thiazide", "em2Text": "CA", "label": "CPR:4"}, {"em1Text": "Thiazide", "em2Text": "EC 4211", "label": "CPR:4"}, {"em1Text": "Thiazide", "em2Text": "carbonic anhydrase", "label": "CPR:4"}, {"em1Text": "CA", "em2Text": "acetazolamide", "label": "CPR:4"}, {"em1Text": "EC 4211", "em2Text": "acetazolamide", "label": "CPR:4"}, {"em1Text": "carbonic anhydrase", "em2Text": "acetazolamide", "label": "CPR:4"}, {"em1Text": "CA", "em2Text": "methazolamide", "label": "CPR:4"}, {"em1Text": "EC 4211", "em2Text": "methazolamide", "label": "CPR:4"}, {"em1Text": "carbonic anhydrase", "em2Text": "methazolamide", "label": "CPR:4"}, {"em1Text": "CA", "em2Text": "ethoxzolamide", "label": "CPR:4"}, {"em1Text": "EC 4211", "em2Text": "ethoxzolamide", "label": "CPR:4"}, {"em1Text": "carbonic anhydrase", "em2Text": "ethoxzolamide", "label": "CPR:4"}]}
{"sentText": "We discovered sergliflozin etabonate a novel selective SGLT2 inhibitor and found that selective inhibition of SGLT2 increased urinary glucose excretion and consequently decreased plasma glucose levels", "relationMentions": [{"em1Text": "sergliflozin etabonate", "em2Text": "SGLT2", "label": "CPR:4"}, {"em1Text": "sergliflozin etabonate", "em2Text": "SGLT2", "label": "CPR:4"}]}
{"sentText": "In this report we examined the antihyperglycemic effects of sergliflozin etabonate in normal and diabetic rats in comparison with those of a sulfonylurea gliclazide and an alphaglucosidase inhibitor voglibose", "relationMentions": [{"em1Text": "alphaglucosidase", "em2Text": "voglibose", "label": "CPR:4"}]}
{"sentText": "Sergliflozin etabonate a selective SGLT2 inhibitor improves glycemic control in streptozotocininduced diabetic rats and Zucker fatty rats", "relationMentions": [{"em1Text": "Sergliflozin etabonate", "em2Text": "SGLT2", "label": "CPR:4"}]}
{"sentText": "Chronic treatment with sergliflozin etabonate reduced the levels of glycated hemoglobin and fasting plasma glucose and improved the glycemic response after glucose loading in Zucker fatty rats", "relationMentions": [{"em1Text": "sergliflozin etabonate", "em2Text": "glycated hemoglobin", "label": "CPR:4"}]}
{"sentText": "The lowaffinity sodium glucose cotransporter SGLT2 is responsible for most of the glucose reabsorption in the kidney and has been highlighted as a novel therapeutic target for the treatment of diabetes", "relationMentions": [{"em1Text": "sodium glucose cotransporter", "em2Text": "glucose", "label": "CPR:9"}, {"em1Text": "glucose", "em2Text": "SGLT2", "label": "CPR:9"}]}
{"sentText": "Although the D1like receptor by itself had no effect on VSMC proliferation stimulation with fenoldopam a D1like receptor agonist inhibited the stimulatory effect of insulin", "relationMentions": [{"em1Text": "fenoldopam", "em2Text": "insulin", "label": "CPR:4"}, {"em1Text": "D1like receptor", "em2Text": "fenoldopam", "label": "CPR:5"}]}
{"sentText": "The inhibitory effect of fenoldopam on insulin mediated VSMC proliferation was receptor specific because its effect could be blocked by SCH23390 a D1like receptor antagonist", "relationMentions": [{"em1Text": "fenoldopam", "em2Text": "insulin", "label": "CPR:4"}, {"em1Text": "SCH23390", "em2Text": "D1like receptor", "label": "CPR:6"}]}
{"sentText": "Fenoldopam also inhibited insulin receptor mRNA and protein expression which was time dependent and concentration dependent", "relationMentions": [{"em1Text": "Fenoldopam", "em2Text": "insulin receptor", "label": "CPR:4"}]}
{"sentText": "A PKC or MAP kinase inhibitor blocked the inhibitory effect of fenoldopam on insulin receptor expression indicating that PKC and MAP kinase were involved in the signaling pathway", "relationMentions": [{"em1Text": "fenoldopam", "em2Text": "insulin receptor", "label": "CPR:4"}]}
{"sentText": "The progress of the enzymatic reaction of the hydrolysis of acetylthiocholine at pH 8 in the presence of AChE and the inhibitor studied is determined by measuring at 230 nm the peak area of the reaction product thiocholine TCh", "relationMentions": [{"em1Text": "acetylthiocholine", "em2Text": "AChE", "label": "CPR:9"}]}
{"sentText": "atropine AChE reactivator such as one of the recommended pyridinium oximes pralidoxime trimedoxime obidoxime and HI6 and diazepam are used for the treatment of OP poisoning in humans", "relationMentions": [{"em1Text": "AChE", "em2Text": "trimedoxime", "label": "CPR:3"}, {"em1Text": "AChE", "em2Text": "obidoxime", "label": "CPR:3"}, {"em1Text": "AChE", "em2Text": "HI6", "label": "CPR:3"}, {"em1Text": "AChE", "em2Text": "diazepam", "label": "CPR:3"}, {"em1Text": "atropine", "em2Text": "AChE", "label": "CPR:3"}, {"em1Text": "AChE", "em2Text": "pyridinium oximes", "label": "CPR:3"}, {"em1Text": "AChE", "em2Text": "pralidoxime", "label": "CPR:3"}, {"em1Text": "AChE", "em2Text": "OP", "label": "CPR:4"}]}
{"sentText": "The mechanism of OP poisoning involves inhibition of acetylcholinesterase AChE leading to inactivation of the enzyme which has an important role in neurotransmission", "relationMentions": [{"em1Text": "OP", "em2Text": "acetylcholinesterase", "label": "CPR:4"}, {"em1Text": "OP", "em2Text": "AChE", "label": "CPR:4"}]}
{"sentText": "They act by reactivation of AChE inhibited by OP", "relationMentions": [{"em1Text": "AChE", "em2Text": "OP", "label": "CPR:4"}]}
{"sentText": "Oral palonosetron is likely to be a useful addition to oral formulations of other 5HT3 recepto r antagonists in preventing CINV in patients receiving MEC", "relationMentions": [{"em1Text": "palonosetron", "em2Text": "5HT3 recepto", "label": "CPR:6"}]}
{"sentText": "Palonosetron is a secondgeneration serotonin 5HT3 receptor antagonist with a distinct pharmacological profile that differs from firstgeneration 5HT3 receptor antagonists", "relationMentions": [{"em1Text": "Palonosetron", "em2Text": "5HT3 receptor", "label": "CPR:6"}, {"em1Text": "Palonosetron", "em2Text": "serotonin 5HT3 receptor", "label": "CPR:6"}]}
{"sentText": "Luteinizing hormonereleasing hormone LHRH agonists such as buserelin goserelin leuprorelin and triptorelin stimulate the pituitarys gonadotrophinreleasing hormone GnRH receptor ultimately leading to its desensitization and subsequent reduction of LH and testosterone levels", "relationMentions": [{"em1Text": "buserelin", "em2Text": "gonadotrophinreleasing hormone GnRH receptor", "label": "CPR:3"}, {"em1Text": "goserelin", "em2Text": "gonadotrophinreleasing hormone GnRH receptor", "label": "CPR:3"}, {"em1Text": "leuprorelin", "em2Text": "gonadotrophinreleasing hormone GnRH receptor", "label": "CPR:3"}, {"em1Text": "triptorelin", "em2Text": "gonadotrophinreleasing hormone GnRH receptor", "label": "CPR:3"}, {"em1Text": "LH", "em2Text": "buserelin", "label": "CPR:4"}, {"em1Text": "LH", "em2Text": "goserelin", "label": "CPR:4"}, {"em1Text": "LH", "em2Text": "leuprorelin", "label": "CPR:4"}, {"em1Text": "LH", "em2Text": "triptorelin", "label": "CPR:4"}, {"em1Text": "Luteinizing hormonereleasing hormone", "em2Text": "buserelin", "label": "CPR:5"}, {"em1Text": "LHRH", "em2Text": "buserelin", "label": "CPR:5"}, {"em1Text": "Luteinizing hormonereleasing hormone", "em2Text": "goserelin", "label": "CPR:5"}, {"em1Text": "LHRH", "em2Text": "goserelin", "label": "CPR:5"}, {"em1Text": "Luteinizing hormonereleasing hormone", "em2Text": "leuprorelin", "label": "CPR:5"}, {"em1Text": "LHRH", "em2Text": "leuprorelin", "label": "CPR:5"}, {"em1Text": "Luteinizing hormonereleasing hormone", "em2Text": "triptorelin", "label": "CPR:5"}, {"em1Text": "LHRH", "em2Text": "triptorelin", "label": "CPR:5"}]}
{"sentText": "Two pure GnRH antagonists have been developed abarelix and degarelix that are devoid of any agonist effect on the GnRH receptor and consequently do not result in testosterone flare", "relationMentions": [{"em1Text": "GnRH", "em2Text": "abarelix", "label": "CPR:6"}, {"em1Text": "GnRH", "em2Text": "degarelix", "label": "CPR:6"}]}
{"sentText": "Abarelix was the first GnRH antagonist to be developed and was approved by the USA Food and Drug Administration in 2004 for the initiation of hormonal castration in advanced or metastasizing hormonedependent prostate carcinoma when rapid androgen suppression is necessary", "relationMentions": [{"em1Text": "Abarelix", "em2Text": "GnRH", "label": "CPR:6"}]}
{"sentText": "Fulvestrant a pure estrogen receptor downregulator is a new addition to the antiestrogen therapeutic armamentarium since its FDA approval in 2002", "relationMentions": [{"em1Text": "Fulvestrant", "em2Text": "estrogen receptor", "label": "CPR:4"}]}
{"sentText": "The concentration of estramustine phosphate required to inhibit the assembly or to induce the disassembly of chick brain MAP2 tubulin microtubules is markedly dependent upon the microtubule protein concentration", "relationMentions": [{"em1Text": "estramustine phosphate", "em2Text": "chick brain MAP2", "label": "CPR:3"}, {"em1Text": "estramustine phosphate", "em2Text": "tubulin", "label": "CPR:3"}, {"em1Text": "estramustine phosphate", "em2Text": "chick brain MAP2", "label": "CPR:4"}, {"em1Text": "estramustine phosphate", "em2Text": "tubulin", "label": "CPR:4"}]}
{"sentText": "It is proposed that two molecules of estramustine phosphate interact with each of the three tubulinbinding sites of MAP2 and inhibit the MAP2 tubulin interaction by neutralising two highly conserved basic residues", "relationMentions": [{"em1Text": "estramustine phosphate", "em2Text": "MAP2", "label": "CPR:4"}, {"em1Text": "estramustine phosphate", "em2Text": "tubulin", "label": "CPR:4"}]}
{"sentText": "PURPOSE XL184 cabozantinib is a potent inhibitor of MET vascular endothelial growth factor receptor 2 VEGFR2 and RET with robust antiangiogenic antitumor and antiinvasive effects in preclinical models", "relationMentions": [{"em1Text": "cabozantinib", "em2Text": "VEGFR2", "label": "CPR:4"}, {"em1Text": "cabozantinib", "em2Text": "RET", "label": "CPR:4"}, {"em1Text": "cabozantinib", "em2Text": "MET", "label": "CPR:4"}, {"em1Text": "cabozantinib", "em2Text": "vascular endothelial growth factor receptor 2", "label": "CPR:4"}, {"em1Text": "XL184", "em2Text": "VEGFR2", "label": "CPR:4"}, {"em1Text": "XL184", "em2Text": "RET", "label": "CPR:4"}, {"em1Text": "XL184", "em2Text": "MET", "label": "CPR:4"}, {"em1Text": "XL184", "em2Text": "vascular endothelial growth factor receptor 2", "label": "CPR:4"}]}
{"sentText": "Activity of XL184 Cabozantinib an oral tyrosine kinase inhibitor in patients with medullary thyroid cancer", "relationMentions": [{"em1Text": "XL184", "em2Text": "tyrosine kinase", "label": "CPR:4"}, {"em1Text": "Cabozantinib", "em2Text": "tyrosine kinase", "label": "CPR:4"}]}
{"sentText": "Further we used this model to test the efficacy of GDC0941 a PI3K inhibitor in clinical development and showed that the tumors respond to PI3K inhibition", "relationMentions": [{"em1Text": "GDC0941", "em2Text": "PI3K", "label": "CPR:4"}, {"em1Text": "GDC0941", "em2Text": "PI3K", "label": "CPR:4"}]}
{"sentText": "4MA a well known 5 alphareductase inhibitor is also a potent inhibitor of 3 betaHSD with a Ki value of 56 nM", "relationMentions": [{"em1Text": "4MA", "em2Text": "5 alphareductase", "label": "CPR:4"}, {"em1Text": "4MA", "em2Text": "3 betaHSD", "label": "CPR:4"}]}
{"sentText": "Cyproterone acetate a progestin used in the treatment of hirsutism acne and prostate cancer as well as norgestrel and norethindrone that are widely used as oral contraceptives also inhibit 3 betaHSD activity at Ki values of 15 17 and 25 microM respectively", "relationMentions": [{"em1Text": "Cyproterone acetate", "em2Text": "3 betaHSD", "label": "CPR:4"}, {"em1Text": "progestin", "em2Text": "3 betaHSD", "label": "CPR:4"}, {"em1Text": "norgestrel", "em2Text": "3 betaHSD", "label": "CPR:4"}, {"em1Text": "norethindrone", "em2Text": "3 betaHSD", "label": "CPR:4"}]}
{"sentText": "Inhibitory effect of synthetic progestins 4MA and cyanoketone on human placental 3 betahydroxysteroid dehydrogenase54eneisomerase activity", "relationMentions": [{"em1Text": "progestins", "em2Text": "human placental 3 betahydroxysteroid dehydrogenase54eneisomerase", "label": "CPR:4"}, {"em1Text": "4MA", "em2Text": "human placental 3 betahydroxysteroid dehydrogenase54eneisomerase", "label": "CPR:4"}, {"em1Text": "cyanoketone", "em2Text": "human placental 3 betahydroxysteroid dehydrogenase54eneisomerase", "label": "CPR:4"}]}
{"sentText": "Trilostane epostane and cyanoketone are potent inhibitors of 3 betaHSD with Ki values of approximately 50 nM", "relationMentions": [{"em1Text": "Trilostane", "em2Text": "3 betaHSD", "label": "CPR:4"}, {"em1Text": "epostane", "em2Text": "3 betaHSD", "label": "CPR:4"}, {"em1Text": "cyanoketone", "em2Text": "3 betaHSD", "label": "CPR:4"}]}
{"sentText": "Human placental 3 betahydroxysteroid dehydrogenase54ene isomerase 3 betaHSD purified from human placenta transforms C21 pregnenolone and 17 alphahydroxy pregnenolone as well as C19 dehydroepiandrosterone and androst5ene3 beta 17 betadiol steroids into the corresponding 3keto4enesteroids and is thus involved in the biosynthesis of all classes of hormonal steroids", "relationMentions": [{"em1Text": "Human placental 3 betahydroxysteroid dehydrogenase54ene isomerase", "em2Text": "pregnenolone", "label": "CPR:9"}, {"em1Text": "3 betaHSD", "em2Text": "pregnenolone", "label": "CPR:9"}, {"em1Text": "Human placental 3 betahydroxysteroid dehydrogenase54ene isomerase", "em2Text": "17 alphahydroxy pregnenolone", "label": "CPR:9"}, {"em1Text": "3 betaHSD", "em2Text": "17 alphahydroxy pregnenolone", "label": "CPR:9"}, {"em1Text": "Human placental 3 betahydroxysteroid dehydrogenase54ene isomerase", "em2Text": "dehydroepiandrosterone", "label": "CPR:9"}, {"em1Text": "3 betaHSD", "em2Text": "dehydroepiandrosterone", "label": "CPR:9"}, {"em1Text": "Human placental 3 betahydroxysteroid dehydrogenase54ene isomerase", "em2Text": "androst5ene3 beta 17 betadiol", "label": "CPR:9"}, {"em1Text": "3 betaHSD", "em2Text": "androst5ene3 beta 17 betadiol", "label": "CPR:9"}, {"em1Text": "Human placental 3 betahydroxysteroid dehydrogenase54ene isomerase", "em2Text": "3keto4enesteroids", "label": "CPR:9"}, {"em1Text": "3 betaHSD", "em2Text": "3keto4enesteroids", "label": "CPR:9"}]}
{"sentText": "However chronic treatment of cLH rats with MPEP did not reverse learned helplessness indicating that the enhanced mGlu5 receptor function is not the only player in the behavioral phenotype of this genetic model of depression", "relationMentions": [{"em1Text": "MPEP", "em2Text": "mGlu5 receptor", "label": "CPR:3"}]}
{"sentText": "Rescue of both impaired extinction acquisition and deficient extinction consolidationretrieval was achieved with prior extinction training administration of valproic acid a GABAergic enhancer and HDAC inhibitor or AMN082 metabotropic glutamate receptor 7 mGlu7 agonist while MS275 or PEPA AMPA receptor potentiator failed to affect extinction acquisition in S1 mice", "relationMentions": [{"em1Text": "MS275", "em2Text": "AMPA receptor", "label": "CPR:3"}, {"em1Text": "PEPA", "em2Text": "AMPA receptor", "label": "CPR:3"}, {"em1Text": "valproic acid", "em2Text": "HDAC", "label": "CPR:4"}, {"em1Text": "AMN082", "em2Text": "metabotropic glutamate receptor 7", "label": "CPR:5"}, {"em1Text": "AMN082", "em2Text": "mGlu7", "label": "CPR:5"}]}
{"sentText": "Rescue of this impaired extinction consolidationretrieval was achieved with dcycloserine Nmethlydaspartate partial agonist or MS275 histone deacetylase HDAC inhibitor applied after extinction training", "relationMentions": [{"em1Text": "MS275", "em2Text": "histone deacetylase", "label": "CPR:4"}, {"em1Text": "MS275", "em2Text": "HDAC", "label": "CPR:4"}]}
{"sentText": "These findings suggest that oral consumption of nicotine enhances the efficacy of nicotinic acetylcholine receptors", "relationMentions": [{"em1Text": "nicotine", "em2Text": "nicotinic acetylcholine receptors", "label": "CPR:3"}]}
{"sentText": "Electroencephalographic recordings during substance consumption showed reduced alpha activity and P300 latencies in the nicotine group compared to the control group", "relationMentions": [{"em1Text": "P300", "em2Text": "nicotine", "label": "CPR:4"}]}
{"sentText": "GDC0152 induces NF\u03baB transcriptional activity leading to expression of several chemokines and cytokines of which tumor necrosis factor alpha TNF\u03b1 is the most important for singleagent tumor activity", "relationMentions": [{"em1Text": "GDC0152", "em2Text": "NF\u03baB", "label": "CPR:3"}]}
{"sentText": "GDC0152 is a smallmolecule drug that triggers tumor cell apoptosis by selectively antagonizing IAPs", "relationMentions": [{"em1Text": "GDC0152", "em2Text": "IAPs", "label": "CPR:6"}]}
{"sentText": "Toxicity profile of smallmolecule IAP antagonist GDC0152 is linked to TNF\u03b1 pharmacology", "relationMentions": [{"em1Text": "IAP", "em2Text": "GDC0152", "label": "CPR:6"}]}
{"sentText": "In TPC1 BCPAP FRO WRO cell lines PJ34 induced a strong increase in NIS mRNA levels", "relationMentions": [{"em1Text": "PJ34", "em2Text": "NIS", "label": "CPR:3"}]}
{"sentText": "Accordingly in transfection experiments performed in TPC1 cells treatment with PJ34 increased NIS promoter activity without affecting PARP1 binding to the promoter sequence", "relationMentions": [{"em1Text": "PJ34", "em2Text": "NIS promoter", "label": "CPR:3"}]}
{"sentText": "We also investigated the epigenetic status of NIS promoter after PJ34 treatment in TPC1 cell line in addition to an increase of histone modification activation marks H3K9K14ac H3K4me3 surprisingly we observed also an increase of H3K27me3 a classical repressive mark", "relationMentions": [{"em1Text": "PJ34", "em2Text": "histone modification activation marks", "label": "CPR:3"}, {"em1Text": "PJ34", "em2Text": "H3K9K14ac", "label": "CPR:3"}, {"em1Text": "PJ34", "em2Text": "H3K4me3", "label": "CPR:3"}]}
{"sentText": "Since PARP1 is supposed to be part of a multimeric repressor of sodium iodide symporter NIS expression in this study the effect of the PARP inhibitor PJ34 on several properties of thyroid cancer cell lines was investigated", "relationMentions": [{"em1Text": "PARP", "em2Text": "PJ34", "label": "CPR:4"}]}
{"sentText": "The PARP inhibitor PJ34 modifies proliferation NIS expression and epigenetic marks in thyroid cancer cell lines", "relationMentions": [{"em1Text": "PARP", "em2Text": "PJ34", "label": "CPR:4"}]}
{"sentText": "Both apolycopenoic acids also decreased CSEinduced ROS production 8OHdG formation and reduced the increase in NOX4 and COX2 expressions caused by CSE", "relationMentions": [{"em1Text": "apolycopenoic acids", "em2Text": "NOX4", "label": "CPR:4"}, {"em1Text": "apolycopenoic acids", "em2Text": "COX2", "label": "CPR:4"}]}
{"sentText": "Here in expressing cocaine hydrolyzing mutants of BChE in Nicotiana benthamiana using the MagnICON virusassisted transient expression system and in reporting their initial biochemical analysis we provide proofofprinciple that plants can express engineered BChE proteins with desired properties", "relationMentions": [{"em1Text": "cocaine", "em2Text": "BChE", "label": "CPR:9"}]}
{"sentText": "Recent studies however have demonstrated a promising potential treatment option with the help of the serum enzyme butyrylcholinesterase BChE which is capable of breaking down naturally occurring cocaine before the drug can influence the reward centers of the brain or affect other areas of the body", "relationMentions": [{"em1Text": "butyrylcholinesterase", "em2Text": "cocaine", "label": "CPR:9"}, {"em1Text": "BChE", "em2Text": "cocaine", "label": "CPR:9"}]}
{"sentText": "This prompted the design of variants of BChE which exhibit significantly improved catalytic activity against cocaine", "relationMentions": [{"em1Text": "BChE", "em2Text": "cocaine", "label": "CPR:9"}]}
{"sentText": "Second feeding increased both the expression of COX isoforms and PGE2 level in the duodenum and the effects were markedly inhibited by pretreatment with cimetidine", "relationMentions": [{"em1Text": "COX", "em2Text": "cimetidine", "label": "CPR:4"}]}
{"sentText": "We examined in cats the 1 ulcerogenic effects of selective COX1 SC560 ketorolac and COX2 celecoxib meloxicam inhibitors on the gastrointestinal mucosa 2 effect of feeding and cimetidine on the expression of COX isoforms and prostaglandin E2 PGE2 level in the duodenum and 3 localization of COX isoforms in the duodenum", "relationMentions": [{"em1Text": "COX1", "em2Text": "SC560", "label": "CPR:4"}, {"em1Text": "COX1", "em2Text": "ketorolac", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "celecoxib", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "meloxicam", "label": "CPR:4"}]}
{"sentText": "Reversal of inhibition by D2 agonist quinpirole was produced by serotonin 50 \u00b5M and by neurotensin 510 nM", "relationMentions": [{"em1Text": "D2", "em2Text": "neurotensin", "label": "CPR:3"}, {"em1Text": "D2", "em2Text": "serotonin", "label": "CPR:3"}, {"em1Text": "D2", "em2Text": "quinpirole", "label": "CPR:5"}]}
{"sentText": "Serotonininduced or neurotensininduced reversal was blocked by \u03b2ARK1 inhibitor dynasore or cPKC antagonist 56713tetrahydro13methyl5oxo12Hindolo23apyrrolo34ccarbazole12propanenitrile G\u00f66976", "relationMentions": [{"em1Text": "cPKC", "em2Text": "56713tetrahydro13methyl5oxo12Hindolo23apyrrolo34ccarbazole12propanenitrile", "label": "CPR:6"}, {"em1Text": "cPKC", "em2Text": "G\u00f66976", "label": "CPR:6"}]}
{"sentText": "However 4GRSV but not 3GRSV induced SIRT1 dependent histone H3 deacetylation and SOD2 expression in mouse C2C12 skeletal myoblasts as with RSV SIRT1 knockdown blunted these effects", "relationMentions": [{"em1Text": "4GRSV", "em2Text": "SIRT1", "label": "CPR:3"}, {"em1Text": "4GRSV", "em2Text": "SOD2", "label": "CPR:3"}]}
{"sentText": "RSV targets and activates the NADdependent protein deacetylase SIRT1 in turn SIRT1 induces an intracellular antioxidative mechanism by inducing mitochondrial superoxide dismutase SOD2", "relationMentions": [{"em1Text": "RSV", "em2Text": "NADdependent protein deacetylase SIRT1", "label": "CPR:3"}, {"em1Text": "RSV", "em2Text": "SIRT1", "label": "CPR:3"}, {"em1Text": "RSV", "em2Text": "mitochondrial superoxide dismutase", "label": "CPR:3"}, {"em1Text": "RSV", "em2Text": "SOD2", "label": "CPR:3"}]}
{"sentText": "These results provide a rationale for future design of therapeutic apolipoprotein mimetic peptides and provide new insights into the interaction of hydrophobic residues on apolipoproteins with phospholipids in the lipid microdomain created by the ABCA1 transporter during the cholesterol efflux process", "relationMentions": [{"em1Text": "ABCA1", "em2Text": "cholesterol", "label": "CPR:9"}]}
{"sentText": "The bihelical apolipoprotein mimetic peptide 5A effluxes cholesterol from cells and reduces inflammation and atherosclerosis in animal models", "relationMentions": [{"em1Text": "apolipoprotein mimetic peptide 5A", "em2Text": "cholesterol", "label": "CPR:9"}]}
{"sentText": "Compared with active peptides containing F or W peptides containing E in either of these two positions were more than 10fold less effective in effluxing cholesterol by the ABCA1 transporter", "relationMentions": [{"em1Text": "cholesterol", "em2Text": "ABCA1", "label": "CPR:9"}]}
{"sentText": "Hydrophobic amino acids in the hinge region of the 5A apolipoprotein mimetic peptide are essential for promoting cholesterol efflux by the ABCA1 transporter", "relationMentions": [{"em1Text": "cholesterol", "em2Text": "ABCA1", "label": "CPR:9"}]}
{"sentText": "To determine if control of seizures and survival are still possible without pretreatment or immediate pharmacologic intervention we studied the anticonvulsant efficacy of the GluK1 GluR5 \u03b1amino3hydroxy5methyl4isoxazolepropionic acid AMPA receptor antagonist 3S4aR6R8aR6212Htetrazole5ylethyldecahydroisoquinoline3carboxylic acid LY293558 in rats that did not receive any treatment until 20 minutes after exposure to the nerve agent soman", "relationMentions": [{"em1Text": "GluK1", "em2Text": "3S4aR6R8aR6212Htetrazole5ylethyldecahydroisoquinoline3carboxylic acid", "label": "CPR:6"}, {"em1Text": "GluR5", "em2Text": "3S4aR6R8aR6212Htetrazole5ylethyldecahydroisoquinoline3carboxylic acid", "label": "CPR:6"}, {"em1Text": "\u03b1amino3hydroxy5methyl4isoxazolepropionic acid AMPA receptor", "em2Text": "3S4aR6R8aR6212Htetrazole5ylethyldecahydroisoquinoline3carboxylic acid", "label": "CPR:6"}, {"em1Text": "GluK1", "em2Text": "LY293558", "label": "CPR:6"}, {"em1Text": "GluR5", "em2Text": "LY293558", "label": "CPR:6"}, {"em1Text": "\u03b1amino3hydroxy5methyl4isoxazolepropionic acid AMPA receptor", "em2Text": "LY293558", "label": "CPR:6"}]}
{"sentText": "Efficacy of the GluK1 AMPA receptor antagonist LY293558 against seizures and neuropathology in a somanexposure model without pretreatment and its pharmacokinetics after intramuscular administration", "relationMentions": [{"em1Text": "GluK1", "em2Text": "LY293558", "label": "CPR:6"}, {"em1Text": "AMPA receptor", "em2Text": "LY293558", "label": "CPR:6"}]}
{"sentText": "Cellular release of AChE by SHSY5Y is significantly enhanced by the muscarinic acetylcholine receptor mAChR agonists carbachol or muscarine with the effect of carbachol blocked by the mAChR antagonist atropine", "relationMentions": [{"em1Text": "AChE", "em2Text": "carbachol", "label": "CPR:3"}, {"em1Text": "AChE", "em2Text": "muscarine", "label": "CPR:3"}, {"em1Text": "AChE", "em2Text": "carbachol", "label": "CPR:3"}, {"em1Text": "AChE", "em2Text": "atropine", "label": "CPR:4"}, {"em1Text": "muscarinic acetylcholine receptor", "em2Text": "carbachol", "label": "CPR:5"}, {"em1Text": "mAChR", "em2Text": "carbachol", "label": "CPR:5"}, {"em1Text": "muscarinic acetylcholine receptor", "em2Text": "muscarine", "label": "CPR:5"}, {"em1Text": "mAChR", "em2Text": "muscarine", "label": "CPR:5"}, {"em1Text": "mAChR", "em2Text": "atropine", "label": "CPR:6"}]}
{"sentText": "Although acetylcholinesterase AChE is primarily a hydrolytic enzyme metabolising the neurotransmitter acetylcholine in cholinergic synapses it also has some noncatalytic functions in the brain which are far less well characterised", "relationMentions": [{"em1Text": "acetylcholine", "em2Text": "AChE", "label": "CPR:9"}, {"em1Text": "acetylcholine", "em2Text": "acetylcholinesterase", "label": "CPR:9"}]}
{"sentText": "Nevertheless low LBMAA concentrations \u2265 01mM 48 h increased protein ubiquitination 20S proteasomal and caspase 12 activity expression of the endoplasmic reticulum ER stress marker CHOP and enhanced phosphorylation of elf2\u03b1 in SHSY5Y cells", "relationMentions": [{"em1Text": "LBMAA", "em2Text": "20S proteasomal", "label": "CPR:3"}, {"em1Text": "LBMAA", "em2Text": "caspase 12", "label": "CPR:3"}, {"em1Text": "LBMAA", "em2Text": "CHOP", "label": "CPR:3"}, {"em1Text": "LBMAA", "em2Text": "elf2\u03b1", "label": "CPR:3"}]}
{"sentText": "LBMAA induced ER stress and enhanced caspase 12 cleavage in human neuroblastoma SHSY5Y cells at low nonexcitotoxic concentrations", "relationMentions": [{"em1Text": "LBMAA", "em2Text": "caspase 12", "label": "CPR:3"}]}
{"sentText": "We found that intracellular GTP depletion by ribavirin as well as other IMPDH inosine5monophosphate dehydrogenase inhibitors such as mycophenolic acid and 6mercaptopurine upregulated F7 expression", "relationMentions": [{"em1Text": "mycophenolic acid", "em2Text": "F7", "label": "CPR:3"}, {"em1Text": "6mercaptopurine", "em2Text": "F7", "label": "CPR:3"}]}
{"sentText": "Ribavirin unregulated ELL elevennineteen lysinerich leukaemia 3 mRNA expression before F7 upregulation", "relationMentions": [{"em1Text": "Ribavirin", "em2Text": "ELL", "label": "CPR:3"}, {"em1Text": "Ribavirin", "em2Text": "elevennineteen lysinerich leukaemia 3", "label": "CPR:3"}, {"em1Text": "Ribavirin", "em2Text": "F7", "label": "CPR:3"}]}
{"sentText": "We observed that ribavirin enhanced ELL3 recruitment to F7 whereas knockdown of ELL3 diminished ribavirin induced FVII mRNA upregulation", "relationMentions": [{"em1Text": "ribavirin", "em2Text": "ELL3", "label": "CPR:3"}, {"em1Text": "ribavirin", "em2Text": "F7", "label": "CPR:3"}, {"em1Text": "ribavirin", "em2Text": "FVII", "label": "CPR:3"}]}
{"sentText": "Ribavirin induced intracellular GTP depletion activates transcription elongation in coagulation factor VII gene expression", "relationMentions": [{"em1Text": "Ribavirin", "em2Text": "coagulation factor VII", "label": "CPR:3"}]}
{"sentText": "Ribavirin also enhanced recruitment of CDK9 cyclindependent kinase 9 and AFF4 to F7", "relationMentions": [{"em1Text": "Ribavirin", "em2Text": "CDK9", "label": "CPR:3"}, {"em1Text": "Ribavirin", "em2Text": "cyclindependent kinase 9", "label": "CPR:3"}, {"em1Text": "Ribavirin", "em2Text": "AFF4", "label": "CPR:3"}, {"em1Text": "Ribavirin", "em2Text": "F7", "label": "CPR:3"}]}
{"sentText": "These data suggest that ribavirin induced intracellular GTP depletion recruits a super elongation complex containing PTEFb AFF4 and ELL3 to F7 and modulates FVII mRNA transcription elongation", "relationMentions": [{"em1Text": "ribavirin", "em2Text": "PTEFb", "label": "CPR:3"}, {"em1Text": "ribavirin", "em2Text": "AFF4", "label": "CPR:3"}, {"em1Text": "ribavirin", "em2Text": "ELL3", "label": "CPR:3"}, {"em1Text": "ribavirin", "em2Text": "F7", "label": "CPR:3"}]}
{"sentText": "Collectively we have elucidated a basal mechanism for ribavirin induced FVII mRNA upregulation by acceleration of transcription elongation which may be crucial in understanding its pleiotropic functions in vivo", "relationMentions": [{"em1Text": "ribavirin", "em2Text": "FVII", "label": "CPR:3"}]}
{"sentText": "It was reported previously that FVII gene F7 expression was upregulated by ribavirin treatment in hepatitis C virusinfected haemophilia patients however its precise mechanism is still unknown", "relationMentions": [{"em1Text": "FVII", "em2Text": "ribavirin", "label": "CPR:3"}, {"em1Text": "F7", "em2Text": "ribavirin", "label": "CPR:3"}]}
{"sentText": "In the present study we investigated the molecular mechanism of ribavirin induced upregulation of F7 expression in HepG2 human hepatoma cell line", "relationMentions": [{"em1Text": "ribavirin", "em2Text": "F7", "label": "CPR:3"}]}
{"sentText": "Protein kinase C PKC inhibition reduced the potentiation by mGlu1 of GluK2 GluK5 and conversely direct activation of PKC by phorbol 12myristate13acetate potentiated GluK2 GluK5", "relationMentions": [{"em1Text": "PKC", "em2Text": "phorbol 12myristate13acetate", "label": "CPR:3"}, {"em1Text": "GluK2", "em2Text": "phorbol 12myristate13acetate", "label": "CPR:3"}, {"em1Text": "GluK5", "em2Text": "phorbol 12myristate13acetate", "label": "CPR:3"}]}
{"sentText": "The potentiation of heteromeric KARs by mGlu1 activation was attenuated by GDP\u03b2S blocked by an inhibitor of phospholipase C or the calcium chelator 12bisoaminophenoxyethaneNNNNtetraacetic acid BAPTA prolonged by the phosphatase inhibitor okadaic acid but unaffected by the tyrosine kinase inhibitor lavendustin A", "relationMentions": [{"em1Text": "KARs", "em2Text": "12bisoaminophenoxyethaneNNNNtetraacetic acid", "label": "CPR:4"}, {"em1Text": "mGlu1", "em2Text": "12bisoaminophenoxyethaneNNNNtetraacetic acid", "label": "CPR:4"}, {"em1Text": "KARs", "em2Text": "BAPTA", "label": "CPR:4"}, {"em1Text": "mGlu1", "em2Text": "BAPTA", "label": "CPR:4"}, {"em1Text": "phosphatase", "em2Text": "okadaic acid", "label": "CPR:4"}, {"em1Text": "KARs", "em2Text": "okadaic acid", "label": "CPR:4"}, {"em1Text": "mGlu1", "em2Text": "okadaic acid", "label": "CPR:4"}, {"em1Text": "tyrosine kinase", "em2Text": "lavendustin A", "label": "CPR:4"}, {"em1Text": "KARs", "em2Text": "lavendustin A", "label": "CPR:4"}, {"em1Text": "mGlu1", "em2Text": "lavendustin A", "label": "CPR:4"}]}
{"sentText": "Fingolimod FTY720 a novel drug approved for the treatment of relapsingremitting multiple sclerosis activates different sphingosine1phosphate receptor S1PR subtypes", "relationMentions": [{"em1Text": "Fingolimod", "em2Text": "sphingosine1phosphate receptor", "label": "CPR:3"}, {"em1Text": "Fingolimod", "em2Text": "S1PR", "label": "CPR:3"}, {"em1Text": "FTY720", "em2Text": "sphingosine1phosphate receptor", "label": "CPR:3"}, {"em1Text": "FTY720", "em2Text": "S1PR", "label": "CPR:3"}]}
{"sentText": "Neuroprotection was attenuated by pertussis toxin and inhibited by the selective type1 S1PR S1P1R antagonist W146 and by inhibitors of the mitogen associated protein kinase MAPK and the phosphatidylinositol3kinase PtdIns3K pathways", "relationMentions": [{"em1Text": "type1 S1PR", "em2Text": "W146", "label": "CPR:6"}, {"em1Text": "S1P1R", "em2Text": "W146", "label": "CPR:6"}]}
{"sentText": "The disposition of anagliptin an orally active highly selective dipeptidyl peptidase4 inhibitor was investigated after a single oral dose of 100 mg192 MBq 14Canagliptin to six healthy men", "relationMentions": [{"em1Text": "anagliptin", "em2Text": "dipeptidyl peptidase4", "label": "CPR:4"}]}
{"sentText": "Pharmacokinetics and metabolism of 14Canagliptin a novel dipeptidyl peptidase4 inhibitor in humans", "relationMentions": [{"em1Text": "14Canagliptin", "em2Text": "dipeptidyl peptidase4", "label": "CPR:4"}]}
{"sentText": "Renal clearance of unbound anagliptin and unbound M1 far exceeded glomerular filtration rate indicating active renal elimination that might reflect the fact that anagliptin may be a substrate of OAT1 OAT3 MDR1 and MRP2 and M1 a substrate of OAT3 BCRP MRP2 and MRP4", "relationMentions": [{"em1Text": "anagliptin", "em2Text": "OAT1", "label": "CPR:9"}, {"em1Text": "anagliptin", "em2Text": "OAT3", "label": "CPR:9"}, {"em1Text": "anagliptin", "em2Text": "MDR1", "label": "CPR:9"}, {"em1Text": "anagliptin", "em2Text": "MRP2", "label": "CPR:9"}]}
{"sentText": "Antiretroviral protease inhibitors lopinavir LPV and ritonavir RTV are reported BSEP inhibitors", "relationMentions": [{"em1Text": "protease", "em2Text": "lopinavir", "label": "CPR:4"}, {"em1Text": "lopinavir", "em2Text": "BSEP", "label": "CPR:4"}, {"em1Text": "protease", "em2Text": "LPV", "label": "CPR:4"}, {"em1Text": "LPV", "em2Text": "BSEP", "label": "CPR:4"}, {"em1Text": "protease", "em2Text": "ritonavir", "label": "CPR:4"}, {"em1Text": "ritonavir", "em2Text": "BSEP", "label": "CPR:4"}, {"em1Text": "protease", "em2Text": "RTV", "label": "CPR:4"}, {"em1Text": "RTV", "em2Text": "BSEP", "label": "CPR:4"}]}
{"sentText": "GHRP6 is a growth hormone secretagogue that also enhances tissue viability in different organs", "relationMentions": [{"em1Text": "GHRP6", "em2Text": "growth hormone", "label": "CPR:3"}]}
{"sentText": "The altered activities of key enzymes such as glucose6phosphatase and fructose16bisphosphatase of carbohydrate metabolism significantly p005 increased whereas hexokinase pyruvate kinase glucose6phosphate dehydrogenase and glycogen content significantly p005 decreased in the liver of diabetic rats and also increased activities of aspartate transaminase AST alanine transaminase ALT and alkaline phosphatase ALP", "relationMentions": [{"em1Text": "glucose6phosphatase", "em2Text": "carbohydrate", "label": "CPR:9"}, {"em1Text": "fructose16bisphosphatase", "em2Text": "carbohydrate", "label": "CPR:9"}]}
{"sentText": "Ibandronate increases the expression of the proapoptotic gene FAS by epigenetic mechanisms in tumor cells", "relationMentions": [{"em1Text": "Ibandronate", "em2Text": "FAS", "label": "CPR:3"}]}
{"sentText": "Data suggest that bisphosphonates via modulation of the activity of smallGTPases induce apoptosis in neoplastic cells by DNACpGdemethylation and stimulation of FAS expression", "relationMentions": [{"em1Text": "bisphosphonates", "em2Text": "FAS", "label": "CPR:3"}]}
{"sentText": "Further we found stimulation of FASexpression as a result of epigenetic DNA demethylation that was due to downregulation of DNMT1 which was rescued by reisoprenylation by both geranylgeranylpyrophosphate and farnesylpyrophosphate", "relationMentions": [{"em1Text": "DNMT1", "em2Text": "geranylgeranylpyrophosphate", "label": "CPR:3"}, {"em1Text": "DNMT1", "em2Text": "farnesylpyrophosphate", "label": "CPR:3"}]}
{"sentText": "The AhR target gene CYP1A1 mRNA expression was induced by TCDD but was not affected by the AR CAG length", "relationMentions": [{"em1Text": "CYP1A1", "em2Text": "TCDD", "label": "CPR:3"}]}
{"sentText": "TCDD had no effect on AR activity in PC3 cells whereas the shortest AR variant was induced by TCDD in PNT1A cells", "relationMentions": [{"em1Text": "TCDD", "em2Text": "AR", "label": "CPR:3"}]}
{"sentText": "Systemic injection to mice of siRNA lipoplexes rather than of cationic liposome triggered a production of several cytokines in mice and replacement of plasmid by polyglutamate reduced the elevation of all assayed cytokines", "relationMentions": [{"em1Text": "cytokines", "em2Text": "polyglutamate", "label": "CPR:4"}]}
{"sentText": "We found that helenalin markedly induced endoplasmic reticulum ER stressrelated genes such as regulated in development and DNA damage responses REDD 1 activating transcription factor4 ATF4 andor the CCAAT enhancerbinding proteinhomologous protein CHOP", "relationMentions": [{"em1Text": "helenalin", "em2Text": "regulated in development and DNA damage responses REDD 1", "label": "CPR:3"}, {"em1Text": "helenalin", "em2Text": "activating transcription factor4", "label": "CPR:3"}, {"em1Text": "helenalin", "em2Text": "ATF4", "label": "CPR:3"}, {"em1Text": "helenalin", "em2Text": "CCAAT enhancerbinding proteinhomologous protein", "label": "CPR:3"}, {"em1Text": "helenalin", "em2Text": "CHOP", "label": "CPR:3"}]}
{"sentText": "In conclusion rCtr1 can transport copper and platinum drugs and sensitizes cells to their cytotoxicities", "relationMentions": [{"em1Text": "rCtr1", "em2Text": "platinum", "label": "CPR:9"}, {"em1Text": "rCtr1", "em2Text": "copper", "label": "CPR:9"}]}
{"sentText": "DRG neurons display substantial capacity for accumulating copper via a transport process mediated by rCtr1 but appear able to resist copper toxicity and use alternative mechanisms to take up oxaliplatin", "relationMentions": [{"em1Text": "copper", "em2Text": "rCtr1", "label": "CPR:9"}, {"em1Text": "rCtr1", "em2Text": "oxaliplatin", "label": "CPR:9"}]}
{"sentText": "Heterologous expression of rCtr1 in HEK293 cells HEKrCtr1 cells increased the uptake and cytotoxicity of copper oxaliplatin cisplatin and carboplatin in comparison to isogenic vectortransfected control cells", "relationMentions": [{"em1Text": "rCtr1", "em2Text": "copper", "label": "CPR:9"}, {"em1Text": "rCtr1", "em2Text": "copper", "label": "CPR:9"}, {"em1Text": "rCtr1", "em2Text": "oxaliplatin", "label": "CPR:9"}, {"em1Text": "rCtr1", "em2Text": "oxaliplatin", "label": "CPR:9"}, {"em1Text": "rCtr1", "em2Text": "cisplatin", "label": "CPR:9"}, {"em1Text": "rCtr1", "em2Text": "cisplatin", "label": "CPR:9"}, {"em1Text": "rCtr1", "em2Text": "carboplatin", "label": "CPR:9"}, {"em1Text": "rCtr1", "em2Text": "carboplatin", "label": "CPR:9"}]}
{"sentText": "Cultured rat DRG neurons endogenously expressed rCtr1 protein on their neuronal cell body plasma membranes and cytoplasm and displayed substantial capacity for taking up copper but were resistant to copper toxicity", "relationMentions": [{"em1Text": "rCtr1", "em2Text": "copper", "label": "CPR:9"}]}
{"sentText": "The uptake of copper by both cultured rat DRG neurons and HEK rCtr1 cells was saturable and inhibited by cold temperature silver and zinc consistent with it being mediated by rCtr1", "relationMentions": [{"em1Text": "copper", "em2Text": "rCtr1", "label": "CPR:9"}]}
{"sentText": "Contributions of rat Ctr1 to the uptake and toxicity of copper and platinum anticancer drugs in dorsal root ganglion neurons", "relationMentions": [{"em1Text": "rat Ctr1", "em2Text": "copper", "label": "CPR:9"}, {"em1Text": "rat Ctr1", "em2Text": "platinum", "label": "CPR:9"}]}
{"sentText": "In addition glucosamine attenuated p21 protein stability via the proteasomal proteolytic pathway as well as inducing p21 nuclear accumulation", "relationMentions": [{"em1Text": "glucosamine", "em2Text": "p21", "label": "CPR:3"}, {"em1Text": "glucosamine", "em2Text": "p21", "label": "CPR:4"}]}
{"sentText": "Altogether our results suggest that a high dose of glucosamine may inhibit cell proliferation through apoptosis and disturb cell cycle progression with a halt at G0G1 phase and that this occurs at least in part by a reduction in Rb phosphorylation together with modulation of p21 p53 and HO1 expression and nuclear p21 accumulation", "relationMentions": [{"em1Text": "glucosamine", "em2Text": "p21", "label": "CPR:3"}, {"em1Text": "glucosamine", "em2Text": "Rb", "label": "CPR:4"}]}
{"sentText": "Glucosamine at 50 mM was demonstrated to elevate both the mRNA and protein expression of p53 and heme oxygenase1 HO1 but also caused a reduction in p21 protein expression", "relationMentions": [{"em1Text": "Glucosamine", "em2Text": "p53", "label": "CPR:3"}, {"em1Text": "Glucosamine", "em2Text": "heme oxygenase1", "label": "CPR:3"}, {"em1Text": "Glucosamine", "em2Text": "p21", "label": "CPR:4"}]}
{"sentText": "Examination of phosphorylation in retinoblastoma Rb protein we found an inhibitory effect by glucosamine at 20 and 50 mM", "relationMentions": [{"em1Text": "retinoblastoma Rb protein", "em2Text": "glucosamine", "label": "CPR:4"}]}
{"sentText": "Characterization of substituted phenylpropylamides as highly selective agonists at the melatonin MT2 receptor", "relationMentions": [{"em1Text": "phenylpropylamides", "em2Text": "melatonin MT2 receptor", "label": "CPR:5"}]}
{"sentText": "We show that the expression of PIM1 is induced in response to estradiol in MCF7 cells and that the induction is mediated by ER\u03b1 regulated enhancers located distally upstream from the gene", "relationMentions": [{"em1Text": "PIM1", "em2Text": "estradiol", "label": "CPR:3"}, {"em1Text": "estradiol", "em2Text": "ER\u03b1", "label": "CPR:3"}]}
{"sentText": "In this work the metabolism of four frequently prescribed inhaled GCs triamcinolone acetonide flunisolide budesonide and fluticasone propionate by the CYP3A family of enzymes was studied to identify differences in their rates of clearance and to identify their metabolites", "relationMentions": [{"em1Text": "triamcinolone acetonide", "em2Text": "CYP3A", "label": "CPR:9"}, {"em1Text": "flunisolide", "em2Text": "CYP3A", "label": "CPR:9"}, {"em1Text": "budesonide", "em2Text": "CYP3A", "label": "CPR:9"}, {"em1Text": "fluticasone propionate", "em2Text": "CYP3A", "label": "CPR:9"}]}
{"sentText": "CYP3A5 which is particularly relevant to GC metabolism in the lungs was also shown to efficiently metabolize triamcinolone acetonide budesonide and fluticasone propionate", "relationMentions": [{"em1Text": "CYP3A5", "em2Text": "triamcinolone acetonide", "label": "CPR:9"}, {"em1Text": "CYP3A5", "em2Text": "budesonide", "label": "CPR:9"}, {"em1Text": "CYP3A5", "em2Text": "fluticasone propionate", "label": "CPR:9"}]}
{"sentText": "In contrast flunisolide was only metabolized via CYP3A4 with no significant turnover by CYP3A5 or CYP3A7", "relationMentions": [{"em1Text": "flunisolide", "em2Text": "CYP3A4", "label": "CPR:9"}]}
{"sentText": "Distinct roles of methamphetamine in modulating spatial memory consolidation retrieval reconsolidation and the accompanying changes of ERK and CREB activation in hippocampus and prefrontal cortex", "relationMentions": [{"em1Text": "methamphetamine", "em2Text": "ERK", "label": "CPR:3"}, {"em1Text": "methamphetamine", "em2Text": "CREB", "label": "CPR:3"}]}
{"sentText": "In contrast activation of both ERK and CREB in the PFC was found following memory retrieval but not other processes in METH treated mouse groups", "relationMentions": [{"em1Text": "ERK", "em2Text": "METH", "label": "CPR:3"}, {"em1Text": "CREB", "em2Text": "METH", "label": "CPR:3"}]}
{"sentText": "Moreover activation of the ERK and CREB signaling pathway in the hippocampus might be involved in METH induced spatial memory changes", "relationMentions": [{"em1Text": "ERK", "em2Text": "METH", "label": "CPR:3"}, {"em1Text": "CREB", "em2Text": "METH", "label": "CPR:3"}]}
{"sentText": "A reporter construct driven by 4 kb of the chicken rasdva 5flanking region containing six putative pituitaryspecific transcription factor1 Pit1 binding sites and two potential glucocorticoid receptor GR binding sites was highly activated in embryonic pituitary cells and upregulated by corticosterone", "relationMentions": [{"em1Text": "chicken rasdva", "em2Text": "corticosterone", "label": "CPR:3"}, {"em1Text": "pituitaryspecific transcription factor1 Pit1 binding sites", "em2Text": "corticosterone", "label": "CPR:3"}, {"em1Text": "glucocorticoid receptor GR binding sites", "em2Text": "corticosterone", "label": "CPR:3"}]}
{"sentText": "However mutating putative GR binding sites did not substantially reduce induction of rasdva promoter activity by corticosterone suggesting additional DNA elements within the 5flanking region are responsible for glucocorticoid regulation", "relationMentions": [{"em1Text": "GR binding sites", "em2Text": "corticosterone", "label": "CPR:3"}, {"em1Text": "rasdva promoter", "em2Text": "corticosterone", "label": "CPR:3"}]}
{"sentText": "To investigate the role of mGluR8 in modulating the synaptic responses of retinal ganglion cells we used a recently identified positive allosteric modulator of mGluR8 AZ12216052 AZ and the mGluR8 specific orthosteric agonist S34dicarboxyphenylglycine DCPG", "relationMentions": [{"em1Text": "mGluR8", "em2Text": "S34dicarboxyphenylglycine", "label": "CPR:5"}, {"em1Text": "mGluR8", "em2Text": "DCPG", "label": "CPR:5"}]}
{"sentText": "Here we compared the effects of a dimeric PSD95 inhibitor UCCB01125 and the NMDAR antagonist MK801 on mechanical hypersensitivity in the complete Freunds adjuvant CFA model of inflammatory pain", "relationMentions": [{"em1Text": "PSD95", "em2Text": "UCCB01125", "label": "CPR:4"}, {"em1Text": "NMDAR", "em2Text": "MK801", "label": "CPR:6"}]}
{"sentText": "UCCB01125 a dimeric inhibitor of PSD95 reduces inflammatory pain without disrupting cognitive or motor performance comparison with the NMDA receptor antagonist MK801", "relationMentions": [{"em1Text": "NMDA receptor", "em2Text": "MK801", "label": "CPR:6"}]}
{"sentText": "The treatment also prevented the high cholesterol dietinduced increase in serum creatine kinase total and isoforms markers of neurological cardiac and muscular damage", "relationMentions": [{"em1Text": "cholesterol", "em2Text": "creatine kinase", "label": "CPR:3"}]}
{"sentText": "GIP potentiates glucose stimulated insulin secretion and induces energy accumulation into adipose tissue resulting in obesity", "relationMentions": [{"em1Text": "glucose", "em2Text": "insulin", "label": "CPR:3"}]}
{"sentText": "We concluded that in overweight and obese women with PCOS Orlistat administration combined with diet and physical exercise for 24 weeks resulted in significant weight loss improvement of hyperandrogenism and insulin sensitivity and increased serum AMH levels", "relationMentions": [{"em1Text": "Orlistat", "em2Text": "AMH", "label": "CPR:3"}]}
{"sentText": "Diet physical exercise and Orlistat administration increase serum AntiM\u00fcllerian Hormone AMH levels in women with polycystic ovary syndrome PCOS", "relationMentions": [{"em1Text": "Orlistat", "em2Text": "AntiM\u00fcllerian Hormone", "label": "CPR:3"}, {"em1Text": "Orlistat", "em2Text": "AMH", "label": "CPR:3"}]}
{"sentText": "Moreover 125OH2D3 decreased expression of Oat1 and Oat3 in rat kidney", "relationMentions": [{"em1Text": "125OH2D3", "em2Text": "Oat1", "label": "CPR:4"}, {"em1Text": "125OH2D3", "em2Text": "Oat3", "label": "CPR:4"}]}
{"sentText": "The mechanism of interaction between JBP485 and 125OH2D3 could be explained at least in part by inhibitory effect of 125OH2D3 on expression of Oats in rat kidney", "relationMentions": [{"em1Text": "125OH2D3", "em2Text": "Oats", "label": "CPR:4"}]}
{"sentText": "These results demonstrated for the first time that ISO induces apoptosis in HepG2 cells through inactivating ERK12 kinase and activating JNK and p38 kinases and ROS stimulated by ISO is able to activate the MAPK singaling pathway as the upstream signaling molecules", "relationMentions": [{"em1Text": "ISO", "em2Text": "JNK", "label": "CPR:3"}, {"em1Text": "ISO", "em2Text": "p38", "label": "CPR:3"}, {"em1Text": "ISO", "em2Text": "kinases", "label": "CPR:3"}, {"em1Text": "ISO", "em2Text": "MAPK", "label": "CPR:3"}]}
{"sentText": "ISO significantly inhibited the levels of ERK12 kinase and increased the expression of JNK and p38 kinases", "relationMentions": [{"em1Text": "ISO", "em2Text": "JNK", "label": "CPR:3"}, {"em1Text": "ISO", "em2Text": "p38", "label": "CPR:3"}, {"em1Text": "ISO", "em2Text": "kinases", "label": "CPR:3"}]}
{"sentText": "Furthermore U0126 an ERK12 inhibitor significantly enhanced the ISO induced the Bax Bcl2 ratio the release of cytochrome c to the cytosol fraction and the levels of cleaved caspase3", "relationMentions": [{"em1Text": "U0126", "em2Text": "Bax", "label": "CPR:3"}, {"em1Text": "U0126", "em2Text": "Bcl2", "label": "CPR:3"}, {"em1Text": "ISO", "em2Text": "Bax", "label": "CPR:3"}, {"em1Text": "ISO", "em2Text": "Bcl2", "label": "CPR:3"}]}
{"sentText": "While SP600125 a JNK inhibitor and SB203580 a p38 inhibitor markedly prevented the expression of these proteins induced by ISO", "relationMentions": [{"em1Text": "JNK", "em2Text": "ISO", "label": "CPR:3"}, {"em1Text": "p38", "em2Text": "ISO", "label": "CPR:3"}, {"em1Text": "SP600125", "em2Text": "JNK", "label": "CPR:4"}, {"em1Text": "SB203580", "em2Text": "p38", "label": "CPR:4"}]}
{"sentText": "ISO is able to induce apoptosis through mitochondrial dysfunction and inhibition of PI3K Akt signaling pathway in HepG2 cells however the effects of ISO on MAPK signaling pathways remain unknown", "relationMentions": [{"em1Text": "ISO", "em2Text": "PI3K", "label": "CPR:4"}, {"em1Text": "ISO", "em2Text": "Akt", "label": "CPR:4"}]}
{"sentText": "NAC also suppressed the p JNK and pp38 but failed to reverse the effects of ISO", "relationMentions": [{"em1Text": "NAC", "em2Text": "JNK", "label": "CPR:4"}, {"em1Text": "NAC", "em2Text": "pp38", "label": "CPR:4"}]}
{"sentText": "Treatment with IMG and hyperoside resulted in significantly prolonged aPTT and PT and inhibition of the activities of thrombin and FXa and IMG or hyperoside inhibited production of thrombin and FXa in HUVECs", "relationMentions": [{"em1Text": "IMG", "em2Text": "thrombin", "label": "CPR:3"}, {"em1Text": "IMG", "em2Text": "thrombin", "label": "CPR:4"}, {"em1Text": "IMG", "em2Text": "FXa", "label": "CPR:4"}, {"em1Text": "hyperoside", "em2Text": "thrombin", "label": "CPR:4"}, {"em1Text": "hyperoside", "em2Text": "FXa", "label": "CPR:4"}, {"em1Text": "IMG", "em2Text": "FXa", "label": "CPR:4"}, {"em1Text": "hyperoside", "em2Text": "thrombin", "label": "CPR:4"}, {"em1Text": "hyperoside", "em2Text": "FXa", "label": "CPR:4"}]}
{"sentText": "In addition treatment with IMG and hyperoside resulted in inhibition of TNF\u03b1 induced production of PAI1 and treatment with IMG resulted in significant reduction of the PAI1 to tPA ratio", "relationMentions": [{"em1Text": "IMG", "em2Text": "TNF\u03b1", "label": "CPR:4"}, {"em1Text": "IMG", "em2Text": "PAI1", "label": "CPR:4"}, {"em1Text": "hyperoside", "em2Text": "TNF\u03b1", "label": "CPR:4"}, {"em1Text": "hyperoside", "em2Text": "PAI1", "label": "CPR:4"}, {"em1Text": "IMG", "em2Text": "PAI1", "label": "CPR:4"}, {"em1Text": "IMG", "em2Text": "tPA", "label": "CPR:4"}]}
{"sentText": "In previous study we discovered multitarget drugs towards the AA metabolic network among which a dualtarget inhibitor JMC084 for human nonpancreatic secretory phospholipase A2 hnpsPLA2 and human leukotriene A4 hydrolase LTA4Hh was found", "relationMentions": [{"em1Text": "JMC084", "em2Text": "human leukotriene A4 hydrolase", "label": "CPR:4"}, {"em1Text": "JMC084", "em2Text": "LTA4Hh", "label": "CPR:4"}, {"em1Text": "JMC084", "em2Text": "human nonpancreatic secretory phospholipase A2", "label": "CPR:4"}, {"em1Text": "JMC084", "em2Text": "hnpsPLA2", "label": "CPR:4"}]}
{"sentText": "Optimization of 5hydroxytryptamines as dual function inhibitors targeting phospholipase A2 and leukotriene A4 hydrolase", "relationMentions": [{"em1Text": "5hydroxytryptamines", "em2Text": "phospholipase A2", "label": "CPR:4"}, {"em1Text": "5hydroxytryptamines", "em2Text": "leukotriene A4 hydrolase", "label": "CPR:4"}]}
{"sentText": "Dual function inhibitors targeting phospholipase A2 PLA2 and leukotriene A4 hydrolase LTA4H may balance the arachidonic acid AA metabolic network and be used as new antiinflammatory drugs", "relationMentions": [{"em1Text": "PLA2", "em2Text": "arachidonic acid", "label": "CPR:9"}, {"em1Text": "leukotriene A4 hydrolase", "em2Text": "arachidonic acid", "label": "CPR:9"}, {"em1Text": "LTA4H", "em2Text": "arachidonic acid", "label": "CPR:9"}, {"em1Text": "phospholipase A2", "em2Text": "arachidonic acid", "label": "CPR:9"}]}
{"sentText": "In addition we provide evidence that apomorphine also acts on endogenous TRPA1 in cultured dorsal root ganglion neurons from rats and in the enterochromaffin model cell line QGP1 from which serotonin is released upon activation of TRPA1", "relationMentions": [{"em1Text": "apomorphine", "em2Text": "TRPA1", "label": "CPR:3"}]}
{"sentText": "Our study shows that human TRPA1 is a target for apomorphine suggesting that an activation of TRPA1 might contribute to adverse side effects such as nausea and painful injections which can occur during treatment with apomorphine", "relationMentions": [{"em1Text": "TRPA1", "em2Text": "apomorphine", "label": "CPR:3"}, {"em1Text": "TRPA1", "em2Text": "apomorphine", "label": "CPR:3"}]}
{"sentText": "Whereas the addition of apomorphine in the low micromolar range produced an irreversible activation of the channel application of higher concentrations caused a reversible voltagedependent inhibition of heterologously expressed TRPA1 channels resulting from a reduction of singlechannel open times", "relationMentions": [{"em1Text": "apomorphine", "em2Text": "TRPA1", "label": "CPR:4"}]}
{"sentText": "Dietary carbohydrates increase SCD1 gene expression in liver by sterol response element binding protein SREBP1cdependent and SREBP1c independent pathways", "relationMentions": [{"em1Text": "carbohydrates", "em2Text": "SCD1", "label": "CPR:3"}]}
{"sentText": "Previous report demonstrated that thyroid hormone TH negatively regulates mouse SCD1 gene promoter before SREBP1c was revealed", "relationMentions": [{"em1Text": "thyroid hormone", "em2Text": "mouse SCD1 gene promoter", "label": "CPR:4"}]}
{"sentText": "Human stearoylCoA desaturase 1 SCD1 gene expression is negatively regulated by thyroid hormone without direct binding of thyroid hormone receptor to the gene promoter", "relationMentions": [{"em1Text": "Human stearoylCoA desaturase 1", "em2Text": "thyroid hormone", "label": "CPR:4"}, {"em1Text": "SCD1", "em2Text": "thyroid hormone", "label": "CPR:4"}]}
{"sentText": "Finally chronic administration of metformin in diabetic mice restored cardiac autophagy by activating JNK1 Bcl2 pathways and dissociating Beclin1 and Bcl2", "relationMentions": [{"em1Text": "metformin", "em2Text": "JNK1", "label": "CPR:3"}, {"em1Text": "metformin", "em2Text": "Bcl2", "label": "CPR:3"}]}
{"sentText": "Exposure of H9c2 cells to high glucose reduced AMPK activity inhibited Jun NH2terminal kinase 1 JNK1 Bcell lymphoma 2 Bcl2 signaling and promoted Beclin1 binding to Bcl2", "relationMentions": [{"em1Text": "glucose", "em2Text": "AMPK", "label": "CPR:4"}, {"em1Text": "glucose", "em2Text": "Jun NH2terminal kinase 1", "label": "CPR:4"}, {"em1Text": "glucose", "em2Text": "JNK1", "label": "CPR:4"}, {"em1Text": "glucose", "em2Text": "Bcell lymphoma 2", "label": "CPR:4"}, {"em1Text": "glucose", "em2Text": "Bcl2", "label": "CPR:4"}]}
{"sentText": "In this current study paclitaxel was found to increase phosphorylation of mitogenactivated protein kinase MAPK kinase 36 MKK36 p38 MAPK as well as protein and mRNA levels of ERCC1 in H1650 and H1703 cells", "relationMentions": [{"em1Text": "paclitaxel", "em2Text": "mitogenactivated protein kinase", "label": "CPR:3"}, {"em1Text": "paclitaxel", "em2Text": "p38", "label": "CPR:3"}, {"em1Text": "paclitaxel", "em2Text": "MAPK", "label": "CPR:3"}, {"em1Text": "paclitaxel", "em2Text": "ERCC1", "label": "CPR:3"}]}
{"sentText": "Moreover paclitaxel induced ERCC1 protein and mRNA levels significantly decreased via the downregulation of p38 activity by either a p38 MAPK inhibitor SB202190 or p38 knockdown with specific small interfering RNA siRNA", "relationMentions": [{"em1Text": "paclitaxel", "em2Text": "ERCC1", "label": "CPR:3"}, {"em1Text": "p38", "em2Text": "SB202190", "label": "CPR:4"}, {"em1Text": "p38", "em2Text": "SB202190", "label": "CPR:4"}, {"em1Text": "MAPK", "em2Text": "SB202190", "label": "CPR:4"}]}
{"sentText": "Furthermore metformin was able to not only decrease the paclitaxel induced p38 MAPK mediated ERCC1 expression but also augment the cytotoxic effect induced by paclitaxel", "relationMentions": [{"em1Text": "paclitaxel", "em2Text": "p38", "label": "CPR:3"}, {"em1Text": "paclitaxel", "em2Text": "MAPK", "label": "CPR:3"}, {"em1Text": "paclitaxel", "em2Text": "ERCC1", "label": "CPR:3"}, {"em1Text": "metformin", "em2Text": "p38", "label": "CPR:4"}, {"em1Text": "metformin", "em2Text": "MAPK", "label": "CPR:4"}, {"em1Text": "metformin", "em2Text": "ERCC1", "label": "CPR:4"}]}
{"sentText": "Metformin mediated downregulation of p38 mitogenactivated protein kinase dependent excision repair crosscomplementing 1 decreases DNA repair capacity and sensitizes human lung cancer cells to paclitaxel", "relationMentions": [{"em1Text": "Metformin", "em2Text": "p38", "label": "CPR:4"}, {"em1Text": "Metformin", "em2Text": "mitogenactivated protein kinase", "label": "CPR:4"}]}
{"sentText": "Finally expression of constitutive activate MKK6 or HAp38 MAPK vectors in lung cancer cells was able to abrogate ERCC1 downregulation by metformin and paclitaxel as well as cell viability and DNA repair capacity", "relationMentions": [{"em1Text": "ERCC1", "em2Text": "metformin", "label": "CPR:4"}, {"em1Text": "ERCC1", "em2Text": "paclitaxel", "label": "CPR:4"}]}
{"sentText": "Overall our results suggest that inhibition of the p38 MAPK signaling by metformin coupled with paclitaxel therapy in human NSCLC cells may be a clinically useful combination which however will require further validation", "relationMentions": [{"em1Text": "p38", "em2Text": "metformin", "label": "CPR:4"}, {"em1Text": "MAPK", "em2Text": "metformin", "label": "CPR:4"}]}
{"sentText": "Contrary to the hypothesis orlistat at 1 nM inhibited CES2 activity by 75 but no inhibition on CES1 placing CES2 one of the most sensitive targets of orlistat", "relationMentions": [{"em1Text": "orlistat", "em2Text": "CES2", "label": "CPR:4"}, {"em1Text": "orlistat", "em2Text": "CES2", "label": "CPR:4"}]}
{"sentText": "Orlistat has been the most used antiobesity drug and the mechanism of its action is to reduce lipid absorption by inhibiting gastrointestinal lipases", "relationMentions": [{"em1Text": "Orlistat", "em2Text": "lipases", "label": "CPR:4"}]}
{"sentText": "Inhibition of this carboxylesterase probably presents a major source for altered therapeutic activity of these medicines if coadministered with orlistat", "relationMentions": [{"em1Text": "carboxylesterase", "em2Text": "orlistat", "label": "CPR:4"}]}
{"sentText": "This study was designed to test the hypothesis that orlistat inhibits CESs with higher potency toward CES1 than CES2 a carboxylesterase with little lipase activity", "relationMentions": [{"em1Text": "orlistat", "em2Text": "CESs", "label": "CPR:4"}, {"em1Text": "orlistat", "em2Text": "CES1", "label": "CPR:4"}, {"em1Text": "orlistat", "em2Text": "CES2", "label": "CPR:4"}, {"em1Text": "orlistat", "em2Text": "carboxylesterase", "label": "CPR:4"}, {"em1Text": "orlistat", "em2Text": "lipase", "label": "CPR:4"}]}
{"sentText": "On stimulation by Gs the activities of ACs can be further selectively modulated by other pathways to ensure precise control of intracellular cAMP responses to specific stimuli", "relationMentions": [{"em1Text": "ACs", "em2Text": "cAMP", "label": "CPR:9"}]}
{"sentText": "Regulation of multiple adenylyl cyclases AC provides unique inputs to mediate the synthesis of cAMP a ubiquitous second messenger that controls many aspects of cellular function", "relationMentions": [{"em1Text": "adenylyl cyclases", "em2Text": "cAMP", "label": "CPR:9"}, {"em1Text": "AC", "em2Text": "cAMP", "label": "CPR:9"}]}
{"sentText": "We identified one compound E235 N1benzylpiperidin4yl24fluorophenylbenzodimidazo21bthiazole7carboxamide that activated the ISR and dosedependently increased levels of ATF4 in transformed cells", "relationMentions": [{"em1Text": "E235", "em2Text": "ATF4", "label": "CPR:3"}, {"em1Text": "N1benzylpiperidin4yl24fluorophenylbenzodimidazo21bthiazole7carboxamide", "em2Text": "ATF4", "label": "CPR:3"}]}
{"sentText": "E235 also activated DNA damage response signaling resulting in increased levels of Ser15 phosphorylated p53 \u03b3H2AX and phosphorylated checkpoint kinase 2 Chk2 although E235 does not appear to cause physical DNA damage", "relationMentions": [{"em1Text": "E235", "em2Text": "phosphorylated p53", "label": "CPR:3"}, {"em1Text": "E235", "em2Text": "\u03b3H2AX", "label": "CPR:3"}, {"em1Text": "E235", "em2Text": "phosphorylated checkpoint kinase 2", "label": "CPR:3"}, {"em1Text": "E235", "em2Text": "Chk2", "label": "CPR:3"}]}
{"sentText": "Cell culture studies demonstrated that PKAA is capable of delivering antiTNF tumor necrosis factor\u03b1 siRNA to lipopolysaccharide LPSstimulated macrophages and significantly inhibits the expression of TNF\u03b1", "relationMentions": [{"em1Text": "PKAA", "em2Text": "TNF\u03b1", "label": "CPR:4"}]}
{"sentText": "PKAA antiTNF\u03b1 siRNA nanocomplexes significantly reduced the ALT alanine transaminase and the hepatic cellular damages in APAPintoxicated mice", "relationMentions": [{"em1Text": "PKAA", "em2Text": "ALT", "label": "CPR:4"}, {"em1Text": "PKAA", "em2Text": "alanine transaminase", "label": "CPR:4"}]}
{"sentText": "Moreover wogonin repressed anisomycin induced phosphorylation of p38 cav1 and vascular permeability", "relationMentions": [{"em1Text": "anisomycin", "em2Text": "p38", "label": "CPR:3"}, {"em1Text": "anisomycin", "em2Text": "cav1", "label": "CPR:3"}, {"em1Text": "wogonin", "em2Text": "p38", "label": "CPR:4"}, {"em1Text": "wogonin", "em2Text": "cav1", "label": "CPR:4"}]}
{"sentText": "These results suggested that wogonin could inhibit H2O2 induced vascular permeability by downregulating the phosphorylation of cav1 and that it might have a therapeutic potential for the diseases associated with the development of both oxidant and vascular permeability", "relationMentions": [{"em1Text": "H2O2", "em2Text": "cav1", "label": "CPR:3"}, {"em1Text": "wogonin", "em2Text": "cav1", "label": "CPR:4"}]}
{"sentText": "Wogonin inhibits H2O2 induced vascular permeability through suppressing the phosphorylation of caveolin1", "relationMentions": [{"em1Text": "H2O2", "em2Text": "caveolin1", "label": "CPR:3"}, {"em1Text": "Wogonin", "em2Text": "caveolin1", "label": "CPR:4"}]}
{"sentText": "We found that wogonin can suppress the H2O2 stimulated actin remodeling and albumin uptake of HUVECs as well as transendothelial cell migration of the human breast carcinoma cell MDAMB231", "relationMentions": [{"em1Text": "H2O2", "em2Text": "actin", "label": "CPR:3"}, {"em1Text": "H2O2", "em2Text": "albumin", "label": "CPR:3"}, {"em1Text": "wogonin", "em2Text": "actin", "label": "CPR:4"}, {"em1Text": "wogonin", "em2Text": "albumin", "label": "CPR:4"}]}
{"sentText": "The mechanism revealed that wogonin inhibited H2O2 induced phosphorylation of caveolin1 cav1 associating with the suppression of stabilization of VEcadherin and \u03b2catenin", "relationMentions": [{"em1Text": "H2O2", "em2Text": "caveolin1", "label": "CPR:3"}, {"em1Text": "H2O2", "em2Text": "cav1", "label": "CPR:3"}, {"em1Text": "wogonin", "em2Text": "caveolin1", "label": "CPR:4"}, {"em1Text": "wogonin", "em2Text": "cav1", "label": "CPR:4"}, {"em1Text": "wogonin", "em2Text": "VEcadherin", "label": "CPR:4"}, {"em1Text": "wogonin", "em2Text": "\u03b2catenin", "label": "CPR:4"}]}
{"sentText": "In an attempt to further improve overall profiles of the oxadiazine series of GSMs in particular the hERG activity conformational modifications of the core structure resulted in the identification of fused oxadiazepines such as 7i which had an improved hERG inhibition profile and was a highly efficacious GSM in vitro and in vivo in rats", "relationMentions": [{"em1Text": "hERG", "em2Text": "oxadiazepines", "label": "CPR:4"}]}
{"sentText": "Both CE and E2 alone increased DNA synthesis and reduced apoptosis with activation of MAPK Akt and p70S6K and upregulation of antiapoptotic factors survivin Bcl2 and Xlinked inhibitor of apoptosis protein These effects could be completely blocked by BZA", "relationMentions": [{"em1Text": "MAPK", "em2Text": "BZA", "label": "CPR:4"}, {"em1Text": "Akt", "em2Text": "BZA", "label": "CPR:4"}, {"em1Text": "p70S6K", "em2Text": "BZA", "label": "CPR:4"}, {"em1Text": "survivin", "em2Text": "BZA", "label": "CPR:4"}, {"em1Text": "Bcl2", "em2Text": "BZA", "label": "CPR:4"}, {"em1Text": "Xlinked inhibitor of apoptosis protein", "em2Text": "BZA", "label": "CPR:4"}]}
{"sentText": "The reduction of BiFC signal mediated by nutlin3 was correlated with an increase in Puma transactivation PARP cleavage and cell death", "relationMentions": [{"em1Text": "nutlin3", "em2Text": "Puma", "label": "CPR:3"}, {"em1Text": "nutlin3", "em2Text": "PARP", "label": "CPR:3"}]}
{"sentText": "We used nutlin3 a wellknown disruptor of p53 Mdm2 interaction to validate the specificity of the assay", "relationMentions": [{"em1Text": "nutlin3", "em2Text": "p53", "label": "CPR:4"}, {"em1Text": "nutlin3", "em2Text": "Mdm2", "label": "CPR:4"}]}
{"sentText": "Sal toxicity coincided with reduced pAkt level and its downstream effectors pCREB pGSK3\u03b2 Bcl2 and neurotrophins GDNF BDNF suggesting repressed PI3K Akt signaling", "relationMentions": [{"em1Text": "Sal", "em2Text": "pAkt", "label": "CPR:4"}, {"em1Text": "Sal", "em2Text": "pCREB", "label": "CPR:4"}, {"em1Text": "Sal", "em2Text": "pGSK3\u03b2", "label": "CPR:4"}, {"em1Text": "Sal", "em2Text": "Bcl2", "label": "CPR:4"}, {"em1Text": "Sal", "em2Text": "neurotrophins", "label": "CPR:4"}, {"em1Text": "Sal", "em2Text": "GDNF", "label": "CPR:4"}, {"em1Text": "Sal", "em2Text": "BDNF", "label": "CPR:4"}, {"em1Text": "Sal", "em2Text": "PI3K", "label": "CPR:4"}, {"em1Text": "Sal", "em2Text": "Akt", "label": "CPR:4"}]}
{"sentText": "This was confirmed on adding LY294002 the PI3K inhibitor which abolished the protection", "relationMentions": [{"em1Text": "LY294002", "em2Text": "PI3K", "label": "CPR:4"}]}
{"sentText": "Isoproterenol induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers heart mitochondrial lipid peroxidation calcium and a significant decrease in the activitieslevels of heart mitochondrial glutathione peroxidase glutathione reductase reduced glutathione isocitrate succinate malate \u03b1ketoglutarate and NADHdehydrogenases cytochromeCoxidase and adenosine triphosphate", "relationMentions": [{"em1Text": "Isoproterenol", "em2Text": "glutathione peroxidase", "label": "CPR:4"}, {"em1Text": "Isoproterenol", "em2Text": "glutathione reductase", "label": "CPR:4"}, {"em1Text": "Isoproterenol", "em2Text": "NADHdehydrogenases", "label": "CPR:4"}, {"em1Text": "Isoproterenol", "em2Text": "cytochromeCoxidase", "label": "CPR:4"}]}
{"sentText": "Increased urinary excretion of albumin hemopexin transferrin and VDBP correlates with chronic sensitization to gentamicin nephrotoxicity in rats", "relationMentions": [{"em1Text": "albumin", "em2Text": "gentamicin", "label": "CPR:3"}, {"em1Text": "hemopexin", "em2Text": "gentamicin", "label": "CPR:3"}, {"em1Text": "transferrin", "em2Text": "gentamicin", "label": "CPR:3"}, {"em1Text": "VDBP", "em2Text": "gentamicin", "label": "CPR:3"}]}
{"sentText": "Design and synthesis of novel 2methyl45substitutedbenzof33a45tetrahydropyrazolo15d14oxazepin87Hone derivatives as telomerase inhibitors", "relationMentions": [{"em1Text": "2methyl45substitutedbenzof33a45tetrahydropyrazolo15d14oxazepin87Hone", "em2Text": "telomerase", "label": "CPR:4"}]}
{"sentText": "DPEP inhibited LPSinduced phosphorylation of ERK JNK and p38", "relationMentions": [{"em1Text": "DPEP", "em2Text": "ERK", "label": "CPR:4"}, {"em1Text": "DPEP", "em2Text": "JNK", "label": "CPR:4"}, {"em1Text": "DPEP", "em2Text": "p38", "label": "CPR:4"}]}
{"sentText": "Furthermore DPEP inhibited the LPSinduced phosphorylation of inhibitor \u03baB I\u03baB\u03b1 and NF\u03baB p50", "relationMentions": [{"em1Text": "DPEP", "em2Text": "p50", "label": "CPR:4"}, {"em1Text": "DPEP", "em2Text": "inhibitor \u03baB I\u03baB\u03b1", "label": "CPR:4"}, {"em1Text": "DPEP", "em2Text": "NF\u03baB", "label": "CPR:4"}]}
{"sentText": "Taken together the results of this study demonstrate that DPEP inhibits LPSstimulated inflammation by blocking the NF\u03baB and MAPK pathways in macrophages", "relationMentions": [{"em1Text": "DPEP", "em2Text": "NF\u03baB", "label": "CPR:4"}, {"em1Text": "DPEP", "em2Text": "MAPK", "label": "CPR:4"}]}
{"sentText": "DPEP induced dosedependent reduction of the protein levels of inducible nitric oxide synthase iNOS and cyclooxygenase2 COX2 and concomitant reduction in the production of NO and prostaglandin E2 PGE2", "relationMentions": [{"em1Text": "DPEP", "em2Text": "inducible nitric oxide synthase", "label": "CPR:4"}, {"em1Text": "DPEP", "em2Text": "iNOS", "label": "CPR:4"}, {"em1Text": "DPEP", "em2Text": "cyclooxygenase2", "label": "CPR:4"}, {"em1Text": "DPEP", "em2Text": "COX2", "label": "CPR:4"}]}
{"sentText": "Additionally DPEP suppressed the production of inflammatory cytokines including tumor necrosis factor\u03b1 TNF\u03b1 interleukin IL1\u03b2 and IL6", "relationMentions": [{"em1Text": "DPEP", "em2Text": "cytokines", "label": "CPR:4"}, {"em1Text": "DPEP", "em2Text": "tumor necrosis factor\u03b1", "label": "CPR:4"}, {"em1Text": "DPEP", "em2Text": "TNF\u03b1", "label": "CPR:4"}, {"em1Text": "DPEP", "em2Text": "interleukin IL1\u03b2", "label": "CPR:4"}, {"em1Text": "DPEP", "em2Text": "IL6", "label": "CPR:4"}]}
{"sentText": "This leads to decreased expression of glutamate aspartate transporter which in turn reduces glutamate transport", "relationMentions": [{"em1Text": "glutamate", "em2Text": "glutamate aspartate transporter", "label": "CPR:9"}]}
{"sentText": "Tetrahydropyrroloquinolinone type dual inhibitors of aromatase aldosterone synthase as a novel strategy for breast cancer patients with elevated cardiovascular risks", "relationMentions": [{"em1Text": "Tetrahydropyrroloquinolinone", "em2Text": "aromatase", "label": "CPR:4"}, {"em1Text": "Tetrahydropyrroloquinolinone", "em2Text": "aldosterone synthase", "label": "CPR:4"}]}
{"sentText": "Furthermore MDZ caused mechanismbased inactivation of cytochrome P450 3A dependent TRZ 1hydroxylation in mouse rat and human intestinal microsomes with similar potencies", "relationMentions": [{"em1Text": "MDZ", "em2Text": "cytochrome P450 3A", "label": "CPR:4"}, {"em1Text": "cytochrome P450 3A", "em2Text": "TRZ", "label": "CPR:9"}]}
{"sentText": "Tamoxifen represses miR200 microRNAs and promotes epithelialtomesenchymal transition by upregulating cMyc in endometrial carcinoma cell lines", "relationMentions": [{"em1Text": "Tamoxifen", "em2Text": "cMyc", "label": "CPR:3"}, {"em1Text": "Tamoxifen", "em2Text": "miR200", "label": "CPR:4"}]}
{"sentText": "Consistent with zinc finger Ebox binding homeobox 2 which was confirmed as a direct target of miR200b in endometrial cancer cell lines some other key factors of EMT such as Snail and Ncadherin increased whereas Ecadherin decreased in the TAM treated cells contributing to TAMinduced EMT in these endometrial cancer cells", "relationMentions": [{"em1Text": "Snail", "em2Text": "TAM", "label": "CPR:3"}, {"em1Text": "Ncadherin", "em2Text": "TAM", "label": "CPR:3"}, {"em1Text": "Ecadherin", "em2Text": "TAM", "label": "CPR:4"}]}
{"sentText": "Collectively our data suggest that TAM can repress the miR200 family and induce EMT via the upregulation of cMyc in endometrial cancer cells", "relationMentions": [{"em1Text": "TAM", "em2Text": "cMyc", "label": "CPR:3"}, {"em1Text": "TAM", "em2Text": "miR200", "label": "CPR:4"}]}
{"sentText": "miR200 a miRNA family with tumor suppressive functions in a wide range of cancers was found reduced in response to TAM treatment", "relationMentions": [{"em1Text": "miR200", "em2Text": "TAM", "label": "CPR:4"}]}
{"sentText": "In addition we showed that cMyc directly binds to and represses the promoter of miR200 miRNAs and its upregulation in TAM treated endometrial cancer cells leads to the downregulation of miR200 and eventually to EMT", "relationMentions": [{"em1Text": "miR200", "em2Text": "TAM", "label": "CPR:4"}]}
{"sentText": "Here we show that oral administration of resveratrol which leads to activation of an NADdependent protein deacetylase SIRT1 suppresses cardiac hypertrophy and fibrosis and restores cardiac diastolic function in dystrophindeficient mdx mice", "relationMentions": [{"em1Text": "resveratrol", "em2Text": "NADdependent protein deacetylase SIRT1", "label": "CPR:3"}]}
{"sentText": "The prohypertrophic coactivator p300 protein but not p300 mRNA was upregulated in the mdx heart and resveratrol administration downregulated the p300 protein level", "relationMentions": [{"em1Text": "p300", "em2Text": "resveratrol", "label": "CPR:4"}]}
{"sentText": "In cultured cardiomyocytes cardiomyocyte hypertrophy induced by the \u03b11agonist phenylephrine was inhibited by the overexpression of SIRT1 as well as resveratrol both of which downregulated p300 protein levels but not p300 mRNA levels", "relationMentions": [{"em1Text": "resveratrol", "em2Text": "p300", "label": "CPR:4"}]}
{"sentText": "We previously reported that caffeoylamino acidylhydroxamic acid CAXaaNHOH acted as both a good antioxidant and tyrosinase inhibitor in particular when caffeic acid was conjugated with proline or amino acids having aromatic ring like phenylalanine", "relationMentions": [{"em1Text": "CAXaaNHOH", "em2Text": "tyrosinase", "label": "CPR:4"}, {"em1Text": "caffeoylamino acidylhydroxamic acid", "em2Text": "tyrosinase", "label": "CPR:4"}]}
{"sentText": "In addition derivatives of caffeic acid and sinapic acid efficiently inhibited tyrosinase activity and reduced melanin content in melanocytes MelAb cell", "relationMentions": [{"em1Text": "caffeic acid", "em2Text": "tyrosinase", "label": "CPR:4"}, {"em1Text": "sinapic acid", "em2Text": "tyrosinase", "label": "CPR:4"}]}
{"sentText": "Synthesis and dual biological effects of hydroxycinnamoyl phenylalanyl prolyl hydroxamic acid derivatives as tyrosinase inhibitor and antioxidant", "relationMentions": [{"em1Text": "hydroxycinnamoyl phenylalanyl", "em2Text": "tyrosinase", "label": "CPR:4"}, {"em1Text": "prolyl hydroxamic acid", "em2Text": "tyrosinase", "label": "CPR:4"}]}
{"sentText": "Ruxolitinib is a smallmolecule inhibitor of JAK1 and JAK2 and recently became the first drug approved by the United States Food and Drug Administration for the treatment of symptomatic intermediate or highrisk myelofibrosis", "relationMentions": [{"em1Text": "Ruxolitinib", "em2Text": "JAK1", "label": "CPR:4"}, {"em1Text": "Ruxolitinib", "em2Text": "JAK2", "label": "CPR:4"}]}
{"sentText": "Pb and BaP treatments significantly increased active caspase3 levels in a timedependent manner", "relationMentions": [{"em1Text": "Pb", "em2Text": "caspase3", "label": "CPR:3"}, {"em1Text": "BaP", "em2Text": "caspase3", "label": "CPR:3"}]}
{"sentText": "TAA increased the number and area of glutathione Stransferase placental form GSTP liver cell foci and the numbers of proliferating and apoptotic cells in randomly selected areas in liver sections", "relationMentions": [{"em1Text": "TAA", "em2Text": "glutathione Stransferase placental form", "label": "CPR:3"}, {"em1Text": "TAA", "em2Text": "GSTP", "label": "CPR:3"}]}
{"sentText": "TAA also increased the numbers of ED2 cyclooxygenase2 and heme oxygenase1 liver cells as well as the number of CD3 lymphocytes", "relationMentions": [{"em1Text": "TAA", "em2Text": "cyclooxygenase2", "label": "CPR:4"}, {"em1Text": "TAA", "em2Text": "heme oxygenase1", "label": "CPR:4"}, {"em1Text": "TAA", "em2Text": "CD3", "label": "CPR:4"}]}
{"sentText": "Although ICA greatly attenuates ERG inactivation by shifting its voltage dependence to more positive potentials it enhances the rate and extent of EAG inactivation without altering its voltage dependence", "relationMentions": [{"em1Text": "ICA", "em2Text": "ERG", "label": "CPR:3"}, {"em1Text": "ICA", "em2Text": "EAG", "label": "CPR:4"}]}
{"sentText": "ICA105574 interacts with a common binding site to elicit opposite effects on inactivation gating of EAG and ERG potassium channels", "relationMentions": [{"em1Text": "ICA105574", "em2Text": "EAG", "label": "CPR:3"}, {"em1Text": "ICA105574", "em2Text": "ERG", "label": "CPR:3"}, {"em1Text": "ICA105574", "em2Text": "potassium channels", "label": "CPR:3"}]}
{"sentText": "ICA is a mixed agonist of mutant EAG and EAG ERG chimera channels that inactivate by a combination of slow and fast mechanisms", "relationMentions": [{"em1Text": "ICA", "em2Text": "EAG", "label": "CPR:5"}, {"em1Text": "ICA", "em2Text": "EAG", "label": "CPR:5"}, {"em1Text": "ICA", "em2Text": "ERG", "label": "CPR:5"}]}
{"sentText": "PNU282987 on the other hand displayed an increase in anxietylike behavior at a higher dose 10 mgkg that was significantly reduced by the serotonin 5HT1a receptor antagonist WAY100135", "relationMentions": [{"em1Text": "serotonin 5HT1a receptor", "em2Text": "WAY100135", "label": "CPR:6"}]}
{"sentText": "However the \u03b17 receptor antagonist methyllycaconitine was unable to reverse these anxietylike effects seen with PNU282987", "relationMentions": [{"em1Text": "\u03b17 receptor", "em2Text": "methyllycaconitine", "label": "CPR:6"}]}
{"sentText": "A Ventura F V Houten S M Carnitine palmitoyltransferase 2 and carnitineacylcarnitine translocase are involved in the mitochondrial synthesis and export of acylcarnitines", "relationMentions": [{"em1Text": "Carnitine palmitoyltransferase 2", "em2Text": "acylcarnitines", "label": "CPR:9"}, {"em1Text": "carnitineacylcarnitine translocase", "em2Text": "acylcarnitines", "label": "CPR:9"}]}
{"sentText": "Carnitine palmitoyltransferase 2 and carnitineacylcarnitine translocase are involved in the mitochondrial synthesis and export of acylcarnitines", "relationMentions": [{"em1Text": "Carnitine palmitoyltransferase 2", "em2Text": "acylcarnitines", "label": "CPR:9"}, {"em1Text": "carnitineacylcarnitine translocase", "em2Text": "acylcarnitines", "label": "CPR:9"}]}
{"sentText": "This shows that CPT2 and CACT are crucial for mitochondrial acylcarnitine formation and export to the extracellular fluids in mFAODViolante S IJlst L te Brinke H Tavares de Almeida I Wanders R J", "relationMentions": [{"em1Text": "CPT2", "em2Text": "acylcarnitine", "label": "CPR:9"}, {"em1Text": "CACT", "em2Text": "acylcarnitine", "label": "CPR:9"}]}
{"sentText": "As a result of this study microgrewiapine A 1 was found to be a selective cytotoxic agent for colon cancer cells over normal colon cells and to exhibit nicotinic receptor antagonistic activity for both the h\u03b13\u03b24 and h\u03b14\u03b22 receptor subtypes", "relationMentions": [{"em1Text": "microgrewiapine A", "em2Text": "nicotinic receptor", "label": "CPR:6"}]}
{"sentText": "PURPOSE To characterise further the previously observed cytochrome P450 3A4 CYP3A4 interaction of the dual orexin receptor antagonist almorexant", "relationMentions": [{"em1Text": "orexin receptor", "em2Text": "almorexant", "label": "CPR:6"}]}
{"sentText": "In vitro molecular pharmacology studies showed that 5HT2C agonists potent for attenuating the DOIelicitedHTR also reduced the efficacy of DOI to activate mouse 5HT2C receptormediated PLC signaling in HEK cells", "relationMentions": [{"em1Text": "DOI", "em2Text": "mouse 5HT2C", "label": "CPR:3"}]}
{"sentText": "Commerciallyavailable 5HT2C agonists CP 809101 Ro 600175 WAY 161503 mCPP and 1methylpsilocin novel 4phenyl2NNdimethylaminotetralin PAT type 5HT2C agonists with 5HT2A2B antagonist activity and antagonists selective for 5HT2A M100907 5HT2C SB242084 and 5HT2B2C SB206553 receptors attenuated the DOIelicitedHTR", "relationMentions": [{"em1Text": "5HT2C", "em2Text": "CP 809101", "label": "CPR:5"}, {"em1Text": "5HT2C", "em2Text": "Ro 600175", "label": "CPR:5"}, {"em1Text": "5HT2C", "em2Text": "WAY 161503", "label": "CPR:5"}, {"em1Text": "5HT2C", "em2Text": "mCPP", "label": "CPR:5"}, {"em1Text": "5HT2C", "em2Text": "1methylpsilocin", "label": "CPR:5"}, {"em1Text": "5HT2C", "em2Text": "4phenyl2NNdimethylaminotetralin", "label": "CPR:5"}, {"em1Text": "5HT2C", "em2Text": "PAT", "label": "CPR:5"}, {"em1Text": "5HT2A", "em2Text": "M100907", "label": "CPR:6"}, {"em1Text": "5HT2C", "em2Text": "SB242084", "label": "CPR:6"}]}
{"sentText": "This investigation tested the hypothesis that CYP2B6 is a prominent CYP isoform responsible for clinical methadone N demethylation and clearance using the in vivo mechanismbased CYP2B6 inhibitor ticlopidine given orally for 4 days", "relationMentions": [{"em1Text": "CYP2B6", "em2Text": "ticlopidine", "label": "CPR:4"}, {"em1Text": "CYP2B6", "em2Text": "methadone", "label": "CPR:9"}, {"em1Text": "CYP", "em2Text": "methadone", "label": "CPR:9"}, {"em1Text": "CYP2B6", "em2Text": "N", "label": "CPR:9"}, {"em1Text": "CYP", "em2Text": "N", "label": "CPR:9"}]}
{"sentText": "Methadone N demethylation in vitro is catalyzed by hepatic cytochrome P4502B6 CYP2B6 and CYP3A4 but clinical disposition is often attributed to CYP3A4", "relationMentions": [{"em1Text": "Methadone", "em2Text": "CYP3A4", "label": "CPR:9"}, {"em1Text": "Methadone", "em2Text": "cytochrome P4502B6", "label": "CPR:9"}, {"em1Text": "Methadone", "em2Text": "CYP2B6", "label": "CPR:9"}, {"em1Text": "Methadone", "em2Text": "CYP3A4", "label": "CPR:9"}, {"em1Text": "N", "em2Text": "CYP3A4", "label": "CPR:9"}, {"em1Text": "N", "em2Text": "cytochrome P4502B6", "label": "CPR:9"}, {"em1Text": "N", "em2Text": "CYP2B6", "label": "CPR:9"}, {"em1Text": "N", "em2Text": "CYP3A4", "label": "CPR:9"}]}
{"sentText": "CYP2B6 inhibition reduces methadone Ndemethylation and clearance and alters methadone concentrations demonstrating an important role for CYP2B6 in clinical methadone disposition", "relationMentions": [{"em1Text": "CYP2B6", "em2Text": "methadone", "label": "CPR:9"}]}
{"sentText": "We found that treatment of both differentiated dopaminergiclike SHSY5Y cells and rat midbrain slices with the dopamine D2 receptor D2R agonist quinpirole triggered an increase in the expression of GDNF that was temporally preceded by an increase in the levels of zincfinger protein 268 Zif268 a DNAbinding transcription factor encoded by an immediateearly gene", "relationMentions": [{"em1Text": "quinpirole", "em2Text": "GDNF", "label": "CPR:3"}, {"em1Text": "quinpirole", "em2Text": "zincfinger protein 268", "label": "CPR:3"}, {"em1Text": "quinpirole", "em2Text": "Zif268", "label": "CPR:3"}, {"em1Text": "dopamine D2 receptor", "em2Text": "quinpirole", "label": "CPR:5"}, {"em1Text": "D2R", "em2Text": "quinpirole", "label": "CPR:5"}]}
{"sentText": "Moreover the D2R inhibitor raclopride blocked the increase of both GDNF and Zif268 expression following potassiumevoked dopamine release in SHSY5Y cells", "relationMentions": [{"em1Text": "D2R", "em2Text": "raclopride", "label": "CPR:4"}, {"em1Text": "raclopride", "em2Text": "GDNF", "label": "CPR:4"}, {"em1Text": "raclopride", "em2Text": "Zif268", "label": "CPR:4"}]}
{"sentText": "In this paper a series of new 134thiadiazole derivatives has been designed synthesized and evaluated as the acetyl and butyrylcholinesterase inhibitors", "relationMentions": [{"em1Text": "134thiadiazole", "em2Text": "acetyl and butyrylcholinesterase", "label": "CPR:4"}]}
{"sentText": "Synthesis and biological evaluation of 134thiadiazole analogues as novel AChE and BuChE inhibitors", "relationMentions": [{"em1Text": "134thiadiazole", "em2Text": "AChE", "label": "CPR:4"}, {"em1Text": "134thiadiazole", "em2Text": "BuChE", "label": "CPR:4"}]}
{"sentText": "LY294002 a specific PI3K AKT inhibitor selectively activated the p38 MAPK kinase pathway and enhanced cJun phosphorylation but did not activate JNK", "relationMentions": [{"em1Text": "LY294002", "em2Text": "p38", "label": "CPR:3"}, {"em1Text": "LY294002", "em2Text": "MAPK", "label": "CPR:3"}, {"em1Text": "LY294002", "em2Text": "kinase", "label": "CPR:3"}, {"em1Text": "LY294002", "em2Text": "cJun", "label": "CPR:3"}, {"em1Text": "LY294002", "em2Text": "PI3K", "label": "CPR:4"}, {"em1Text": "LY294002", "em2Text": "AKT", "label": "CPR:4"}]}
{"sentText": "The pharmacological inhibitors SB203580 p38 inhibitor and SP600125 a JNK inhibitor protected primary cultures of rat CGCs from LY294002induced apoptosis", "relationMentions": [{"em1Text": "SB203580", "em2Text": "p38", "label": "CPR:4"}, {"em1Text": "SP600125", "em2Text": "JNK", "label": "CPR:4"}]}
{"sentText": "Today we used cobalt chloride a hypoxia mimetic that inhibits proteasomal HIF1 degradation and generates reactive oxygen species ROS", "relationMentions": [{"em1Text": "cobalt chloride", "em2Text": "HIF1", "label": "CPR:3"}]}
{"sentText": "An autophagic signaling was evidenced by an increase of Beclin1 ATG 512 and LC3II expression whereas the p53 mut presence decreased with CoCl2 time exposure", "relationMentions": [{"em1Text": "p53", "em2Text": "CoCl2", "label": "CPR:4"}]}
{"sentText": "Cellular responses to DNA damage induced by etoposide or doxorubicin include downregulation of endogenous supervillin coincident with increases in p53", "relationMentions": [{"em1Text": "etoposide", "em2Text": "p53", "label": "CPR:3"}, {"em1Text": "doxorubicin", "em2Text": "p53", "label": "CPR:3"}, {"em1Text": "etoposide", "em2Text": "supervillin", "label": "CPR:4"}, {"em1Text": "doxorubicin", "em2Text": "supervillin", "label": "CPR:4"}]}
{"sentText": "Novel acylethanolamide derivatives that modulate body weight through enhancement of hypothalamic proopiomelanocortin POMC andor decreased neuropeptide Y NPY", "relationMentions": [{"em1Text": "acylethanolamide", "em2Text": "POMC", "label": "CPR:3"}, {"em1Text": "acylethanolamide", "em2Text": "proopiomelanocortin", "label": "CPR:3"}, {"em1Text": "acylethanolamide", "em2Text": "neuropeptide Y", "label": "CPR:4"}, {"em1Text": "acylethanolamide", "em2Text": "NPY", "label": "CPR:4"}]}
{"sentText": "Dexamethasone suppressed IL11 gene transcription enhanced by PTH134 without affecting \u0394FosB expression or Smad1 phosphorylation and dexamethasoneGC receptor complex was bound to JunD which forms heterodimers with \u0394FosB", "relationMentions": [{"em1Text": "Dexamethasone", "em2Text": "IL11", "label": "CPR:4"}]}
{"sentText": "Number and area of preneoplastic foci positive for glutathione Stransferase placental form GSTP were consistently higher in these groups than the sum of individual values in the groups treated with HEP or HCB alone", "relationMentions": [{"em1Text": "glutathione Stransferase placental form", "em2Text": "HEP", "label": "CPR:3"}, {"em1Text": "GSTP", "em2Text": "HEP", "label": "CPR:3"}, {"em1Text": "glutathione Stransferase placental form", "em2Text": "HCB", "label": "CPR:3"}, {"em1Text": "GSTP", "em2Text": "HCB", "label": "CPR:3"}]}
{"sentText": "On the basis of these findings we conclude that HEP and HCB have additive and synergistic effects on the development of GSTP positive foci and that higher risks are associated with a combination of residual organochlorine pesticides in foods than with individual residual organochlorine pesticides", "relationMentions": [{"em1Text": "HEP", "em2Text": "GSTP", "label": "CPR:3"}, {"em1Text": "HCB", "em2Text": "GSTP", "label": "CPR:3"}]}
{"sentText": "Taken together these results indicate that in vivo or ex vivo exposure of intestinal tissue to DON lead to similar intestinal lesions and activation of MAPK", "relationMentions": [{"em1Text": "DON", "em2Text": "MAPK", "label": "CPR:3"}]}
{"sentText": "The food contaminant deoxynivalenol activates the mitogen activated protein kinases in the intestine interest of ex vivo models as an alternative to in vivo experiments", "relationMentions": [{"em1Text": "deoxynivalenol", "em2Text": "mitogen activated protein kinases", "label": "CPR:3"}]}
{"sentText": "In particular we showed that Paeoniflorin significantly reduced the formation of intracellular reactive oxygen species ROS the level of malondialdehyde MDA and lactate dehydrogenase LDH leakage and enhanced production of the endogenous antioxidants glutathione GSH and superoxide dismutase SOD in EAhy926 cells", "relationMentions": [{"em1Text": "Paeoniflorin", "em2Text": "superoxide dismutase", "label": "CPR:3"}, {"em1Text": "Paeoniflorin", "em2Text": "SOD", "label": "CPR:3"}, {"em1Text": "Paeoniflorin", "em2Text": "lactate dehydrogenase", "label": "CPR:4"}, {"em1Text": "Paeoniflorin", "em2Text": "LDH", "label": "CPR:4"}]}
{"sentText": "Treatment of these cells with Paeoniflorin significantly induced HO1 expression", "relationMentions": [{"em1Text": "Paeoniflorin", "em2Text": "HO1", "label": "CPR:3"}]}
{"sentText": "Paeoniflorin protects human EAhy926 endothelial cells against gammaradiation induced oxidative injury by activating the NFE2related factor 2 heme oxygenase1 pathway", "relationMentions": [{"em1Text": "Paeoniflorin", "em2Text": "NFE2related factor 2", "label": "CPR:3"}, {"em1Text": "Paeoniflorin", "em2Text": "heme oxygenase1", "label": "CPR:3"}]}
{"sentText": "The Paeoniflorin induced HO1 expression was abrogated by Nrf2 siRNA", "relationMentions": [{"em1Text": "Paeoniflorin", "em2Text": "HO1", "label": "CPR:3"}]}
{"sentText": "Furthermore inhibition of HO1 with zinc protoporphyrin IX ZNPP significantly reversed the protective effect of Paeoniflorin against radiationinduced damage in EAhy926 cells", "relationMentions": [{"em1Text": "HO1", "em2Text": "Paeoniflorin", "label": "CPR:3"}, {"em1Text": "HO1", "em2Text": "zinc protoporphyrin IX", "label": "CPR:4"}, {"em1Text": "HO1", "em2Text": "ZNPP", "label": "CPR:4"}]}
{"sentText": "Our findings confirmed that Paeoniflorin protected EAhy926 cells against radiationinduced injury through the Nrf2 HO1 pathway", "relationMentions": [{"em1Text": "Paeoniflorin", "em2Text": "Nrf2", "label": "CPR:3"}, {"em1Text": "Paeoniflorin", "em2Text": "HO1", "label": "CPR:3"}]}
{"sentText": "Palonosetron a secondgeneration 5HT3 receptor antagonist with a different halflife a different binding capacity and a different mechanism of action than the firstgeneration 5HT3 receptor antagonists appears to be the most effective agent in its class", "relationMentions": [{"em1Text": "Palonosetron", "em2Text": "5HT3", "label": "CPR:6"}]}
{"sentText": "Aprepitant the first and only agent clinically available in the NK1 receptor antagonist drug class has been used effectively as an additive agent to the 5HT3 receptor antagonists and dexamethasone to control CINV", "relationMentions": [{"em1Text": "Aprepitant", "em2Text": "NK1 receptor", "label": "CPR:6"}]}
{"sentText": "Rolapitant and netupitant are other NK1 receptor antagonists that are currently in phase III clinical trials", "relationMentions": [{"em1Text": "Rolapitant", "em2Text": "NK1 receptor", "label": "CPR:6"}, {"em1Text": "netupitant", "em2Text": "NK1 receptor", "label": "CPR:6"}]}
{"sentText": "Moderate inhibitory effect of LDL C oxidation by phytosteryl phenolates was observed", "relationMentions": [{"em1Text": "LDL", "em2Text": "phytosteryl phenolates", "label": "CPR:4"}]}
{"sentText": "Aqueous ethanol 80 extract of lentil hulls exhibited high antioxidant and antiinflammatory activities preferentially inhibiting 15LOX IC50 55 \u03bcgml with moderate COX1 IC50 66 \u03bcgml and COX2 IC50 119 \u03bcgml inhibitory effects on the COX pathway whereas faba bean hull extracts exerted relatively mild LOX inhibitory activity", "relationMentions": [{"em1Text": "ethanol", "em2Text": "15LOX", "label": "CPR:4"}, {"em1Text": "ethanol", "em2Text": "COX1", "label": "CPR:4"}, {"em1Text": "ethanol", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "ethanol", "em2Text": "COX", "label": "CPR:4"}, {"em1Text": "ethanol", "em2Text": "LOX", "label": "CPR:4"}]}
{"sentText": "We searched for inhibitors of HDC from the ethyl acetate extract of the petal of Filipendula ulmaria also called meadowsweet", "relationMentions": [{"em1Text": "HDC", "em2Text": "ethyl acetate", "label": "CPR:4"}]}
{"sentText": "Histidine decarboxylase HDC catalyses the formation of hist amine a bioactive amine", "relationMentions": [{"em1Text": "Histidine decarboxylase", "em2Text": "amine", "label": "CPR:9"}, {"em1Text": "HDC", "em2Text": "amine", "label": "CPR:9"}]}
{"sentText": "High throughput screening led to the identification of a novel series of quinolone \u03b17 nicotinic acetylcholine receptor nAChR agonists", "relationMentions": [{"em1Text": "quinolone", "em2Text": "nAChR", "label": "CPR:5"}, {"em1Text": "quinolone", "em2Text": "\u03b17 nicotinic acetylcholine receptor", "label": "CPR:5"}]}
{"sentText": "Discovery of a novel series of quinolone \u03b17 nicotinic acetylcholine receptor agonists", "relationMentions": [{"em1Text": "quinolone", "em2Text": "\u03b17 nicotinic acetylcholine receptor", "label": "CPR:5"}]}
{"sentText": "This is distinct from Rock inhibitors based on non amino acid derived quinazolinones where high selectivity against PKA could be obtained", "relationMentions": [{"em1Text": "Rock", "em2Text": "amino acid", "label": "CPR:4"}, {"em1Text": "amino acid", "em2Text": "PKA", "label": "CPR:4"}, {"em1Text": "Rock", "em2Text": "quinazolinones", "label": "CPR:4"}, {"em1Text": "quinazolinones", "em2Text": "PKA", "label": "CPR:4"}]}
{"sentText": "SAR and lead optimization studies for Rock inhibitors based on amino acid derived quinazolines are described", "relationMentions": [{"em1Text": "Rock", "em2Text": "amino acid", "label": "CPR:4"}, {"em1Text": "Rock", "em2Text": "quinazolines", "label": "CPR:4"}]}
{"sentText": "Amino acid derived quinazolines as Rock PKA inhibitors", "relationMentions": [{"em1Text": "Amino acid", "em2Text": "Rock", "label": "CPR:4"}, {"em1Text": "Amino acid", "em2Text": "PKA", "label": "CPR:4"}, {"em1Text": "quinazolines", "em2Text": "Rock", "label": "CPR:4"}, {"em1Text": "quinazolines", "em2Text": "PKA", "label": "CPR:4"}]}
{"sentText": "The cyclooxygenase2 inhibitor diflunisal is used in the clinic for its antiinflammatory activity", "relationMentions": [{"em1Text": "cyclooxygenase2", "em2Text": "diflunisal", "label": "CPR:4"}]}
{"sentText": "Although there was no change in the levels of insulin receptor IR Akt protein kinase B and glucose transporter4 GLUT4 messenger RNA BPA significantly decreased the IR Akt and GLUT4 protein levels both plasma membrane and cytosolic fraction of the gastrocnemius muscle", "relationMentions": [{"em1Text": "Akt", "em2Text": "BPA", "label": "CPR:4"}, {"em1Text": "GLUT4", "em2Text": "BPA", "label": "CPR:4"}, {"em1Text": "IR", "em2Text": "BPA", "label": "CPR:4"}]}
{"sentText": "In conclusion BPA has adverse effects on phosphorylation of Akt GLUT4 translocation and 14Cglucose oxidation", "relationMentions": [{"em1Text": "BPA", "em2Text": "Akt", "label": "CPR:4"}, {"em1Text": "BPA", "em2Text": "GLUT4", "label": "CPR:4"}]}
{"sentText": "The obtained results showed that Cd increased lipid peroxidation and abnormal sperm count and decreased plasma testosterone lactate dehydrogenase acid phosphatase alkaline phosphatase and testicular steroidogenic enzymes 3\u03b2hydroxysteroid dehydrogenase HSD 17\u03b2HSD activities as well as epididymal sperm counts and motility while RUT and Se treatment reversed this change to control values", "relationMentions": [{"em1Text": "Cd", "em2Text": "lactate dehydrogenase", "label": "CPR:4"}, {"em1Text": "Cd", "em2Text": "acid phosphatase", "label": "CPR:4"}, {"em1Text": "Cd", "em2Text": "alkaline phosphatase", "label": "CPR:4"}, {"em1Text": "Cd", "em2Text": "testicular steroidogenic enzymes", "label": "CPR:4"}, {"em1Text": "Cd", "em2Text": "3\u03b2hydroxysteroid dehydrogenase", "label": "CPR:4"}, {"em1Text": "Cd", "em2Text": "HSD", "label": "CPR:4"}, {"em1Text": "Cd", "em2Text": "17\u03b2HSD", "label": "CPR:4"}]}
{"sentText": "Acute intoxication with Cd was also followed by significantly decreased activity of the antioxidant defence system superoxide dismutase SOD catalase CAT glutathione peroxidase GSHPx glutathione reductase GR glutathione GSH and glutathioneStransferase GST", "relationMentions": [{"em1Text": "Cd", "em2Text": "GST", "label": "CPR:4"}, {"em1Text": "Cd", "em2Text": "superoxide dismutase", "label": "CPR:4"}, {"em1Text": "Cd", "em2Text": "SOD", "label": "CPR:4"}, {"em1Text": "Cd", "em2Text": "catalase", "label": "CPR:4"}, {"em1Text": "Cd", "em2Text": "CAT", "label": "CPR:4"}, {"em1Text": "Cd", "em2Text": "glutathione peroxidase", "label": "CPR:4"}, {"em1Text": "Cd", "em2Text": "GSHPx", "label": "CPR:4"}, {"em1Text": "Cd", "em2Text": "glutathione reductase", "label": "CPR:4"}, {"em1Text": "Cd", "em2Text": "GR", "label": "CPR:4"}, {"em1Text": "Cd", "em2Text": "glutathioneStransferase", "label": "CPR:4"}]}
{"sentText": "MeHg significantly increased DA precursor accumulation in cells treated with 3hydroxybenzylhydrazine 10\u00b5M revealing that MeHg increases tyrosine hydroxylase activity", "relationMentions": [{"em1Text": "MeHg", "em2Text": "tyrosine hydroxylase", "label": "CPR:3"}]}
{"sentText": "The tyrosine hydroxylase inhibitor \u03b1methyltyrosine 300\u00b5M 24h completely abolished MeHginduced DA release", "relationMentions": [{"em1Text": "tyrosine hydroxylase", "em2Text": "\u03b1methyltyrosine", "label": "CPR:4"}]}
{"sentText": "The solubilitydriven structural modification of pyridin3yl benzoxazinyloxazolidinones is described which resulted in the development of a new series of benzoxazinyloxazolidinone analogues with high antibacterial activity against Grampositive pathogens including that against linezolidresistant strains and low hERG inhibition", "relationMentions": [{"em1Text": "benzoxazinyloxazolidinone", "em2Text": "hERG", "label": "CPR:4"}]}
{"sentText": "Secondary point mutations in the Fmslike tyrosine kinase 3 FLT3 tyrosine kinase domain KD are common causes of acquired clinical resistance to the FLT3 inhibitors AC220 quizartinib and sorafenib", "relationMentions": [{"em1Text": "FLT3", "em2Text": "AC220", "label": "CPR:4"}, {"em1Text": "FLT3", "em2Text": "quizartinib", "label": "CPR:4"}, {"em1Text": "FLT3", "em2Text": "sorafenib", "label": "CPR:4"}]}
{"sentText": "Ponatinib AP24534 is a multikinase inhibitor with in vitro and clinical activity in tyrosine kinase inhibitor TKIresistant chronic myeloid leukemia irrespective of BCRABL KD mutation", "relationMentions": [{"em1Text": "Ponatinib", "em2Text": "multikinase", "label": "CPR:4"}, {"em1Text": "AP24534", "em2Text": "multikinase", "label": "CPR:4"}]}
{"sentText": "However the involvement of the caspasedependent pathway in the process of cell death induced by either BSC 3g or 3n is discarded since cell death could not be prevented by pretreatment with the pan caspase inhibitor zVADfmk", "relationMentions": [{"em1Text": "caspase", "em2Text": "zVADfmk", "label": "CPR:4"}]}
{"sentText": "Moreover since reduced levels of p21CIP1 and Chk2 proteins but no change in p53 levels could be detected in MCF7 cells after BSC 3g or 3n treatment our results suggest that BSC treated cells die from lethal mitosis", "relationMentions": [{"em1Text": "p21CIP1", "em2Text": "BSC", "label": "CPR:4"}, {"em1Text": "Chk2", "em2Text": "BSC", "label": "CPR:4"}]}
{"sentText": "These compounds were evaluated for their acetylcholinesterase AChE inhibitory activity and 5amino27bis4methoxyphenyl23dihydrobenzobthiophene46dicarbonitrile was found to be the most potent against AChE with IC50 416 \u03bcmolL", "relationMentions": [{"em1Text": "AChE", "em2Text": "5amino27bis4methoxyphenyl23dihydrobenzobthiophene46dicarbonitrile", "label": "CPR:4"}]}
{"sentText": "A onepot domino synthesis and discovery of highly functionalized dihydrobenzobthiophenes as AChE inhibitors", "relationMentions": [{"em1Text": "dihydrobenzobthiophenes", "em2Text": "AChE", "label": "CPR:4"}]}
{"sentText": "Furthermore knockdown of OPN enhanced cell death caused by other drugs including paclitaxel doxorubicin actinomycinD and rapamycin which are also Pgp substrates", "relationMentions": [{"em1Text": "paclitaxel", "em2Text": "Pgp", "label": "CPR:9"}, {"em1Text": "doxorubicin", "em2Text": "Pgp", "label": "CPR:9"}, {"em1Text": "actinomycinD", "em2Text": "Pgp", "label": "CPR:9"}, {"em1Text": "rapamycin", "em2Text": "Pgp", "label": "CPR:9"}]}
{"sentText": "Compared with normallyfed counterparts PMCP rats exhibited higher glutathione Stransferase aminopeptidase N and cysteine Sconjugate betalyase CCBL and lower gammaglutamyltransferase activities PMFU rats exhibited decreased dihydropyrimidine dehydrogenase and cytochrome P450 1A12 activities and PM MMC rats showed higher quinone reductase and depleted xanthine oxidase activities", "relationMentions": [{"em1Text": "MMC", "em2Text": "quinone reductase", "label": "CPR:3"}, {"em1Text": "MMC", "em2Text": "xanthine oxidase", "label": "CPR:4"}]}
{"sentText": "Conclusively protein malnutrition alters CP FU and MMC metabolism in rat stomach by enhancing CCBL pathway for CP activation delaying FU elimination and activating twoelectron reduction of MMC potentiating their gastrotoxicity", "relationMentions": [{"em1Text": "MMC", "em2Text": "CCBL", "label": "CPR:9"}]}
{"sentText": "Nacetylcysteine NAC 33 mM and the cjun Nterminal kinase JNK inhibitor SP600125 33 \u03bcM further decreased the viability in the presence of DEP 200 \u03bcgml and 33 FCS", "relationMentions": [{"em1Text": "JNK", "em2Text": "SP600125", "label": "CPR:4"}, {"em1Text": "cjun Nterminal kinase", "em2Text": "SP600125", "label": "CPR:4"}]}
{"sentText": "HENA activated the BK cbv1 \u03b21 channels cloned from rat cerebral artery myocytes with a potency EC50 = 53 \u03bcM similar to and an efficacy \u00d725 potentiation significantly greater than that of LCA", "relationMentions": [{"em1Text": "HENA", "em2Text": "BK cbv1 \u03b21 channels", "label": "CPR:3"}, {"em1Text": "BK cbv1 \u03b21 channels", "em2Text": "LCA", "label": "CPR:3"}]}
{"sentText": "HENA failed to activate the channels made of cbv1 \u03b22 \u03b23 \u03b24 or \u03b21T169A indicating that this drug selectively targets \u03b21containing BK channels via the BK \u03b21 steroidsensing site", "relationMentions": [{"em1Text": "HENA", "em2Text": "\u03b21containing BK channels", "label": "CPR:3"}]}
{"sentText": "RATIONALE Histamine H3 receptor antagonists such as ABT288 have been shown to possess cognitiveenhancing and wakefulnesspromoting effects", "relationMentions": [{"em1Text": "Histamine H3 receptor", "em2Text": "ABT288", "label": "CPR:6"}]}
{"sentText": "Assessment of the abuse liability of ABT288 a novel histamine H3 receptor antagonist", "relationMentions": [{"em1Text": "ABT288", "em2Text": "histamine H3 receptor", "label": "CPR:6"}]}
{"sentText": "CONCLUSIONS The sum of these preclinical data the first of their kind applied to H3 antagonists indicates that ABT288 is unlikely to possess a high potential for abuse in the human population and suggests that H3 antagonists as a class are similar in this regard", "relationMentions": [{"em1Text": "H3", "em2Text": "ABT288", "label": "CPR:6"}]}
{"sentText": "This methodology was subsequently used to assess the relative contribution of OATP1B1 uptake in human hepatocytes for olmesartan 4262 valsartan 2881 rosuvastatin 6472 pitavastatin 8498 and lopinavir 6489", "relationMentions": [{"em1Text": "OATP1B1", "em2Text": "pitavastatin", "label": "CPR:9"}, {"em1Text": "OATP1B1", "em2Text": "lopinavir", "label": "CPR:9"}, {"em1Text": "OATP1B1", "em2Text": "olmesartan", "label": "CPR:9"}, {"em1Text": "OATP1B1", "em2Text": "valsartan", "label": "CPR:9"}, {"em1Text": "OATP1B1", "em2Text": "rosuvastatin", "label": "CPR:9"}]}
{"sentText": "Uptake of estrone3sulfate 5 nM by OATP1B1 was reduced by 8295", "relationMentions": [{"em1Text": "estrone3sulfate", "em2Text": "OATP1B1", "label": "CPR:9"}]}
{"sentText": "lglutamine decreased plasma glucose increased plasma and pancreatic insulin increased plasma and colonic active GLP1 736 amide secretion as well as decreased oxidative stress in streptozotocinnicotinamide induced diabetic rats", "relationMentions": [{"em1Text": "lglutamine", "em2Text": "insulin", "label": "CPR:3"}, {"em1Text": "lglutamine", "em2Text": "GLP1", "label": "CPR:3"}]}
{"sentText": "The objective of the present investigation was to evaluate lglutamine increases glucagon like peptide1 GLP1 736 amide secretion in streptozotocinnicotinamide STZNTM induced diabetic Sprague Dawley rats", "relationMentions": [{"em1Text": "lglutamine", "em2Text": "glucagon like peptide1", "label": "CPR:3"}, {"em1Text": "lglutamine", "em2Text": "GLP1", "label": "CPR:3"}]}
{"sentText": "Oral lglutamine increases active GLP1 736 amide secretion and improves glycemic control in stretpozotocinnicotinamide induced diabetic rats", "relationMentions": [{"em1Text": "lglutamine", "em2Text": "GLP1", "label": "CPR:3"}]}
{"sentText": "In the present study hinokitiol 1 and 2\u03bcM inhibited the collagen induced aggregation of human platelets but did not inhibit the activation of platelets by other agonists including thrombin arachidonic acid and ADP", "relationMentions": [{"em1Text": "hinokitiol", "em2Text": "collagen", "label": "CPR:4"}]}
{"sentText": "Hinokitiol inhibited the phosphorylation of phospholipase C PLC\u03b32 protein kinase C PKC mitogenactivated protein kinases MAPKs and Akt in collagen activated human platelets and significantly reduced intracellular calcium mobilization and hydroxyl radical OH formation", "relationMentions": [{"em1Text": "Hinokitiol", "em2Text": "phospholipase C PLC\u03b32", "label": "CPR:4"}, {"em1Text": "Hinokitiol", "em2Text": "protein kinase C", "label": "CPR:4"}, {"em1Text": "Hinokitiol", "em2Text": "PKC", "label": "CPR:4"}, {"em1Text": "Hinokitiol", "em2Text": "mitogenactivated protein kinases", "label": "CPR:4"}, {"em1Text": "Hinokitiol", "em2Text": "MAPKs", "label": "CPR:4"}, {"em1Text": "Hinokitiol", "em2Text": "Akt", "label": "CPR:4"}, {"em1Text": "Hinokitiol", "em2Text": "collagen", "label": "CPR:4"}]}
{"sentText": "Hinokitiol also reduced the PKC activation and platelet aggregation stimulated by PDBu", "relationMentions": [{"em1Text": "Hinokitiol", "em2Text": "PKC", "label": "CPR:4"}]}
{"sentText": "In conclusion hinokitiol may inhibit platelet activation by inhibiting the PLC\u03b32 PKC cascade and hydroxyl radical formation followed by suppressing the activation of MAPKs and Akt", "relationMentions": [{"em1Text": "hinokitiol", "em2Text": "PLC\u03b32", "label": "CPR:4"}, {"em1Text": "hinokitiol", "em2Text": "PKC", "label": "CPR:4"}, {"em1Text": "hinokitiol", "em2Text": "MAPKs", "label": "CPR:4"}, {"em1Text": "hinokitiol", "em2Text": "Akt", "label": "CPR:4"}]}
{"sentText": "Novel 5benzyloxypyridin21Hone derivatives as potent cMet inhibitors", "relationMentions": [{"em1Text": "5benzyloxypyridin21Hone", "em2Text": "cMet", "label": "CPR:4"}]}
{"sentText": "Design Synthesis and Pharmacological Characterization of Novel Endomorphin1 Analogues as Extremely Potent \u03bcOpioid Agonists", "relationMentions": [{"em1Text": "Endomorphin1", "em2Text": "\u03bcOpioid", "label": "CPR:5"}]}
{"sentText": "Furthermore no impact on cytokine release ie on IL10 IL6 IL12 23p40 and TNF\u03b1 levels was seen in LPSstimulated human PBMCs except with JWH210 and JWH122 which caused a decrease of TNF\u03b1 and IL12 23p40", "relationMentions": [{"em1Text": "TNF\u03b1", "em2Text": "JWH210", "label": "CPR:4"}, {"em1Text": "IL12", "em2Text": "JWH210", "label": "CPR:4"}, {"em1Text": "23p40", "em2Text": "JWH210", "label": "CPR:4"}, {"em1Text": "TNF\u03b1", "em2Text": "JWH122", "label": "CPR:4"}, {"em1Text": "IL12", "em2Text": "JWH122", "label": "CPR:4"}, {"em1Text": "23p40", "em2Text": "JWH122", "label": "CPR:4"}]}
{"sentText": "GTLE pretreatment completely reversed the damaging effects of AlCl3 on AA and superoxide dismutase activity markedly corrected COX and AChE activities and moderately improved TGC", "relationMentions": [{"em1Text": "AlCl3", "em2Text": "superoxide dismutase", "label": "CPR:4"}, {"em1Text": "AlCl3", "em2Text": "COX", "label": "CPR:4"}, {"em1Text": "AlCl3", "em2Text": "AChE", "label": "CPR:4"}]}
{"sentText": "AlCl3 markedly reduced AA performance and activities of cytochrome c oxidase COX and acetylcholinesterase AChE in all regions", "relationMentions": [{"em1Text": "AlCl3", "em2Text": "cytochrome c oxidase", "label": "CPR:4"}, {"em1Text": "AlCl3", "em2Text": "COX", "label": "CPR:4"}, {"em1Text": "AlCl3", "em2Text": "acetylcholinesterase", "label": "CPR:4"}, {"em1Text": "AlCl3", "em2Text": "AChE", "label": "CPR:4"}]}
{"sentText": "Our study demonstrated that curcumin inhibited OVA induced increases in eosinophil count interleukin IL17A level were recovered in bronchoalveolar lavage fluid increased IL10 level in bronchoalveolar lavage fluid", "relationMentions": [{"em1Text": "curcumin", "em2Text": "IL10", "label": "CPR:3"}, {"em1Text": "curcumin", "em2Text": "OVA", "label": "CPR:4"}, {"em1Text": "curcumin", "em2Text": "interleukin IL17A", "label": "CPR:4"}]}
{"sentText": "Histological studies demonstrated that curcumin substantially inhibited OVA induced eosinophilia in lung tissue", "relationMentions": [{"em1Text": "curcumin", "em2Text": "OVA", "label": "CPR:4"}]}
{"sentText": "The results in vivo show ovalbumin induced significantly broke TregTh17 balance curcumin treatments markedly attenuated the inflammatory in asthma model by regulating TregTh17 balance", "relationMentions": [{"em1Text": "ovalbumin", "em2Text": "curcumin", "label": "CPR:4"}]}
{"sentText": "To overcome this limitation we de novo synthesized a conjugate that covalently combines a Gd based MRI contrast agent encaged with a chelating agent DOTA with pantoprazole which is a widely used proton pump inhibitor that binds to proton pumps in the stomach and colon", "relationMentions": [{"em1Text": "Gd", "em2Text": "proton pump", "label": "CPR:4"}, {"em1Text": "DOTA", "em2Text": "proton pump", "label": "CPR:4"}, {"em1Text": "pantoprazole", "em2Text": "proton pump", "label": "CPR:4"}]}
{"sentText": "Synthesis of a DOTA Gd3 conjugate of protonpump inhibitor pantoprazole for gastric wall imaging studies", "relationMentions": [{"em1Text": "DOTA", "em2Text": "protonpump", "label": "CPR:4"}, {"em1Text": "Gd3", "em2Text": "protonpump", "label": "CPR:4"}, {"em1Text": "protonpump", "em2Text": "pantoprazole", "label": "CPR:4"}]}
{"sentText": "Second EPSCs were recorded from rat hippocampal slices before and after their superfusion with the reversible AChE inhibitor donepezil 100nM", "relationMentions": [{"em1Text": "AChE", "em2Text": "donepezil", "label": "CPR:4"}]}
{"sentText": "CYP3A5 carrier status had no influence on midazolam oral clearance or its inhibition by ketoconazole", "relationMentions": [{"em1Text": "CYP3A5", "em2Text": "ketoconazole", "label": "CPR:4"}, {"em1Text": "CYP3A5", "em2Text": "midazolam", "label": "CPR:9"}]}
{"sentText": "We then evaluated the interactions with the CYP3A inhibitor ketoconazole 400 mg qd", "relationMentions": [{"em1Text": "CYP3A", "em2Text": "ketoconazole", "label": "CPR:4"}]}
{"sentText": "A Nanogram Dose of the CYP3A Probe Substrate Midazolam to Evaluate Drug Interactions", "relationMentions": [{"em1Text": "CYP3A", "em2Text": "Midazolam", "label": "CPR:9"}]}
{"sentText": "These studies show that CYP3A4 and CYP3A5 metabolize BDP to inactive metabolites and suggest that differences in the expression or function of these enzymes in the lung andor liver could influence BDP disposition in humans", "relationMentions": [{"em1Text": "CYP3A4", "em2Text": "BDP", "label": "CPR:9"}, {"em1Text": "CYP3A5", "em2Text": "BDP", "label": "CPR:9"}]}
{"sentText": "It is possible that variations in cytochrome P450 3A enzymemediated metabolism of BDP may contribute to this phenomenon", "relationMentions": [{"em1Text": "cytochrome P450 3A", "em2Text": "BDP", "label": "CPR:9"}]}
{"sentText": "This hypothesis was explored by evaluating the contributions of CYP3A4 3A5 3A7 and esterase enzymes in the metabolism of BDP in vitro and relating metabolism to changes in CYP3A enzyme mRNA expression via the glucocorticoid receptor in lung and liver cells", "relationMentions": [{"em1Text": "esterase", "em2Text": "BDP", "label": "CPR:9"}]}
{"sentText": "CYP3A4 and CYP3A5 metabolized BDP via hydroxylation M4 and M6 and dehydrogenation M5 at similar rates CYP3A7 did not metabolize BDP", "relationMentions": [{"em1Text": "CYP3A4", "em2Text": "BDP", "label": "CPR:9"}, {"em1Text": "CYP3A5", "em2Text": "BDP", "label": "CPR:9"}]}
{"sentText": "Metabolism of Beclomethasone Dipropionate by Cytochrome P450 3A Enzymes", "relationMentions": [{"em1Text": "Beclomethasone Dipropionate", "em2Text": "Cytochrome P450 3A", "label": "CPR:9"}]}
{"sentText": "In macrophages levels of TNF\u03b1 IFN\u03b3 NO IL6 and IL10 were increased by CDM used alone or in combination with HSV2", "relationMentions": [{"em1Text": "TNF\u03b1", "em2Text": "CDM", "label": "CPR:3"}, {"em1Text": "IFN\u03b3", "em2Text": "CDM", "label": "CPR:3"}, {"em1Text": "IL6", "em2Text": "CDM", "label": "CPR:3"}, {"em1Text": "IL10", "em2Text": "CDM", "label": "CPR:3"}]}
{"sentText": "Besides CDM not only synergized TNF\u03b1 production combined with IFN\u03b3 but also prolonged its expression in time", "relationMentions": [{"em1Text": "CDM", "em2Text": "TNF\u03b1", "label": "CPR:3"}, {"em1Text": "CDM", "em2Text": "IFN\u03b3", "label": "CPR:3"}]}
{"sentText": "Results indicate that CDM inhibits HSV2 multiplication in epithelial cells and also increases cytokine production in macrophages both important actions to the clearance of infecting virus in the mouse vagina", "relationMentions": [{"em1Text": "CDM", "em2Text": "cytokine", "label": "CPR:3"}]}
{"sentText": "A catheterized rat model was used to define the intestinal and hepatic components of oral bioavailability for an 11\u03b2HSD1 inhibitor AMG 221", "relationMentions": [{"em1Text": "11\u03b2HSD1", "em2Text": "AMG 221", "label": "CPR:4"}]}
{"sentText": "Intestinal and hepatic firstpass extraction of the 11\u03b2HSD1 inhibitor AMG 221 in rats with chronic vascular catheters", "relationMentions": [{"em1Text": "11\u03b2HSD1", "em2Text": "AMG 221", "label": "CPR:4"}]}
{"sentText": "In DUPM cells with acquired resistance to elisidepsin ErbB3 expression was decreased while Bcl2 was increased", "relationMentions": [{"em1Text": "elisidepsin", "em2Text": "Bcl2", "label": "CPR:3"}, {"em1Text": "elisidepsin", "em2Text": "ErbB3", "label": "CPR:4"}]}
{"sentText": "Administration of bicuculline a GABAA inhibitor isolated a single response to \u03c9agatoxin which was characterized by a reduction in network activity", "relationMentions": [{"em1Text": "bicuculline", "em2Text": "GABAA", "label": "CPR:4"}, {"em1Text": "bicuculline", "em2Text": "\u03c9agatoxin", "label": "CPR:4"}]}
{"sentText": "Compounds 8 b and 10 c selectively inhibited HDAC6 at the nanomolar level whereas the other hydroxamates effected an increase in acetyl\u03b1tubulin levels in human acute myeloid leukemia U937 cells", "relationMentions": [{"em1Text": "hydroxamates", "em2Text": "acetyl\u03b1tubulin", "label": "CPR:3"}]}
{"sentText": "Herein we report novel pyrrole and benzene based hydroxamates 8 10 and 2aminoanilides 9 11 bearing the tertbutylcarbamate group at the CAP moiety as histone deacetylase HDAC inhibitors", "relationMentions": [{"em1Text": "tertbutylcarbamate", "em2Text": "histone deacetylase", "label": "CPR:4"}, {"em1Text": "tertbutylcarbamate", "em2Text": "HDAC", "label": "CPR:4"}, {"em1Text": "pyrrole", "em2Text": "histone deacetylase", "label": "CPR:4"}, {"em1Text": "pyrrole", "em2Text": "HDAC", "label": "CPR:4"}, {"em1Text": "benzene", "em2Text": "histone deacetylase", "label": "CPR:4"}, {"em1Text": "benzene", "em2Text": "HDAC", "label": "CPR:4"}, {"em1Text": "hydroxamates", "em2Text": "histone deacetylase", "label": "CPR:4"}, {"em1Text": "hydroxamates", "em2Text": "HDAC", "label": "CPR:4"}, {"em1Text": "2aminoanilides", "em2Text": "histone deacetylase", "label": "CPR:4"}, {"em1Text": "2aminoanilides", "em2Text": "HDAC", "label": "CPR:4"}]}
{"sentText": "tertButylcarbamate Containing Histone Deacetylase Inhibitors Apoptosis Induction Cytodifferentiation and Antiproliferative Activities in Cancer Cells", "relationMentions": [{"em1Text": "tertButylcarbamate", "em2Text": "Histone Deacetylase", "label": "CPR:4"}]}
{"sentText": "As a potent synthetic APN inhibitor IC50=850nM versus bestatin of 81\u03bcM LB4b was determined to have more significant block effects to cancer cell invasion and angiogenesis than bestatin", "relationMentions": [{"em1Text": "APN", "em2Text": "bestatin", "label": "CPR:4"}, {"em1Text": "APN", "em2Text": "LB4b", "label": "CPR:4"}, {"em1Text": "APN", "em2Text": "bestatin", "label": "CPR:4"}]}
{"sentText": "LB4b is the first synthetic APN inhibitor to be evaluated for both of its antiinvasion and antiangiogenesis effects", "relationMentions": [{"em1Text": "LB4b", "em2Text": "APN", "label": "CPR:4"}]}
{"sentText": "Discovery of a synthetic Aminopeptidase N inhibitor LB4b as a potential anticancer agent", "relationMentions": [{"em1Text": "Aminopeptidase N", "em2Text": "LB4b", "label": "CPR:4"}]}
{"sentText": "Both types of granules contain catechol oxidase that catalyzes oxidative crosslinking of LDOPA", "relationMentions": [{"em1Text": "catechol oxidase", "em2Text": "LDOPA", "label": "CPR:9"}]}
{"sentText": "Under NaCl and sorbitol stresses catalase CAT activity in wnk8 mutant was 192 and 37times of that in Col0 respectively", "relationMentions": [{"em1Text": "NaCl", "em2Text": "catalase", "label": "CPR:3"}, {"em1Text": "NaCl", "em2Text": "CAT", "label": "CPR:3"}, {"em1Text": "sorbitol", "em2Text": "catalase", "label": "CPR:3"}, {"em1Text": "sorbitol", "em2Text": "CAT", "label": "CPR:3"}]}
{"sentText": "Immunofluorescence staining and western blotting demonstrated that cilostazol treatment reduced GFAP and VEGF expression in the retinas of OLETF rats", "relationMentions": [{"em1Text": "cilostazol", "em2Text": "VEGF", "label": "CPR:4"}, {"em1Text": "cilostazol", "em2Text": "GFAP", "label": "CPR:4"}]}
{"sentText": "Other dams received 18ngkgday of a mixture of aryl hydrocarbon receptor AhR agonists nonortho PCB s PCdibenzodioxins and PCdibenzofurans without or with 05M 05MAhR", "relationMentions": [{"em1Text": "aryl hydrocarbon receptor", "em2Text": "PCdibenzofurans", "label": "CPR:5"}, {"em1Text": "aryl hydrocarbon receptor", "em2Text": "nonortho PCB", "label": "CPR:5"}, {"em1Text": "aryl hydrocarbon receptor", "em2Text": "PCdibenzodioxins", "label": "CPR:5"}]}
{"sentText": "We report the discovery of a novel series of ATPcompetitive Janus kinase 3 JAK3 inhibitors based on the 5Hpyrrolo23bpyrazine scaffold", "relationMentions": [{"em1Text": "Janus kinase 3", "em2Text": "5Hpyrrolo23bpyrazine", "label": "CPR:4"}, {"em1Text": "JAK3", "em2Text": "5Hpyrrolo23bpyrazine", "label": "CPR:4"}]}
{"sentText": "Discovery of a series of novel 5Hpyrrolo23bpyrazine2phenyl ethers as potent JAK3 kinase inhibitors", "relationMentions": [{"em1Text": "5Hpyrrolo23bpyrazine2phenyl ethers", "em2Text": "JAK3", "label": "CPR:4"}, {"em1Text": "5Hpyrrolo23bpyrazine2phenyl ethers", "em2Text": "kinase", "label": "CPR:4"}]}
{"sentText": "ATO inhibited the phosphorylation and activation of AKT and STAT3 through Notch signaling blockade", "relationMentions": [{"em1Text": "ATO", "em2Text": "STAT3", "label": "CPR:4"}, {"em1Text": "ATO", "em2Text": "Notch", "label": "CPR:4"}, {"em1Text": "ATO", "em2Text": "AKT", "label": "CPR:4"}]}
{"sentText": "These data show that the ATO is a promising new approach to decrease glioblastoma proliferation and recurrence by downregulation of Notch pathway", "relationMentions": [{"em1Text": "ATO", "em2Text": "Notch", "label": "CPR:4"}]}
{"sentText": "Arsenic trioxide depletes cancer stemlike cells and inhibits repopulation of neurosphere derived from glioblastoma by downregulation of Notch pathway", "relationMentions": [{"em1Text": "Arsenic trioxide", "em2Text": "Notch", "label": "CPR:4"}]}
{"sentText": "Finally epididymal mRNA abundance of GLUT4 was significantly increased by fisetin supplementation compared to levels in the control and HF groups", "relationMentions": [{"em1Text": "GLUT4", "em2Text": "fisetin", "label": "CPR:3"}]}
{"sentText": "Enhancement of GLUT4 expression by fisetin was further confirmed in differentiated 3T3L1 adipocytes", "relationMentions": [{"em1Text": "GLUT4", "em2Text": "fisetin", "label": "CPR:3"}]}
{"sentText": "The high fat diet significantly increased hepatic mRNA expressions of PPAR\u03b3 SREBP1C and SCD1 genes in comparison to the control diet which was subsequently reversed by supplementation with fisetin", "relationMentions": [{"em1Text": "PPAR\u03b3", "em2Text": "fisetin", "label": "CPR:4"}, {"em1Text": "SREBP1C", "em2Text": "fisetin", "label": "CPR:4"}, {"em1Text": "SCD1", "em2Text": "fisetin", "label": "CPR:4"}]}
{"sentText": "In addition fisetin supplementation significantly reduced hepatic mRNA abundance of FAS ATPCL and G6Pase compared to the control group", "relationMentions": [{"em1Text": "fisetin", "em2Text": "FAS", "label": "CPR:4"}, {"em1Text": "fisetin", "em2Text": "ATPCL", "label": "CPR:4"}, {"em1Text": "fisetin", "em2Text": "G6Pase", "label": "CPR:4"}]}
{"sentText": "Western blot assay demonstrated that DICO decreased Bcl2 level and induced Bax translocation to cause cytochrome c release", "relationMentions": [{"em1Text": "DICO", "em2Text": "Bax", "label": "CPR:3"}, {"em1Text": "DICO", "em2Text": "cytochrome c", "label": "CPR:3"}, {"em1Text": "DICO", "em2Text": "Bcl2", "label": "CPR:4"}]}
{"sentText": "Quercetin and rutin also increased alkaline phosphatase activity by about 150 and 240 and demonstrated mineralization up to 110 and 200 respectively as compared to control which was considered as 100", "relationMentions": [{"em1Text": "Quercetin", "em2Text": "alkaline phosphatase", "label": "CPR:3"}, {"em1Text": "rutin", "em2Text": "alkaline phosphatase", "label": "CPR:3"}]}
{"sentText": "Further both the flavonoids were also found to increase the expression of some of the prominent markers for differentiation of osteoblast like osteopontin osterix RunX2 osteoprotegerin and osteocalcin", "relationMentions": [{"em1Text": "flavonoids", "em2Text": "osteopontin", "label": "CPR:3"}, {"em1Text": "flavonoids", "em2Text": "osterix", "label": "CPR:3"}, {"em1Text": "flavonoids", "em2Text": "RunX2", "label": "CPR:3"}, {"em1Text": "flavonoids", "em2Text": "osteoprotegerin", "label": "CPR:3"}, {"em1Text": "flavonoids", "em2Text": "osteocalcin", "label": "CPR:3"}]}
{"sentText": "LPO was increased while as GSH CAT and GPx decreased by the administration of CCl4 and TAA p0001 coadministration of NAC restored these liver markers to normal levels p0001", "relationMentions": [{"em1Text": "CAT", "em2Text": "NAC", "label": "CPR:3"}, {"em1Text": "GPx", "em2Text": "NAC", "label": "CPR:3"}]}
{"sentText": "Serum markers of liver damage AST ALT ALP and Bilirubin were increased by CCl4 and TAA intoxication p0001 whereas cotreatment with NAC reversed such changes p0001", "relationMentions": [{"em1Text": "AST", "em2Text": "CCl4", "label": "CPR:3"}, {"em1Text": "ALT", "em2Text": "CCl4", "label": "CPR:3"}, {"em1Text": "ALP", "em2Text": "CCl4", "label": "CPR:3"}, {"em1Text": "AST", "em2Text": "TAA", "label": "CPR:3"}, {"em1Text": "ALT", "em2Text": "TAA", "label": "CPR:3"}, {"em1Text": "ALP", "em2Text": "TAA", "label": "CPR:3"}, {"em1Text": "AST", "em2Text": "NAC", "label": "CPR:4"}, {"em1Text": "ALT", "em2Text": "NAC", "label": "CPR:4"}, {"em1Text": "ALP", "em2Text": "NAC", "label": "CPR:4"}]}
{"sentText": "Cytochrome P450 2E1 CYP 450 2E1 activity was determined as hydroxylation of aniline in liver microsomes", "relationMentions": [{"em1Text": "Cytochrome P450 2E1", "em2Text": "aniline", "label": "CPR:9"}, {"em1Text": "CYP 450 2E1", "em2Text": "aniline", "label": "CPR:9"}]}
{"sentText": "This report concerns the marked upregulation in differentiated CaCo2 colonic epithelial cells of two key inflammatory interleukins IL6 and IL8 caused by a mixture of oxysterols representative of a high cholesterol diet", "relationMentions": [{"em1Text": "interleukins", "em2Text": "oxysterols", "label": "CPR:3"}, {"em1Text": "IL6", "em2Text": "oxysterols", "label": "CPR:3"}, {"em1Text": "IL8", "em2Text": "oxysterols", "label": "CPR:3"}, {"em1Text": "interleukins", "em2Text": "cholesterol", "label": "CPR:3"}, {"em1Text": "IL6", "em2Text": "cholesterol", "label": "CPR:3"}, {"em1Text": "IL8", "em2Text": "cholesterol", "label": "CPR:3"}]}
{"sentText": "Oxysterol dependent NOX1 activation as well as interleukin synthesis were completely prevented by Cannonau red wine extract that contains an abundant phenolic fraction in particular phenolic acids and flavonoids", "relationMentions": [{"em1Text": "Oxysterol", "em2Text": "NOX1", "label": "CPR:3"}, {"em1Text": "Oxysterol", "em2Text": "interleukin", "label": "CPR:3"}, {"em1Text": "NOX1", "em2Text": "phenolic acids", "label": "CPR:4"}, {"em1Text": "interleukin", "em2Text": "phenolic acids", "label": "CPR:4"}, {"em1Text": "NOX1", "em2Text": "flavonoids", "label": "CPR:4"}, {"em1Text": "interleukin", "em2Text": "flavonoids", "label": "CPR:4"}]}
{"sentText": "Conversely cell pretreatment with Vermentino white wine extract with smaller phenolic fraction showed only a partial NOX1 downregulation and was ineffective in interleukin synthesis induced by dietary oxysterols", "relationMentions": [{"em1Text": "NOX1", "em2Text": "oxysterols", "label": "CPR:3"}, {"em1Text": "interleukin", "em2Text": "oxysterols", "label": "CPR:3"}]}
{"sentText": "Besides this direct activity an excess of phenolic compounds detectable in red wine may exert an additional indirect action by blocking oxysterol related NOX1 induction thus totally preventing the prooxidant and proinflammatory events triggered by dietary oxysterols", "relationMentions": [{"em1Text": "oxysterol", "em2Text": "NOX1", "label": "CPR:3"}, {"em1Text": "phenolic", "em2Text": "NOX1", "label": "CPR:4"}]}
{"sentText": "Arsenic inhibits autophagic flux activating the Nrf2 Keap1 pathway in a p62dependent manner", "relationMentions": [{"em1Text": "Arsenic", "em2Text": "Nrf2", "label": "CPR:3"}, {"em1Text": "Arsenic", "em2Text": "Keap1", "label": "CPR:3"}]}
{"sentText": "Collectively these findings provide evidence that arsenic causes prolonged activation of Nrf2 through autophagy dysfunction possibly providing a similar scenario to constitutive activation of Nrf2 found in certain human cancers", "relationMentions": [{"em1Text": "arsenic", "em2Text": "Nrf2", "label": "CPR:3"}, {"em1Text": "arsenic", "em2Text": "Nrf2", "label": "CPR:3"}]}
{"sentText": "Thus arsenic activates Nrf2 through a noncanonical mechanism p62dependent leading to a chronic sustained activation of Nrf2", "relationMentions": [{"em1Text": "arsenic", "em2Text": "Nrf2", "label": "CPR:3"}, {"em1Text": "arsenic", "em2Text": "Nrf2", "label": "CPR:3"}]}
{"sentText": "In contrast activation of Nrf2 by sulforaphane and tertbutylhydroquinone depend upon Keap1C151 and not p62 the canonical mechanism", "relationMentions": [{"em1Text": "Nrf2", "em2Text": "sulforaphane", "label": "CPR:3"}, {"em1Text": "Nrf2", "em2Text": "tertbutylhydroquinone", "label": "CPR:3"}]}
{"sentText": "Arsenic deregulates the autophagic pathway through blockage of autophagic flux resulting in accumulation of autophagosomes and sequestration of p62 Keap1 and LC3", "relationMentions": [{"em1Text": "Arsenic", "em2Text": "p62", "label": "CPR:4"}, {"em1Text": "Arsenic", "em2Text": "Keap1", "label": "CPR:4"}, {"em1Text": "Arsenic", "em2Text": "LC3", "label": "CPR:4"}]}
{"sentText": "MT1R was increased in ovaries and uteri of melatonin treated rats", "relationMentions": [{"em1Text": "MT1R", "em2Text": "melatonin", "label": "CPR:3"}]}
{"sentText": "Ovarian AR was not influenced by either treatment and oviduct AR was reduced after ethanol melatonin combination", "relationMentions": [{"em1Text": "AR", "em2Text": "ethanol", "label": "CPR:4"}, {"em1Text": "AR", "em2Text": "melatonin", "label": "CPR:4"}]}
{"sentText": "Oviduct ER\u03b1 ER\u03b2 and uterine ER\u03b2 were downregulated by either ethanol or melatonin", "relationMentions": [{"em1Text": "ER\u03b1", "em2Text": "ethanol", "label": "CPR:4"}, {"em1Text": "ER\u03b2", "em2Text": "ethanol", "label": "CPR:4"}, {"em1Text": "ER\u03b2", "em2Text": "ethanol", "label": "CPR:4"}, {"em1Text": "ER\u03b1", "em2Text": "melatonin", "label": "CPR:4"}, {"em1Text": "ER\u03b2", "em2Text": "melatonin", "label": "CPR:4"}, {"em1Text": "ER\u03b2", "em2Text": "melatonin", "label": "CPR:4"}]}
{"sentText": "Conversely ovarian PRA and PRB were positively regulated by ethanol and ethanolmelatonin combination whereas PRA was downregulated in the uterus and oviduct after ethanol consumption", "relationMentions": [{"em1Text": "PRA", "em2Text": "ethanol", "label": "CPR:4"}]}
{"sentText": "Intraplantar or intrathecal administered Ph\u03b11\u03b2 reduced both nocifensive behavior and mechanical hypersensitivity induced by capsaicin similarly to that observed with SB366791 a specific TRPV1 antagonist", "relationMentions": [{"em1Text": "SB366791", "em2Text": "TRPV1", "label": "CPR:6"}]}
{"sentText": "We found that before apoptosis cisplatin induces cAbl and TAp73 expression in the oocyte", "relationMentions": [{"em1Text": "cisplatin", "em2Text": "cAbl", "label": "CPR:3"}, {"em1Text": "cisplatin", "em2Text": "TAp73", "label": "CPR:3"}]}
{"sentText": "While imatinib was unable to block cisplatin induced DNA damage and damage response such as the upregulation of p53 imatinib inhibited the cisplatin induced nuclear accumulation of cAbl TAp73 and the subsequent downregulation of TAp63 and upregulation of Bax thereby abrogating oocyte cell death", "relationMentions": [{"em1Text": "cisplatin", "em2Text": "p53", "label": "CPR:3"}, {"em1Text": "imatinib", "em2Text": "TAp63", "label": "CPR:3"}, {"em1Text": "cisplatin", "em2Text": "cAbl", "label": "CPR:3"}, {"em1Text": "cisplatin", "em2Text": "TAp73", "label": "CPR:3"}, {"em1Text": "cisplatin", "em2Text": "Bax", "label": "CPR:3"}, {"em1Text": "imatinib", "em2Text": "cAbl", "label": "CPR:4"}, {"em1Text": "imatinib", "em2Text": "TAp73", "label": "CPR:4"}, {"em1Text": "imatinib", "em2Text": "Bax", "label": "CPR:4"}, {"em1Text": "cisplatin", "em2Text": "TAp63", "label": "CPR:4"}]}
{"sentText": "Surprisingly the conditional deletion of Trp63 but not \u0394Np63 in oocytes inhibited apoptosis as well as the accumulation of cAbl and TAp73 caused by cisplatin", "relationMentions": [{"em1Text": "cAbl", "em2Text": "cisplatin", "label": "CPR:3"}, {"em1Text": "TAp73", "em2Text": "cisplatin", "label": "CPR:3"}]}
{"sentText": "The expression kinetics of TAp63 cAbl and TAp73 suggest that cisplatin activates TAp63dependent expression of cAbl and TAp73 and in turn the activation of TAp73 by cAblinduced BAX expression", "relationMentions": [{"em1Text": "TAp63", "em2Text": "cisplatin", "label": "CPR:3"}, {"em1Text": "cAbl", "em2Text": "cisplatin", "label": "CPR:3"}, {"em1Text": "TAp73", "em2Text": "cisplatin", "label": "CPR:3"}, {"em1Text": "TAp73", "em2Text": "cisplatin", "label": "CPR:3"}, {"em1Text": "cAbl", "em2Text": "cisplatin", "label": "CPR:3"}, {"em1Text": "cisplatin", "em2Text": "BAX", "label": "CPR:3"}]}
{"sentText": "Our findings indicate that imatinib protects oocytes from cisplatin induced cell death by inhibiting cAbl kinase which would otherwise activate TAp73 BAX mediated apoptosis", "relationMentions": [{"em1Text": "imatinib", "em2Text": "kinase", "label": "CPR:3"}, {"em1Text": "cisplatin", "em2Text": "cAbl", "label": "CPR:3"}, {"em1Text": "cisplatin", "em2Text": "kinase", "label": "CPR:3"}, {"em1Text": "cisplatin", "em2Text": "TAp73", "label": "CPR:3"}, {"em1Text": "cisplatin", "em2Text": "BAX", "label": "CPR:3"}, {"em1Text": "imatinib", "em2Text": "cAbl", "label": "CPR:4"}, {"em1Text": "imatinib", "em2Text": "TAp73", "label": "CPR:4"}, {"em1Text": "imatinib", "em2Text": "BAX", "label": "CPR:4"}]}
{"sentText": "Recently the cAbl kinase inhibitor imatinib mesylate imatinib has become the focus of research as a fertoprotective drug against cisplatin", "relationMentions": [{"em1Text": "cAbl", "em2Text": "imatinib mesylate", "label": "CPR:4"}, {"em1Text": "kinase", "em2Text": "imatinib mesylate", "label": "CPR:4"}, {"em1Text": "cAbl", "em2Text": "imatinib", "label": "CPR:4"}, {"em1Text": "kinase", "em2Text": "imatinib", "label": "CPR:4"}]}
{"sentText": "Thus imatinib and other cAbl kinase inhibitors provide an intriguing new way to halt cisplatininduced oocyte death in early follicles and perhaps conserve the endocrine function of the ovary against chemotherapyCell Death and Differentiation advance online publication 19 April 2013 doi101038cdd201331", "relationMentions": [{"em1Text": "imatinib", "em2Text": "cAbl", "label": "CPR:4"}, {"em1Text": "imatinib", "em2Text": "kinase", "label": "CPR:4"}]}
{"sentText": "These results suggest that ZIP8 plays a pivotal role in the transport and toxicity of Cd2 and Mn2 in RBL2H3 cells", "relationMentions": [{"em1Text": "ZIP8", "em2Text": "Cd2", "label": "CPR:9"}, {"em1Text": "ZIP8", "em2Text": "Mn2", "label": "CPR:9"}]}
{"sentText": "Among the possible transporters involved in the uptake of Cd2 and Mn2 the expression of ZIP8 Zrt Irtrelated protein 8 encoded by Slc39a8 showed a marked suppression in both RBLCdr and RBLMnr cells", "relationMentions": [{"em1Text": "Cd2", "em2Text": "Slc39a8", "label": "CPR:9"}, {"em1Text": "Cd2", "em2Text": "ZIP8", "label": "CPR:9"}, {"em1Text": "Cd2", "em2Text": "Zrt Irtrelated protein 8", "label": "CPR:9"}, {"em1Text": "Mn2", "em2Text": "Slc39a8", "label": "CPR:9"}, {"em1Text": "Mn2", "em2Text": "ZIP8", "label": "CPR:9"}, {"em1Text": "Mn2", "em2Text": "Zrt Irtrelated protein 8", "label": "CPR:9"}]}
{"sentText": "Detailed structureactivity relationships of the C3phenyl moiety that allow for the optimization of antiviral potency of a series of 15dihydrobenzob14diazepine24dione inhibitors of HIV capsid CA assembly are described", "relationMentions": [{"em1Text": "15dihydrobenzob14diazepine24dione", "em2Text": "HIV capsid", "label": "CPR:4"}, {"em1Text": "15dihydrobenzob14diazepine24dione", "em2Text": "CA", "label": "CPR:4"}]}
{"sentText": "Optimization of a 15dihydrobenzob14diazepine24dione series of HIV capsid assembly inhibitors 2 Structureactivity relationships SAR of the C3 phenyl moiety", "relationMentions": [{"em1Text": "HIV capsid", "em2Text": "phenyl", "label": "CPR:4"}, {"em1Text": "15dihydrobenzob14diazepine24dione", "em2Text": "HIV capsid", "label": "CPR:4"}]}
{"sentText": "Arsenic upregulates the expression of angiotensin II Type I receptor in mouse aortic endothelial cells", "relationMentions": [{"em1Text": "Arsenic", "em2Text": "angiotensin II Type I receptor", "label": "CPR:3"}]}
{"sentText": "Taken together our results indicate that arsenic indeed upregulates the AT1R expression thus highlighting a role of arsenicinduced aberrant AT1R signaling in the pathogenesis of hypertension", "relationMentions": [{"em1Text": "arsenic", "em2Text": "AT1R", "label": "CPR:3"}, {"em1Text": "arsenic", "em2Text": "AT1R", "label": "CPR:3"}]}
{"sentText": "To delineate the pathogenesis we examined changes in the mRNA levels of 2 angiotensin II Type I receptor AT1R subtypes AT1AR and AT1BR in a mouse aortic endothelial cell line ENDD Quantitative realtime PCR analysis revealed significant increases in the mRNA levels of 2 AT1R subtypes AT1AR and AT1BR following sodium arsenite SA treatment", "relationMentions": [{"em1Text": "AT1R", "em2Text": "sodium arsenite", "label": "CPR:3"}, {"em1Text": "AT1AR", "em2Text": "sodium arsenite", "label": "CPR:3"}, {"em1Text": "AT1BR", "em2Text": "sodium arsenite", "label": "CPR:3"}]}
{"sentText": "Finally SAinduced AT1R expression was found to be prevented both by NAC and specific JNK inhibitor SP6001325 strongly indicating that AT1R upregulation is a result of the ROSmediated activation of the JNK signaling pathway", "relationMentions": [{"em1Text": "JNK", "em2Text": "SP6001325", "label": "CPR:4"}, {"em1Text": "AT1R", "em2Text": "SP6001325", "label": "CPR:4"}]}
{"sentText": "The expressions of HSP70 and HO1 were significantly P005 increased in the NaAsO2 group and reduced in the combined treatment group", "relationMentions": [{"em1Text": "HSP70", "em2Text": "NaAsO2", "label": "CPR:3"}, {"em1Text": "HO1", "em2Text": "NaAsO2", "label": "CPR:3"}]}
{"sentText": "The mRNA levels of SOD1 CAT GPx and Txnrd1 were increased significantly P005 in the combined Na2SeO3 NaAsO2 treatment group", "relationMentions": [{"em1Text": "SOD1", "em2Text": "Na2SeO3", "label": "CPR:3"}, {"em1Text": "CAT", "em2Text": "Na2SeO3", "label": "CPR:3"}, {"em1Text": "GPx", "em2Text": "Na2SeO3", "label": "CPR:3"}, {"em1Text": "SOD1", "em2Text": "NaAsO2", "label": "CPR:4"}, {"em1Text": "CAT", "em2Text": "NaAsO2", "label": "CPR:4"}, {"em1Text": "GPx", "em2Text": "NaAsO2", "label": "CPR:4"}, {"em1Text": "Txnrd1", "em2Text": "NaAsO2", "label": "CPR:4"}, {"em1Text": "Txnrd1", "em2Text": "Na2SeO3", "label": "CPR:4"}]}
{"sentText": "In the kinetic analyses using LineweaverBurk plots of 1velocity and 1substrate methyl35diOcaffeoylquinate showed competitive inhibition of rhAR", "relationMentions": [{"em1Text": "methyl35diOcaffeoylquinate", "em2Text": "rhAR", "label": "CPR:4"}]}
{"sentText": "From the 10 isolated compounds methyl35diOcaffeoylquinate showed the most potent inhibition with IC50 values of 030 and 067 \u03bcM for rAR and rhAR respectively", "relationMentions": [{"em1Text": "methyl35diOcaffeoylquinate", "em2Text": "rAR", "label": "CPR:4"}, {"em1Text": "methyl35diOcaffeoylquinate", "em2Text": "rhAR", "label": "CPR:4"}]}
{"sentText": "Using recombinant UGT2B10 we found that it catalyzes the Nglucuronidation of amitriptyline imipramine ketotifen pizotifen olanzapine diphenhydramine tamoxifen ketoconazole and midazolam", "relationMentions": [{"em1Text": "UGT2B10", "em2Text": "amitriptyline", "label": "CPR:9"}, {"em1Text": "UGT2B10", "em2Text": "imipramine", "label": "CPR:9"}, {"em1Text": "UGT2B10", "em2Text": "ketotifen", "label": "CPR:9"}, {"em1Text": "UGT2B10", "em2Text": "pizotifen", "label": "CPR:9"}, {"em1Text": "UGT2B10", "em2Text": "olanzapine", "label": "CPR:9"}, {"em1Text": "UGT2B10", "em2Text": "diphenhydramine", "label": "CPR:9"}, {"em1Text": "UGT2B10", "em2Text": "tamoxifen", "label": "CPR:9"}, {"em1Text": "UGT2B10", "em2Text": "ketoconazole", "label": "CPR:9"}, {"em1Text": "UGT2B10", "em2Text": "midazolam", "label": "CPR:9"}]}
{"sentText": "This group of drugs contains secondary or primary amines and these results suggest that UGT2B10 preferably conjugates tertiary amines", "relationMentions": [{"em1Text": "UGT2B10", "em2Text": "tertiary amines", "label": "CPR:9"}]}
{"sentText": "Recent observations revealed that human UDPglucuronosyltransferase UGT 2B10 catalyzes Nglucuronidation of amine containing compounds", "relationMentions": [{"em1Text": "human UDPglucuronosyltransferase UGT 2B10", "em2Text": "amine", "label": "CPR:9"}]}
{"sentText": "Kinetic analyses revealed that the affinity and clearance of UGT2B10 for amitriptyline imipramine and diphenhydramine are significantly higher than the corresponding values of UGT1A4 and UGT1A3 although the Vmax values of UGT1A4 toward these drugs are considerably higher", "relationMentions": [{"em1Text": "UGT2B10", "em2Text": "amitriptyline", "label": "CPR:9"}, {"em1Text": "amitriptyline", "em2Text": "UGT1A4", "label": "CPR:9"}, {"em1Text": "amitriptyline", "em2Text": "UGT1A4", "label": "CPR:9"}, {"em1Text": "UGT2B10", "em2Text": "imipramine", "label": "CPR:9"}, {"em1Text": "imipramine", "em2Text": "UGT1A4", "label": "CPR:9"}, {"em1Text": "imipramine", "em2Text": "UGT1A3", "label": "CPR:9"}, {"em1Text": "imipramine", "em2Text": "UGT1A4", "label": "CPR:9"}, {"em1Text": "UGT2B10", "em2Text": "diphenhydramine", "label": "CPR:9"}, {"em1Text": "diphenhydramine", "em2Text": "UGT1A4", "label": "CPR:9"}, {"em1Text": "diphenhydramine", "em2Text": "UGT1A3", "label": "CPR:9"}, {"em1Text": "diphenhydramine", "em2Text": "UGT1A4", "label": "CPR:9"}]}
{"sentText": "In conclusion this study expands the understanding of the substrate specificity of UGT2B10 highlighting its preference for tertiary amines with higher affinities and clearance values than those of UGT1A4 and UGT1A3", "relationMentions": [{"em1Text": "UGT2B10", "em2Text": "tertiary amines", "label": "CPR:9"}, {"em1Text": "tertiary amines", "em2Text": "UGT1A4", "label": "CPR:9"}, {"em1Text": "tertiary amines", "em2Text": "UGT1A3", "label": "CPR:9"}]}
{"sentText": "SB225002 SB is an IL8 receptor B IL8RB antagonist that has previously been shown to inhibit IL8based cancer cell invasion and to possess in vivo antiinflammatory and antinociceptive effects", "relationMentions": [{"em1Text": "SB225002", "em2Text": "IL8", "label": "CPR:4"}, {"em1Text": "SB225002", "em2Text": "IL8 receptor B", "label": "CPR:6"}, {"em1Text": "SB225002", "em2Text": "IL8RB", "label": "CPR:6"}]}
{"sentText": "Of note SB265610 which is a close structural analogue of SB225002 with a potent IL8RB antagonistic activity did not exhibit a similar antimitotic activity", "relationMentions": [{"em1Text": "SB265610", "em2Text": "IL8RB", "label": "CPR:6"}, {"em1Text": "SB225002", "em2Text": "IL8RB", "label": "CPR:6"}]}
{"sentText": "In support of this observation elongation can be reversed by the tyrosine kinase inhibitor SU5402 mRNA for the FGFR antagonist sprouty4 or FGF8 morpholino", "relationMentions": [{"em1Text": "tyrosine kinase", "em2Text": "SU5402", "label": "CPR:4"}]}
{"sentText": "Treatment with CAPE decreased protein abundance of Akt Akt1 Akt2 Akt3 phosphoAkt Ser473 phosphoAkt Thr 308 GSK3\u03b2 FOXO1 FOXO3a phosphoFOXO1 Thr24 phosphoFoxO3a Thr32 NF\u03baB phosphoNF\u03baB Ser536 Rb phosphoRb Ser807811 Skp2 and cyclin D1 but increased cell cycle inhibitor p27Kip", "relationMentions": [{"em1Text": "CAPE", "em2Text": "p27Kip", "label": "CPR:3"}, {"em1Text": "CAPE", "em2Text": "Akt", "label": "CPR:4"}, {"em1Text": "CAPE", "em2Text": "Akt1", "label": "CPR:4"}, {"em1Text": "CAPE", "em2Text": "Akt2", "label": "CPR:4"}, {"em1Text": "CAPE", "em2Text": "Akt3", "label": "CPR:4"}, {"em1Text": "CAPE", "em2Text": "phosphoAkt", "label": "CPR:4"}, {"em1Text": "CAPE", "em2Text": "phosphoAkt", "label": "CPR:4"}, {"em1Text": "CAPE", "em2Text": "GSK3\u03b2", "label": "CPR:4"}, {"em1Text": "CAPE", "em2Text": "FOXO1", "label": "CPR:4"}, {"em1Text": "CAPE", "em2Text": "FOXO3a", "label": "CPR:4"}, {"em1Text": "CAPE", "em2Text": "phosphoFOXO1", "label": "CPR:4"}, {"em1Text": "CAPE", "em2Text": "phosphoFoxO3a", "label": "CPR:4"}, {"em1Text": "CAPE", "em2Text": "NF\u03baB", "label": "CPR:4"}, {"em1Text": "CAPE", "em2Text": "phosphoNF\u03baB", "label": "CPR:4"}, {"em1Text": "CAPE", "em2Text": "Rb", "label": "CPR:4"}, {"em1Text": "CAPE", "em2Text": "phosphoRb", "label": "CPR:4"}, {"em1Text": "CAPE", "em2Text": "Skp2", "label": "CPR:4"}, {"em1Text": "CAPE", "em2Text": "cyclin D1", "label": "CPR:4"}]}
{"sentText": "Caffeic Acid Phenethyl Ester Suppresses Proliferation and Survival of TW26 Human Oral Cancer Cells via Inhibition of Akt Signaling", "relationMentions": [{"em1Text": "Caffeic Acid Phenethyl Ester", "em2Text": "Akt", "label": "CPR:4"}]}
{"sentText": "Here we show that fisetin rapidly increases the levels of both Nrf2 and ATF4 as well as Nrf2 and ATF4 dependent gene transcription via distinct mechanisms", "relationMentions": [{"em1Text": "fisetin", "em2Text": "Nrf2", "label": "CPR:3"}, {"em1Text": "fisetin", "em2Text": "ATF4", "label": "CPR:3"}, {"em1Text": "fisetin", "em2Text": "Nrf2", "label": "CPR:3"}, {"em1Text": "fisetin", "em2Text": "ATF4", "label": "CPR:3"}]}
{"sentText": "Although fisetin greatly increases the stability of both Nrf2 and ATF4 only the effect on ATF4 is dependent on protein kinase activity", "relationMentions": [{"em1Text": "fisetin", "em2Text": "Nrf2", "label": "CPR:3"}, {"em1Text": "fisetin", "em2Text": "ATF4", "label": "CPR:3"}]}
{"sentText": "Cynomolgus FMO1 FMO2 FMO3 and FMO5 metabolized benzydamine and FMO1FMO3 and FMO3 also metabolized methimazole and trimethylamine respectively", "relationMentions": [{"em1Text": "Cynomolgus FMO1", "em2Text": "benzydamine", "label": "CPR:9"}, {"em1Text": "FMO2", "em2Text": "benzydamine", "label": "CPR:9"}, {"em1Text": "FMO3", "em2Text": "benzydamine", "label": "CPR:9"}, {"em1Text": "FMO5", "em2Text": "benzydamine", "label": "CPR:9"}, {"em1Text": "FMO1", "em2Text": "methimazole", "label": "CPR:9"}, {"em1Text": "FMO3", "em2Text": "methimazole", "label": "CPR:9"}, {"em1Text": "FMO3", "em2Text": "methimazole", "label": "CPR:9"}, {"em1Text": "FMO1", "em2Text": "trimethylamine", "label": "CPR:9"}, {"em1Text": "FMO3", "em2Text": "trimethylamine", "label": "CPR:9"}, {"em1Text": "FMO3", "em2Text": "trimethylamine", "label": "CPR:9"}]}
{"sentText": "Rates of benzydamine N oxygenation catalyzed by FMO3 varied approximately 20fold among the 28 cynomolgus livers and were significantly correlated with FMO3 protein expression indicating that the interanimal variations in benzydamine N oxygenation might be partly accounted for by the variable FMO3 expression", "relationMentions": [{"em1Text": "benzydamine", "em2Text": "FMO3", "label": "CPR:9"}, {"em1Text": "N", "em2Text": "FMO3", "label": "CPR:9"}, {"em1Text": "benzydamine", "em2Text": "FMO3", "label": "CPR:9"}, {"em1Text": "N", "em2Text": "FMO3", "label": "CPR:9"}]}
{"sentText": "Cynomolgus FMO6 metabolized benzydamine only slightly but minimal expression of FMO6 in all tissue precludes the importance of FMO6 in drug metabolism unlike cynomolgus FMO1 FMO2 FMO3 and FMO5 which were all functional", "relationMentions": [{"em1Text": "Cynomolgus FMO6", "em2Text": "benzydamine", "label": "CPR:9"}, {"em1Text": "benzydamine", "em2Text": "FMO1", "label": "CPR:9"}, {"em1Text": "benzydamine", "em2Text": "FMO2", "label": "CPR:9"}, {"em1Text": "benzydamine", "em2Text": "FMO3", "label": "CPR:9"}, {"em1Text": "benzydamine", "em2Text": "FMO5", "label": "CPR:9"}]}
{"sentText": "Activation of AMPK using AICAR resulted in STIM1 phosphorylation on serine residues and prevented PAR1 induced Ca2 entry", "relationMentions": [{"em1Text": "AMPK", "em2Text": "AICAR", "label": "CPR:3"}, {"em1Text": "AICAR", "em2Text": "STIM1", "label": "CPR:3"}, {"em1Text": "AICAR", "em2Text": "PAR1", "label": "CPR:4"}]}
{"sentText": "Further AICAR pretreatment blocked PAR1 induced increase in permeability of mouselung microvessels", "relationMentions": [{"em1Text": "AICAR", "em2Text": "PAR1", "label": "CPR:4"}]}
{"sentText": "Interestingly SB203580 a selective inhibitor of p38 MAPK blocked STIM1 phosphorylation and led to sustained STIM1puncta formation and Ca2 entry", "relationMentions": [{"em1Text": "SB203580", "em2Text": "p38", "label": "CPR:4"}, {"em1Text": "SB203580", "em2Text": "MAPK", "label": "CPR:4"}, {"em1Text": "SB203580", "em2Text": "STIM1", "label": "CPR:4"}]}
{"sentText": "The precise fashion in which these proteins interact and move cholesterol from the OMM to P450scc and the means by which cholesterol is loaded into the OMM remain unclear", "relationMentions": [{"em1Text": "cholesterol", "em2Text": "P450scc", "label": "CPR:9"}]}
{"sentText": "Mitochondria in the steroidogenic cells of the adrenal gonad placenta and brain contain the cholesterol sidechain cleavage enzyme P450scc and its two electrontransfer partners ferredoxin reductase and ferredoxin", "relationMentions": [{"em1Text": "cholesterol", "em2Text": "P450scc", "label": "CPR:9"}]}
{"sentText": "New series of pyrrolidine mercaptosulfide 2mercaptocyclopentane arylsulfonamide and 3mercapto4arylsulfonamido pyrrolidine matrix metalloproteinase inhibitors MMPIs were designed synthesized and evaluated", "relationMentions": [{"em1Text": "pyrrolidine mercaptosulfide", "em2Text": "matrix metalloproteinase", "label": "CPR:4"}, {"em1Text": "2mercaptocyclopentane arylsulfonamide", "em2Text": "matrix metalloproteinase", "label": "CPR:4"}, {"em1Text": "3mercapto4arylsulfonamido pyrrolidine", "em2Text": "matrix metalloproteinase", "label": "CPR:4"}]}
{"sentText": "Exhibiting unique properties over other MMPIs eg hydroxamates these newly reported compounds are capable of modulating activities of several MMPs in the low nanomolar range including MMP2 2 to 50 nM MMP13 2 to 50 nM and MMP14 4 to 60 nM", "relationMentions": [{"em1Text": "hydroxamates", "em2Text": "MMPs", "label": "CPR:4"}, {"em1Text": "hydroxamates", "em2Text": "MMP2", "label": "CPR:4"}, {"em1Text": "hydroxamates", "em2Text": "MMP13", "label": "CPR:4"}, {"em1Text": "hydroxamates", "em2Text": "MMP14", "label": "CPR:4"}]}
{"sentText": "Matrix Metalloproteinase Inhibitors Based on the 3Mercaptopyrrolidine Core", "relationMentions": [{"em1Text": "Matrix Metalloproteinase", "em2Text": "3Mercaptopyrrolidine", "label": "CPR:4"}]}
{"sentText": "RESULTS By Western blot analysis of spinal cord tissues we have demonstrated that treatment with bioactive RS GRA significantly decreased nuclear factor NFkB translocation proinflammatory cytokine production such as interleukin1\u03b2 IL1\u03b2 and apoptosis Bax and caspase 3 expression", "relationMentions": [{"em1Text": "RS GRA", "em2Text": "interleukin1\u03b2", "label": "CPR:4"}, {"em1Text": "RS GRA", "em2Text": "IL1\u03b2", "label": "CPR:4"}, {"em1Text": "RS GRA", "em2Text": "Bax", "label": "CPR:4"}, {"em1Text": "RS GRA", "em2Text": "caspase 3", "label": "CPR:4"}, {"em1Text": "RS GRA", "em2Text": "nuclear factor NFkB", "label": "CPR:4"}, {"em1Text": "RS GRA", "em2Text": "cytokine", "label": "CPR:4"}]}
{"sentText": "Recent literature shows that Brassica vegetables Cruciferae possess therapeutic effects particularly ascribed due to their content in glucosinolates which upon myrosinase hydrolysis release the corresponding isothiocyanates", "relationMentions": [{"em1Text": "glucosinolates", "em2Text": "myrosinase", "label": "CPR:9"}, {"em1Text": "myrosinase", "em2Text": "isothiocyanates", "label": "CPR:9"}]}
{"sentText": "There was also an increase in \u03b3GCS and HO1 levels in calycopterin pretreated cells", "relationMentions": [{"em1Text": "\u03b3GCS", "em2Text": "calycopterin", "label": "CPR:3"}, {"em1Text": "HO1", "em2Text": "calycopterin", "label": "CPR:3"}]}
{"sentText": "In the presence of H2O2 calycopterin inhibited decrease in GSH level and SOD activity", "relationMentions": [{"em1Text": "calycopterin", "em2Text": "SOD", "label": "CPR:3"}]}
{"sentText": "Moreover calycopterin in presence of H2O2 inhibited the decrease caused by oxidative stress in stresssensing transcription factors CREB and Nrf2 which play an important role in antioxidant capacity of the cell", "relationMentions": [{"em1Text": "calycopterin", "em2Text": "CREB", "label": "CPR:3"}, {"em1Text": "calycopterin", "em2Text": "Nrf2", "label": "CPR:3"}]}
{"sentText": "Herein we investigated the effect of a natural neuroprotective flavonoid calycopterin on H2O2 induced disruption of phase II detoxifying enzyme system and cAMP response element binding protein CREB phosphorylation", "relationMentions": [{"em1Text": "H2O2", "em2Text": "phase II detoxifying enzyme", "label": "CPR:4"}, {"em1Text": "H2O2", "em2Text": "cAMP response element binding protein", "label": "CPR:4"}, {"em1Text": "H2O2", "em2Text": "CREB", "label": "CPR:4"}]}
{"sentText": "In H2O2treated cells calycopterin also suppressed cytochrome C release to cytosol that is necessary for maintaining mitochondrial homeostasis in survived cells", "relationMentions": [{"em1Text": "calycopterin", "em2Text": "cytochrome C", "label": "CPR:4"}]}
{"sentText": "Activation of STAT3 which is phosphorylated by the IL6 signaling pathways and thus is necessary for Th17 differentiation was strongly stimulated by I3S and TCDD", "relationMentions": [{"em1Text": "STAT3", "em2Text": "TCDD", "label": "CPR:3"}, {"em1Text": "IL6", "em2Text": "TCDD", "label": "CPR:3"}, {"em1Text": "STAT3", "em2Text": "I3S", "label": "CPR:3"}, {"em1Text": "IL6", "em2Text": "I3S", "label": "CPR:3"}]}
{"sentText": "Phosphorylation of cSrc which was shown to be activated by AhR ligands was also increased by I3S and TCDD and blocking of cSrc activity by 4amino54chlorophenyl7tbutyl pyrazolo34dpyrimidine PP2 inhibited phosphorylation of both cSrc and STAT3 raising a possibility that stimulatory activities of I3S and TCDD on Th17 differentiation could be exerted via increased phosphorylation of cSrc which in turn stimulates STAT3 activation", "relationMentions": [{"em1Text": "cSrc", "em2Text": "I3S", "label": "CPR:3"}, {"em1Text": "cSrc", "em2Text": "TCDD", "label": "CPR:3"}, {"em1Text": "cSrc", "em2Text": "I3S", "label": "CPR:3"}, {"em1Text": "I3S", "em2Text": "STAT3", "label": "CPR:3"}, {"em1Text": "cSrc", "em2Text": "TCDD", "label": "CPR:3"}, {"em1Text": "TCDD", "em2Text": "STAT3", "label": "CPR:3"}, {"em1Text": "cSrc", "em2Text": "4amino54chlorophenyl7tbutyl pyrazolo34dpyrimidine", "label": "CPR:4"}, {"em1Text": "cSrc", "em2Text": "4amino54chlorophenyl7tbutyl pyrazolo34dpyrimidine", "label": "CPR:4"}, {"em1Text": "4amino54chlorophenyl7tbutyl pyrazolo34dpyrimidine", "em2Text": "STAT3", "label": "CPR:4"}]}
{"sentText": "Indoxyl 3sulfate stimulates Th17 differentiation enhancing phosphorylation of cSrc and STAT3 to worsen experimental autoimmune encephalomyelitis", "relationMentions": [{"em1Text": "Indoxyl 3sulfate", "em2Text": "cSrc", "label": "CPR:3"}, {"em1Text": "Indoxyl 3sulfate", "em2Text": "STAT3", "label": "CPR:3"}]}
{"sentText": "Finally we found that I3S worsened experimental autoimmune encephalomyelitis EAE which is primarily mediated by Th17 cells enhancing the frequency of IL17 producing cells in draining lymph nodes", "relationMentions": [{"em1Text": "I3S", "em2Text": "IL17", "label": "CPR:3"}]}
{"sentText": "In the present study using in vitro Th17 differentiation model we examined effects of AhR activation by indoxyl 3sulfate I3S a uremic toxin on Th17 differentiation and investigated underlying mechanisms", "relationMentions": [{"em1Text": "AhR", "em2Text": "indoxyl 3sulfate", "label": "CPR:3"}, {"em1Text": "AhR", "em2Text": "I3S", "label": "CPR:3"}]}
{"sentText": "I3S increased expression of ROR\u03b3t the master transcription factor for Th17 differentiation and stimulated Th17 differentiation in a comparative manner as 2378tetrachlorodibenzopdioxin TCDD a prototypical AhR ligand", "relationMentions": [{"em1Text": "I3S", "em2Text": "ROR\u03b3t", "label": "CPR:3"}]}
{"sentText": "This inhibition was mediated by a TCDD induced secreted factor which was identified as insulinlike growth factor binding protein 4 IGFBP4", "relationMentions": [{"em1Text": "TCDD", "em2Text": "insulinlike growth factor binding protein 4", "label": "CPR:3"}, {"em1Text": "TCDD", "em2Text": "IGFBP4", "label": "CPR:3"}]}
{"sentText": "TCDD induces the expression of insulinlike growth factor binding protein 4 in 5L rat hepatoma cells a cautionary tale of the use of this cell line in studies on dioxin toxicity", "relationMentions": [{"em1Text": "TCDD", "em2Text": "insulinlike growth factor binding protein 4", "label": "CPR:3"}]}
{"sentText": "The observations suggest that in 5L cells the Igfbp4 gene may have got under the control of a promoter containing dioxin responsive elements leading to the induction of IGFBP4 by TCDD", "relationMentions": [{"em1Text": "IGFBP4", "em2Text": "TCDD", "label": "CPR:3"}]}
{"sentText": "By working upwards from mTOR we observed that TCDD inhibited endogenous and IGFI induced AKT and ERK activation by interfering with tyrosine phosphorylation of insulin receptor substrate 1", "relationMentions": [{"em1Text": "TCDD", "em2Text": "IGFI", "label": "CPR:4"}, {"em1Text": "TCDD", "em2Text": "AKT", "label": "CPR:4"}, {"em1Text": "TCDD", "em2Text": "ERK", "label": "CPR:4"}]}
{"sentText": "The induction of IGFBP4 protein was dependent on a functional aryl hydrocarbon receptor and was preceded by a rapid increase in the level of IGFBP4 mRNA indicating that IGFBP4 is a previously unknown transcriptional target of TCDD in 5L cells", "relationMentions": [{"em1Text": "IGFBP4", "em2Text": "TCDD", "label": "CPR:4"}]}
{"sentText": "Inhibition of MCF7 cell growth by the selective calmodulin antagonists W13 and W12 is consistent with a role for calmodulin antagonism in the broad growthinhibitory properties of pimozide", "relationMentions": [{"em1Text": "calmodulin", "em2Text": "pimozide", "label": "CPR:4"}, {"em1Text": "calmodulin", "em2Text": "W13", "label": "CPR:6"}, {"em1Text": "calmodulin", "em2Text": "W12", "label": "CPR:6"}]}
{"sentText": "Although numerous mechanisms of action of pimozide and thioridazine have been identified both drugs are calmodulin antagonists at drug concentrations that inhibit breast cancer cell growth in vitro", "relationMentions": [{"em1Text": "pimozide", "em2Text": "calmodulin", "label": "CPR:6"}, {"em1Text": "thioridazine", "em2Text": "calmodulin", "label": "CPR:6"}]}
{"sentText": "MAOB by deprenyl 1 mgkg ip", "relationMentions": [{"em1Text": "MAOB", "em2Text": "deprenyl", "label": "CPR:4"}]}
{"sentText": "both MAOA and MAOB by nialamide 75 mgkg ip", "relationMentions": [{"em1Text": "MAOA", "em2Text": "nialamide", "label": "CPR:4"}, {"em1Text": "MAOB", "em2Text": "nialamide", "label": "CPR:4"}]}
{"sentText": "or peripheral neuronal MAO by debrisoquin 40 mgkg ip", "relationMentions": [{"em1Text": "MAO", "em2Text": "debrisoquin", "label": "CPR:4"}]}
{"sentText": "Levels of homovanillic acid HVA dihydroxyphenylacetic acid DOPAC and dihydroxyphenylglycol DHPG in plasma and the striatium were measured after inhibition of monoamine oxidase type A MAOA by clorgyline 4 mgkg ip", "relationMentions": [{"em1Text": "monoamine oxidase type A", "em2Text": "clorgyline", "label": "CPR:4"}, {"em1Text": "MAOA", "em2Text": "clorgyline", "label": "CPR:4"}]}
{"sentText": "The results suggest that most of the HVA in plasma is derived from deamination of DA by MAOA in peripheral neurons that DOPAC in plasma is derived from cells outside the central nervous system that DHPG in plasma is derived virtually exclusively from the metabolism of norepinephrine in sympathetic nerve endings and that residual levels of HVA after treatment with debrisoquin provide an improved but limited indication of central dopaminergic activity", "relationMentions": [{"em1Text": "DA", "em2Text": "MAOA", "label": "CPR:9"}, {"em1Text": "HVA", "em2Text": "MAOA", "label": "CPR:9"}]}
{"sentText": "After loperamide administration ACTH levels fell to a nadir of 135 76 pgml and then CRH was still able to induce an ACTH increase the pattern of ACTH response to CRH was slightly delayed", "relationMentions": [{"em1Text": "loperamide", "em2Text": "ACTH", "label": "CPR:3"}, {"em1Text": "loperamide", "em2Text": "ACTH", "label": "CPR:4"}]}
{"sentText": "Ambenonium was a less potent antagonist of tissue responses to acetylcholine and the underestimation in the pKB as compared to that obtained with bethanechol could be eliminated by prior treatment of tissues with the acetylcholinesterase inhibitor neostigmine", "relationMentions": [{"em1Text": "acetylcholinesterase", "em2Text": "neostigmine", "label": "CPR:4"}]}
{"sentText": "These data suggested that ambenonium had a dual effect on tissue responses to acetylcholine producing potentiation by blockade of acetylcholine sterase and concomitant antagonism by blockade of muscarinic receptors", "relationMentions": [{"em1Text": "ambenonium", "em2Text": "muscarinic receptors", "label": "CPR:4"}, {"em1Text": "ambenonium", "em2Text": "muscarinic receptors", "label": "CPR:6"}]}
{"sentText": "Ambenonium is known to be an inhibitor of acetylcholinesterase and recent data have shown this drug to antagonize muscarinic receptors as well", "relationMentions": [{"em1Text": "Ambenonium", "em2Text": "acetylcholinesterase", "label": "CPR:4"}, {"em1Text": "Ambenonium", "em2Text": "muscarinic receptors", "label": "CPR:6"}]}
{"sentText": "However betaxolol produces less systemic beta 2 and possibly beta 1adrenergic receptor blockade than either timolol or levobunolol", "relationMentions": [{"em1Text": "betaxolol", "em2Text": "beta 1adrenergic receptor", "label": "CPR:4"}, {"em1Text": "beta 1adrenergic receptor", "em2Text": "timolol", "label": "CPR:4"}, {"em1Text": "beta 1adrenergic receptor", "em2Text": "levobunolol", "label": "CPR:4"}]}
{"sentText": "Phenol oxidase inhibitors such as phenylthiourea potassium cyanide and sodium azide inhibited the reaction drastically suggesting the participation of the active site copper of the enzyme in the catalysis", "relationMentions": [{"em1Text": "Phenol oxidase", "em2Text": "phenylthiourea", "label": "CPR:4"}, {"em1Text": "Phenol oxidase", "em2Text": "potassium cyanide", "label": "CPR:4"}, {"em1Text": "Phenol oxidase", "em2Text": "sodium azide", "label": "CPR:4"}]}
{"sentText": "Mimosine a wellknown competitive inhibitor of tyrosinase competitively inhibited the new reaction also", "relationMentions": [{"em1Text": "Mimosine", "em2Text": "tyrosinase", "label": "CPR:4"}]}
{"sentText": "Present studies demonstrate that mushroom tyrosinase will also catalyze quinone methide production with the same active site copper if a suitable substrate such as 34dihydroxymandelic acid is provided", "relationMentions": [{"em1Text": "mushroom tyrosinase", "em2Text": "34dihydroxymandelic acid", "label": "CPR:9"}, {"em1Text": "mushroom tyrosinase", "em2Text": "quinone methide", "label": "CPR:9"}]}
{"sentText": "Tyrosinase usually catalyzes the conversion of monophenols to odiphenols and oxidation of diphenols to the corresponding quinones", "relationMentions": [{"em1Text": "Tyrosinase", "em2Text": "monophenols", "label": "CPR:9"}, {"em1Text": "Tyrosinase", "em2Text": "diphenols", "label": "CPR:9"}]}
{"sentText": "Tyrosinase catalyzes an unusual oxidative decarboxylation of 34dihydroxymandelate", "relationMentions": [{"em1Text": "Tyrosinase", "em2Text": "34dihydroxymandelate", "label": "CPR:9"}]}
{"sentText": "The activation of human Glu1plasminogen Glu1Pg by human recombinant rec twochain tissue plasminogen activator tPA is inhibited by Cl at physiological concentrations and stimulated by epsilonaminocaproic acid EACA as well as fibrinogen", "relationMentions": [{"em1Text": "tPA", "em2Text": "epsilonaminocaproic acid", "label": "CPR:3"}, {"em1Text": "human Glu1plasminogen", "em2Text": "epsilonaminocaproic acid", "label": "CPR:3"}, {"em1Text": "Glu1Pg", "em2Text": "epsilonaminocaproic acid", "label": "CPR:3"}, {"em1Text": "tissue plasminogen activator", "em2Text": "epsilonaminocaproic acid", "label": "CPR:3"}, {"em1Text": "tPA", "em2Text": "EACA", "label": "CPR:3"}, {"em1Text": "human Glu1plasminogen", "em2Text": "EACA", "label": "CPR:3"}, {"em1Text": "Glu1Pg", "em2Text": "EACA", "label": "CPR:3"}, {"em1Text": "tissue plasminogen activator", "em2Text": "EACA", "label": "CPR:3"}, {"em1Text": "tPA", "em2Text": "Cl", "label": "CPR:4"}, {"em1Text": "human Glu1plasminogen", "em2Text": "Cl", "label": "CPR:4"}, {"em1Text": "Glu1Pg", "em2Text": "Cl", "label": "CPR:4"}, {"em1Text": "tissue plasminogen activator", "em2Text": "Cl", "label": "CPR:4"}]}
{"sentText": "The presence of Cl inhibits the stimulation of Glu1Pg activation that would normally occur in the presence of fibrinogen a result of possible importance to the observation that some degree of systemic fibrinogenolysis accompanies therapeutic use of tissue plasminogen activator", "relationMentions": [{"em1Text": "Cl", "em2Text": "Glu1Pg", "label": "CPR:4"}]}
{"sentText": "Wholecell voltageclamp of hNET 293 cells reveals NE induced Nadependent currents blocked by antidepressants and cocaine that are absent in parental cells", "relationMentions": [{"em1Text": "hNET", "em2Text": "NE", "label": "CPR:3"}, {"em1Text": "hNET", "em2Text": "cocaine", "label": "CPR:4"}]}
{"sentText": "Sodiumdependent norepinephrine induced currents in norepinephrinetransporter transfected HEK293 cells blocked by cocaine and antidepressants", "relationMentions": [{"em1Text": "norepinephrine", "em2Text": "norepinephrinetransporter", "label": "CPR:3"}, {"em1Text": "norepinephrinetransporter", "em2Text": "cocaine", "label": "CPR:4"}]}
{"sentText": "To explain our observations we propose that hNETs function as iongated ligand channels with an indefinite stoichiometry relating ion flux to NE transport", "relationMentions": [{"em1Text": "hNETs", "em2Text": "NE", "label": "CPR:9"}]}
{"sentText": "BACKGROUND The active metabolite of the antiinflammatory drug nabumetone has been characterized as a selective inhibitor of the inducible prostaglandin H synthase PGHS", "relationMentions": [{"em1Text": "nabumetone", "em2Text": "prostaglandin H synthase", "label": "CPR:4"}, {"em1Text": "nabumetone", "em2Text": "PGHS", "label": "CPR:4"}]}
{"sentText": "The daily administration of lowdose aspirin 40 mg a selective inhibitor of platelet PGHS1 caused a cumulative inhibition of urinary 11dehydroTXB2 and whole blood TXB2 production that recovered with a timecourse consistent with platelet turnover", "relationMentions": [{"em1Text": "aspirin", "em2Text": "PGHS1", "label": "CPR:4"}, {"em1Text": "PGHS1", "em2Text": "11dehydroTXB2", "label": "CPR:9"}, {"em1Text": "PGHS1", "em2Text": "TXB2", "label": "CPR:9"}]}
{"sentText": "CONCLUSIONS Nabumetone does dosedependently inhibit the cyclooxygenase activity of platelet PGHS1 of healthy subjects both in vivo and ex vivo", "relationMentions": [{"em1Text": "Nabumetone", "em2Text": "cyclooxygenase", "label": "CPR:4"}, {"em1Text": "Nabumetone", "em2Text": "PGHS1", "label": "CPR:4"}]}
{"sentText": "Moreover the production of TXB2 during whole blood clotting was assessed as an index of the cyclooxygenase activity of platelet PGHS1 ex vivo", "relationMentions": [{"em1Text": "TXB2", "em2Text": "cyclooxygenase", "label": "CPR:9"}, {"em1Text": "TXB2", "em2Text": "PGHS1", "label": "CPR:9"}]}
{"sentText": "Preclinical efficacy of emedastine a potent selective histamine H1 antagonist for topical ocular use", "relationMentions": [{"em1Text": "emedastine", "em2Text": "histamine H1", "label": "CPR:6"}]}
{"sentText": "2 Exposure histories vary in secondary 11q23 leukemia as the only topoisomerase II inhibitor was dactinomycin in one case and in another case no topoisomerase II inhibitor was administered", "relationMentions": [{"em1Text": "topoisomerase II", "em2Text": "dactinomycin", "label": "CPR:4"}]}
{"sentText": "Indomethacin piroxicam and sulindac sulfide were found to preferentially inhibit PGHS1", "relationMentions": [{"em1Text": "Indomethacin", "em2Text": "PGHS1", "label": "CPR:4"}, {"em1Text": "piroxicam", "em2Text": "PGHS1", "label": "CPR:4"}, {"em1Text": "sulindac sulfide", "em2Text": "PGHS1", "label": "CPR:4"}]}
{"sentText": "6Methoxy2naphthylacetic acid the active metabolite of Relafen inhibits murine PGHS2 preferentially", "relationMentions": [{"em1Text": "6Methoxy2naphthylacetic acid", "em2Text": "PGHS2", "label": "CPR:4"}, {"em1Text": "Relafen", "em2Text": "PGHS2", "label": "CPR:4"}]}
{"sentText": "Aspirin irreversibly inhibits PGHS1 preventing this isozyme from forming PGH2 or any other oxygenated product in contrast aspirin treatment of PGHS2 causes this enzyme to form 15hydroxy5c8c11c13teicosatetraenoic acid 15HETE instead of PGH2", "relationMentions": [{"em1Text": "Aspirin", "em2Text": "PGHS1", "label": "CPR:4"}, {"em1Text": "PGHS2", "em2Text": "15HETE", "label": "CPR:9"}, {"em1Text": "PGHS2", "em2Text": "15hydroxy5c8c11c13teicosatetraenoic acid", "label": "CPR:9"}]}
{"sentText": "Anorexia induced by amphetamine phentermine diethylpropion and phenylpropanolamine seems to be the result of their ability to increase the release of noradrenaline andor dopamine from nerve terminals and inhibit their reuptake or in the case of phenylpropanolamine to stimulate directly alpha 1adrenoceptors", "relationMentions": [{"em1Text": "phenylpropanolamine", "em2Text": "alpha 1adrenoceptors", "label": "CPR:3"}]}
{"sentText": "Under these conditions blockade of monoamine oxidase with pargyline 100 microM for 15 min caused a leftward displacement of concentrationeffect curves for both 5methoxytryptamine 5MeOT and tryptamine", "relationMentions": [{"em1Text": "monoamine oxidase", "em2Text": "pargyline", "label": "CPR:4"}]}
{"sentText": "In addition several ligands known to act as agonists at either 5HT2A or 5HT2C receptors including 1mchlorophenylpiperazine mCPP Ru 24969 MK 212 and SCH 23390 were also agonists in rat fundus whilst sumatriptan renzapride and 8hydroxy2dinpropylamino tetralin 8OHDPAT were very weak or inactive", "relationMentions": [{"em1Text": "5HT2A", "em2Text": "Ru 24969", "label": "CPR:5"}, {"em1Text": "5HT2C", "em2Text": "Ru 24969", "label": "CPR:5"}, {"em1Text": "5HT2A", "em2Text": "MK 212", "label": "CPR:5"}, {"em1Text": "5HT2C", "em2Text": "MK 212", "label": "CPR:5"}, {"em1Text": "5HT2A", "em2Text": "SCH 23390", "label": "CPR:5"}, {"em1Text": "5HT2C", "em2Text": "SCH 23390", "label": "CPR:5"}, {"em1Text": "5HT2A", "em2Text": "1mchlorophenylpiperazine", "label": "CPR:5"}, {"em1Text": "5HT2C", "em2Text": "1mchlorophenylpiperazine", "label": "CPR:5"}, {"em1Text": "5HT2A", "em2Text": "mCPP", "label": "CPR:5"}, {"em1Text": "5HT2C", "em2Text": "mCPP", "label": "CPR:5"}]}
{"sentText": "Neither ryanodine nor EGTA inhibited downregulation of alphaAR mRNA by NE", "relationMentions": [{"em1Text": "EGTA", "em2Text": "alphaAR", "label": "CPR:3"}, {"em1Text": "ryanodine", "em2Text": "alphaAR", "label": "CPR:3"}, {"em1Text": "alphaAR", "em2Text": "NE", "label": "CPR:4"}]}
{"sentText": "Actinomycin D caused alphaAR mRNA level to decrease with a halflife of 32 04 h and blocked the effect of H7 to decrease basal alphaAR mRNA level", "relationMentions": [{"em1Text": "Actinomycin D", "em2Text": "alphaAR", "label": "CPR:4"}, {"em1Text": "Actinomycin D", "em2Text": "alphaAR", "label": "CPR:4"}]}
{"sentText": "Both NE and phorbol esters increased the rate of alphaAR mRNA degradation", "relationMentions": [{"em1Text": "NE", "em2Text": "alphaAR", "label": "CPR:4"}, {"em1Text": "phorbol esters", "em2Text": "alphaAR", "label": "CPR:4"}]}
{"sentText": "In NE desensitized cells phorbol esters and bradykinin each caused the expected downregulation of alphaAR mRNA", "relationMentions": [{"em1Text": "NE", "em2Text": "alphaAR", "label": "CPR:4"}, {"em1Text": "phorbol esters", "em2Text": "alphaAR", "label": "CPR:4"}]}
{"sentText": "The protein phosphatase inhibitor okadaic acid prolonged the normally transient effect of NE for at least 24 h We conclude that protein kinase C exerts two opposing effects on alphaAR mRNA levels 1 a decrease in the stability of the mRNA that requires the sustained phosphorylation of a protein kinase C substrate and 2 a permissive effect on alphaAR gene transcription", "relationMentions": [{"em1Text": "protein phosphatase", "em2Text": "okadaic acid", "label": "CPR:4"}]}
{"sentText": "NE phorbol esters and bradykinin each decreased alphaAR mRNA levels by 7080", "relationMentions": [{"em1Text": "NE", "em2Text": "alphaAR", "label": "CPR:4"}, {"em1Text": "phorbol esters", "em2Text": "alphaAR", "label": "CPR:4"}]}
{"sentText": "Phorbol esters and norepinephrine destabilize alpha 1Badrenergic receptor mRNA in vascular smooth muscle cells", "relationMentions": [{"em1Text": "norepinephrine", "em2Text": "alpha 1Badrenergic receptor", "label": "CPR:4"}]}
{"sentText": "The mechanism by which norepinephrine NE downregulates alpha 1Badrenergic receptor alphaAR mRNA was studied in rabbit aortic smooth muscle cells", "relationMentions": [{"em1Text": "norepinephrine", "em2Text": "alpha 1Badrenergic receptor", "label": "CPR:4"}, {"em1Text": "norepinephrine", "em2Text": "alphaAR", "label": "CPR:4"}, {"em1Text": "NE", "em2Text": "alpha 1Badrenergic receptor", "label": "CPR:4"}, {"em1Text": "NE", "em2Text": "alphaAR", "label": "CPR:4"}]}
{"sentText": "The protein kinase C inhibitor 15isoquinolinesulfonyl2methylpiperazine dihydrochloride H7 abolished the effects of phorbol esters and NE and decreased basal mRNA levels by 52 3", "relationMentions": [{"em1Text": "protein kinase C", "em2Text": "15isoquinolinesulfonyl2methylpiperazine dihydrochloride", "label": "CPR:4"}, {"em1Text": "protein kinase C", "em2Text": "H7", "label": "CPR:4"}]}
{"sentText": "HeLa cells transfected with the MR77 gene exhibited inhibition of adenylate cyclase in response to serotonin", "relationMentions": [{"em1Text": "adenylate cyclase", "em2Text": "serotonin", "label": "CPR:4"}]}
{"sentText": "The specific binding is displaced by the selective 5HT1D agonist sumatriptan but not by the mixed 5HT1A1D agonist 5carboxyamidotryptamine", "relationMentions": [{"em1Text": "5HT1D", "em2Text": "sumatriptan", "label": "CPR:5"}]}
{"sentText": "The antiarrhythmic effects of exogenous adenosine and Valsalva on this form of VT may be due to receptormediated inhibition of adenylate cyclase or to noncardiac receptormediated effects ie exogenous adenosine may modulate VT through alterations in autonomic tone by activation of arterial chemoreceptors and Valsalva has been shown to decrease venous return resulting in a reduction in cardiac dimensions and myocardial stretch", "relationMentions": [{"em1Text": "adenosine", "em2Text": "chemoreceptors", "label": "CPR:3"}]}
{"sentText": "a cholinesterase inhibitor that potentiates the effects of acetylcholine at the muscarinic cholinergic receptor terminated VT in four of four patients an effect that was reversed by atropine", "relationMentions": [{"em1Text": "muscarinic cholinergic receptor", "em2Text": "atropine", "label": "CPR:4"}]}
{"sentText": "VT recurred with the addition of aminophylline a competitive adenosine A1receptor antagonist", "relationMentions": [{"em1Text": "aminophylline", "em2Text": "adenosine A1receptor", "label": "CPR:6"}]}
{"sentText": "Pretreatment with the dopamine D1 receptor antagonist SCH23390 and the NMDA receptor antagonist MK801 blocked amantadine induction of Fos in the striatum", "relationMentions": [{"em1Text": "amantadine", "em2Text": "Fos", "label": "CPR:3"}, {"em1Text": "SCH23390", "em2Text": "Fos", "label": "CPR:4"}, {"em1Text": "MK801", "em2Text": "Fos", "label": "CPR:4"}, {"em1Text": "dopamine D1 receptor", "em2Text": "SCH23390", "label": "CPR:6"}, {"em1Text": "NMDA receptor", "em2Text": "MK801", "label": "CPR:6"}]}
{"sentText": "However amantadine induction of Fos in the striatum was unaffected by the dopamine D2 receptor antagonist sulpiride", "relationMentions": [{"em1Text": "amantadine", "em2Text": "Fos", "label": "CPR:3"}, {"em1Text": "dopamine D2 receptor", "em2Text": "sulpiride", "label": "CPR:6"}]}
{"sentText": "These results suggest that amantadine induction of Fos in the rat striatum is related to dopamine D1 and NMDA receptors", "relationMentions": [{"em1Text": "amantadine", "em2Text": "Fos", "label": "CPR:3"}]}
{"sentText": "Amantadine induces cfos in rat striatum reversal with dopamine D1 and NMDA receptor antagonists", "relationMentions": [{"em1Text": "Amantadine", "em2Text": "cfos", "label": "CPR:3"}]}
{"sentText": "Amantadine 1aminoadamantane induced Fos expression in the central dorsalmedial and ventralmedial part of the striatum", "relationMentions": [{"em1Text": "Amantadine", "em2Text": "Fos", "label": "CPR:3"}, {"em1Text": "1aminoadamantane", "em2Text": "Fos", "label": "CPR:3"}]}
{"sentText": "The distribution pattern of Fos induced by amantadine was more similar to those seen with dopaminomimetics than with NmethylDaspartate NMDA receptor antagonists", "relationMentions": [{"em1Text": "Fos", "em2Text": "amantadine", "label": "CPR:3"}]}
{"sentText": "bolus finally 8 rabbits received aurintrycarboxilic acid ATA an inhibitor of platelet glycoprotein Ib von Willebrand factor interaction 10 mgkg iv", "relationMentions": [{"em1Text": "aurintrycarboxilic acid", "em2Text": "glycoprotein Ib", "label": "CPR:4"}, {"em1Text": "aurintrycarboxilic acid", "em2Text": "von Willebrand factor", "label": "CPR:4"}, {"em1Text": "ATA", "em2Text": "glycoprotein Ib", "label": "CPR:4"}, {"em1Text": "ATA", "em2Text": "von Willebrand factor", "label": "CPR:4"}]}
{"sentText": "These events are stimulated by NE and by guanethidine an hNET substrate and they are blocked by cocaine and the antidepressant desipramine", "relationMentions": [{"em1Text": "hNET", "em2Text": "cocaine", "label": "CPR:4"}, {"em1Text": "hNET", "em2Text": "desipramine", "label": "CPR:4"}, {"em1Text": "NE", "em2Text": "hNET", "label": "CPR:9"}, {"em1Text": "guanethidine", "em2Text": "hNET", "label": "CPR:9"}]}
{"sentText": "Voltageclamp data combined with NE uptake data from these same cells indicate that hNETs have two functional modes of conduction a classical transporter mode Tmode and a novel channel mode Cmode", "relationMentions": [{"em1Text": "NE", "em2Text": "hNETs", "label": "CPR:9"}]}
{"sentText": "The results when considered with previous reports in the literature show that amezinium is about 1000 times more potent and debrisoquine is about 20 times more potent for MAO inhibition in rat lungs than in tissue homogenates and the reason for their high potencies in the intact lungs is transport and accumulation of the drugs in the pulmonary endothelial cells by uptake1", "relationMentions": [{"em1Text": "amezinium", "em2Text": "MAO", "label": "CPR:4"}, {"em1Text": "debrisoquine", "em2Text": "MAO", "label": "CPR:4"}, {"em1Text": "amezinium", "em2Text": "uptake1", "label": "CPR:9"}, {"em1Text": "debrisoquine", "em2Text": "uptake1", "label": "CPR:9"}]}
{"sentText": "Amezinium is much less potent as a MAO inhibitor in cells with the uptake2 transporter such as the myocardial cells of the heart", "relationMentions": [{"em1Text": "Amezinium", "em2Text": "MAO", "label": "CPR:4"}, {"em1Text": "Amezinium", "em2Text": "uptake2 transporter", "label": "CPR:9"}]}
{"sentText": "The results also confirmed previous reports that amezinium is highly selective for MAOA", "relationMentions": [{"em1Text": "amezinium", "em2Text": "MAOA", "label": "CPR:4"}]}
{"sentText": "Previous studies have resulted in the classification of amezinium as a selective inhibitor of neuronal monoamine oxidase MAO because it is a much more potent MAO inhibitor in intact tissues in which it is accumulated in noradrenergic neurones by uptake1 than in tissue homogenates", "relationMentions": [{"em1Text": "amezinium", "em2Text": "monoamine oxidase", "label": "CPR:4"}, {"em1Text": "amezinium", "em2Text": "MAO", "label": "CPR:4"}, {"em1Text": "amezinium", "em2Text": "MAO", "label": "CPR:4"}]}
{"sentText": "In addition another drug that is both a substrate of uptake1 and a MAO inhibitor debrisoquine was investigated in the study", "relationMentions": [{"em1Text": "MAO", "em2Text": "debrisoquine", "label": "CPR:4"}, {"em1Text": "uptake1", "em2Text": "debrisoquine", "label": "CPR:9"}]}
{"sentText": "Amezinium and debrisoquine are substrates of uptake1 and potent inhibitors of monoamine oxidase in perfused lungs of rats", "relationMentions": [{"em1Text": "Amezinium", "em2Text": "monoamine oxidase", "label": "CPR:4"}, {"em1Text": "debrisoquine", "em2Text": "monoamine oxidase", "label": "CPR:4"}, {"em1Text": "Amezinium", "em2Text": "uptake1", "label": "CPR:9"}, {"em1Text": "debrisoquine", "em2Text": "uptake1", "label": "CPR:9"}]}
{"sentText": "When MAOB was also inhibited 10 nmoll amezinium caused 84 inhibition of the deamination of noradrenaline by MAOA in the lungs", "relationMentions": [{"em1Text": "amezinium", "em2Text": "MAOA", "label": "CPR:4"}]}
{"sentText": "We have investigated the effects of CP99994 2s3s32methoxybenzylamino2phenylpiperidine a tachykinin NK1 receptor antagonist HOE 140 DArgHyp3Thi5DTic7Oic8bradykinin a bradykinin B2 receptor antagonist and ketotifen 41methyl4piperidylidene4 Hbenzo45cycloheptal12bthiophen109Hone hydrogen fumarate a histamine H1 receptor antagonist with mast cellstabilizing properties on microvascular leakage induced by gaseous formaldehyde", "relationMentions": [{"em1Text": "CP99994", "em2Text": "tachykinin NK1 receptor", "label": "CPR:6"}, {"em1Text": "2s3s32methoxybenzylamino2phenylpiperidine", "em2Text": "tachykinin NK1 receptor", "label": "CPR:6"}, {"em1Text": "HOE 140", "em2Text": "bradykinin B2 receptor", "label": "CPR:6"}, {"em1Text": "DArgHyp3Thi5DTic7Oic8bradykinin", "em2Text": "bradykinin B2 receptor", "label": "CPR:6"}, {"em1Text": "ketotifen", "em2Text": "histamine H1 receptor", "label": "CPR:6"}, {"em1Text": "41methyl4piperidylidene4 Hbenzo45cycloheptal12bthiophen109Hone hydrogen fumarate", "em2Text": "histamine H1 receptor", "label": "CPR:6"}]}
{"sentText": "HERG IKr channels are a prime target for the pharmacological management of arrhythmias and are selectively blocked by class III antiarrhythmic methanesulfonanilide drugs such as dofetilide E4031 and MK499 at submicromolar concentrations", "relationMentions": [{"em1Text": "HERG", "em2Text": "E4031", "label": "CPR:4"}, {"em1Text": "IKr", "em2Text": "E4031", "label": "CPR:4"}, {"em1Text": "HERG", "em2Text": "MK499", "label": "CPR:4"}, {"em1Text": "IKr", "em2Text": "MK499", "label": "CPR:4"}, {"em1Text": "HERG", "em2Text": "methanesulfonanilide", "label": "CPR:4"}, {"em1Text": "IKr", "em2Text": "methanesulfonanilide", "label": "CPR:4"}, {"em1Text": "HERG", "em2Text": "dofetilide", "label": "CPR:4"}, {"em1Text": "IKr", "em2Text": "dofetilide", "label": "CPR:4"}]}
{"sentText": "Molecular determinants of dofetilide block of HERG K channels", "relationMentions": [{"em1Text": "dofetilide", "em2Text": "HERG", "label": "CPR:4"}, {"em1Text": "dofetilide", "em2Text": "K channels", "label": "CPR:4"}]}
{"sentText": "Treatment using a combination of testosterone and the aromatase inhibitor testolactone may have significantly better effects on sexual function and also seizure frequency than testosterone alone", "relationMentions": [{"em1Text": "aromatase", "em2Text": "testolactone", "label": "CPR:4"}]}
{"sentText": "A 59yearold female suffering from malignant lymphoma developed therapyrelated acute myeloblastic leukemia tAML after chemotherapy consisting of treatment with DNAtopoisomerase II inhibitors etoposide and mitoxantrone and an alkylating agent cyclophosphamide", "relationMentions": [{"em1Text": "DNAtopoisomerase II", "em2Text": "etoposide", "label": "CPR:4"}, {"em1Text": "DNAtopoisomerase II", "em2Text": "mitoxantrone", "label": "CPR:4"}]}
{"sentText": "A case of therapyrelated acute myeloblastic leukemia with t1621q24q22 after chemotherapy with DNAtopoisomerase II inhibitors etoposide and mitoxantrone and the alkylating agent cyclophosphamide", "relationMentions": [{"em1Text": "DNAtopoisomerase II", "em2Text": "etoposide", "label": "CPR:4"}, {"em1Text": "DNAtopoisomerase II", "em2Text": "mitoxantrone", "label": "CPR:4"}]}
{"sentText": "A low tyramine diet is recommended if selegiline is used together with nonselective MAO inhibitors or the selective reversible MAOA inhibitor moclobemide", "relationMentions": [{"em1Text": "selegiline", "em2Text": "MAO", "label": "CPR:4"}, {"em1Text": "MAOA", "em2Text": "moclobemide", "label": "CPR:4"}]}
{"sentText": "Selegiline deprenyl a selective irreversible inhibitor of monoamine oxidase type B MAOB is widely used in the treatment of Parkinsons disease", "relationMentions": [{"em1Text": "Selegiline", "em2Text": "monoamine oxidase type B", "label": "CPR:4"}, {"em1Text": "Selegiline", "em2Text": "MAOB", "label": "CPR:4"}, {"em1Text": "deprenyl", "em2Text": "monoamine oxidase type B", "label": "CPR:4"}, {"em1Text": "deprenyl", "em2Text": "MAOB", "label": "CPR:4"}]}
{"sentText": "Unlike the nonselective MAO inhibitors selegiline does not significantly potentiate tyramineinduced hypertension the cheese effect at the dosages 5 to 10 mg daily used for the treatment of Parkinsons disease", "relationMentions": [{"em1Text": "MAO", "em2Text": "selegiline", "label": "CPR:4"}]}
{"sentText": "Ibuprofen inhibits cystic fibrosis transmembrane conductance regulator mediated Cl secretion", "relationMentions": [{"em1Text": "Ibuprofen", "em2Text": "cystic fibrosis transmembrane conductance regulator", "label": "CPR:4"}]}
{"sentText": "Ibuprofen 300 microM reduced CFTR Cl current by 6016 and this was explained by a shortlived block approximately 12 ms which causes an apparent reduction in single channel amplitude from 107004 pA to 059004 pA n = 3", "relationMentions": [{"em1Text": "Ibuprofen", "em2Text": "CFTR", "label": "CPR:4"}]}
{"sentText": "Similarly salicylic acid 3 mM reduced CFTR Cl current by 508 with an apparent reduction in single channel amplitude from 108003 pA to 048006 pA n = 4", "relationMentions": [{"em1Text": "salicylic acid", "em2Text": "CFTR", "label": "CPR:4"}]}
{"sentText": "Based on these results we conclude that the NSAIDs ibuprofen and salicylic acid inhibit cAMPmediated Cl secretion in human colonic and airway epithelia via a direct inhibition of CFTR Cl channels as well as basolateral membrane K channels", "relationMentions": [{"em1Text": "ibuprofen", "em2Text": "CFTR", "label": "CPR:4"}, {"em1Text": "ibuprofen", "em2Text": "Cl channels", "label": "CPR:4"}, {"em1Text": "ibuprofen", "em2Text": "K channels", "label": "CPR:4"}, {"em1Text": "salicylic acid", "em2Text": "CFTR", "label": "CPR:4"}, {"em1Text": "salicylic acid", "em2Text": "Cl channels", "label": "CPR:4"}, {"em1Text": "salicylic acid", "em2Text": "K channels", "label": "CPR:4"}]}
{"sentText": "These data indicate that mixed 5HT1 5HT2 receptor antagonists such as pizotifen and methysergide and mixed 5HT and catecholamine antagonists such as mianserin and mirtazapine are more potent antagonists of mCPPinduced behavioural inhibition in rats than the more selective 5HT2A 5HT2C antagonist ritanserin", "relationMentions": [{"em1Text": "5HT2A", "em2Text": "ritanserin", "label": "CPR:6"}, {"em1Text": "5HT2C", "em2Text": "ritanserin", "label": "CPR:6"}, {"em1Text": "5HT1", "em2Text": "pizotifen", "label": "CPR:6"}, {"em1Text": "5HT2", "em2Text": "pizotifen", "label": "CPR:6"}, {"em1Text": "5HT1", "em2Text": "methysergide", "label": "CPR:6"}, {"em1Text": "5HT2", "em2Text": "methysergide", "label": "CPR:6"}]}
{"sentText": "The cardiovascular effects of three different acetylcholinesterase inhibitors physostigmine tacrine and rivastigmine injected by intravenous iv", "relationMentions": [{"em1Text": "acetylcholinesterase", "em2Text": "physostigmine", "label": "CPR:4"}, {"em1Text": "acetylcholinesterase", "em2Text": "tacrine", "label": "CPR:4"}, {"em1Text": "acetylcholinesterase", "em2Text": "rivastigmine", "label": "CPR:4"}]}
{"sentText": "The alpha1adrenoceptor antagonist prazosin or the vasopressin V1 receptor antagonist betamercaptobetabetacyclopentamethylenepropionyl1 OMeTyr2 Arg8 vasopressin partially but significantly reduced tacrine pressor effect and mostly abolished it when administered concomitantly", "relationMentions": [{"em1Text": "alpha1adrenoceptor", "em2Text": "prazosin", "label": "CPR:6"}, {"em1Text": "vasopressin V1 receptor", "em2Text": "betamercaptobetabetacyclopentamethylenepropionyl1 OMeTyr2 Arg8 vasopressin", "label": "CPR:6"}]}
{"sentText": "administration of the nonselective muscarinic receptor antagonist atropine ID50 = 145 microg the muscarinic M1 receptor antagonist pirenzepine ID50 = 433 microg the muscarinic M2 receptor antagonist methoctramine ID50 = 139 microg and the muscarinic M3 receptor antagonist parafluorohexahydrosiladifenidol ID50 = 3119 microg", "relationMentions": [{"em1Text": "muscarinic receptor", "em2Text": "atropine", "label": "CPR:6"}, {"em1Text": "muscarinic M1 receptor", "em2Text": "pirenzepine", "label": "CPR:6"}, {"em1Text": "muscarinic M2 receptor", "em2Text": "methoctramine", "label": "CPR:6"}, {"em1Text": "muscarinic M3 receptor", "em2Text": "parafluorohexahydrosiladifenidol", "label": "CPR:6"}]}
{"sentText": "Cocaine block of human cardiac hH1 and rat skeletal mu1 muscle sodium channels was examined under wholecell voltage clamp in transiently transfected HEK293t cells", "relationMentions": [{"em1Text": "Cocaine", "em2Text": "human cardiac hH1", "label": "CPR:4"}, {"em1Text": "Cocaine", "em2Text": "rat skeletal mu1 muscle sodium channels", "label": "CPR:4"}]}
{"sentText": "Cocaine block of hH1 channels was greater than block of mu1 channels at voltages between 120 mV and 90 mV suggesting that greater steadystate inactivation of hH1 channels in this voltage range makes them more susceptible to cocaine block", "relationMentions": [{"em1Text": "Cocaine", "em2Text": "hH1 channels", "label": "CPR:4"}, {"em1Text": "Cocaine", "em2Text": "mu1 channels", "label": "CPR:4"}, {"em1Text": "Cocaine", "em2Text": "hH1 channels", "label": "CPR:4"}, {"em1Text": "hH1 channels", "em2Text": "cocaine", "label": "CPR:4"}]}
{"sentText": "Statedependent cocaine block of sodium channel isoforms chimeras and channels coexpressed with the beta1 subunit", "relationMentions": [{"em1Text": "cocaine", "em2Text": "sodium channel", "label": "CPR:4"}]}
